©	PMC4064952	0	1	O	-1	-1	0
2014	PMC4064952	2	6	O	-1	-1	0

Zoni	PMC4064952	7	11	O	-1	-1	0
-	PMC4064952	11	12	O	-1	-1	0
Berisso	PMC4064952	12	19	O	-1	-1	0
et	PMC4064952	20	22	O	-1	-1	0
al	PMC4064952	23	25	O	-1	-1	0
.	PMC4064952	25	26	O	-1	-1	0

This	PMC4064952	27	31	O	-1	-1	0
work	PMC4064952	32	36	O	-1	-1	0
is	PMC4064952	37	39	O	-1	-1	0
published	PMC4064952	40	49	O	-1	-1	0
by	PMC4064952	50	52	O	-1	-1	0
Dove	PMC4064952	53	57	O	-1	-1	0
Medical	PMC4064952	58	65	O	-1	-1	0
Press	PMC4064952	66	71	O	-1	-1	0
Limited	PMC4064952	72	79	O	-1	-1	0
,	PMC4064952	79	80	O	-1	-1	0
and	PMC4064952	81	84	O	-1	-1	0
licensed	PMC4064952	85	93	O	-1	-1	0
under	PMC4064952	94	99	O	-1	-1	0
Creative	PMC4064952	100	108	O	-1	-1	0
Commons	PMC4064952	109	116	O	-1	-1	0
Attribution	PMC4064952	117	128	O	-1	-1	0
–	PMC4064952	129	130	O	-1	-1	0

Non	PMC4064952	131	134	O	-1	-1	0
Commercial	PMC4064952	135	145	O	-1	-1	0
(	PMC4064952	146	147	O	-1	-1	0
unported	PMC4064952	147	155	O	-1	-1	0
,	PMC4064952	155	156	O	-1	-1	0
v3.0	PMC4064952	157	161	O	-1	-1	0
)	PMC4064952	161	162	O	-1	-1	0
License	PMC4064952	163	170	O	-1	-1	0
.	PMC4064952	170	171	O	-1	-1	0

The	PMC4064952	172	175	O	-1	-1	0
full	PMC4064952	176	180	O	-1	-1	0
terms	PMC4064952	181	186	O	-1	-1	0
of	PMC4064952	187	189	O	-1	-1	0
the	PMC4064952	190	193	O	-1	-1	0
License	PMC4064952	194	201	O	-1	-1	0
are	PMC4064952	202	205	O	-1	-1	0
available	PMC4064952	206	215	O	-1	-1	0
at	PMC4064952	216	218	O	-1	-1	0
http://creativecommons.org/licenses/by-nc/3.0/.	PMC4064952	219	266	O	-1	-1	0
Non	PMC4064952	267	270	O	-1	-1	0
-	PMC4064952	270	271	O	-1	-1	0
commercial	PMC4064952	271	281	O	-1	-1	0
uses	PMC4064952	282	286	O	-1	-1	0
of	PMC4064952	287	289	O	-1	-1	0
the	PMC4064952	290	293	O	-1	-1	0
work	PMC4064952	294	298	O	-1	-1	0
are	PMC4064952	299	302	O	-1	-1	0
permitted	PMC4064952	303	312	O	-1	-1	0
without	PMC4064952	313	320	O	-1	-1	0
any	PMC4064952	321	324	O	-1	-1	0
further	PMC4064952	325	332	O	-1	-1	0
permission	PMC4064952	333	343	O	-1	-1	0
from	PMC4064952	344	348	O	-1	-1	0
Dove	PMC4064952	349	353	O	-1	-1	0
Medical	PMC4064952	354	361	O	-1	-1	0
Press	PMC4064952	362	367	O	-1	-1	0
Limited	PMC4064952	368	375	O	-1	-1	0
,	PMC4064952	375	376	O	-1	-1	0
provided	PMC4064952	377	385	O	-1	-1	0
the	PMC4064952	386	389	O	-1	-1	0
work	PMC4064952	390	394	O	-1	-1	0
is	PMC4064952	395	397	O	-1	-1	0
properly	PMC4064952	398	406	O	-1	-1	0
attributed	PMC4064952	407	417	O	-1	-1	0
.	PMC4064952	417	418	O	-1	-1	0

Permissions	PMC4064952	419	430	O	-1	-1	0
beyond	PMC4064952	431	437	O	-1	-1	0
the	PMC4064952	438	441	O	-1	-1	0
scope	PMC4064952	442	447	O	-1	-1	0
of	PMC4064952	448	450	O	-1	-1	0
the	PMC4064952	451	454	O	-1	-1	0
License	PMC4064952	455	462	O	-1	-1	0
are	PMC4064952	463	466	O	-1	-1	0
administered	PMC4064952	467	479	O	-1	-1	0
by	PMC4064952	480	482	O	-1	-1	0
Dove	PMC4064952	483	487	O	-1	-1	0
Medical	PMC4064952	488	495	O	-1	-1	0
Press	PMC4064952	496	501	O	-1	-1	0
Limited	PMC4064952	502	509	O	-1	-1	0
.	PMC4064952	509	510	O	-1	-1	0

Information	PMC4064952	511	522	O	-1	-1	0
on	PMC4064952	523	525	O	-1	-1	0
how	PMC4064952	526	529	O	-1	-1	0
to	PMC4064952	530	532	O	-1	-1	0
request	PMC4064952	533	540	O	-1	-1	0
permission	PMC4064952	541	551	O	-1	-1	0
may	PMC4064952	552	555	O	-1	-1	0
be	PMC4064952	556	558	O	-1	-1	0
found	PMC4064952	559	564	O	-1	-1	0
at	PMC4064952	565	567	O	-1	-1	0
:	PMC4064952	567	568	O	-1	-1	0
http://www.dovepress.com/permissions.php	PMC4064952	569	609	O	-1	-1	0

Clinical	PMC4064952	610	618	O	-1	-1	0
Epidemiology	PMC4064952	619	631	O	-1	-1	0
2014:6	PMC4064952	632	638	O	-1	-1	0
213–220	PMC4064952	639	646	O	-1	-1	0

Clinical	PMC4064952	647	655	O	-1	-1	0
Epidemiology	PMC4064952	656	668	O	-1	-1	0
Dovepress	PMC4064952	669	678	O	-1	-1	0
submit	PMC4064952	679	685	O	-1	-1	0
your	PMC4064952	686	690	O	-1	-1	0
manuscript	PMC4064952	691	701	O	-1	-1	0
|	PMC4064952	702	703	O	-1	-1	0

www.dovepress.com	PMC4064952	704	721	O	-1	-1	0

Dovepress	PMC4064952	722	731	O	-1	-1	0

213	PMC4064952	732	735	O	-1	-1	0
R	PMC4064952	736	737	O	-1	-1	0
e	PMC4064952	738	739	O	-1	-1	0

v	PMC4064952	740	741	O	-1	-1	0

i	PMC4064952	742	743	O	-1	-1	0
e	PMC4064952	744	745	O	-1	-1	0
w	PMC4064952	746	747	O	-1	-1	0
open	PMC4064952	748	752	O	-1	-1	0
access	PMC4064952	753	759	O	-1	-1	0
to	PMC4064952	760	762	O	-1	-1	0
scientific	PMC4064952	763	773	O	-1	-1	0
and	PMC4064952	774	777	O	-1	-1	0
medical	PMC4064952	778	785	O	-1	-1	0
research	PMC4064952	786	794	O	-1	-1	0

Open	PMC4064952	795	799	O	-1	-1	0
Access	PMC4064952	800	806	O	-1	-1	0
Full	PMC4064952	807	811	O	-1	-1	0
Text	PMC4064952	812	816	O	-1	-1	0
Article	PMC4064952	817	824	O	-1	-1	0

http://dx.doi.org/10.2147/CLEP.S47385	PMC4064952	825	862	O	-1	-1	0

Epidemiology	PMC4064952	863	875	O	-1	-1	0
of	PMC4064952	876	878	O	-1	-1	0
atrial	PMC4064952	879	885	O	-1	-1	0
fibrillation	PMC4064952	886	898	O	-1	-1	0
:	PMC4064952	898	899	O	-1	-1	0

European	PMC4064952	900	908	O	-1	-1	0
perspective	PMC4064952	909	920	O	-1	-1	0

Massimo	PMC4064952	921	928	O	-1	-1	0
Zoni	PMC4064952	929	933	O	-1	-1	0
-	PMC4064952	933	934	O	-1	-1	0
Berisso	PMC4064952	934	941	O	-1	-1	0

Fabrizio	PMC4064952	942	950	O	-1	-1	0
Lercari	PMC4064952	951	958	O	-1	-1	0

Tiziana	PMC4064952	959	966	O	-1	-1	0
Carazza	PMC4064952	967	974	O	-1	-1	0

Stefano	PMC4064952	975	982	O	-1	-1	0
Domenicucci	PMC4064952	983	994	O	-1	-1	0
Department	PMC4064952	995	1005	O	-1	-1	0
of	PMC4064952	1006	1008	O	-1	-1	0
Cardiology	PMC4064952	1009	1019	O	-1	-1	0
,	PMC4064952	1019	1020	O	-1	-1	0
ASL	PMC4064952	1021	1024	O	-1	-1	0
3	PMC4064952	1025	1026	O	-1	-1	0
,	PMC4064952	1026	1027	O	-1	-1	0

Padre	PMC4064952	1028	1033	O	-1	-1	0
A	PMC4064952	1034	1035	O	-1	-1	0
Micone	PMC4064952	1036	1042	O	-1	-1	0
Hospital	PMC4064952	1043	1051	O	-1	-1	0
,	PMC4064952	1051	1052	O	-1	-1	0
Genoa	PMC4064952	1053	1058	O	-1	-1	0
,	PMC4064952	1058	1059	O	-1	-1	0
Italy	PMC4064952	1060	1065	O	-1	-1	0

Correspondence	PMC4064952	1066	1080	O	-1	-1	0
:	PMC4064952	1080	1081	O	-1	-1	0

Massimo	PMC4064952	1082	1089	O	-1	-1	0
Zoni	PMC4064952	1090	1094	O	-1	-1	0
-	PMC4064952	1094	1095	O	-1	-1	0
Berisso	PMC4064952	1095	1102	O	-1	-1	0

Padre	PMC4064952	1103	1108	O	-1	-1	0
A	PMC4064952	1109	1110	O	-1	-1	0
Micone	PMC4064952	1111	1117	O	-1	-1	0
Hospital	PMC4064952	1118	1126	O	-1	-1	0
,	PMC4064952	1126	1127	O	-1	-1	0
Largo	PMC4064952	1128	1133	O	-1	-1	0
N	PMC4064952	1134	1135	O	-1	-1	0

Rosso	PMC4064952	1136	1141	O	-1	-1	0
2	PMC4064952	1142	1143	O	-1	-1	0
,	PMC4064952	1143	1144	O	-1	-1	0
Genoa	PMC4064952	1145	1150	O	-1	-1	0
16153	PMC4064952	1151	1156	O	-1	-1	0
,	PMC4064952	1156	1157	O	-1	-1	0
Italy	PMC4064952	1158	1163	O	-1	-1	0

Tel	PMC4064952	1164	1167	O	-1	-1	0
+39	PMC4064952	1168	1171	O	-1	-1	0

01	PMC4064952	1172	1174	O	-1	-1	0
0849	PMC4064952	1175	1179	O	-1	-1	0
8427	PMC4064952	1180	1184	O	-1	-1	0

Fax	PMC4064952	1185	1188	O	-1	-1	0
+39	PMC4064952	1189	1192	O	-1	-1	0

01	PMC4064952	1193	1195	O	-1	-1	0
0849	PMC4064952	1196	1200	O	-1	-1	0
8421	PMC4064952	1201	1205	O	-1	-1	0
Email	PMC4064952	1206	1211	O	-1	-1	0
massimo.zoniberisso@libero.it	PMC4064952	1212	1241	O	-1	-1	0

Abstract	PMC4064952	1242	1250	O	-1	-1	0
:	PMC4064952	1250	1251	O	-1	-1	0

In	PMC4064952	1252	1254	O	-1	-1	0
the	PMC4064952	1255	1258	O	-1	-1	0
last	PMC4064952	1259	1263	O	-1	-1	0
20	PMC4064952	1264	1266	O	-1	-1	0
years	PMC4064952	1267	1272	O	-1	-1	0
,	PMC4064952	1272	1273	O	-1	-1	0
atrial	PMC4064952	1274	1280	O	-1	-1	0
fibrillation	PMC4064952	1281	1293	O	-1	-1	0
(	PMC4064952	1294	1295	O	-1	-1	0
AF	PMC4064952	1295	1297	O	-1	-1	0
)	PMC4064952	1297	1298	O	-1	-1	0
has	PMC4064952	1299	1302	O	-1	-1	0
become	PMC4064952	1303	1309	O	-1	-1	0
one	PMC4064952	1310	1313	O	-1	-1	0
of	PMC4064952	1314	1316	O	-1	-1	0
the	PMC4064952	1317	1320	O	-1	-1	0
most	PMC4064952	1321	1325	O	-1	-1	0
important	PMC4064952	1326	1335	O	-1	-1	0
public	PMC4064952	1336	1342	O	-1	-1	0
health	PMC4064952	1343	1349	O	-1	-1	0
problems	PMC4064952	1350	1358	O	-1	-1	0
and	PMC4064952	1359	1362	O	-1	-1	0
a	PMC4064952	1363	1364	O	-1	-1	0
significant	PMC4064952	1365	1376	O	-1	-1	0
cause	PMC4064952	1377	1382	O	-1	-1	0
of	PMC4064952	1383	1385	O	-1	-1	0
increasing	PMC4064952	1386	1396	O	-1	-1	0
health	PMC4064952	1397	1403	O	-1	-1	0
care	PMC4064952	1404	1408	O	-1	-1	0
costs	PMC4064952	1409	1414	O	-1	-1	0
in	PMC4064952	1415	1417	O	-1	-1	0
western	PMC4064952	1418	1425	O	-1	-1	0
countries	PMC4064952	1426	1435	O	-1	-1	0
.	PMC4064952	1435	1436	O	-1	-1	0

The	PMC4064952	1437	1440	O	-1	-1	0
prevalence	PMC4064952	1441	1451	O	-1	-1	0
of	PMC4064952	1452	1454	O	-1	-1	0
AF	PMC4064952	1455	1457	O	-1	-1	0
is	PMC4064952	1458	1460	O	-1	-1	0
increasing	PMC4064952	1461	1471	O	-1	-1	0
due	PMC4064952	1472	1475	O	-1	-1	0
to	PMC4064952	1476	1478	O	-1	-1	0
our	PMC4064952	1479	1482	O	-1	-1	0
greater	PMC4064952	1483	1490	O	-1	-1	0
ability	PMC4064952	1491	1498	O	-1	-1	0
to	PMC4064952	1499	1501	O	-1	-1	0
treat	PMC4064952	1502	1507	O	-1	-1	0
chronic	PMC4064952	1508	1515	O	-1	-1	0
cardiac	PMC4064952	1516	1523	O	-1	-1	0
and	PMC4064952	1524	1527	O	-1	-1	0
noncardiac	PMC4064952	1528	1538	O	-1	-1	0
diseases	PMC4064952	1539	1547	O	-1	-1	0
,	PMC4064952	1547	1548	O	-1	-1	0
and	PMC4064952	1549	1552	O	-1	-1	0
the	PMC4064952	1553	1556	O	-1	-1	0
improved	PMC4064952	1557	1565	O	-1	-1	0
ability	PMC4064952	1566	1573	O	-1	-1	0
to	PMC4064952	1574	1576	O	-1	-1	0
suspect	PMC4064952	1577	1584	O	-1	-1	0
and	PMC4064952	1585	1588	O	-1	-1	0
diagnose	PMC4064952	1589	1597	O	-1	-1	0
AF	PMC4064952	1598	1600	O	-1	-1	0
.	PMC4064952	1600	1601	O	-1	-1	0

At	PMC4064952	1602	1604	O	-1	-1	0
the	PMC4064952	1605	1608	O	-1	-1	0
present	PMC4064952	1609	1616	O	-1	-1	0
time	PMC4064952	1617	1621	O	-1	-1	0
,	PMC4064952	1621	1622	O	-1	-1	0
the	PMC4064952	1623	1626	O	-1	-1	0
prevalence	PMC4064952	1627	1637	O	-1	-1	0
of	PMC4064952	1638	1640	O	-1	-1	0
AF	PMC4064952	1641	1643	O	-1	-1	0
(	PMC4064952	1644	1645	O	-1	-1	0
2	PMC4064952	1645	1646	O	-1	-1	0
%	PMC4064952	1646	1647	O	-1	-1	0
)	PMC4064952	1647	1648	O	-1	-1	0
is	PMC4064952	1649	1651	O	-1	-1	0
double	PMC4064952	1652	1658	O	-1	-1	0
that	PMC4064952	1659	1663	O	-1	-1	0
reported	PMC4064952	1664	1672	O	-1	-1	0
in	PMC4064952	1673	1675	O	-1	-1	0
the	PMC4064952	1676	1679	O	-1	-1	0
last	PMC4064952	1680	1684	O	-1	-1	0
decade	PMC4064952	1685	1691	O	-1	-1	0
.	PMC4064952	1691	1692	O	-1	-1	0

The	PMC4064952	1693	1696	O	-1	-1	0
prevalence	PMC4064952	1697	1707	O	-1	-1	0
of	PMC4064952	1708	1710	O	-1	-1	0
AF	PMC4064952	1711	1713	O	-1	-1	0
varies	PMC4064952	1714	1720	O	-1	-1	0
with	PMC4064952	1721	1725	O	-1	-1	0
age	PMC4064952	1726	1729	O	-1	-1	0
and	PMC4064952	1730	1733	O	-1	-1	0
sex	PMC4064952	1734	1737	O	-1	-1	0
.	PMC4064952	1737	1738	O	-1	-1	0

AF	PMC4064952	1739	1741	O	-1	-1	0
is	PMC4064952	1742	1744	O	-1	-1	0
present	PMC4064952	1745	1752	O	-1	-1	0
in	PMC4064952	1753	1755	O	-1	-1	0
0.12%–0.16	PMC4064952	1756	1766	O	-1	-1	0
%	PMC4064952	1766	1767	O	-1	-1	0
of	PMC4064952	1768	1770	O	-1	-1	0
those	PMC4064952	1771	1776	O	-1	-1	0
younger	PMC4064952	1777	1784	O	-1	-1	0
than	PMC4064952	1785	1789	O	-1	-1	0
49	PMC4064952	1790	1792	O	-1	-1	0
years	PMC4064952	1793	1798	O	-1	-1	0
,	PMC4064952	1798	1799	O	-1	-1	0
in	PMC4064952	1800	1802	O	-1	-1	0
3.7%–4.2	PMC4064952	1803	1811	O	-1	-1	0
%	PMC4064952	1811	1812	O	-1	-1	0
of	PMC4064952	1813	1815	O	-1	-1	0
those	PMC4064952	1816	1821	O	-1	-1	0
aged	PMC4064952	1822	1826	O	-1	-1	0
60–70	PMC4064952	1827	1832	O	-1	-1	0
years	PMC4064952	1833	1838	O	-1	-1	0
,	PMC4064952	1838	1839	O	-1	-1	0
and	PMC4064952	1840	1843	O	-1	-1	0
in	PMC4064952	1844	1846	O	-1	-1	0
10%–17	PMC4064952	1847	1853	O	-1	-1	0
%	PMC4064952	1853	1854	O	-1	-1	0
of	PMC4064952	1855	1857	O	-1	-1	0
those	PMC4064952	1858	1863	O	-1	-1	0
aged	PMC4064952	1864	1868	O	-1	-1	0

80	PMC4064952	1869	1871	O	-1	-1	0
years	PMC4064952	1872	1877	O	-1	-1	0
or	PMC4064952	1878	1880	O	-1	-1	0
older	PMC4064952	1881	1886	O	-1	-1	0
.	PMC4064952	1886	1887	O	-1	-1	0

In	PMC4064952	1888	1890	O	-1	-1	0
addition	PMC4064952	1891	1899	O	-1	-1	0
,	PMC4064952	1899	1900	O	-1	-1	0
it	PMC4064952	1901	1903	O	-1	-1	0
occurs	PMC4064952	1904	1910	O	-1	-1	0
more	PMC4064952	1911	1915	O	-1	-1	0
frequently	PMC4064952	1916	1926	O	-1	-1	0
in	PMC4064952	1927	1929	O	-1	-1	0
males	PMC4064952	1930	1935	O	-1	-1	0
,	PMC4064952	1935	1936	O	-1	-1	0
with	PMC4064952	1937	1941	O	-1	-1	0
a	PMC4064952	1942	1943	O	-1	-1	0
male	PMC4064952	1944	1948	O	-1	-1	0
to	PMC4064952	1949	1951	O	-1	-1	0
female	PMC4064952	1952	1958	O	-1	-1	0
ratio	PMC4064952	1959	1964	O	-1	-1	0
of	PMC4064952	1965	1967	O	-1	-1	0
1.2:1	PMC4064952	1968	1973	O	-1	-1	0
.	PMC4064952	1973	1974	O	-1	-1	0

The	PMC4064952	1975	1978	O	-1	-1	0
incidence	PMC4064952	1979	1988	O	-1	-1	0
of	PMC4064952	1989	1991	O	-1	-1	0
AF	PMC4064952	1992	1994	O	-1	-1	0
ranges	PMC4064952	1995	2001	O	-1	-1	0
between	PMC4064952	2002	2009	O	-1	-1	0
0.21	PMC4064952	2010	2014	O	-1	-1	0
and	PMC4064952	2015	2018	O	-1	-1	0
0.41	PMC4064952	2019	2023	O	-1	-1	0
per	PMC4064952	2024	2027	O	-1	-1	0
1,000	PMC4064952	2028	2033	O	-1	-1	0
person	PMC4064952	2034	2040	O	-1	-1	0
/	PMC4064952	2040	2041	O	-1	-1	0
years	PMC4064952	2041	2046	O	-1	-1	0
.	PMC4064952	2046	2047	O	-1	-1	0

Permanent	PMC4064952	2048	2057	O	-1	-1	0
AF	PMC4064952	2058	2060	O	-1	-1	0
occurs	PMC4064952	2061	2067	O	-1	-1	0
in	PMC4064952	2068	2070	O	-1	-1	0
approximately	PMC4064952	2071	2084	O	-1	-1	0
50	PMC4064952	2085	2087	O	-1	-1	0
%	PMC4064952	2087	2088	O	-1	-1	0
of	PMC4064952	2089	2091	O	-1	-1	0
patients	PMC4064952	2092	2100	O	-1	-1	0
,	PMC4064952	2100	2101	O	-1	-1	0
and	PMC4064952	2102	2105	O	-1	-1	0
paroxysmal	PMC4064952	2106	2116	O	-1	-1	0
and	PMC4064952	2117	2120	O	-1	-1	0
persistent	PMC4064952	2121	2131	O	-1	-1	0
AF	PMC4064952	2132	2134	O	-1	-1	0
in	PMC4064952	2135	2137	O	-1	-1	0
25	PMC4064952	2138	2140	O	-1	-1	0
%	PMC4064952	2140	2141	O	-1	-1	0
each	PMC4064952	2142	2146	O	-1	-1	0
.	PMC4064952	2146	2147	O	-1	-1	0

AF	PMC4064952	2148	2150	O	-1	-1	0
is	PMC4064952	2151	2153	O	-1	-1	0
frequently	PMC4064952	2154	2164	O	-1	-1	0
associated	PMC4064952	2165	2175	O	-1	-1	0
with	PMC4064952	2176	2180	O	-1	-1	0
cardiac	PMC4064952	2181	2188	O	-1	-1	0
disease	PMC4064952	2189	2196	O	-1	-1	0
and	PMC4064952	2197	2200	O	-1	-1	0
comorbidities	PMC4064952	2201	2214	O	-1	-1	0
.	PMC4064952	2214	2215	O	-1	-1	0

The	PMC4064952	2216	2219	O	-1	-1	0
most	PMC4064952	2220	2224	O	-1	-1	0
common	PMC4064952	2225	2231	O	-1	-1	0
concomitant	PMC4064952	2232	2243	O	-1	-1	0
diseases	PMC4064952	2244	2252	O	-1	-1	0
are	PMC4064952	2253	2256	O	-1	-1	0
coronary	PMC4064952	2257	2265	O	-1	-1	0
artery	PMC4064952	2266	2272	O	-1	-1	0
disease	PMC4064952	2273	2280	O	-1	-1	0
,	PMC4064952	2280	2281	O	-1	-1	0
valvular	PMC4064952	2282	2290	O	-1	-1	0
heart	PMC4064952	2291	2296	O	-1	-1	0
disease	PMC4064952	2297	2304	O	-1	-1	0
,	PMC4064952	2304	2305	O	-1	-1	0
and	PMC4064952	2306	2309	O	-1	-1	0
cardiomyopathy	PMC4064952	2310	2324	O	-1	-1	0
.	PMC4064952	2324	2325	O	-1	-1	0

The	PMC4064952	2326	2329	O	-1	-1	0
most	PMC4064952	2330	2334	O	-1	-1	0
common	PMC4064952	2335	2341	O	-1	-1	0
comorbidities	PMC4064952	2342	2355	O	-1	-1	0
are	PMC4064952	2356	2359	O	-1	-1	0
hypertension	PMC4064952	2360	2372	O	-1	-1	0
,	PMC4064952	2372	2373	O	-1	-1	0
diabetes	PMC4064952	2374	2382	O	-1	-1	0
,	PMC4064952	2382	2383	O	-1	-1	0
heart	PMC4064952	2384	2389	O	-1	-1	0
failure	PMC4064952	2390	2397	O	-1	-1	0
,	PMC4064952	2397	2398	O	-1	-1	0
chronic	PMC4064952	2399	2406	O	-1	-1	0
obstructive	PMC4064952	2407	2418	O	-1	-1	0
pulmonary	PMC4064952	2419	2428	O	-1	-1	0
disease	PMC4064952	2429	2436	O	-1	-1	0
,	PMC4064952	2436	2437	O	-1	-1	0
renal	PMC4064952	2438	2443	O	-1	-1	0
failure	PMC4064952	2444	2451	O	-1	-1	0
,	PMC4064952	2451	2452	O	-1	-1	0
stroke	PMC4064952	2453	2459	O	-1	-1	0
,	PMC4064952	2459	2460	O	-1	-1	0
and	PMC4064952	2461	2464	O	-1	-1	0
cognitive	PMC4064952	2465	2474	O	-1	-1	0
disturbance	PMC4064952	2475	2486	O	-1	-1	0
.	PMC4064952	2486	2487	O	-1	-1	0

­	PMC4064952	2488	2489	O	-1	-1	0

Paroxysmal	PMC4064952	2490	2500	O	-1	-1	0
AF	PMC4064952	2501	2503	O	-1	-1	0
occurs	PMC4064952	2504	2510	O	-1	-1	0
in	PMC4064952	2511	2513	O	-1	-1	0
younger	PMC4064952	2514	2521	O	-1	-1	0
patients	PMC4064952	2522	2530	O	-1	-1	0
and	PMC4064952	2531	2534	O	-1	-1	0
with	PMC4064952	2535	2539	O	-1	-1	0
a	PMC4064952	2540	2541	O	-1	-1	0
reduced	PMC4064952	2542	2549	O	-1	-1	0
burden	PMC4064952	2550	2556	O	-1	-1	0
of	PMC4064952	2557	2559	O	-1	-1	0
both	PMC4064952	2560	2564	O	-1	-1	0
cardiac	PMC4064952	2565	2572	O	-1	-1	0
dis-	PMC4064952	2573	2577	O	-1	-1	0
ease	PMC4064952	2578	2582	O	-1	-1	0
and	PMC4064952	2583	2586	O	-1	-1	0
comorbidities	PMC4064952	2587	2600	O	-1	-1	0
.	PMC4064952	2600	2601	O	-1	-1	0

Generally	PMC4064952	2602	2611	O	-1	-1	0
,	PMC4064952	2611	2612	O	-1	-1	0
the	PMC4064952	2613	2616	O	-1	-1	0
history	PMC4064952	2617	2624	O	-1	-1	0
of	PMC4064952	2625	2627	O	-1	-1	0
AF	PMC4064952	2628	2630	O	-1	-1	0
is	PMC4064952	2631	2633	O	-1	-1	0
long	PMC4064952	2634	2638	O	-1	-1	0
,	PMC4064952	2638	2639	O	-1	-1	0
burdened	PMC4064952	2640	2648	O	-1	-1	0
by	PMC4064952	2649	2651	O	-1	-1	0
frequent	PMC4064952	2652	2660	O	-1	-1	0
recur-	PMC4064952	2661	2667	O	-1	-1	0
rences	PMC4064952	2668	2674	O	-1	-1	0
,	PMC4064952	2674	2675	O	-1	-1	0
and	PMC4064952	2676	2679	O	-1	-1	0
associated	PMC4064952	2680	2690	O	-1	-1	0
with	PMC4064952	2691	2695	O	-1	-1	0
symptoms	PMC4064952	2696	2704	O	-1	-1	0
(	PMC4064952	2705	2706	O	-1	-1	0
in	PMC4064952	2706	2708	O	-1	-1	0
two	PMC4064952	2709	2712	O	-1	-1	0
thirds	PMC4064952	2713	2719	O	-1	-1	0
of	PMC4064952	2720	2722	O	-1	-1	0
patients	PMC4064952	2723	2731	O	-1	-1	0
)	PMC4064952	2731	2732	O	-1	-1	0
.	PMC4064952	2732	2733	O	-1	-1	0

Patients	PMC4064952	2734	2742	O	-1	-1	0
with	PMC4064952	2743	2747	O	-1	-1	0
AF	PMC4064952	2748	2750	O	-1	-1	0
have	PMC4064952	2751	2755	O	-1	-1	0
a	PMC4064952	2756	2757	O	-1	-1	0
five	PMC4064952	2758	2762	O	-1	-1	0
-	PMC4064952	2762	2763	O	-1	-1	0
fold	PMC4064952	2763	2767	O	-1	-1	0
and	PMC4064952	2768	2771	O	-1	-1	0
two	PMC4064952	2772	2775	O	-1	-1	0
-	PMC4064952	2775	2776	O	-1	-1	0
fold	PMC4064952	2776	2780	O	-1	-1	0
higher	PMC4064952	2781	2787	O	-1	-1	0
risk	PMC4064952	2788	2792	O	-1	-1	0
of	PMC4064952	2793	2795	O	-1	-1	0
stroke	PMC4064952	2796	2802	O	-1	-1	0
and	PMC4064952	2803	2806	O	-1	-1	0
death	PMC4064952	2807	2812	O	-1	-1	0
,	PMC4064952	2812	2813	O	-1	-1	0
respectively	PMC4064952	2814	2826	O	-1	-1	0
.	PMC4064952	2826	2827	O	-1	-1	0

We	PMC4064952	2828	2830	O	-1	-1	0
estimate	PMC4064952	2831	2839	O	-1	-1	0
that	PMC4064952	2840	2844	O	-1	-1	0
the	PMC4064952	2845	2848	O	-1	-1	0
number	PMC4064952	2849	2855	O	-1	-1	0
of	PMC4064952	2856	2858	O	-1	-1	0
patients	PMC4064952	2859	2867	O	-1	-1	0
with	PMC4064952	2868	2872	O	-1	-1	0
AF	PMC4064952	2873	2875	O	-1	-1	0
in	PMC4064952	2876	2878	O	-1	-1	0
2030	PMC4064952	2879	2883	O	-1	-1	0
in	PMC4064952	2884	2886	O	-1	-1	0
Europe	PMC4064952	2887	2893	O	-1	-1	0
will	PMC4064952	2894	2898	O	-1	-1	0
be	PMC4064952	2899	2901	O	-1	-1	0
14–17	PMC4064952	2902	2907	O	-1	-1	0
million	PMC4064952	2908	2915	O	-1	-1	0
and	PMC4064952	2916	2919	O	-1	-1	0
the	PMC4064952	2920	2923	O	-1	-1	0
number	PMC4064952	2924	2930	O	-1	-1	0
of	PMC4064952	2931	2933	O	-1	-1	0
new	PMC4064952	2934	2937	O	-1	-1	0
cases	PMC4064952	2938	2943	O	-1	-1	0
of	PMC4064952	2944	2946	O	-1	-1	0
AF	PMC4064952	2947	2949	O	-1	-1	0
per	PMC4064952	2950	2953	O	-1	-1	0
year	PMC4064952	2954	2958	O	-1	-1	0
at	PMC4064952	2959	2961	O	-1	-1	0
120,000–215,000	PMC4064952	2962	2977	O	-1	-1	0
.	PMC4064952	2977	2978	O	-1	-1	0

Given	PMC4064952	2979	2984	O	-1	-1	0
that	PMC4064952	2985	2989	O	-1	-1	0
AF	PMC4064952	2990	2992	O	-1	-1	0
is	PMC4064952	2993	2995	O	-1	-1	0
associated	PMC4064952	2996	3006	O	-1	-1	0
with	PMC4064952	3007	3011	O	-1	-1	0
significant	PMC4064952	3012	3023	O	-1	-1	0
morbidity	PMC4064952	3024	3033	O	-1	-1	0
and	PMC4064952	3034	3037	O	-1	-1	0
mortality	PMC4064952	3038	3047	O	-1	-1	0
,	PMC4064952	3047	3048	O	-1	-1	0
this	PMC4064952	3049	3053	O	-1	-1	0
increasing	PMC4064952	3054	3064	O	-1	-1	0
number	PMC4064952	3065	3071	O	-1	-1	0
of	PMC4064952	3072	3074	O	-1	-1	0
individuals	PMC4064952	3075	3086	O	-1	-1	0
with	PMC4064952	3087	3091	O	-1	-1	0
AF	PMC4064952	3092	3094	O	-1	-1	0
will	PMC4064952	3095	3099	O	-1	-1	0
have	PMC4064952	3100	3104	O	-1	-1	0
major	PMC4064952	3105	3110	O	-1	-1	0
public	PMC4064952	3111	3117	O	-1	-1	0
health	PMC4064952	3118	3124	O	-1	-1	0
implications	PMC4064952	3125	3137	O	-1	-1	0
.	PMC4064952	3137	3138	O	-1	-1	0

Keywords	PMC4064952	3139	3147	O	-1	-1	0
:	PMC4064952	3147	3148	O	-1	-1	0
atrial	PMC4064952	3149	3155	O	-1	-1	0
fibrillation	PMC4064952	3156	3168	O	-1	-1	0
,	PMC4064952	3168	3169	O	-1	-1	0
epidemiology	PMC4064952	3170	3182	O	-1	-1	0
,	PMC4064952	3182	3183	O	-1	-1	0
risk	PMC4064952	3184	3188	O	-1	-1	0
factors	PMC4064952	3189	3196	O	-1	-1	0
,	PMC4064952	3196	3197	O	-1	-1	0
mortality	PMC4064952	3198	3207	O	-1	-1	0
,	PMC4064952	3207	3208	O	-1	-1	0
stroke	PMC4064952	3209	3215	O	-1	-1	0

Introduction	PMC4064952	3216	3228	O	-1	-1	0

In	PMC4064952	3229	3231	O	-1	-1	0
the	PMC4064952	3232	3235	O	-1	-1	0
last	PMC4064952	3236	3240	O	-1	-1	0
two	PMC4064952	3241	3244	O	-1	-1	0
decades	PMC4064952	3245	3252	O	-1	-1	0
,	PMC4064952	3252	3253	O	-1	-1	0
atrial	PMC4064952	3254	3260	O	-1	-1	0
fibrillation	PMC4064952	3261	3273	O	-1	-1	0
(	PMC4064952	3274	3275	O	-1	-1	0
AF	PMC4064952	3275	3277	O	-1	-1	0
)	PMC4064952	3277	3278	O	-1	-1	0
has	PMC4064952	3279	3282	O	-1	-1	0
become	PMC4064952	3283	3289	O	-1	-1	0
one	PMC4064952	3290	3293	O	-1	-1	0
of	PMC4064952	3294	3296	O	-1	-1	0
the	PMC4064952	3297	3300	O	-1	-1	0
most	PMC4064952	3301	3305	O	-1	-1	0
important	PMC4064952	3306	3315	O	-1	-1	0
public	PMC4064952	3316	3322	O	-1	-1	0
health	PMC4064952	3323	3329	O	-1	-1	0
issues	PMC4064952	3330	3336	O	-1	-1	0
and	PMC4064952	3337	3340	O	-1	-1	0
an	PMC4064952	3341	3343	O	-1	-1	0
important	PMC4064952	3344	3353	O	-1	-1	0
cause	PMC4064952	3354	3359	O	-1	-1	0
of	PMC4064952	3360	3362	O	-1	-1	0
health	PMC4064952	3363	3369	O	-1	-1	0
care	PMC4064952	3370	3374	O	-1	-1	0
expenditure	PMC4064952	3375	3386	O	-1	-1	0
in	PMC4064952	3387	3389	O	-1	-1	0
western	PMC4064952	3390	3397	O	-1	-1	0
countries	PMC4064952	3398	3407	O	-1	-1	0
.	PMC4064952	3407	3408	O	-1	-1	0

Even	PMC4064952	3409	3413	O	-1	-1	0
if	PMC4064952	3414	3416	O	-1	-1	0
AF	PMC4064952	3417	3419	O	-1	-1	0
is	PMC4064952	3420	3422	O	-1	-1	0
not	PMC4064952	3423	3426	O	-1	-1	0
a	PMC4064952	3427	3428	O	-1	-1	0
life	PMC4064952	3429	3433	O	-1	-1	0
-	PMC4064952	3433	3434	O	-1	-1	0
threatening	PMC4064952	3434	3445	O	-1	-1	0
arrhythmia	PMC4064952	3446	3456	O	-1	-1	0
,	PMC4064952	3456	3457	O	-1	-1	0
it	PMC4064952	3458	3460	O	-1	-1	0
influences	PMC4064952	3461	3471	O	-1	-1	0
quality	PMC4064952	3472	3479	O	-1	-1	0
of	PMC4064952	3480	3482	O	-1	-1	0
life	PMC4064952	3483	3487	O	-1	-1	0
significantly	PMC4064952	3488	3501	O	-1	-1	0
as	PMC4064952	3502	3504	O	-1	-1	0
a	PMC4064952	3505	3506	O	-1	-1	0
result	PMC4064952	3507	3513	O	-1	-1	0
of	PMC4064952	3514	3516	O	-1	-1	0
its	PMC4064952	3517	3520	O	-1	-1	0
anatomic	PMC4064952	3521	3529	O	-1	-1	0
,	PMC4064952	3529	3530	O	-1	-1	0
hemodynamic	PMC4064952	3531	3542	O	-1	-1	0
,	PMC4064952	3542	3543	O	-1	-1	0
and	PMC4064952	3544	3547	O	-1	-1	0
hemocoagulative	PMC4064952	3548	3563	O	-1	-1	0
consequences	PMC4064952	3564	3576	O	-1	-1	0
.	PMC4064952	3576	3577	O	-1	-1	0

In	PMC4064952	3578	3580	O	-1	-1	0
addition	PMC4064952	3581	3589	O	-1	-1	0
,	PMC4064952	3589	3590	O	-1	-1	0
AF	PMC4064952	3591	3593	O	-1	-1	0
is	PMC4064952	3594	3596	O	-1	-1	0
frequently	PMC4064952	3597	3607	O	-1	-1	0
associated	PMC4064952	3608	3618	O	-1	-1	0
with	PMC4064952	3619	3623	O	-1	-1	0
disturbing	PMC4064952	3624	3634	O	-1	-1	0
symptoms	PMC4064952	3635	3643	O	-1	-1	0
and	PMC4064952	3644	3647	O	-1	-1	0
very	PMC4064952	3648	3652	O	-1	-1	0
important	PMC4064952	3653	3662	O	-1	-1	0
socioeconomic	PMC4064952	3663	3676	O	-1	-1	0
problems	PMC4064952	3677	3685	O	-1	-1	0
,	PMC4064952	3685	3686	O	-1	-1	0
such	PMC4064952	3687	3691	O	-1	-1	0
as	PMC4064952	3692	3694	O	-1	-1	0
permanent	PMC4064952	3695	3704	O	-1	-1	0
disability	PMC4064952	3705	3715	O	-1	-1	0
,	PMC4064952	3715	3716	O	-1	-1	0
cognitive	PMC4064952	3717	3726	O	-1	-1	0
disturbance	PMC4064952	3727	3738	O	-1	-1	0
,	PMC4064952	3738	3739	O	-1	-1	0
hospitalization	PMC4064952	3740	3755	O	-1	-1	0
,	PMC4064952	3755	3756	O	-1	-1	0
and	PMC4064952	3757	3760	O	-1	-1	0
absence	PMC4064952	3761	3768	O	-1	-1	0
from	PMC4064952	3769	3773	O	-1	-1	0
work.1	PMC4064952	3774	3780	O	-1	-1	0

Given	PMC4064952	3781	3786	O	-1	-1	0
that	PMC4064952	3787	3791	O	-1	-1	0
the	PMC4064952	3792	3795	O	-1	-1	0
prevalence	PMC4064952	3796	3806	O	-1	-1	0
ofAF	PMC4064952	3807	3811	O	-1	-1	0
continues	PMC4064952	3812	3821	O	-1	-1	0
to	PMC4064952	3822	3824	O	-1	-1	0
increase	PMC4064952	3825	3833	O	-1	-1	0
,	PMC4064952	3833	3834	O	-1	-1	0
it	PMC4064952	3835	3837	O	-1	-1	0
is	PMC4064952	3838	3840	O	-1	-1	0
crucial	PMC4064952	3841	3848	O	-1	-1	0
to	PMC4064952	3849	3851	O	-1	-1	0
have	PMC4064952	3852	3856	O	-1	-1	0
an	PMC4064952	3857	3859	O	-1	-1	0
updated	PMC4064952	3860	3867	O	-1	-1	0
picture	PMC4064952	3868	3875	O	-1	-1	0
of	PMC4064952	3876	3878	O	-1	-1	0
the	PMC4064952	3879	3882	O	-1	-1	0
epidemiological	PMC4064952	3883	3898	O	-1	-1	0
,	PMC4064952	3898	3899	O	-1	-1	0
clinical	PMC4064952	3900	3908	O	-1	-1	0
,	PMC4064952	3908	3909	O	-1	-1	0
and	PMC4064952	3910	3913	O	-1	-1	0
social	PMC4064952	3914	3920	O	-1	-1	0
impact	PMC4064952	3921	3927	O	-1	-1	0
of	PMC4064952	3928	3930	O	-1	-1	0
AF	PMC4064952	3931	3933	O	-1	-1	0
to	PMC4064952	3934	3936	O	-1	-1	0
plan	PMC4064952	3937	3941	O	-1	-1	0
appropriate	PMC4064952	3942	3953	O	-1	-1	0
interventions	PMC4064952	3954	3967	O	-1	-1	0
and	PMC4064952	3968	3971	O	-1	-1	0
adequately	PMC4064952	3972	3982	O	-1	-1	0
allocate	PMC4064952	3983	3991	O	-1	-1	0
human	PMC4064952	3992	3997	O	-1	-1	0
and	PMC4064952	3998	4001	O	-1	-1	0
economic	PMC4064952	4002	4010	O	-1	-1	0
resources	PMC4064952	4011	4020	O	-1	-1	0
.	PMC4064952	4020	4021	O	-1	-1	0

Number	PMC4064952	4022	4028	O	-1	-1	0
of	PMC4064952	4029	4031	O	-1	-1	0
times	PMC4064952	4032	4037	O	-1	-1	0
this	PMC4064952	4038	4042	O	-1	-1	0
article	PMC4064952	4043	4050	O	-1	-1	0
has	PMC4064952	4051	4054	O	-1	-1	0
been	PMC4064952	4055	4059	O	-1	-1	0
viewed	PMC4064952	4060	4066	O	-1	-1	0
This	PMC4064952	4067	4071	O	-1	-1	0
article	PMC4064952	4072	4079	O	-1	-1	0
was	PMC4064952	4080	4083	O	-1	-1	0
published	PMC4064952	4084	4093	O	-1	-1	0
in	PMC4064952	4094	4096	O	-1	-1	0
the	PMC4064952	4097	4100	O	-1	-1	0
following	PMC4064952	4101	4110	O	-1	-1	0
Dove	PMC4064952	4111	4115	O	-1	-1	0
Press	PMC4064952	4116	4121	O	-1	-1	0
journal	PMC4064952	4122	4129	O	-1	-1	0
:	PMC4064952	4129	4130	O	-1	-1	0
Clinical	PMC4064952	4131	4139	O	-1	-1	0
Epidemiology	PMC4064952	4140	4152	O	-1	-1	0

16	PMC4064952	4153	4155	O	-1	-1	0
June	PMC4064952	4156	4160	O	-1	-1	0
2014	PMC4064952	4161	4165	O	-1	-1	0

Clinical	PMC4064952	4166	4174	O	-1	-1	0
Epidemiology	PMC4064952	4175	4187	O	-1	-1	0
2014:6	PMC4064952	4188	4194	O	-1	-1	0
submit	PMC4064952	4195	4201	O	-1	-1	0
your	PMC4064952	4202	4206	O	-1	-1	0
manuscript	PMC4064952	4207	4217	O	-1	-1	0
|	PMC4064952	4218	4219	O	-1	-1	0

www.dovepress.com	PMC4064952	4220	4237	O	-1	-1	0

Dovepress	PMC4064952	4238	4247	O	-1	-1	0

Dovepress	PMC4064952	4248	4257	O	-1	-1	0

214	PMC4064952	4258	4261	O	-1	-1	0

Zoni	PMC4064952	4262	4266	O	-1	-1	0
-	PMC4064952	4266	4267	O	-1	-1	0
Berisso	PMC4064952	4267	4274	O	-1	-1	0
et	PMC4064952	4275	4277	O	-1	-1	0
al	PMC4064952	4278	4280	O	-1	-1	0
Search	PMC4064952	4281	4287	O	-1	-1	0
strategy	PMC4064952	4288	4296	O	-1	-1	0

A	PMC4064952	4297	4298	O	-1	-1	0
systematic	PMC4064952	4299	4309	O	-1	-1	0
review	PMC4064952	4310	4316	O	-1	-1	0
of	PMC4064952	4317	4319	O	-1	-1	0
the	PMC4064952	4320	4323	O	-1	-1	0
studies	PMC4064952	4324	4331	O	-1	-1	0
reported	PMC4064952	4332	4340	O	-1	-1	0
on	PMC4064952	4341	4343	O	-1	-1	0
the	PMC4064952	4344	4347	O	-1	-1	0
epidemi-	PMC4064952	4348	4356	O	-1	-1	0
ology	PMC4064952	4357	4362	O	-1	-1	0
of	PMC4064952	4363	4365	O	-1	-1	0
AF	PMC4064952	4366	4368	O	-1	-1	0
in	PMC4064952	4369	4371	O	-1	-1	0
Europe	PMC4064952	4372	4378	B-Location	-1	-1	0
was	PMC4064952	4379	4382	O	-1	-1	0
performed	PMC4064952	4383	4392	O	-1	-1	0
using	PMC4064952	4393	4398	O	-1	-1	0
the	PMC4064952	4399	4402	O	-1	-1	0
electronic	PMC4064952	4403	4413	O	-1	-1	0
MEDLINE	PMC4064952	4414	4421	O	-1	-1	0
and	PMC4064952	4422	4425	O	-1	-1	0
PubMed	PMC4064952	4426	4432	O	-1	-1	0
databases	PMC4064952	4433	4442	O	-1	-1	0
.	PMC4064952	4442	4443	O	-1	-1	0

The	PMC4064952	4444	4447	O	-1	-1	0
search	PMC4064952	4448	4454	O	-1	-1	0
terms	PMC4064952	4455	4460	O	-1	-1	0
included	PMC4064952	4461	4469	O	-1	-1	0
:	PMC4064952	4469	4470	O	-1	-1	0
“	PMC4064952	4471	4472	O	-1	-1	0
atrial	PMC4064952	4472	4478	O	-1	-1	0
fibrillation	PMC4064952	4479	4491	O	-1	-1	0
”	PMC4064952	4491	4492	O	-1	-1	0
,	PMC4064952	4492	4493	O	-1	-1	0
“	PMC4064952	4494	4495	O	-1	-1	0
atrial	PMC4064952	4495	4501	O	-1	-1	0
tachyarrhythmias	PMC4064952	4502	4518	O	-1	-1	0
”	PMC4064952	4518	4519	O	-1	-1	0
,	PMC4064952	4519	4520	O	-1	-1	0
“	PMC4064952	4521	4522	O	-1	-1	0
epidemiology	PMC4064952	4522	4534	O	-1	-1	0
”	PMC4064952	4534	4535	O	-1	-1	0
,	PMC4064952	4535	4536	O	-1	-1	0
“	PMC4064952	4537	4538	O	-1	-1	0
burden	PMC4064952	4538	4544	O	-1	-1	0
”	PMC4064952	4544	4545	O	-1	-1	0
,	PMC4064952	4545	4546	O	-1	-1	0
“	PMC4064952	4547	4548	O	-1	-1	0
rhythm	PMC4064952	4548	4554	O	-1	-1	0
control	PMC4064952	4555	4562	O	-1	-1	0
”	PMC4064952	4562	4563	O	-1	-1	0
,	PMC4064952	4563	4564	O	-1	-1	0
“	PMC4064952	4565	4566	O	-1	-1	0
rate	PMC4064952	4566	4570	O	-1	-1	0
control	PMC4064952	4571	4578	O	-1	-1	0
”	PMC4064952	4578	4579	O	-1	-1	0
,	PMC4064952	4579	4580	O	-1	-1	0

“	PMC4064952	4581	4582	O	-1	-1	0
stroke	PMC4064952	4582	4588	O	-1	-1	0
”	PMC4064952	4588	4589	O	-1	-1	0
,	PMC4064952	4589	4590	O	-1	-1	0
“	PMC4064952	4591	4592	O	-1	-1	0
heart	PMC4064952	4592	4597	O	-1	-1	0
failure	PMC4064952	4598	4605	O	-1	-1	0
”	PMC4064952	4605	4606	O	-1	-1	0
,	PMC4064952	4606	4607	O	-1	-1	0
“	PMC4064952	4608	4609	O	-1	-1	0
outcome	PMC4064952	4609	4616	O	-1	-1	0
”	PMC4064952	4616	4617	O	-1	-1	0
,	PMC4064952	4617	4618	O	-1	-1	0
“	PMC4064952	4619	4620	O	-1	-1	0
anticoagulant	PMC4064952	4620	4633	O	-1	-1	0
therapy	PMC4064952	4634	4641	O	-1	-1	0
”	PMC4064952	4641	4642	O	-1	-1	0
,	PMC4064952	4642	4643	O	-1	-1	0
and	PMC4064952	4644	4647	O	-1	-1	0
“	PMC4064952	4648	4649	O	-1	-1	0
antiplatelet	PMC4064952	4649	4661	O	-1	-1	0
therapy	PMC4064952	4662	4669	O	-1	-1	0
”	PMC4064952	4669	4670	O	-1	-1	0
.	PMC4064952	4670	4671	O	-1	-1	0

Studies	PMC4064952	4672	4679	O	-1	-1	0
published	PMC4064952	4680	4689	O	-1	-1	0
from	PMC4064952	4690	4694	O	-1	-1	0
2005	PMC4064952	4695	4699	O	-1	-1	0
to	PMC4064952	4700	4702	O	-1	-1	0
2014	PMC4064952	4703	4707	O	-1	-1	0
with	PMC4064952	4708	4712	O	-1	-1	0
a	PMC4064952	4713	4714	O	-1	-1	0
prespecified	PMC4064952	4715	4727	O	-1	-1	0
protocol	PMC4064952	4728	4736	O	-1	-1	0
(	PMC4064952	4737	4738	O	-1	-1	0
how	PMC4064952	4738	4741	O	-1	-1	0
AF	PMC4064952	4742	4744	O	-1	-1	0
was	PMC4064952	4745	4748	O	-1	-1	0
ascertained	PMC4064952	4749	4760	O	-1	-1	0
,	PMC4064952	4760	4761	O	-1	-1	0
diligence	PMC4064952	4762	4771	O	-1	-1	0
with	PMC4064952	4772	4776	O	-1	-1	0
which	PMC4064952	4777	4782	O	-1	-1	0
medical	PMC4064952	4783	4790	O	-1	-1	0
records	PMC4064952	4791	4798	O	-1	-1	0
were	PMC4064952	4799	4803	O	-1	-1	0
sought	PMC4064952	4804	4810	O	-1	-1	0
,	PMC4064952	4810	4811	O	-1	-1	0
modes	PMC4064952	4812	4817	O	-1	-1	0
of	PMC4064952	4818	4820	O	-1	-1	0
clinical	PMC4064952	4821	4829	O	-1	-1	0
assessment	PMC4064952	4830	4840	O	-1	-1	0
,	PMC4064952	4840	4841	O	-1	-1	0
and	PMC4064952	4842	4845	O	-1	-1	0
follow	PMC4064952	4846	4852	O	-1	-1	0
-	PMC4064952	4852	4853	O	-1	-1	0
up	PMC4064952	4853	4855	O	-1	-1	0
of	PMC4064952	4856	4858	O	-1	-1	0
patient	PMC4064952	4859	4866	O	-1	-1	0
subgroups	PMC4064952	4867	4876	O	-1	-1	0
)	PMC4064952	4876	4877	O	-1	-1	0
analyzing	PMC4064952	4878	4887	O	-1	-1	0
the	PMC4064952	4888	4891	O	-1	-1	0
epidemiology	PMC4064952	4892	4904	O	-1	-1	0
ofAF	PMC4064952	4905	4909	O	-1	-1	0
exclusively	PMC4064952	4910	4921	O	-1	-1	0
in	PMC4064952	4922	4924	O	-1	-1	0
the	PMC4064952	4925	4928	O	-1	-1	0
general	PMC4064952	4929	4936	O	-1	-1	0
population	PMC4064952	4937	4947	O	-1	-1	0
were	PMC4064952	4948	4952	O	-1	-1	0
considered	PMC4064952	4953	4963	O	-1	-1	0
.	PMC4064952	4963	4964	O	-1	-1	0

When	PMC4064952	4965	4969	O	-1	-1	0
necessary	PMC4064952	4970	4979	O	-1	-1	0
(	PMC4064952	4980	4981	O	-1	-1	0
ie	PMC4064952	4981	4983	O	-1	-1	0
,	PMC4064952	4983	4984	O	-1	-1	0
absence	PMC4064952	4985	4992	O	-1	-1	0
in	PMC4064952	4993	4995	O	-1	-1	0
the	PMC4064952	4996	4999	O	-1	-1	0
literature	PMC4064952	5000	5010	O	-1	-1	0
of	PMC4064952	5011	5013	O	-1	-1	0
data	PMC4064952	5014	5018	O	-1	-1	0
on	PMC4064952	5019	5021	O	-1	-1	0
temporal	PMC4064952	5022	5030	O	-1	-1	0
trends	PMC4064952	5031	5037	O	-1	-1	0
regarding	PMC4064952	5038	5047	O	-1	-1	0
the	PMC4064952	5048	5051	O	-1	-1	0
inci-	PMC4064952	5052	5057	O	-1	-1	0
dence	PMC4064952	5058	5063	O	-1	-1	0
/	PMC4064952	5063	5064	O	-1	-1	0
prevalence	PMC4064952	5064	5074	O	-1	-1	0
ofAF	PMC4064952	5075	5079	O	-1	-1	0
and	PMC4064952	5080	5083	O	-1	-1	0
risk	PMC4064952	5084	5088	O	-1	-1	0
of	PMC4064952	5089	5091	O	-1	-1	0
stroke	PMC4064952	5092	5098	O	-1	-1	0
)	PMC4064952	5098	5099	O	-1	-1	0
,	PMC4064952	5099	5100	O	-1	-1	0
investigations	PMC4064952	5101	5115	O	-1	-1	0
per-	PMC4064952	5116	5120	O	-1	-1	0
formed	PMC4064952	5121	5127	O	-1	-1	0
before	PMC4064952	5128	5134	O	-1	-1	0
2005	PMC4064952	5135	5139	O	-1	-1	0
were	PMC4064952	5140	5144	O	-1	-1	0
used	PMC4064952	5145	5149	O	-1	-1	0
.	PMC4064952	5149	5150	O	-1	-1	0

The	PMC4064952	5151	5154	O	-1	-1	0
projected	PMC4064952	5155	5164	O	-1	-1	0
­	PMC4064952	5165	5166	O	-1	-1	0
burden	PMC4064952	5167	5173	O	-1	-1	0
of	PMC4064952	5174	5176	O	-1	-1	0
AF	PMC4064952	5177	5179	O	-1	-1	0
in	PMC4064952	5180	5182	O	-1	-1	0
the	PMC4064952	5183	5186	O	-1	-1	0
European	PMC4064952	5187	5195	O	-1	-1	0
population	PMC4064952	5196	5206	O	-1	-1	0
in	PMC4064952	5207	5209	O	-1	-1	0
2030	PMC4064952	5210	5214	O	-1	-1	0
is	PMC4064952	5215	5217	O	-1	-1	0
based	PMC4064952	5218	5223	O	-1	-1	0
on	PMC4064952	5224	5226	O	-1	-1	0
­	PMC4064952	5227	5228	O	-1	-1	0
estimates	PMC4064952	5229	5238	O	-1	-1	0
of	PMC4064952	5239	5241	O	-1	-1	0
demographic	PMC4064952	5242	5253	O	-1	-1	0
progression	PMC4064952	5254	5265	O	-1	-1	0
in	PMC4064952	5266	5268	O	-1	-1	0
Europe	PMC4064952	5269	5275	B-Location	-1	-1	0
­	PMC4064952	5276	5277	O	-1	-1	0
according	PMC4064952	5278	5287	O	-1	-1	0
to	PMC4064952	5288	5290	O	-1	-1	0
Eurostat.2	PMC4064952	5291	5301	O	-1	-1	0
Prevalence	PMC4064952	5302	5312	O	-1	-1	0
and	PMC4064952	5313	5316	O	-1	-1	0
incidence	PMC4064952	5317	5326	O	-1	-1	0
of	PMC4064952	5327	5329	O	-1	-1	0
AF	PMC4064952	5330	5332	O	-1	-1	0

The	PMC4064952	5333	5336	O	-1	-1	0
most	PMC4064952	5337	5341	O	-1	-1	0
important	PMC4064952	5342	5351	O	-1	-1	0
studies	PMC4064952	5352	5359	O	-1	-1	0
on	PMC4064952	5360	5362	O	-1	-1	0
the	PMC4064952	5363	5366	O	-1	-1	0
epidemiology	PMC4064952	5367	5379	O	-1	-1	0
of	PMC4064952	5380	5382	O	-1	-1	0
AF	PMC4064952	5383	5385	O	-1	-1	0
carried	PMC4064952	5386	5393	O	-1	-1	0
out	PMC4064952	5394	5397	O	-1	-1	0
in	PMC4064952	5398	5400	O	-1	-1	0
developed	PMC4064952	5401	5410	O	-1	-1	0
countries	PMC4064952	5411	5420	O	-1	-1	0
and	PMC4064952	5421	5424	O	-1	-1	0
published	PMC4064952	5425	5434	O	-1	-1	0
between	PMC4064952	5435	5442	O	-1	-1	0

the	PMC4064952	5443	5446	O	-1	-1	0
end	PMC4064952	5447	5450	O	-1	-1	0
of	PMC4064952	5451	5453	O	-1	-1	0
the	PMC4064952	5454	5457	O	-1	-1	0
20th	PMC4064952	5458	5462	O	-1	-1	0
century	PMC4064952	5463	5470	O	-1	-1	0
and	PMC4064952	5471	5474	O	-1	-1	0
the	PMC4064952	5475	5478	O	-1	-1	0
first	PMC4064952	5479	5484	O	-1	-1	0
years	PMC4064952	5485	5490	O	-1	-1	0
of	PMC4064952	5491	5493	O	-1	-1	0
the	PMC4064952	5494	5497	O	-1	-1	0
21st	PMC4064952	5498	5502	O	-1	-1	0
century	PMC4064952	5503	5510	O	-1	-1	0
estimated	PMC4064952	5511	5520	O	-1	-1	0
that	PMC4064952	5521	5525	O	-1	-1	0
the	PMC4064952	5526	5529	O	-1	-1	0
prevalence	PMC4064952	5530	5540	O	-1	-1	0
ofAF	PMC4064952	5541	5545	O	-1	-1	0
ranged	PMC4064952	5546	5552	O	-1	-1	0
between	PMC4064952	5553	5560	O	-1	-1	0
0.5	PMC4064952	5561	5564	O	-1	-1	0
%	PMC4064952	5564	5565	O	-1	-1	0
and	PMC4064952	5566	5569	O	-1	-1	0
1	PMC4064952	5570	5571	O	-1	-1	0
%	PMC4064952	5571	5572	O	-1	-1	0
in	PMC4064952	5573	5575	O	-1	-1	0
the	PMC4064952	5576	5579	O	-1	-1	0
general	PMC4064952	5580	5587	O	-1	-1	0
population.3,4	PMC4064952	5588	5602	O	-1	-1	0

However	PMC4064952	5603	5610	O	-1	-1	0
,	PMC4064952	5610	5611	O	-1	-1	0
in	PMC4064952	5612	5614	O	-1	-1	0
the	PMC4064952	5615	5618	O	-1	-1	0
last	PMC4064952	5619	5623	O	-1	-1	0
decade	PMC4064952	5624	5630	O	-1	-1	0
,	PMC4064952	5630	5631	O	-1	-1	0
the	PMC4064952	5632	5635	O	-1	-1	0
common	PMC4064952	5636	5642	O	-1	-1	0
opinion	PMC4064952	5643	5650	O	-1	-1	0
was	PMC4064952	5651	5654	O	-1	-1	0
that	PMC4064952	5655	5659	O	-1	-1	0
the	PMC4064952	5660	5663	O	-1	-1	0
prevalence	PMC4064952	5664	5674	O	-1	-1	0
of	PMC4064952	5675	5677	O	-1	-1	0
AF	PMC4064952	5678	5680	O	-1	-1	0
,	PMC4064952	5680	5681	O	-1	-1	0
as	PMC4064952	5682	5684	O	-1	-1	0
perceived	PMC4064952	5685	5694	O	-1	-1	0
by	PMC4064952	5695	5697	O	-1	-1	0
number	PMC4064952	5698	5704	O	-1	-1	0
of	PMC4064952	5705	5707	O	-1	-1	0
hospitalizations	PMC4064952	5708	5724	O	-1	-1	0
,	PMC4064952	5724	5725	O	-1	-1	0
emergency	PMC4064952	5726	5735	O	-1	-1	0
room	PMC4064952	5736	5740	O	-1	-1	0
visits	PMC4064952	5741	5747	O	-1	-1	0
,	PMC4064952	5747	5748	O	-1	-1	0
and	PMC4064952	5749	5752	O	-1	-1	0
burden	PMC4064952	5753	5759	O	-1	-1	0
of	PMC4064952	5760	5762	O	-1	-1	0
outpatient	PMC4064952	5763	5773	O	-1	-1	0
visits	PMC4064952	5774	5780	O	-1	-1	0
forAF	PMC4064952	5781	5786	O	-1	-1	0
,	PMC4064952	5786	5787	O	-1	-1	0
had	PMC4064952	5788	5791	O	-1	-1	0
to	PMC4064952	5792	5794	O	-1	-1	0
be	PMC4064952	5795	5797	O	-1	-1	0

­	PMC4064952	5798	5799	O	-1	-1	0

markedly	PMC4064952	5800	5808	O	-1	-1	0
higher.4–6	PMC4064952	5809	5819	O	-1	-1	0

The	PMC4064952	5820	5823	O	-1	-1	0
most	PMC4064952	5824	5828	O	-1	-1	0
recent	PMC4064952	5829	5835	O	-1	-1	0
studies	PMC4064952	5836	5843	O	-1	-1	0
have	PMC4064952	5844	5848	O	-1	-1	0
­	PMC4064952	5849	5850	O	-1	-1	0

confirmed	PMC4064952	5851	5860	O	-1	-1	0

this	PMC4064952	5861	5865	O	-1	-1	0
perception	PMC4064952	5866	5876	O	-1	-1	0
and	PMC4064952	5877	5880	O	-1	-1	0
shown	PMC4064952	5881	5886	O	-1	-1	0
that	PMC4064952	5887	5891	O	-1	-1	0
the	PMC4064952	5892	5895	O	-1	-1	0
prevalence	PMC4064952	5896	5906	O	-1	-1	0
of	PMC4064952	5907	5909	O	-1	-1	0
AF	PMC4064952	5910	5912	O	-1	-1	0
in	PMC4064952	5913	5915	O	-1	-1	0
the	PMC4064952	5916	5919	O	-1	-1	0
general	PMC4064952	5920	5927	O	-1	-1	0
adult	PMC4064952	5928	5933	O	-1	-1	0
population	PMC4064952	5934	5944	O	-1	-1	0
of	PMC4064952	5945	5947	O	-1	-1	0
Europe	PMC4064952	5948	5954	B-Location	-1	-1	0
is	PMC4064952	5955	5957	O	-1	-1	0
more	PMC4064952	5958	5962	O	-1	-1	0
than	PMC4064952	5963	5967	O	-1	-1	0
double	PMC4064952	5968	5974	O	-1	-1	0
that	PMC4064952	5975	5979	O	-1	-1	0
reported	PMC4064952	5980	5988	O	-1	-1	0
just	PMC4064952	5989	5993	O	-1	-1	0
one	PMC4064952	5994	5997	O	-1	-1	0
decade	PMC4064952	5998	6004	O	-1	-1	0
earlier	PMC4064952	6005	6012	O	-1	-1	0
,	PMC4064952	6012	6013	O	-1	-1	0
ranging	PMC4064952	6014	6021	O	-1	-1	0
from	PMC4064952	6022	6026	O	-1	-1	0
1.9	PMC4064952	6027	6030	O	-1	-1	0
%	PMC4064952	6030	6031	O	-1	-1	0
in	PMC4064952	6032	6034	O	-1	-1	0
Italy	PMC4064952	6035	6040	B-Location	-1	-1	0
,	PMC4064952	6040	6041	O	-1	-1	0
Iceland	PMC4064952	6042	6049	B-Location	-1	-1	0
,	PMC4064952	6049	6050	O	-1	-1	0
and	PMC4064952	6051	6054	O	-1	-1	0
England	PMC4064952	6055	6062	B-Location	-1	-1	0
to	PMC4064952	6063	6065	O	-1	-1	0
2.3	PMC4064952	6066	6069	O	-1	-1	0
%	PMC4064952	6069	6070	O	-1	-1	0
in	PMC4064952	6071	6073	O	-1	-1	0
Germany	PMC4064952	6074	6081	B-Location	-1	-1	0
and	PMC4064952	6082	6085	O	-1	-1	0
2.9	PMC4064952	6086	6089	O	-1	-1	0
%	PMC4064952	6089	6090	O	-1	-1	0
in	PMC4064952	6091	6093	O	-1	-1	0
­	PMC4064952	6094	6095	O	-1	-1	0

Sweden	PMC4064952	6096	6102	B-Location	-1	-1	0
­	PMC4064952	6103	6104	O	-1	-1	0

(	PMC4064952	6105	6106	O	-1	-1	0
Figure	PMC4064952	6106	6112	O	-1	-1	0
1	PMC4064952	6113	6114	O	-1	-1	0
)	PMC4064952	6114	6115	O	-1	-1	0
.	PMC4064952	6115	6116	O	-1	-1	0

In	PMC4064952	6117	6119	O	-1	-1	0
particular	PMC4064952	6120	6130	O	-1	-1	0
,	PMC4064952	6130	6131	O	-1	-1	0
for	PMC4064952	6132	6135	O	-1	-1	0
Iceland	PMC4064952	6136	6143	B-Location	-1	-1	0
,	PMC4064952	6143	6144	O	-1	-1	0
the	PMC4064952	6145	6148	O	-1	-1	0
mean	PMC4064952	6149	6153	O	-1	-1	0
increase	PMC4064952	6154	6162	O	-1	-1	0
of	PMC4064952	6163	6165	O	-1	-1	0
AF	PMC4064952	6166	6168	O	-1	-1	0
prevalence	PMC4064952	6169	6179	O	-1	-1	0
in	PMC4064952	6180	6182	O	-1	-1	0
the	PMC4064952	6183	6186	O	-1	-1	0
global	PMC4064952	6187	6193	O	-1	-1	0
population	PMC4064952	6194	6204	O	-1	-1	0
is	PMC4064952	6205	6207	O	-1	-1	0
0.04	PMC4064952	6208	6212	O	-1	-1	0
%	PMC4064952	6212	6213	O	-1	-1	0
per	PMC4064952	6214	6217	O	-1	-1	0
year	PMC4064952	6218	6222	O	-1	-1	0
(	PMC4064952	6223	6224	O	-1	-1	0
data	PMC4064952	6224	6228	O	-1	-1	0
for	PMC4064952	6229	6232	O	-1	-1	0
the	PMC4064952	6233	6236	O	-1	-1	0
period	PMC4064952	6237	6243	O	-1	-1	0
1998–2008	PMC4064952	6244	6253	O	-1	-1	0
)	PMC4064952	6253	6254	O	-1	-1	0
,	PMC4064952	6254	6255	O	-1	-1	0
with	PMC4064952	6256	6260	O	-1	-1	0
a	PMC4064952	6261	6262	O	-1	-1	0
mean	PMC4064952	6263	6267	O	-1	-1	0
increase	PMC4064952	6268	6276	O	-1	-1	0
of	PMC4064952	6277	6279	O	-1	-1	0
0.12	PMC4064952	6280	6284	O	-1	-1	0
%	PMC4064952	6284	6285	O	-1	-1	0
and	PMC4064952	6286	6289	O	-1	-1	0
0.07	PMC4064952	6290	6294	O	-1	-1	0
%	PMC4064952	6294	6295	O	-1	-1	0
per	PMC4064952	6296	6299	O	-1	-1	0
year	PMC4064952	6300	6304	O	-1	-1	0
,	PMC4064952	6304	6305	O	-1	-1	0
respectively	PMC4064952	6306	6318	O	-1	-1	0
,	PMC4064952	6318	6319	O	-1	-1	0
in	PMC4064952	6320	6322	O	-1	-1	0
men	PMC4064952	6323	6326	O	-1	-1	0
and	PMC4064952	6327	6330	O	-1	-1	0
women	PMC4064952	6331	6336	O	-1	-1	0
aged	PMC4064952	6337	6341	O	-1	-1	0
65–74	PMC4064952	6342	6347	O	-1	-1	0
years	PMC4064952	6348	6353	O	-1	-1	0
,	PMC4064952	6353	6354	O	-1	-1	0
0.27	PMC4064952	6355	6359	O	-1	-1	0
%	PMC4064952	6359	6360	O	-1	-1	0
and	PMC4064952	6361	6364	O	-1	-1	0
0.23	PMC4064952	6365	6369	O	-1	-1	0
%	PMC4064952	6369	6370	O	-1	-1	0
in	PMC4064952	6371	6373	O	-1	-1	0
those	PMC4064952	6374	6379	O	-1	-1	0
aged	PMC4064952	6380	6384	O	-1	-1	0
75–84	PMC4064952	6385	6390	O	-1	-1	0
years	PMC4064952	6391	6396	O	-1	-1	0
,	PMC4064952	6396	6397	O	-1	-1	0
and	PMC4064952	6398	6401	O	-1	-1	0
2.8	PMC4064952	6402	6405	O	-1	-1	0
%	PMC4064952	6405	6406	O	-1	-1	0
and	PMC4064952	6407	6410	O	-1	-1	0
0.27	PMC4064952	6411	6415	O	-1	-1	0
%	PMC4064952	6415	6416	O	-1	-1	0
in	PMC4064952	6417	6419	O	-1	-1	0
those	PMC4064952	6420	6425	O	-1	-1	0
older	PMC4064952	6426	6431	O	-1	-1	0
than	PMC4064952	6432	6436	O	-1	-1	0
84	PMC4064952	6437	6439	O	-1	-1	0
years	PMC4064952	6440	6445	O	-1	-1	0
.	PMC4064952	6445	6446	O	-1	-1	0

In	PMC4064952	6447	6449	O	-1	-1	0
the	PMC4064952	6450	6453	O	-1	-1	0
USA	PMC4064952	6454	6457	B-Location	-1	-1	0
,	PMC4064952	6457	6458	O	-1	-1	0
although	PMC4064952	6459	6467	O	-1	-1	0
updated	PMC4064952	6468	6475	O	-1	-1	0
information	PMC4064952	6476	6487	O	-1	-1	0
on	PMC4064952	6488	6490	O	-1	-1	0
the	PMC4064952	6491	6494	O	-1	-1	0
prevalence	PMC4064952	6495	6505	O	-1	-1	0
of	PMC4064952	6506	6508	O	-1	-1	0
AF	PMC4064952	6509	6511	O	-1	-1	0
in	PMC4064952	6512	6514	O	-1	-1	0
the	PMC4064952	6515	6518	O	-1	-1	0
global	PMC4064952	6519	6525	O	-1	-1	0
population	PMC4064952	6526	6536	O	-1	-1	0
is	PMC4064952	6537	6539	O	-1	-1	0
not	PMC4064952	6540	6543	O	-1	-1	0
available	PMC4064952	6544	6553	O	-1	-1	0
,	PMC4064952	6553	6554	O	-1	-1	0
it	PMC4064952	6555	6557	O	-1	-1	0
appears	PMC4064952	6558	6565	O	-1	-1	0
that	PMC4064952	6566	6570	O	-1	-1	0
the	PMC4064952	6571	6574	O	-1	-1	0
prevalence	PMC4064952	6575	6585	O	-1	-1	0
of	PMC4064952	6586	6588	O	-1	-1	0
AF	PMC4064952	6589	6591	O	-1	-1	0
has	PMC4064952	6592	6595	O	-1	-1	0
increased	PMC4064952	6596	6605	O	-1	-1	0
by	PMC4064952	6606	6608	O	-1	-1	0
0.3	PMC4064952	6609	6612	O	-1	-1	0
%	PMC4064952	6612	6613	O	-1	-1	0
per	PMC4064952	6614	6617	O	-1	-1	0
year	PMC4064952	6618	6622	O	-1	-1	0
in	PMC4064952	6623	6625	O	-1	-1	0
Medicare	PMC4064952	6626	6634	O	-1	-1	0
beneficiaries	PMC4064952	6635	6648	O	-1	-1	0
older	PMC4064952	6649	6654	O	-1	-1	0
than	PMC4064952	6655	6659	O	-1	-1	0
65	PMC4064952	6660	6662	O	-1	-1	0
years	PMC4064952	6663	6668	O	-1	-1	0
,	PMC4064952	6668	6669	O	-1	-1	0
with	PMC4064952	6670	6674	O	-1	-1	0
an	PMC4064952	6675	6677	O	-1	-1	0
absolute	PMC4064952	6678	6686	O	-1	-1	0
growth	PMC4064952	6687	6693	O	-1	-1	0
of	PMC4064952	6694	6696	O	-1	-1	0
4.5	PMC4064952	6697	6700	O	-1	-1	0
%	PMC4064952	6700	6701	O	-1	-1	0
(	PMC4064952	6702	6703	O	-1	-1	0
from	PMC4064952	6703	6707	O	-1	-1	0
4.1	PMC4064952	6708	6711	O	-1	-1	0
%	PMC4064952	6711	6712	O	-1	-1	0
to	PMC4064952	6713	6715	O	-1	-1	0
8.6	PMC4064952	6716	6719	O	-1	-1	0
%	PMC4064952	6719	6720	O	-1	-1	0
)	PMC4064952	6720	6721	O	-1	-1	0
in	PMC4064952	6722	6724	O	-1	-1	0
the	PMC4064952	6725	6728	O	-1	-1	0
period	PMC4064952	6729	6735	O	-1	-1	0
1993–2007.7–12	PMC4064952	6736	6750	O	-1	-1	0

The	PMC4064952	6751	6754	O	-1	-1	0
most	PMC4064952	6755	6759	O	-1	-1	0
likely	PMC4064952	6760	6766	O	-1	-1	0
explanation	PMC4064952	6767	6778	O	-1	-1	0
for	PMC4064952	6779	6782	O	-1	-1	0
such	PMC4064952	6783	6787	O	-1	-1	0
a	PMC4064952	6788	6789	O	-1	-1	0
significant	PMC4064952	6790	6801	O	-1	-1	0
increase	PMC4064952	6802	6810	O	-1	-1	0
is	PMC4064952	6811	6813	O	-1	-1	0
the	PMC4064952	6814	6817	O	-1	-1	0
greater	PMC4064952	6818	6825	O	-1	-1	0
ability	PMC4064952	6826	6833	O	-1	-1	0
to	PMC4064952	6834	6836	O	-1	-1	0
treat	PMC4064952	6837	6842	O	-1	-1	0
chronic	PMC4064952	6843	6850	O	-1	-1	0
cardiac	PMC4064952	6851	6858	O	-1	-1	0
and	PMC4064952	6859	6862	O	-1	-1	0
noncardiac	PMC4064952	6863	6873	O	-1	-1	0
diseases	PMC4064952	6874	6882	O	-1	-1	0
,	PMC4064952	6882	6883	O	-1	-1	0
the	PMC4064952	6884	6887	O	-1	-1	0
aging	PMC4064952	6888	6893	O	-1	-1	0
population	PMC4064952	6894	6904	O	-1	-1	0
,	PMC4064952	6904	6905	O	-1	-1	0
and	PMC4064952	6906	6909	O	-1	-1	0
the	PMC4064952	6910	6913	O	-1	-1	0
improved	PMC4064952	6914	6922	O	-1	-1	0
ability	PMC4064952	6923	6930	O	-1	-1	0
to	PMC4064952	6931	6933	O	-1	-1	0
suspect	PMC4064952	6934	6941	O	-1	-1	0
and	PMC4064952	6942	6945	O	-1	-1	0
diagnose	PMC4064952	6946	6954	O	-1	-1	0
AF.13	PMC4064952	6955	6960	O	-1	-1	0

However	PMC4064952	6961	6968	O	-1	-1	0
,	PMC4064952	6968	6969	O	-1	-1	0
despite	PMC4064952	6970	6977	O	-1	-1	0
this	PMC4064952	6978	6982	O	-1	-1	0
increase	PMC4064952	6983	6991	O	-1	-1	0
,	PMC4064952	6991	6992	O	-1	-1	0
the	PMC4064952	6993	6996	O	-1	-1	0
real	PMC4064952	6997	7001	O	-1	-1	0
prevalence	PMC4064952	7002	7012	O	-1	-1	0
of	PMC4064952	7013	7015	O	-1	-1	0
AF	PMC4064952	7016	7018	O	-1	-1	0
is	PMC4064952	7019	7021	O	-1	-1	0
probably	PMC4064952	7022	7030	O	-1	-1	0
still	PMC4064952	7031	7036	O	-1	-1	0
underestimated	PMC4064952	7037	7051	O	-1	-1	0
because	PMC4064952	7052	7059	O	-1	-1	0
it	PMC4064952	7060	7062	O	-1	-1	0
is	PMC4064952	7063	7065	O	-1	-1	0
well	PMC4064952	7066	7070	O	-1	-1	0
known	PMC4064952	7071	7076	O	-1	-1	0
thatAF	PMC4064952	7077	7083	O	-1	-1	0
,	PMC4064952	7083	7084	O	-1	-1	0
in	PMC4064952	7085	7087	O	-1	-1	0
a	PMC4064952	7088	7089	O	-1	-1	0
dis-	PMC4064952	7090	7094	O	-1	-1	0
crete	PMC4064952	7095	7100	O	-1	-1	0
proportion	PMC4064952	7101	7111	O	-1	-1	0
(	PMC4064952	7112	7113	O	-1	-1	0
10%–25	PMC4064952	7113	7119	O	-1	-1	0
%	PMC4064952	7119	7120	O	-1	-1	0
)	PMC4064952	7120	7121	O	-1	-1	0
of	PMC4064952	7122	7124	O	-1	-1	0
cases	PMC4064952	7125	7130	O	-1	-1	0
,	PMC4064952	7130	7131	O	-1	-1	0
occurs	PMC4064952	7132	7138	O	-1	-1	0
in	PMC4064952	7139	7141	O	-1	-1	0
the	PMC4064952	7142	7145	O	-1	-1	0
absence	PMC4064952	7146	7153	O	-1	-1	0
of	PMC4064952	7154	7156	O	-1	-1	0
symptoms.13,14	PMC4064952	7157	7171	O	-1	-1	0

Very	PMC4064952	7172	7176	O	-1	-1	0
likely	PMC4064952	7177	7183	O	-1	-1	0
,	PMC4064952	7183	7184	O	-1	-1	0
ifAF	PMC4064952	7185	7189	O	-1	-1	0
was	PMC4064952	7190	7193	O	-1	-1	0
detected	PMC4064952	7194	7202	O	-1	-1	0
appropriately	PMC4064952	7203	7216	O	-1	-1	0
by	PMC4064952	7217	7219	O	-1	-1	0
active	PMC4064952	7220	7226	O	-1	-1	0
screening	PMC4064952	7227	7236	O	-1	-1	0
,	PMC4064952	7236	7237	O	-1	-1	0
its	PMC4064952	7238	7241	O	-1	-1	0
prevalence	PMC4064952	7242	7252	O	-1	-1	0
would	PMC4064952	7253	7258	O	-1	-1	0
be	PMC4064952	7259	7261	O	-1	-1	0
higher	PMC4064952	7262	7268	O	-1	-1	0
and	PMC4064952	7269	7272	O	-1	-1	0
closer	PMC4064952	7273	7279	O	-1	-1	0
to	PMC4064952	7280	7282	O	-1	-1	0
3	PMC4064952	7283	7284	O	-1	-1	0
%	PMC4064952	7284	7285	O	-1	-1	0
,	PMC4064952	7285	7286	O	-1	-1	0
as	PMC4064952	7287	7289	O	-1	-1	0
estimated	PMC4064952	7290	7299	O	-1	-1	0
for	PMC4064952	7300	7303	O	-1	-1	0
2015	PMC4064952	7304	7308	O	-1	-1	0
in	PMC4064952	7309	7311	O	-1	-1	0
the	PMC4064952	7312	7315	O	-1	-1	0
USA.3,14	PMC4064952	7316	7324	B-Location	-1	-1	0

In	PMC4064952	7325	7327	O	-1	-1	0
developing	PMC4064952	7328	7338	O	-1	-1	0
countries	PMC4064952	7339	7348	O	-1	-1	0
,	PMC4064952	7348	7349	O	-1	-1	0
AF	PMC4064952	7350	7352	O	-1	-1	0
occurs	PMC4064952	7353	7359	O	-1	-1	0
in	PMC4064952	7360	7362	O	-1	-1	0
approximately	PMC4064952	7363	7376	O	-1	-1	0
0.6	PMC4064952	7377	7380	O	-1	-1	0
%	PMC4064952	7380	7381	O	-1	-1	0
of	PMC4064952	7382	7384	O	-1	-1	0
males	PMC4064952	7385	7390	O	-1	-1	0
and	PMC4064952	7391	7394	O	-1	-1	0
0.4	PMC4064952	7395	7398	O	-1	-1	0
%	PMC4064952	7398	7399	O	-1	-1	0
of	PMC4064952	7400	7402	O	-1	-1	0
females	PMC4064952	7403	7410	O	-1	-1	0
.	PMC4064952	7410	7411	O	-1	-1	0

Although	PMC4064952	7412	7420	O	-1	-1	0
these	PMC4064952	7421	7426	O	-1	-1	0
rates	PMC4064952	7427	7432	O	-1	-1	0
are	PMC4064952	7433	7436	O	-1	-1	0
markedly	PMC4064952	7437	7445	O	-1	-1	0
lower	PMC4064952	7446	7451	O	-1	-1	0
than	PMC4064952	7452	7456	O	-1	-1	0
in	PMC4064952	7457	7459	O	-1	-1	0
developed	PMC4064952	7460	7469	O	-1	-1	0
nations	PMC4064952	7470	7477	O	-1	-1	0
,	PMC4064952	7477	7478	O	-1	-1	0
it	PMC4064952	7479	7481	O	-1	-1	0
appears	PMC4064952	7482	7489	O	-1	-1	0
that	PMC4064952	7490	7494	O	-1	-1	0
the	PMC4064952	7495	7498	O	-1	-1	0
burden	PMC4064952	7499	7505	O	-1	-1	0
of	PMC4064952	7506	7508	O	-1	-1	0
AF	PMC4064952	7509	7511	O	-1	-1	0

0	PMC4064952	7512	7513	O	-1	-1	0

Iceland	PMC4064952	7514	7521	B-Location	-1	-1	0
Italy	PMC4064952	7522	7527	B-Location	-1	-1	0
Germany	PMC4064952	7528	7535	B-Location	-1	-1	0
England	PMC4064952	7536	7543	B-Location	-1	-1	0
Sweden	PMC4064952	7544	7550	B-Location	-1	-1	0

0.5	PMC4064952	7551	7554	O	-1	-1	0

1	PMC4064952	7555	7556	O	-1	-1	0

1.5	PMC4064952	7557	7560	O	-1	-1	0

2	PMC4064952	7561	7562	O	-1	-1	0
Prevalence	PMC4064952	7563	7573	O	-1	-1	0
(	PMC4064952	7574	7575	O	-1	-1	0
%	PMC4064952	7575	7576	O	-1	-1	0
)	PMC4064952	7576	7577	O	-1	-1	0

2.5	PMC4064952	7578	7581	O	-1	-1	0
3	PMC4064952	7582	7583	O	-1	-1	0

3.5	PMC4064952	7584	7587	O	-1	-1	0

Figure	PMC4064952	7588	7594	O	-1	-1	0
1	PMC4064952	7595	7596	O	-1	-1	0
Prevalence	PMC4064952	7597	7607	O	-1	-1	0
of	PMC4064952	7608	7610	O	-1	-1	0
atrial	PMC4064952	7611	7617	O	-1	-1	0
fibrillation	PMC4064952	7618	7630	O	-1	-1	0
in	PMC4064952	7631	7633	O	-1	-1	0
European	PMC4064952	7634	7642	O	-1	-1	0
countries	PMC4064952	7643	7652	O	-1	-1	0
.	PMC4064952	7652	7653	O	-1	-1	0

Clinical	PMC4064952	7654	7662	O	-1	-1	0
Epidemiology	PMC4064952	7663	7675	O	-1	-1	0
2014:6	PMC4064952	7676	7682	O	-1	-1	0
submit	PMC4064952	7683	7689	O	-1	-1	0
your	PMC4064952	7690	7694	O	-1	-1	0
manuscript	PMC4064952	7695	7705	O	-1	-1	0
|	PMC4064952	7706	7707	O	-1	-1	0

www.dovepress.com	PMC4064952	7708	7725	O	-1	-1	0

Dovepress	PMC4064952	7726	7735	O	-1	-1	0

Dovepress	PMC4064952	7736	7745	O	-1	-1	0
215	PMC4064952	7746	7749	O	-1	-1	0

Epidemiology	PMC4064952	7750	7762	O	-1	-1	0
of	PMC4064952	7763	7765	O	-1	-1	0
atrial	PMC4064952	7766	7772	O	-1	-1	0
fibrillation	PMC4064952	7773	7785	O	-1	-1	0
in	PMC4064952	7786	7788	O	-1	-1	0
these	PMC4064952	7789	7794	O	-1	-1	0
countries	PMC4064952	7795	7804	O	-1	-1	0
is	PMC4064952	7805	7807	O	-1	-1	0
enough	PMC4064952	7808	7814	O	-1	-1	0
to	PMC4064952	7815	7817	O	-1	-1	0
be	PMC4064952	7818	7820	O	-1	-1	0
a	PMC4064952	7821	7822	O	-1	-1	0
potential	PMC4064952	7823	7832	O	-1	-1	0
problem	PMC4064952	7833	7840	O	-1	-1	0
for	PMC4064952	7841	7844	O	-1	-1	0
health	PMC4064952	7845	7851	O	-1	-1	0
care	PMC4064952	7852	7856	O	-1	-1	0
systems.15	PMC4064952	7857	7867	O	-1	-1	0

The	PMC4064952	7868	7871	O	-1	-1	0
prevalence	PMC4064952	7872	7882	O	-1	-1	0
of	PMC4064952	7883	7885	O	-1	-1	0
AF	PMC4064952	7886	7888	O	-1	-1	0
varies	PMC4064952	7889	7895	O	-1	-1	0
with	PMC4064952	7896	7900	O	-1	-1	0
age	PMC4064952	7901	7904	O	-1	-1	0
and	PMC4064952	7905	7908	O	-1	-1	0
sex	PMC4064952	7909	7912	O	-1	-1	0
.	PMC4064952	7912	7913	O	-1	-1	0

AF	PMC4064952	7914	7916	O	-1	-1	0
is	PMC4064952	7917	7919	O	-1	-1	0
present	PMC4064952	7920	7927	O	-1	-1	0
in	PMC4064952	7928	7930	O	-1	-1	0
0.12%–0.16	PMC4064952	7931	7941	O	-1	-1	0
%	PMC4064952	7941	7942	O	-1	-1	0
of	PMC4064952	7943	7945	O	-1	-1	0
subjects	PMC4064952	7946	7954	O	-1	-1	0
younger	PMC4064952	7955	7962	O	-1	-1	0
than	PMC4064952	7963	7967	O	-1	-1	0
49	PMC4064952	7968	7970	O	-1	-1	0
years	PMC4064952	7971	7976	O	-1	-1	0
,	PMC4064952	7976	7977	O	-1	-1	0
3.7%–4.2	PMC4064952	7978	7986	O	-1	-1	0
%	PMC4064952	7986	7987	O	-1	-1	0
of	PMC4064952	7988	7990	O	-1	-1	0
those	PMC4064952	7991	7996	O	-1	-1	0
aged	PMC4064952	7997	8001	O	-1	-1	0
60–70	PMC4064952	8002	8007	O	-1	-1	0
years	PMC4064952	8008	8013	O	-1	-1	0
,	PMC4064952	8013	8014	O	-1	-1	0
and	PMC4064952	8015	8018	O	-1	-1	0
10%–17	PMC4064952	8019	8025	O	-1	-1	0
%	PMC4064952	8025	8026	O	-1	-1	0
of	PMC4064952	8027	8029	O	-1	-1	0
those	PMC4064952	8030	8035	O	-1	-1	0
aged	PMC4064952	8036	8040	O	-1	-1	0
80	PMC4064952	8041	8043	O	-1	-1	0
years	PMC4064952	8044	8049	O	-1	-1	0
or	PMC4064952	8050	8052	O	-1	-1	0
older	PMC4064952	8053	8058	O	-1	-1	0
.	PMC4064952	8058	8059	O	-1	-1	0

In	PMC4064952	8060	8062	O	-1	-1	0
addition	PMC4064952	8063	8071	O	-1	-1	0
,	PMC4064952	8071	8072	O	-1	-1	0
it	PMC4064952	8073	8075	O	-1	-1	0
occurs	PMC4064952	8076	8082	O	-1	-1	0
more	PMC4064952	8083	8087	O	-1	-1	0
frequently	PMC4064952	8088	8098	O	-1	-1	0
in	PMC4064952	8099	8101	O	-1	-1	0
males	PMC4064952	8102	8107	O	-1	-1	0
,	PMC4064952	8107	8108	O	-1	-1	0
with	PMC4064952	8109	8113	O	-1	-1	0
a	PMC4064952	8114	8115	O	-1	-1	0
male	PMC4064952	8116	8120	O	-1	-1	0
to	PMC4064952	8121	8123	O	-1	-1	0
female	PMC4064952	8124	8130	O	-1	-1	0
ratio	PMC4064952	8131	8136	O	-1	-1	0
of	PMC4064952	8137	8139	O	-1	-1	0
approximately	PMC4064952	8140	8153	O	-1	-1	0
1.2:1	PMC4064952	8154	8159	O	-1	-1	0
.	PMC4064952	8159	8160	O	-1	-1	0

Despite	PMC4064952	8161	8168	O	-1	-1	0
the	PMC4064952	8169	8172	O	-1	-1	0
greater	PMC4064952	8173	8180	O	-1	-1	0
prevalence	PMC4064952	8181	8191	O	-1	-1	0
in	PMC4064952	8192	8194	O	-1	-1	0
men	PMC4064952	8195	8198	O	-1	-1	0
,	PMC4064952	8198	8199	O	-1	-1	0
women	PMC4064952	8200	8205	O	-1	-1	0
represent	PMC4064952	8206	8215	O	-1	-1	0
the	PMC4064952	8216	8219	O	-1	-1	0
bulk	PMC4064952	8220	8224	O	-1	-1	0
of	PMC4064952	8225	8227	O	-1	-1	0
patients	PMC4064952	8228	8236	O	-1	-1	0
with	PMC4064952	8237	8241	O	-1	-1	0
AF	PMC4064952	8242	8244	O	-1	-1	0
due	PMC4064952	8245	8248	O	-1	-1	0
to	PMC4064952	8249	8251	O	-1	-1	0
their	PMC4064952	8252	8257	O	-1	-1	0
longer	PMC4064952	8258	8264	O	-1	-1	0
survival.7–12,15,16	PMC4064952	8265	8284	O	-1	-1	0

Less	PMC4064952	8285	8289	O	-1	-1	0
information	PMC4064952	8290	8301	O	-1	-1	0
is	PMC4064952	8302	8304	O	-1	-1	0
available	PMC4064952	8305	8314	O	-1	-1	0
on	PMC4064952	8315	8317	O	-1	-1	0
the	PMC4064952	8318	8321	O	-1	-1	0
incidence	PMC4064952	8322	8331	O	-1	-1	0
ofAF	PMC4064952	8332	8336	O	-1	-1	0
.	PMC4064952	8336	8337	O	-1	-1	0

One	PMC4064952	8338	8341	O	-1	-1	0
of	PMC4064952	8342	8344	O	-1	-1	0
the	PMC4064952	8345	8348	O	-1	-1	0
first	PMC4064952	8349	8354	O	-1	-1	0
investigations	PMC4064952	8355	8369	O	-1	-1	0
of	PMC4064952	8370	8372	O	-1	-1	0
this	PMC4064952	8373	8377	O	-1	-1	0
problem	PMC4064952	8378	8385	O	-1	-1	0
was	PMC4064952	8386	8389	O	-1	-1	0
the	PMC4064952	8390	8393	O	-1	-1	0
Framingham	PMC4064952	8394	8404	O	-1	-1	0

study	PMC4064952	8405	8410	O	-1	-1	0

that	PMC4064952	8411	8415	O	-1	-1	0
in	PMC4064952	8416	8418	O	-1	-1	0
1982	PMC4064952	8419	8423	O	-1	-1	0
reported	PMC4064952	8424	8432	O	-1	-1	0
the	PMC4064952	8433	8436	O	-1	-1	0
overall	PMC4064952	8437	8444	O	-1	-1	0
incidence	PMC4064952	8445	8454	O	-1	-1	0
of	PMC4064952	8455	8457	O	-1	-1	0
chronic	PMC4064952	8458	8465	O	-1	-1	0

AF	PMC4064952	8466	8468	O	-1	-1	0
at	PMC4064952	8469	8471	O	-1	-1	0
two	PMC4064952	8472	8475	O	-1	-1	0
per	PMC4064952	8476	8479	O	-1	-1	0
1,000	PMC4064952	8480	8485	O	-1	-1	0
on	PMC4064952	8486	8488	O	-1	-1	0
biannual	PMC4064952	8489	8497	O	-1	-1	0
electrocardiography	PMC4064952	8498	8517	O	-1	-1	0
in	PMC4064952	8518	8520	O	-1	-1	0
patients	PMC4064952	8521	8529	O	-1	-1	0
aged	PMC4064952	8530	8534	O	-1	-1	0
32–65	PMC4064952	8535	8540	O	-1	-1	0
years.17	PMC4064952	8541	8549	O	-1	-1	0

Subsequently	PMC4064952	8550	8562	O	-1	-1	0
,	PMC4064952	8562	8563	O	-1	-1	0
only	PMC4064952	8564	8568	O	-1	-1	0
few	PMC4064952	8569	8572	O	-1	-1	0
stud-	PMC4064952	8573	8578	O	-1	-1	0
ies	PMC4064952	8579	8582	O	-1	-1	0
have	PMC4064952	8583	8587	O	-1	-1	0
analyzed	PMC4064952	8588	8596	O	-1	-1	0
this	PMC4064952	8597	8601	O	-1	-1	0
issue	PMC4064952	8602	8607	O	-1	-1	0
,	PMC4064952	8607	8608	O	-1	-1	0
with	PMC4064952	8609	8613	O	-1	-1	0
results	PMC4064952	8614	8621	O	-1	-1	0
that	PMC4064952	8622	8626	O	-1	-1	0
are	PMC4064952	8627	8630	O	-1	-1	0
not	PMC4064952	8631	8634	O	-1	-1	0
easily	PMC4064952	8635	8641	O	-1	-1	0
comparable	PMC4064952	8642	8652	O	-1	-1	0
because	PMC4064952	8653	8660	O	-1	-1	0
of	PMC4064952	8661	8663	O	-1	-1	0
a	PMC4064952	8664	8665	O	-1	-1	0
lack	PMC4064952	8666	8670	O	-1	-1	0
of	PMC4064952	8671	8673	O	-1	-1	0
homogeneity	PMC4064952	8674	8685	O	-1	-1	0
with	PMC4064952	8686	8690	O	-1	-1	0
regard	PMC4064952	8691	8697	O	-1	-1	0
to	PMC4064952	8698	8700	O	-1	-1	0
the	PMC4064952	8701	8704	O	-1	-1	0
characteristics	PMC4064952	8705	8720	O	-1	-1	0
of	PMC4064952	8721	8723	O	-1	-1	0
enrolled	PMC4064952	8724	8732	O	-1	-1	0
populations	PMC4064952	8733	8744	O	-1	-1	0
,	PMC4064952	8744	8745	O	-1	-1	0
ie	PMC4064952	8746	8748	O	-1	-1	0
,	PMC4064952	8748	8749	O	-1	-1	0
different	PMC4064952	8750	8759	O	-1	-1	0
age	PMC4064952	8760	8763	O	-1	-1	0
limits	PMC4064952	8764	8770	O	-1	-1	0
,	PMC4064952	8770	8771	O	-1	-1	0
different	PMC4064952	8772	8781	O	-1	-1	0
types	PMC4064952	8782	8787	O	-1	-1	0
of	PMC4064952	8788	8790	O	-1	-1	0
AF	PMC4064952	8791	8793	O	-1	-1	0
analyzed	PMC4064952	8794	8802	O	-1	-1	0
(	PMC4064952	8803	8804	O	-1	-1	0
all	PMC4064952	8804	8807	O	-1	-1	0
together	PMC4064952	8808	8816	O	-1	-1	0
,	PMC4064952	8816	8817	O	-1	-1	0
only	PMC4064952	8818	8822	O	-1	-1	0
permanentAF	PMC4064952	8823	8834	O	-1	-1	0
)	PMC4064952	8834	8835	O	-1	-1	0
,	PMC4064952	8835	8836	O	-1	-1	0
different	PMC4064952	8837	8846	O	-1	-1	0
reservoirs	PMC4064952	8847	8857	O	-1	-1	0
of	PMC4064952	8858	8860	O	-1	-1	0
recruitment	PMC4064952	8861	8872	O	-1	-1	0
(	PMC4064952	8873	8874	O	-1	-1	0
members	PMC4064952	8874	8881	O	-1	-1	0
of	PMC4064952	8882	8884	O	-1	-1	0
health	PMC4064952	8885	8891	O	-1	-1	0
insurance	PMC4064952	8892	8901	O	-1	-1	0
funds	PMC4064952	8902	8907	O	-1	-1	0
or	PMC4064952	8908	8910	O	-1	-1	0
national	PMC4064952	8911	8919	O	-1	-1	0
health	PMC4064952	8920	8926	O	-1	-1	0
care	PMC4064952	8927	8931	O	-1	-1	0
systems	PMC4064952	8932	8939	O	-1	-1	0
)	PMC4064952	8939	8940	O	-1	-1	0
,	PMC4064952	8940	8941	O	-1	-1	0
and	PMC4064952	8942	8945	O	-1	-1	0
different	PMC4064952	8946	8955	O	-1	-1	0
ways	PMC4064952	8956	8960	O	-1	-1	0
of	PMC4064952	8961	8963	O	-1	-1	0
diagnosing	PMC4064952	8964	8974	O	-1	-1	0
AF	PMC4064952	8975	8977	O	-1	-1	0
(	PMC4064952	8978	8979	O	-1	-1	0
classification	PMC4064952	8979	8993	O	-1	-1	0
based	PMC4064952	8994	8999	O	-1	-1	0
on	PMC4064952	9000	9002	O	-1	-1	0
administrative	PMC4064952	9003	9017	O	-1	-1	0
data	PMC4064952	9018	9022	O	-1	-1	0
,	PMC4064952	9022	9023	O	-1	-1	0
identification	PMC4064952	9024	9038	O	-1	-1	0
based	PMC4064952	9039	9044	O	-1	-1	0
on	PMC4064952	9045	9047	O	-1	-1	0
judgment	PMC4064952	9048	9056	O	-1	-1	0
of	PMC4064952	9057	9059	O	-1	-1	0
general	PMC4064952	9060	9067	O	-1	-1	0
practitioners	PMC4064952	9068	9081	O	-1	-1	0
)	PMC4064952	9081	9082	O	-1	-1	0
.	PMC4064952	9082	9083	O	-1	-1	0

However	PMC4064952	9084	9091	O	-1	-1	0
,	PMC4064952	9091	9092	O	-1	-1	0
from	PMC4064952	9093	9097	O	-1	-1	0
these	PMC4064952	9098	9103	O	-1	-1	0
studies	PMC4064952	9104	9111	O	-1	-1	0
,	PMC4064952	9111	9112	O	-1	-1	0
it	PMC4064952	9113	9115	O	-1	-1	0
appears	PMC4064952	9116	9123	O	-1	-1	0
that	PMC4064952	9124	9128	O	-1	-1	0
among	PMC4064952	9129	9134	O	-1	-1	0
US	PMC4064952	9135	9137	O	-1	-1	0
Medicare	PMC4064952	9138	9146	O	-1	-1	0
beneficiaries	PMC4064952	9147	9160	O	-1	-1	0
aged	PMC4064952	9161	9165	O	-1	-1	0
65	PMC4064952	9166	9168	O	-1	-1	0
years	PMC4064952	9169	9174	O	-1	-1	0
or	PMC4064952	9175	9177	O	-1	-1	0
older	PMC4064952	9178	9183	O	-1	-1	0
,	PMC4064952	9183	9184	O	-1	-1	0
the	PMC4064952	9185	9188	O	-1	-1	0
incidence	PMC4064952	9189	9198	O	-1	-1	0
ofAF	PMC4064952	9199	9203	O	-1	-1	0
has	PMC4064952	9204	9207	O	-1	-1	0
not	PMC4064952	9208	9211	O	-1	-1	0
changed	PMC4064952	9212	9219	O	-1	-1	0
substantially	PMC4064952	9220	9233	O	-1	-1	0
from	PMC4064952	9234	9238	O	-1	-1	0
1993	PMC4064952	9239	9243	O	-1	-1	0
(	PMC4064952	9244	9245	O	-1	-1	0
27.3	PMC4064952	9245	9249	O	-1	-1	0
per	PMC4064952	9250	9253	O	-1	-1	0
1,000	PMC4064952	9254	9259	O	-1	-1	0
person	PMC4064952	9260	9266	O	-1	-1	0
/	PMC4064952	9266	9267	O	-1	-1	0
years	PMC4064952	9267	9272	O	-1	-1	0
)	PMC4064952	9272	9273	O	-1	-1	0
to	PMC4064952	9274	9276	O	-1	-1	0
2007	PMC4064952	9277	9281	O	-1	-1	0
(	PMC4064952	9282	9283	O	-1	-1	0
28.3	PMC4064952	9283	9287	O	-1	-1	0
per	PMC4064952	9288	9291	O	-1	-1	0
1,000	PMC4064952	9292	9297	O	-1	-1	0
person	PMC4064952	9298	9304	O	-1	-1	0
/	PMC4064952	9304	9305	O	-1	-1	0
years	PMC4064952	9305	9310	O	-1	-1	0
)	PMC4064952	9310	9311	O	-1	-1	0
,	PMC4064952	9311	9312	O	-1	-1	0
has	PMC4064952	9313	9316	O	-1	-1	0
always	PMC4064952	9317	9323	O	-1	-1	0
remained	PMC4064952	9324	9332	O	-1	-1	0
higher	PMC4064952	9333	9339	O	-1	-1	0
among	PMC4064952	9340	9345	O	-1	-1	0
men	PMC4064952	9346	9349	O	-1	-1	0
(	PMC4064952	9350	9351	O	-1	-1	0
34	PMC4064952	9351	9353	O	-1	-1	0
per	PMC4064952	9354	9357	O	-1	-1	0
1,000	PMC4064952	9358	9363	O	-1	-1	0
person	PMC4064952	9364	9370	O	-1	-1	0
/	PMC4064952	9370	9371	O	-1	-1	0
years	PMC4064952	9371	9376	O	-1	-1	0
in	PMC4064952	9377	9379	O	-1	-1	0
men	PMC4064952	9380	9383	O	-1	-1	0
versus	PMC4064952	9384	9390	O	-1	-1	0
25	PMC4064952	9391	9393	O	-1	-1	0
per	PMC4064952	9394	9397	O	-1	-1	0
1,000	PMC4064952	9398	9403	O	-1	-1	0
person/	PMC4064952	9404	9411	O	-1	-1	0
years	PMC4064952	9412	9417	O	-1	-1	0
in	PMC4064952	9418	9420	O	-1	-1	0
women	PMC4064952	9421	9426	O	-1	-1	0
)	PMC4064952	9426	9427	O	-1	-1	0
,	PMC4064952	9427	9428	O	-1	-1	0
and	PMC4064952	9429	9432	O	-1	-1	0
has	PMC4064952	9433	9436	O	-1	-1	0
continued	PMC4064952	9437	9446	O	-1	-1	0
to	PMC4064952	9447	9449	O	-1	-1	0
be	PMC4064952	9450	9452	O	-1	-1	0
much	PMC4064952	9453	9457	O	-1	-1	0
higher	PMC4064952	9458	9464	O	-1	-1	0
in	PMC4064952	9465	9467	O	-1	-1	0
the	PMC4064952	9468	9471	O	-1	-1	0
elderly	PMC4064952	9472	9479	O	-1	-1	0
population	PMC4064952	9480	9490	O	-1	-1	0
(	PMC4064952	9491	9492	O	-1	-1	0
18.8	PMC4064952	9492	9496	O	-1	-1	0
per	PMC4064952	9497	9500	O	-1	-1	0
1,000	PMC4064952	9501	9506	O	-1	-1	0
person	PMC4064952	9507	9513	O	-1	-1	0
/	PMC4064952	9513	9514	O	-1	-1	0
years	PMC4064952	9514	9519	O	-1	-1	0
in	PMC4064952	9520	9522	O	-1	-1	0
those	PMC4064952	9523	9528	O	-1	-1	0
aged	PMC4064952	9529	9533	O	-1	-1	0
70–74	PMC4064952	9534	9539	O	-1	-1	0
years	PMC4064952	9540	9545	O	-1	-1	0
versus	PMC4064952	9546	9552	O	-1	-1	0
53.9	PMC4064952	9553	9557	O	-1	-1	0
per	PMC4064952	9558	9561	O	-1	-1	0
1,000	PMC4064952	9562	9567	O	-1	-1	0
person	PMC4064952	9568	9574	O	-1	-1	0
/	PMC4064952	9574	9575	O	-1	-1	0
years	PMC4064952	9575	9580	O	-1	-1	0
in	PMC4064952	9581	9583	O	-1	-1	0
those	PMC4064952	9584	9589	O	-1	-1	0
aged	PMC4064952	9590	9594	O	-1	-1	0
84–89	PMC4064952	9595	9600	O	-1	-1	0
years).10	PMC4064952	9601	9610	O	-1	-1	0

Similar	PMC4064952	9611	9618	O	-1	-1	0
data	PMC4064952	9619	9623	O	-1	-1	0
were	PMC4064952	9624	9628	O	-1	-1	0
reported	PMC4064952	9629	9637	O	-1	-1	0
for	PMC4064952	9638	9641	O	-1	-1	0
another	PMC4064952	9642	9649	O	-1	-1	0
study	PMC4064952	9650	9655	O	-1	-1	0
performed	PMC4064952	9656	9665	O	-1	-1	0
in	PMC4064952	9666	9668	O	-1	-1	0
the	PMC4064952	9669	9672	O	-1	-1	0
USA	PMC4064952	9673	9676	B-Location	-1	-1	0
,	PMC4064952	9676	9677	O	-1	-1	0
ie	PMC4064952	9678	9680	O	-1	-1	0
,	PMC4064952	9680	9681	O	-1	-1	0
the	PMC4064952	9682	9685	O	-1	-1	0
Olmsted	PMC4064952	9686	9693	O	-1	-1	0
County	PMC4064952	9694	9700	O	-1	-1	0
population	PMC4064952	9701	9711	O	-1	-1	0
in	PMC4064952	9712	9714	O	-1	-1	0
subjects	PMC4064952	9715	9723	O	-1	-1	0
aged	PMC4064952	9724	9728	O	-1	-1	0
18	PMC4064952	9729	9731	O	-1	-1	0
years	PMC4064952	9732	9737	O	-1	-1	0
and	PMC4064952	9738	9741	O	-1	-1	0
over	PMC4064952	9742	9746	O	-1	-1	0
.	PMC4064952	9746	9747	O	-1	-1	0

The	PMC4064952	9748	9751	O	-1	-1	0
incidence	PMC4064952	9752	9761	O	-1	-1	0
of	PMC4064952	9762	9764	O	-1	-1	0
AF	PMC4064952	9765	9767	O	-1	-1	0
has	PMC4064952	9768	9771	O	-1	-1	0
increased	PMC4064952	9772	9781	O	-1	-1	0
only	PMC4064952	9782	9786	O	-1	-1	0
slightly	PMC4064952	9787	9795	O	-1	-1	0
in	PMC4064952	9796	9798	O	-1	-1	0
this	PMC4064952	9799	9803	O	-1	-1	0
region	PMC4064952	9804	9810	O	-1	-1	0
between	PMC4064952	9811	9818	O	-1	-1	0
1980	PMC4064952	9819	9823	O	-1	-1	0
(	PMC4064952	9824	9825	O	-1	-1	0
3.04	PMC4064952	9825	9829	O	-1	-1	0
per	PMC4064952	9830	9833	O	-1	-1	0
1,000	PMC4064952	9834	9839	O	-1	-1	0
person	PMC4064952	9840	9846	O	-1	-1	0
/	PMC4064952	9846	9847	O	-1	-1	0
years	PMC4064952	9847	9852	O	-1	-1	0
)	PMC4064952	9852	9853	O	-1	-1	0
and	PMC4064952	9854	9857	O	-1	-1	0
2000	PMC4064952	9858	9862	O	-1	-1	0
(	PMC4064952	9863	9864	O	-1	-1	0
3.68	PMC4064952	9864	9868	O	-1	-1	0
per	PMC4064952	9869	9872	O	-1	-1	0
1,000	PMC4064952	9873	9878	O	-1	-1	0
person	PMC4064952	9879	9885	O	-1	-1	0
/	PMC4064952	9885	9886	O	-1	-1	0

years).18	PMC4064952	9886	9895	O	-1	-1	0

In	PMC4064952	9896	9898	O	-1	-1	0
Europe	PMC4064952	9899	9905	B-Location	-1	-1	0
,	PMC4064952	9905	9906	O	-1	-1	0
the	PMC4064952	9907	9910	O	-1	-1	0
most	PMC4064952	9911	9915	O	-1	-1	0
recent	PMC4064952	9916	9922	O	-1	-1	0
studies	PMC4064952	9923	9930	O	-1	-1	0
performed	PMC4064952	9931	9940	O	-1	-1	0
in	PMC4064952	9941	9943	O	-1	-1	0
the	PMC4064952	9944	9947	O	-1	-1	0
global	PMC4064952	9948	9954	O	-1	-1	0
population	PMC4064952	9955	9965	O	-1	-1	0
over	PMC4064952	9966	9970	O	-1	-1	0
the	PMC4064952	9971	9974	O	-1	-1	0
last	PMC4064952	9975	9979	O	-1	-1	0
decade	PMC4064952	9980	9986	O	-1	-1	0
report	PMC4064952	9987	9993	O	-1	-1	0
an	PMC4064952	9994	9996	O	-1	-1	0
incidence	PMC4064952	9997	10006	O	-1	-1	0
of	PMC4064952	10007	10009	O	-1	-1	0
AF	PMC4064952	10010	10012	O	-1	-1	0
ranging	PMC4064952	10013	10020	O	-1	-1	0
from	PMC4064952	10021	10025	O	-1	-1	0
0.23	PMC4064952	10026	10030	O	-1	-1	0
per	PMC4064952	10031	10034	O	-1	-1	0
1,000	PMC4064952	10035	10040	O	-1	-1	0
person	PMC4064952	10041	10047	O	-1	-1	0
/	PMC4064952	10047	10048	O	-1	-1	0
years	PMC4064952	10048	10053	O	-1	-1	0
in	PMC4064952	10054	10056	O	-1	-1	0
Iceland	PMC4064952	10057	10064	B-Location	-1	-1	0
to	PMC4064952	10065	10067	O	-1	-1	0
0.41	PMC4064952	10068	10072	O	-1	-1	0
in	PMC4064952	10073	10075	O	-1	-1	0
Germany	PMC4064952	10076	10083	B-Location	-1	-1	0
and	PMC4064952	10084	10087	O	-1	-1	0
0.9	PMC4064952	10088	10091	O	-1	-1	0
in	PMC4064952	10092	10094	O	-1	-1	0
Scotland	PMC4064952	10095	10103	B-Location	-1	-1	0
,	PMC4064952	10103	10104	O	-1	-1	0
respectively.4,8,11	PMC4064952	10105	10124	O	-1	-1	0

Also	PMC4064952	10125	10129	O	-1	-1	0
,	PMC4064952	10129	10130	O	-1	-1	0
in	PMC4064952	10131	10133	O	-1	-1	0
Europe	PMC4064952	10134	10140	B-Location	-1	-1	0
,	PMC4064952	10140	10141	O	-1	-1	0
the	PMC4064952	10142	10145	O	-1	-1	0
incidence	PMC4064952	10146	10155	O	-1	-1	0
of	PMC4064952	10156	10158	O	-1	-1	0
AF	PMC4064952	10159	10161	O	-1	-1	0
increases	PMC4064952	10162	10171	O	-1	-1	0
with	PMC4064952	10172	10176	O	-1	-1	0
age	PMC4064952	10177	10180	O	-1	-1	0
and	PMC4064952	10181	10184	O	-1	-1	0
differs	PMC4064952	10185	10192	O	-1	-1	0
with	PMC4064952	10193	10197	O	-1	-1	0
sex	PMC4064952	10198	10201	O	-1	-1	0
,	PMC4064952	10201	10202	O	-1	-1	0
even	PMC4064952	10203	10207	O	-1	-1	0
if	PMC4064952	10208	10210	O	-1	-1	0
the	PMC4064952	10211	10214	O	-1	-1	0
reported	PMC4064952	10215	10223	O	-1	-1	0
rates	PMC4064952	10224	10229	O	-1	-1	0
are	PMC4064952	10230	10233	O	-1	-1	0
lower	PMC4064952	10234	10239	O	-1	-1	0
than	PMC4064952	10240	10244	O	-1	-1	0
those	PMC4064952	10245	10250	O	-1	-1	0
of	PMC4064952	10251	10253	O	-1	-1	0
the	PMC4064952	10254	10257	O	-1	-1	0
USA	PMC4064952	10258	10261	B-Location	-1	-1	0
population	PMC4064952	10262	10272	O	-1	-1	0
.	PMC4064952	10272	10273	O	-1	-1	0

In	PMC4064952	10274	10276	O	-1	-1	0
Scotland	PMC4064952	10277	10285	B-Location	-1	-1	0
,	PMC4064952	10285	10286	O	-1	-1	0
Germany	PMC4064952	10287	10294	B-Location	-1	-1	0
,	PMC4064952	10294	10295	O	-1	-1	0
and	PMC4064952	10296	10299	O	-1	-1	0
the	PMC4064952	10300	10303	O	-1	-1	0
USA	PMC4064952	10304	10307	B-Location	-1	-1	0
,	PMC4064952	10307	10308	O	-1	-1	0
subjects	PMC4064952	10309	10317	O	-1	-1	0
aged	PMC4064952	10318	10322	O	-1	-1	0
65	PMC4064952	10323	10325	O	-1	-1	0
years	PMC4064952	10326	10331	O	-1	-1	0
or	PMC4064952	10332	10334	O	-1	-1	0
older	PMC4064952	10335	10340	O	-1	-1	0
show	PMC4064952	10341	10345	O	-1	-1	0
anAF	PMC4064952	10346	10350	O	-1	-1	0
incidence	PMC4064952	10351	10360	O	-1	-1	0
of	PMC4064952	10361	10363	O	-1	-1	0
4.7	PMC4064952	10364	10367	O	-1	-1	0
,	PMC4064952	10367	10368	O	-1	-1	0
4.1	PMC4064952	10369	10372	O	-1	-1	0
,	PMC4064952	10372	10373	O	-1	-1	0
and	PMC4064952	10374	10377	O	-1	-1	0
28.3	PMC4064952	10378	10382	O	-1	-1	0
per	PMC4064952	10383	10386	O	-1	-1	0
1,000	PMC4064952	10387	10392	O	-1	-1	0
person	PMC4064952	10393	10399	O	-1	-1	0
/	PMC4064952	10399	10400	O	-1	-1	0
years	PMC4064952	10400	10405	O	-1	-1	0
,	PMC4064952	10405	10406	O	-1	-1	0
respectively	PMC4064952	10407	10419	O	-1	-1	0
;	PMC4064952	10419	10420	O	-1	-1	0
those	PMC4064952	10421	10426	O	-1	-1	0
aged	PMC4064952	10427	10431	O	-1	-1	0

65–74	PMC4064952	10432	10437	O	-1	-1	0
years	PMC4064952	10438	10443	O	-1	-1	0
show	PMC4064952	10444	10448	O	-1	-1	0
an	PMC4064952	10449	10451	O	-1	-1	0
incidence	PMC4064952	10452	10461	O	-1	-1	0
of	PMC4064952	10462	10464	O	-1	-1	0
3.2	PMC4064952	10465	10468	O	-1	-1	0
,	PMC4064952	10468	10469	O	-1	-1	0
10.8	PMC4064952	10470	10474	O	-1	-1	0
,	PMC4064952	10474	10475	O	-1	-1	0
and	PMC4064952	10476	10479	O	-1	-1	0
15.5	PMC4064952	10480	10484	O	-1	-1	0

(	PMC4064952	10485	10486	O	-1	-1	0
mean	PMC4064952	10486	10490	O	-1	-1	0
value	PMC4064952	10491	10496	O	-1	-1	0
between	PMC4064952	10497	10504	O	-1	-1	0
those	PMC4064952	10505	10510	O	-1	-1	0
aged	PMC4064952	10511	10515	O	-1	-1	0
65–69	PMC4064952	10516	10521	O	-1	-1	0
years	PMC4064952	10522	10527	O	-1	-1	0
and	PMC4064952	10528	10531	O	-1	-1	0
70–74	PMC4064952	10532	10537	O	-1	-1	0
years	PMC4064952	10538	10543	O	-1	-1	0
)	PMC4064952	10543	10544	O	-1	-1	0
per	PMC4064952	10545	10548	O	-1	-1	0
1,000	PMC4064952	10549	10554	O	-1	-1	0
person	PMC4064952	10555	10561	O	-1	-1	0
/	PMC4064952	10561	10562	O	-1	-1	0
years	PMC4064952	10562	10567	O	-1	-1	0
;	PMC4064952	10567	10568	O	-1	-1	0
and	PMC4064952	10569	10572	O	-1	-1	0
those	PMC4064952	10573	10578	O	-1	-1	0
aged	PMC4064952	10579	10583	O	-1	-1	0
75–84	PMC4064952	10584	10589	O	-1	-1	0
years	PMC4064952	10590	10595	O	-1	-1	0
show	PMC4064952	10596	10600	O	-1	-1	0
an	PMC4064952	10601	10603	O	-1	-1	0
incidence	PMC4064952	10604	10613	O	-1	-1	0
of	PMC4064952	10614	10616	O	-1	-1	0
6.2	PMC4064952	10617	10620	O	-1	-1	0
,	PMC4064952	10620	10621	O	-1	-1	0
16.8	PMC4064952	10622	10626	O	-1	-1	0
,	PMC4064952	10626	10627	O	-1	-1	0
and	PMC4064952	10628	10631	O	-1	-1	0
33.5	PMC4064952	10632	10636	O	-1	-1	0

(	PMC4064952	10637	10638	O	-1	-1	0
mean	PMC4064952	10638	10642	O	-1	-1	0
value	PMC4064952	10643	10648	O	-1	-1	0
between	PMC4064952	10649	10656	O	-1	-1	0
those	PMC4064952	10657	10662	O	-1	-1	0
aged	PMC4064952	10663	10667	O	-1	-1	0
75–79	PMC4064952	10668	10673	O	-1	-1	0
years	PMC4064952	10674	10679	O	-1	-1	0
and	PMC4064952	10680	10683	O	-1	-1	0
80–84	PMC4064952	10684	10689	O	-1	-1	0
years	PMC4064952	10690	10695	O	-1	-1	0
)	PMC4064952	10695	10696	O	-1	-1	0
per	PMC4064952	10697	10700	O	-1	-1	0
1,000	PMC4064952	10701	10706	O	-1	-1	0
person	PMC4064952	10707	10713	O	-1	-1	0
/	PMC4064952	10713	10714	O	-1	-1	0
years	PMC4064952	10714	10719	O	-1	-1	0
.	PMC4064952	10719	10720	O	-1	-1	0

A	PMC4064952	10721	10722	O	-1	-1	0
possible	PMC4064952	10723	10731	O	-1	-1	0
explanation	PMC4064952	10732	10743	O	-1	-1	0
for	PMC4064952	10744	10747	O	-1	-1	0
such	PMC4064952	10748	10752	O	-1	-1	0
marked	PMC4064952	10753	10759	O	-1	-1	0
differences	PMC4064952	10760	10771	O	-1	-1	0
lies	PMC4064952	10772	10776	O	-1	-1	0
in	PMC4064952	10777	10779	O	-1	-1	0
the	PMC4064952	10780	10783	O	-1	-1	0
method	PMC4064952	10784	10790	O	-1	-1	0
used	PMC4064952	10791	10795	O	-1	-1	0
to	PMC4064952	10796	10798	O	-1	-1	0
define	PMC4064952	10799	10805	O	-1	-1	0
the	PMC4064952	10806	10809	O	-1	-1	0
first	PMC4064952	10810	10815	O	-1	-1	0
episode	PMC4064952	10816	10823	O	-1	-1	0
of	PMC4064952	10824	10826	O	-1	-1	0
AF	PMC4064952	10827	10829	O	-1	-1	0
,	PMC4064952	10829	10830	O	-1	-1	0
ie	PMC4064952	10831	10833	O	-1	-1	0
,	PMC4064952	10833	10834	O	-1	-1	0
on	PMC4064952	10835	10837	O	-1	-1	0
the	PMC4064952	10838	10841	O	-1	-1	0
basis	PMC4064952	10842	10847	O	-1	-1	0
of	PMC4064952	10848	10850	O	-1	-1	0
administrative	PMC4064952	10851	10865	O	-1	-1	0
data	PMC4064952	10866	10870	O	-1	-1	0
(	PMC4064952	10871	10872	O	-1	-1	0
uncertainty	PMC4064952	10872	10883	O	-1	-1	0
in	PMC4064952	10884	10886	O	-1	-1	0
classifying	PMC4064952	10887	10898	O	-1	-1	0
the	PMC4064952	10899	10902	O	-1	-1	0
types	PMC4064952	10903	10908	O	-1	-1	0
of	PMC4064952	10909	10911	O	-1	-1	0
AF	PMC4064952	10912	10914	O	-1	-1	0
by	PMC4064952	10915	10917	O	-1	-1	0
the	PMC4064952	10918	10921	O	-1	-1	0
International	PMC4064952	10922	10935	O	-1	-1	0
Classification	PMC4064952	10936	10950	O	-1	-1	0
of	PMC4064952	10951	10953	O	-1	-1	0
Diseases	PMC4064952	10954	10962	O	-1	-1	0

diagnosis	PMC4064952	10963	10972	O	-1	-1	0
codes	PMC4064952	10973	10978	O	-1	-1	0
,	PMC4064952	10978	10979	O	-1	-1	0
the	PMC4064952	10980	10983	O	-1	-1	0
definition	PMC4064952	10984	10994	O	-1	-1	0
of	PMC4064952	10995	10997	O	-1	-1	0
prevalent	PMC4064952	10998	11007	O	-1	-1	0
AF	PMC4064952	11008	11010	O	-1	-1	0
generally	PMC4064952	11011	11020	O	-1	-1	0
made	PMC4064952	11021	11025	O	-1	-1	0
in	PMC4064952	11026	11028	O	-1	-1	0
inpatients	PMC4064952	11029	11039	O	-1	-1	0
,	PMC4064952	11039	11040	O	-1	-1	0
difficulties	PMC4064952	11041	11053	O	-1	-1	0
in	PMC4064952	11054	11056	O	-1	-1	0
assessing	PMC4064952	11057	11066	O	-1	-1	0
patients	PMC4064952	11067	11075	O	-1	-1	0
with	PMC4064952	11076	11080	O	-1	-1	0
a	PMC4064952	11081	11082	O	-1	-1	0
first	PMC4064952	11083	11088	O	-1	-1	0
episode	PMC4064952	11089	11096	O	-1	-1	0
of	PMC4064952	11097	11099	O	-1	-1	0
AF	PMC4064952	11100	11102	O	-1	-1	0
)	PMC4064952	11102	11103	O	-1	-1	0
or	PMC4064952	11104	11106	O	-1	-1	0
a	PMC4064952	11107	11108	O	-1	-1	0
documented	PMC4064952	11109	11119	O	-1	-1	0
history	PMC4064952	11120	11127	O	-1	-1	0
of	PMC4064952	11128	11130	O	-1	-1	0
AF	PMC4064952	11131	11133	O	-1	-1	0
as	PMC4064952	11134	11136	O	-1	-1	0
in	PMC4064952	11137	11139	O	-1	-1	0
Germany	PMC4064952	11140	11147	B-Location	-1	-1	0
and	PMC4064952	11148	11151	O	-1	-1	0
Scotland.4,8,10	PMC4064952	11152	11167	B-Location	-1	-1	0

Types	PMC4064952	11168	11173	O	-1	-1	0
of	PMC4064952	11174	11176	O	-1	-1	0
AF	PMC4064952	11177	11179	O	-1	-1	0
,	PMC4064952	11179	11180	O	-1	-1	0
characteristics	PMC4064952	11181	11196	O	-1	-1	0
of	PMC4064952	11197	11199	O	-1	-1	0
AF	PMC4064952	11200	11202	O	-1	-1	0
patients	PMC4064952	11203	11211	O	-1	-1	0
,	PMC4064952	11211	11212	O	-1	-1	0
and	PMC4064952	11213	11216	O	-1	-1	0
impact	PMC4064952	11217	11223	O	-1	-1	0
of	PMC4064952	11224	11226	O	-1	-1	0
AF	PMC4064952	11227	11229	O	-1	-1	0
on	PMC4064952	11230	11232	O	-1	-1	0
health	PMC4064952	11233	11239	O	-1	-1	0
care	PMC4064952	11240	11244	O	-1	-1	0
systems	PMC4064952	11245	11252	O	-1	-1	0

Observational	PMC4064952	11253	11266	O	-1	-1	0
studies	PMC4064952	11267	11274	O	-1	-1	0
performed	PMC4064952	11275	11284	O	-1	-1	0
in	PMC4064952	11285	11287	O	-1	-1	0
the	PMC4064952	11288	11291	O	-1	-1	0
general	PMC4064952	11292	11299	O	-1	-1	0
population	PMC4064952	11300	11310	O	-1	-1	0
or	PMC4064952	11311	11313	O	-1	-1	0
in	PMC4064952	11314	11316	O	-1	-1	0
patients	PMC4064952	11317	11325	O	-1	-1	0
hospitalized	PMC4064952	11326	11338	O	-1	-1	0
forAF	PMC4064952	11339	11344	O	-1	-1	0
show	PMC4064952	11345	11349	O	-1	-1	0
that	PMC4064952	11350	11354	O	-1	-1	0
permanentAF	PMC4064952	11355	11366	O	-1	-1	0
is	PMC4064952	11367	11369	O	-1	-1	0
the	PMC4064952	11370	11373	O	-1	-1	0
most	PMC4064952	11374	11378	O	-1	-1	0
frequent	PMC4064952	11379	11387	O	-1	-1	0
form	PMC4064952	11388	11392	O	-1	-1	0
of	PMC4064952	11393	11395	O	-1	-1	0
diagnosed	PMC4064952	11396	11405	O	-1	-1	0
AF	PMC4064952	11406	11408	O	-1	-1	0
;	PMC4064952	11408	11409	O	-1	-1	0
it	PMC4064952	11410	11412	O	-1	-1	0
occurs	PMC4064952	11413	11419	O	-1	-1	0
in	PMC4064952	11420	11422	O	-1	-1	0
40%–50	PMC4064952	11423	11429	O	-1	-1	0
%	PMC4064952	11429	11430	O	-1	-1	0
of	PMC4064952	11431	11433	O	-1	-1	0
patients	PMC4064952	11434	11442	O	-1	-1	0
,	PMC4064952	11442	11443	O	-1	-1	0
followed	PMC4064952	11444	11452	O	-1	-1	0
by	PMC4064952	11453	11455	O	-1	-1	0
the	PMC4064952	11456	11459	O	-1	-1	0
paroxysmal	PMC4064952	11460	11470	O	-1	-1	0
and	PMC4064952	11471	11474	O	-1	-1	0
­	PMC4064952	11475	11476	O	-1	-1	0
persistent	PMC4064952	11477	11487	O	-1	-1	0
forms	PMC4064952	11488	11493	O	-1	-1	0
that	PMC4064952	11494	11498	O	-1	-1	0
each	PMC4064952	11499	11503	O	-1	-1	0
occur	PMC4064952	11504	11509	O	-1	-1	0
in	PMC4064952	11510	11512	O	-1	-1	0
20%–30	PMC4064952	11513	11519	O	-1	-1	0
%	PMC4064952	11519	11520	O	-1	-1	0
of	PMC4064952	11521	11523	O	-1	-1	0
cases	PMC4064952	11524	11529	O	-1	-1	0

­	PMC4064952	11530	11531	O	-1	-1	0

(	PMC4064952	11532	11533	O	-1	-1	0
Figure	PMC4064952	11533	11539	O	-1	-1	0
2).9,19–22	PMC4064952	11540	11550	O	-1	-1	0

­	PMC4064952	11551	11552	O	-1	-1	0

Generally	PMC4064952	11553	11562	O	-1	-1	0
,	PMC4064952	11562	11563	O	-1	-1	0
the	PMC4064952	11564	11567	O	-1	-1	0
history	PMC4064952	11568	11575	O	-1	-1	0
of	PMC4064952	11576	11578	O	-1	-1	0
AF	PMC4064952	11579	11581	O	-1	-1	0
is	PMC4064952	11582	11584	O	-1	-1	0
long	PMC4064952	11585	11589	O	-1	-1	0
and	PMC4064952	11590	11593	O	-1	-1	0
burdened	PMC4064952	11594	11602	O	-1	-1	0
by	PMC4064952	11603	11605	O	-1	-1	0
fre-	PMC4064952	11606	11610	O	-1	-1	0
quent	PMC4064952	11611	11616	O	-1	-1	0
recurrences	PMC4064952	11617	11628	O	-1	-1	0
.	PMC4064952	11628	11629	O	-1	-1	0

In	PMC4064952	11630	11632	O	-1	-1	0
France	PMC4064952	11633	11639	B-Location	-1	-1	0
and	PMC4064952	11640	11643	O	-1	-1	0
Germany	PMC4064952	11644	11651	B-Location	-1	-1	0
,	PMC4064952	11651	11652	O	-1	-1	0
theALFA	PMC4064952	11653	11660	O	-1	-1	0

(	PMC4064952	11661	11662	O	-1	-1	0
Etude	PMC4064952	11662	11667	O	-1	-1	0
en	PMC4064952	11668	11670	O	-1	-1	0
Activité	PMC4064952	11671	11679	O	-1	-1	0
Libérale	PMC4064952	11680	11688	O	-1	-1	0
de	PMC4064952	11689	11691	O	-1	-1	0
la	PMC4064952	11692	11694	O	-1	-1	0
Fibrillation	PMC4064952	11695	11707	O	-1	-1	0
Auriculaire)23	PMC4064952	11708	11722	O	-1	-1	0

and	PMC4064952	11723	11726	O	-1	-1	0
ATRIUM	PMC4064952	11727	11733	O	-1	-1	0
(	PMC4064952	11734	11735	O	-1	-1	0

OutpAtienT	PMC4064952	11735	11745	O	-1	-1	0
RegIstry	PMC4064952	11746	11754	O	-1	-1	0
Upon	PMC4064952	11755	11759	O	-1	-1	0
Morbidity	PMC4064952	11760	11769	O	-1	-1	0
of	PMC4064952	11770	11772	O	-1	-1	0
atrial	PMC4064952	11773	11779	O	-1	-1	0
fibrillation)19	PMC4064952	11780	11795	O	-1	-1	0
studies	PMC4064952	11796	11803	O	-1	-1	0
showed	PMC4064952	11804	11810	O	-1	-1	0
that	PMC4064952	11811	11815	O	-1	-1	0
the	PMC4064952	11816	11819	O	-1	-1	0
mean	PMC4064952	11820	11824	O	-1	-1	0
time	PMC4064952	11825	11829	O	-1	-1	0
elapsed	PMC4064952	11830	11837	O	-1	-1	0
between	PMC4064952	11838	11845	O	-1	-1	0
the	PMC4064952	11846	11849	O	-1	-1	0
first	PMC4064952	11850	11855	O	-1	-1	0
episode	PMC4064952	11856	11863	O	-1	-1	0
ofAF	PMC4064952	11864	11868	O	-1	-1	0
and	PMC4064952	11869	11872	O	-1	-1	0
the	PMC4064952	11873	11876	O	-1	-1	0
date	PMC4064952	11877	11881	O	-1	-1	0
of	PMC4064952	11882	11884	O	-1	-1	0
patient	PMC4064952	11885	11892	O	-1	-1	0
assess-	PMC4064952	11893	11900	O	-1	-1	0
ment	PMC4064952	11901	11905	O	-1	-1	0
was	PMC4064952	11906	11909	O	-1	-1	0
47±63	PMC4064952	11910	11915	O	-1	-1	0
months	PMC4064952	11916	11922	O	-1	-1	0
and	PMC4064952	11923	11926	O	-1	-1	0
61±66	PMC4064952	11927	11932	O	-1	-1	0
months	PMC4064952	11933	11939	O	-1	-1	0
,	PMC4064952	11939	11940	O	-1	-1	0
respectively	PMC4064952	11941	11953	O	-1	-1	0
;	PMC4064952	11953	11954	O	-1	-1	0
in	PMC4064952	11955	11957	O	-1	-1	0
Italy	PMC4064952	11958	11963	B-Location	-1	-1	0
,	PMC4064952	11963	11964	O	-1	-1	0
the	PMC4064952	11965	11968	O	-1	-1	0
ISAF	PMC4064952	11969	11973	O	-1	-1	0

(	PMC4064952	11974	11975	O	-1	-1	0
Italian	PMC4064952	11975	11982	O	-1	-1	0
Survey	PMC4064952	11983	11989	O	-1	-1	0
of	PMC4064952	11990	11992	O	-1	-1	0
Atrial	PMC4064952	11993	11999	O	-1	-1	0
Fibrillation	PMC4064952	12000	12012	O	-1	-1	0
man-	PMC4064952	12013	12017	O	-1	-1	0
agement	PMC4064952	12018	12025	O	-1	-1	0
)	PMC4064952	12025	12026	O	-1	-1	0
study	PMC4064952	12027	12032	O	-1	-1	0
showed	PMC4064952	12033	12039	O	-1	-1	0
that	PMC4064952	12040	12044	O	-1	-1	0
the	PMC4064952	12045	12048	O	-1	-1	0
history	PMC4064952	12049	12056	O	-1	-1	0
of	PMC4064952	12057	12059	O	-1	-1	0
AF	PMC4064952	12060	12062	O	-1	-1	0
was	PMC4064952	12063	12066	O	-1	-1	0
less	PMC4064952	12067	12071	O	-1	-1	0
than	PMC4064952	12072	12076	O	-1	-1	0
one	PMC4064952	12077	12080	O	-1	-1	0
year	PMC4064952	12081	12085	O	-1	-1	0
in	PMC4064952	12086	12088	O	-1	-1	0
only	PMC4064952	12089	12093	O	-1	-1	0
13	PMC4064952	12094	12096	O	-1	-1	0
%	PMC4064952	12096	12097	O	-1	-1	0
of	PMC4064952	12098	12100	O	-1	-1	0
patients	PMC4064952	12101	12109	O	-1	-1	0
in	PMC4064952	12110	12112	O	-1	-1	0
whom	PMC4064952	12113	12117	O	-1	-1	0
AF	PMC4064952	12118	12120	O	-1	-1	0
was	PMC4064952	12121	12124	O	-1	-1	0
detected	PMC4064952	12125	12133	O	-1	-1	0
,	PMC4064952	12133	12134	O	-1	-1	0
5–10	PMC4064952	12135	12139	O	-1	-1	0
years	PMC4064952	12140	12145	O	-1	-1	0
in	PMC4064952	12146	12148	O	-1	-1	0
30	PMC4064952	12149	12151	O	-1	-1	0
%	PMC4064952	12151	12152	O	-1	-1	0
,	PMC4064952	12152	12153	O	-1	-1	0
and	PMC4064952	12154	12157	O	-1	-1	0
.10	PMC4064952	12158	12161	O	-1	-1	0
years	PMC4064952	12162	12167	O	-1	-1	0
in	PMC4064952	12168	12170	O	-1	-1	0
18	PMC4064952	12171	12173	O	-1	-1	0
%	PMC4064952	12173	12174	O	-1	-1	0
.	PMC4064952	12174	12175	O	-1	-1	0

Approximately	PMC4064952	12176	12189	O	-1	-1	0
one	PMC4064952	12190	12193	O	-1	-1	0
fifth	PMC4064952	12194	12199	O	-1	-1	0
of	PMC4064952	12200	12202	O	-1	-1	0
AF	PMC4064952	12203	12205	O	-1	-1	0
patients	PMC4064952	12206	12214	O	-1	-1	0
are	PMC4064952	12215	12218	O	-1	-1	0
found	PMC4064952	12219	12224	O	-1	-1	0
to	PMC4064952	12225	12227	O	-1	-1	0
have	PMC4064952	12228	12232	O	-1	-1	0
suffered	PMC4064952	12233	12241	O	-1	-1	0
at	PMC4064952	12242	12244	O	-1	-1	0
least	PMC4064952	12245	12250	O	-1	-1	0
two	PMC4064952	12251	12254	O	-1	-1	0
recurrences	PMC4064952	12255	12266	O	-1	-1	0
during	PMC4064952	12267	12273	O	-1	-1	0
the	PMC4064952	12274	12277	O	-1	-1	0
previous	PMC4064952	12278	12286	O	-1	-1	0
year	PMC4064952	12287	12291	O	-1	-1	0
of	PMC4064952	12292	12294	O	-1	-1	0
observation	PMC4064952	12295	12306	O	-1	-1	0
and	PMC4064952	12307	12310	O	-1	-1	0
three	PMC4064952	12311	12316	O	-1	-1	0
quarters	PMC4064952	12317	12325	O	-1	-1	0
during	PMC4064952	12326	12332	O	-1	-1	0
the	PMC4064952	12333	12336	O	-1	-1	0
previous	PMC4064952	12337	12345	O	-1	-1	0
5	PMC4064952	12346	12347	O	-1	-1	0

years.9,19,22,23	PMC4064952	12348	12364	O	-1	-1	0

AF	PMC4064952	12365	12367	O	-1	-1	0
is	PMC4064952	12368	12370	O	-1	-1	0
often	PMC4064952	12371	12376	O	-1	-1	0
associated	PMC4064952	12377	12387	O	-1	-1	0
with	PMC4064952	12388	12392	O	-1	-1	0
symptoms	PMC4064952	12393	12401	O	-1	-1	0
,	PMC4064952	12401	12402	O	-1	-1	0
sometimes	PMC4064952	12403	12412	O	-1	-1	0
disabling	PMC4064952	12413	12422	O	-1	-1	0
,	PMC4064952	12422	12423	O	-1	-1	0
that	PMC4064952	12424	12428	O	-1	-1	0
are	PMC4064952	12429	12432	O	-1	-1	0
resistant	PMC4064952	12433	12442	O	-1	-1	0
to	PMC4064952	12443	12445	O	-1	-1	0
drug	PMC4064952	12446	12450	O	-1	-1	0
therapy	PMC4064952	12451	12458	O	-1	-1	0
and	PMC4064952	12459	12462	O	-1	-1	0
necessitate	PMC4064952	12463	12474	O	-1	-1	0
transcatheter	PMC4064952	12475	12488	O	-1	-1	0

abla-	PMC4064952	12489	12494	O	-1	-1	0
tion	PMC4064952	12495	12499	O	-1	-1	0
.	PMC4064952	12499	12500	O	-1	-1	0

More	PMC4064952	12501	12505	O	-1	-1	0
specifically	PMC4064952	12506	12518	O	-1	-1	0
,	PMC4064952	12518	12519	O	-1	-1	0
despite	PMC4064952	12520	12527	O	-1	-1	0
adequate	PMC4064952	12528	12536	O	-1	-1	0
treatment	PMC4064952	12537	12546	O	-1	-1	0
,	PMC4064952	12546	12547	O	-1	-1	0
palpita-	PMC4064952	12548	12556	O	-1	-1	0
tions	PMC4064952	12557	12562	O	-1	-1	0
occur	PMC4064952	12563	12568	O	-1	-1	0
in	PMC4064952	12569	12571	O	-1	-1	0
42%–55	PMC4064952	12572	12578	O	-1	-1	0
%	PMC4064952	12578	12579	O	-1	-1	0
of	PMC4064952	12580	12582	O	-1	-1	0
patients	PMC4064952	12583	12591	O	-1	-1	0
,	PMC4064952	12591	12592	O	-1	-1	0
asthenia	PMC4064952	12593	12601	O	-1	-1	0
in	PMC4064952	12602	12604	O	-1	-1	0
15%–49	PMC4064952	12605	12611	O	-1	-1	0
%	PMC4064952	12611	12612	O	-1	-1	0
,	PMC4064952	12612	12613	O	-1	-1	0

dyspnea	PMC4064952	12614	12621	O	-1	-1	0
in	PMC4064952	12622	12624	O	-1	-1	0
24%–49	PMC4064952	12625	12631	O	-1	-1	0
%	PMC4064952	12631	12632	O	-1	-1	0
,	PMC4064952	12632	12633	O	-1	-1	0
and	PMC4064952	12634	12637	O	-1	-1	0
angina	PMC4064952	12638	12644	O	-1	-1	0
in	PMC4064952	12645	12647	O	-1	-1	0
10%–20%.Arrhythmia	PMC4064952	12648	12666	O	-1	-1	0
occurs	PMC4064952	12667	12673	O	-1	-1	0
without	PMC4064952	12674	12681	O	-1	-1	0
symptoms	PMC4064952	12682	12690	O	-1	-1	0
in	PMC4064952	12691	12693	O	-1	-1	0
only	PMC4064952	12694	12698	O	-1	-1	0
12%–25	PMC4064952	12699	12705	O	-1	-1	0
%	PMC4064952	12705	12706	O	-1	-1	0
of	PMC4064952	12707	12709	O	-1	-1	0
patients	PMC4064952	12710	12718	O	-1	-1	0
with	PMC4064952	12719	12723	O	-1	-1	0
AF.9,19,21,23	PMC4064952	12724	12737	O	-1	-1	0

The	PMC4064952	12738	12741	O	-1	-1	0
vast	PMC4064952	12742	12746	O	-1	-1	0
majority	PMC4064952	12747	12755	O	-1	-1	0
of	PMC4064952	12756	12758	O	-1	-1	0
patients	PMC4064952	12759	12767	O	-1	-1	0
have	PMC4064952	12768	12772	O	-1	-1	0
a	PMC4064952	12773	12774	O	-1	-1	0
European	PMC4064952	12775	12783	O	-1	-1	0
Heart	PMC4064952	12784	12789	O	-1	-1	0
Rhythm	PMC4064952	12790	12796	O	-1	-1	0
Association	PMC4064952	12797	12808	O	-1	-1	0
score	PMC4064952	12809	12814	O	-1	-1	0
of	PMC4064952	12815	12817	O	-1	-1	0
II	PMC4064952	12818	12820	O	-1	-1	0
to	PMC4064952	12821	12823	O	-1	-1	0
IV	PMC4064952	12824	12826	O	-1	-1	0
;	PMC4064952	12826	12827	O	-1	-1	0
those	PMC4064952	12828	12833	O	-1	-1	0
with	PMC4064952	12834	12838	O	-1	-1	0
­	PMC4064952	12839	12840	O	-1	-1	0
permanent	PMC4064952	12841	12850	O	-1	-1	0

AF	PMC4064952	12851	12853	O	-1	-1	0
complain	PMC4064952	12854	12862	O	-1	-1	0
more	PMC4064952	12863	12867	O	-1	-1	0
frequently	PMC4064952	12868	12878	O	-1	-1	0
of	PMC4064952	12879	12881	O	-1	-1	0
dyspnea	PMC4064952	12882	12889	O	-1	-1	0
or	PMC4064952	12890	12892	O	-1	-1	0
asthenia	PMC4064952	12893	12901	O	-1	-1	0
and	PMC4064952	12902	12905	O	-1	-1	0
fatigue	PMC4064952	12906	12913	O	-1	-1	0
,	PMC4064952	12913	12914	O	-1	-1	0
and	PMC4064952	12915	12918	O	-1	-1	0
those	PMC4064952	12919	12924	O	-1	-1	0
with	PMC4064952	12925	12929	O	-1	-1	0
the	PMC4064952	12930	12933	O	-1	-1	0
paroxysmal	PMC4064952	12934	12944	O	-1	-1	0
form	PMC4064952	12945	12949	O	-1	-1	0
complain	PMC4064952	12950	12958	O	-1	-1	0
more	PMC4064952	12959	12963	O	-1	-1	0
of	PMC4064952	12964	12966	O	-1	-1	0
palpitations.19,23,24	PMC4064952	12967	12988	O	-1	-1	0

The	PMC4064952	12989	12992	O	-1	-1	0
high	PMC4064952	12993	12997	O	-1	-1	0
rates	PMC4064952	12998	13003	O	-1	-1	0
of	PMC4064952	13004	13006	O	-1	-1	0
recurrence	PMC4064952	13007	13017	O	-1	-1	0
,	PMC4064952	13017	13018	O	-1	-1	0
disturbing	PMC4064952	13019	13029	O	-1	-1	0
symptoms	PMC4064952	13030	13038	O	-1	-1	0
,	PMC4064952	13038	13039	O	-1	-1	0
and	PMC4064952	13040	13043	O	-1	-1	0
clinical	PMC4064952	13044	13052	O	-1	-1	0
sequelae	PMC4064952	13053	13061	O	-1	-1	0
(	PMC4064952	13062	13063	O	-1	-1	0
stroke	PMC4064952	13063	13069	O	-1	-1	0
,	PMC4064952	13069	13070	O	-1	-1	0
heart	PMC4064952	13071	13076	O	-1	-1	0
failure	PMC4064952	13077	13084	O	-1	-1	0
,	PMC4064952	13084	13085	O	-1	-1	0
initia-	PMC4064952	13086	13093	O	-1	-1	0
tion	PMC4064952	13094	13098	O	-1	-1	0
of	PMC4064952	13099	13101	O	-1	-1	0
new	PMC4064952	13102	13105	O	-1	-1	0
antiarrhythmic	PMC4064952	13106	13120	O	-1	-1	0
drugs	PMC4064952	13121	13126	O	-1	-1	0
,	PMC4064952	13126	13127	O	-1	-1	0
drug	PMC4064952	13128	13132	O	-1	-1	0
-	PMC4064952	13132	13133	O	-1	-1	0
related	PMC4064952	13133	13140	O	-1	-1	0
complications	PMC4064952	13141	13154	O	-1	-1	0
,	PMC4064952	13154	13155	O	-1	-1	0
interventional	PMC4064952	13156	13170	O	-1	-1	0
therapy	PMC4064952	13171	13178	O	-1	-1	0
)	PMC4064952	13178	13179	O	-1	-1	0
contribute	PMC4064952	13180	13190	O	-1	-1	0
strongly	PMC4064952	13191	13199	O	-1	-1	0
to	PMC4064952	13200	13202	O	-1	-1	0
the	PMC4064952	13203	13206	O	-1	-1	0
use	PMC4064952	13207	13210	O	-1	-1	0
of	PMC4064952	13211	13213	O	-1	-1	0
health	PMC4064952	13214	13220	O	-1	-1	0
care	PMC4064952	13221	13225	O	-1	-1	0
resources	PMC4064952	13226	13235	O	-1	-1	0
.	PMC4064952	13235	13236	O	-1	-1	0

In	PMC4064952	13237	13239	O	-1	-1	0
Italy	PMC4064952	13240	13245	B-Location	-1	-1	0
,	PMC4064952	13245	13246	O	-1	-1	0
AF	PMC4064952	13247	13249	O	-1	-1	0
is	PMC4064952	13250	13252	O	-1	-1	0
the	PMC4064952	13253	13256	O	-1	-1	0
cause	PMC4064952	13257	13262	O	-1	-1	0
of	PMC4064952	13263	13265	O	-1	-1	0
1.5	PMC4064952	13266	13269	O	-1	-1	0
%	PMC4064952	13269	13270	O	-1	-1	0
of	PMC4064952	13271	13273	O	-1	-1	0
all	PMC4064952	13274	13277	O	-1	-1	0
Clinical	PMC4064952	13278	13286	O	-1	-1	0
Epidemiology	PMC4064952	13287	13299	O	-1	-1	0
2014:6	PMC4064952	13300	13306	O	-1	-1	0

submit	PMC4064952	13307	13313	O	-1	-1	0
your	PMC4064952	13314	13318	O	-1	-1	0
manuscript	PMC4064952	13319	13329	O	-1	-1	0
|	PMC4064952	13330	13331	O	-1	-1	0

www.dovepress.com	PMC4064952	13332	13349	O	-1	-1	0

Dovepress	PMC4064952	13350	13359	O	-1	-1	0

Dovepress	PMC4064952	13360	13369	O	-1	-1	0

216	PMC4064952	13370	13373	O	-1	-1	0

Zoni	PMC4064952	13374	13378	O	-1	-1	0
-	PMC4064952	13378	13379	O	-1	-1	0
Berisso	PMC4064952	13379	13386	O	-1	-1	0
et	PMC4064952	13387	13389	O	-1	-1	0
al	PMC4064952	13390	13392	O	-1	-1	0
emergency	PMC4064952	13393	13402	O	-1	-1	0
room	PMC4064952	13403	13407	O	-1	-1	0
visits	PMC4064952	13408	13414	O	-1	-1	0
;	PMC4064952	13414	13415	O	-1	-1	0
in	PMC4064952	13416	13418	O	-1	-1	0
Germany	PMC4064952	13419	13426	B-Location	-1	-1	0
,	PMC4064952	13426	13427	O	-1	-1	0
the	PMC4064952	13428	13431	O	-1	-1	0
average	PMC4064952	13432	13439	O	-1	-1	0
number	PMC4064952	13440	13446	O	-1	-1	0
of	PMC4064952	13447	13449	O	-1	-1	0
hospitalizations	PMC4064952	13450	13466	O	-1	-1	0
with	PMC4064952	13467	13471	O	-1	-1	0
anAF	PMC4064952	13472	13476	O	-1	-1	0
diagnosis	PMC4064952	13477	13486	O	-1	-1	0
is	PMC4064952	13487	13489	O	-1	-1	0
0.24	PMC4064952	13490	13494	O	-1	-1	0
per	PMC4064952	13495	13498	O	-1	-1	0
year	PMC4064952	13499	13503	O	-1	-1	0
and	PMC4064952	13504	13507	O	-1	-1	0
the	PMC4064952	13508	13511	O	-1	-1	0
average	PMC4064952	13512	13519	O	-1	-1	0
number	PMC4064952	13520	13526	O	-1	-1	0
of	PMC4064952	13527	13529	O	-1	-1	0
outpatient	PMC4064952	13530	13540	O	-1	-1	0
consultations	PMC4064952	13541	13554	O	-1	-1	0
is	PMC4064952	13555	13557	O	-1	-1	0
5.62	PMC4064952	13558	13562	O	-1	-1	0
per	PMC4064952	13563	13566	O	-1	-1	0
year	PMC4064952	13567	13571	O	-1	-1	0
;	PMC4064952	13571	13572	O	-1	-1	0
in	PMC4064952	13573	13575	O	-1	-1	0
Scotland	PMC4064952	13576	13584	B-Location	-1	-1	0
,	PMC4064952	13584	13585	O	-1	-1	0
the	PMC4064952	13586	13589	O	-1	-1	0
one	PMC4064952	13590	13593	O	-1	-1	0
-	PMC4064952	13593	13594	O	-1	-1	0
year	PMC4064952	13594	13598	O	-1	-1	0
out	PMC4064952	13599	13602	O	-1	-1	0
-	PMC4064952	13602	13603	O	-1	-1	0
of	PMC4064952	13603	13605	O	-1	-1	0
-	PMC4064952	13605	13606	O	-1	-1	0
hospital	PMC4064952	13606	13614	O	-1	-1	0
contact	PMC4064952	13615	13622	O	-1	-1	0
rate	PMC4064952	13623	13627	O	-1	-1	0
for	PMC4064952	13628	13631	O	-1	-1	0
AF	PMC4064952	13632	13634	O	-1	-1	0
is	PMC4064952	13635	13637	O	-1	-1	0
eight	PMC4064952	13638	13643	O	-1	-1	0
per	PMC4064952	13644	13647	O	-1	-1	0
1,000	PMC4064952	13648	13653	O	-1	-1	0
person	PMC4064952	13654	13660	O	-1	-1	0
/	PMC4064952	13660	13661	O	-1	-1	0
years	PMC4064952	13661	13666	O	-1	-1	0
,	PMC4064952	13666	13667	O	-1	-1	0
ranging	PMC4064952	13668	13675	O	-1	-1	0
from	PMC4064952	13676	13680	O	-1	-1	0
0.2	PMC4064952	13681	13684	O	-1	-1	0
in	PMC4064952	13685	13687	O	-1	-1	0
subjects	PMC4064952	13688	13696	O	-1	-1	0

aged	PMC4064952	13697	13701	O	-1	-1	0
,	PMC4064952	13702	13703	O	-1	-1	0
45	PMC4064952	13703	13705	O	-1	-1	0
years	PMC4064952	13706	13711	O	-1	-1	0
to	PMC4064952	13712	13714	O	-1	-1	0
62	PMC4064952	13715	13717	O	-1	-1	0
per	PMC4064952	13718	13721	O	-1	-1	0
1,000	PMC4064952	13722	13727	O	-1	-1	0
person	PMC4064952	13728	13734	O	-1	-1	0
/	PMC4064952	13734	13735	O	-1	-1	0
years	PMC4064952	13735	13740	O	-1	-1	0
in	PMC4064952	13741	13743	O	-1	-1	0
those	PMC4064952	13744	13749	O	-1	-1	0

aged	PMC4064952	13750	13754	O	-1	-1	0
74–85	PMC4064952	13755	13760	O	-1	-1	0
years.4,6,8,9	PMC4064952	13761	13774	O	-1	-1	0

In	PMC4064952	13775	13777	O	-1	-1	0
the	PMC4064952	13778	13781	O	-1	-1	0
USA	PMC4064952	13782	13785	B-Location	-1	-1	0
,	PMC4064952	13785	13786	O	-1	-1	0
the	PMC4064952	13787	13790	O	-1	-1	0
bed	PMC4064952	13791	13794	O	-1	-1	0
utilization	PMC4064952	13795	13806	O	-1	-1	0
for	PMC4064952	13807	13810	O	-1	-1	0
AF	PMC4064952	13811	13813	O	-1	-1	0
as	PMC4064952	13814	13816	O	-1	-1	0
a	PMC4064952	13817	13818	O	-1	-1	0
primary	PMC4064952	13819	13826	O	-1	-1	0
diagnosis	PMC4064952	13827	13836	O	-1	-1	0
was	PMC4064952	13837	13840	O	-1	-1	0
approximately	PMC4064952	13841	13854	O	-1	-1	0
one	PMC4064952	13855	13858	O	-1	-1	0
million	PMC4064952	13859	13866	O	-1	-1	0
days	PMC4064952	13867	13871	O	-1	-1	0
in	PMC4064952	13872	13874	O	-1	-1	0
1991	PMC4064952	13875	13879	O	-1	-1	0
and	PMC4064952	13880	13883	O	-1	-1	0
1.38	PMC4064952	13884	13888	O	-1	-1	0
million	PMC4064952	13889	13896	O	-1	-1	0
days	PMC4064952	13897	13901	O	-1	-1	0
in	PMC4064952	13902	13904	O	-1	-1	0
1999	PMC4064952	13905	13909	O	-1	-1	0
,	PMC4064952	13909	13910	O	-1	-1	0
representing	PMC4064952	13911	13923	O	-1	-1	0
a	PMC4064952	13924	13925	O	-1	-1	0
bed	PMC4064952	13926	13929	O	-1	-1	0
uti-	PMC4064952	13930	13934	O	-1	-1	0

lization	PMC4064952	13935	13943	O	-1	-1	0
that	PMC4064952	13944	13948	O	-1	-1	0
is	PMC4064952	13949	13951	O	-1	-1	0
similar	PMC4064952	13952	13959	O	-1	-1	0
to	PMC4064952	13960	13962	O	-1	-1	0
that	PMC4064952	13963	13967	O	-1	-1	0
needed	PMC4064952	13968	13974	O	-1	-1	0
for	PMC4064952	13975	13978	O	-1	-1	0
all	PMC4064952	13979	13982	O	-1	-1	0
the	PMC4064952	13983	13986	O	-1	-1	0
other	PMC4064952	13987	13992	O	-1	-1	0
cardiac	PMC4064952	13993	14000	O	-1	-1	0
arrhythmias	PMC4064952	14001	14012	O	-1	-1	0
combined	PMC4064952	14013	14021	O	-1	-1	0
.	PMC4064952	14021	14022	O	-1	-1	0

RealiseAF	PMC4064952	14023	14032	O	-1	-1	0

(	PMC4064952	14033	14034	O	-1	-1	0
REAl	PMC4064952	14034	14038	O	-1	-1	0
-	PMC4064952	14038	14039	O	-1	-1	0
LIfe	PMC4064952	14039	14043	O	-1	-1	0
global	PMC4064952	14044	14050	O	-1	-1	0
Survey	PMC4064952	14051	14057	O	-1	-1	0

Evaluating	PMC4064952	14058	14068	O	-1	-1	0
patients	PMC4064952	14069	14077	O	-1	-1	0
with	PMC4064952	14078	14082	O	-1	-1	0
Atrial	PMC4064952	14083	14089	O	-1	-1	0
Fibrillation	PMC4064952	14090	14102	O	-1	-1	0
)	PMC4064952	14102	14103	O	-1	-1	0
showed	PMC4064952	14104	14110	O	-1	-1	0
that	PMC4064952	14111	14115	O	-1	-1	0
one	PMC4064952	14116	14119	O	-1	-1	0
third	PMC4064952	14120	14125	O	-1	-1	0
of	PMC4064952	14126	14128	O	-1	-1	0
patients	PMC4064952	14129	14137	O	-1	-1	0
withAF	PMC4064952	14138	14144	O	-1	-1	0
had	PMC4064952	14145	14148	O	-1	-1	0
been	PMC4064952	14149	14153	O	-1	-1	0
hospitalized	PMC4064952	14154	14166	O	-1	-1	0
in	PMC4064952	14167	14169	O	-1	-1	0
the	PMC4064952	14170	14173	O	-1	-1	0
previous	PMC4064952	14174	14182	O	-1	-1	0
12	PMC4064952	14183	14185	O	-1	-1	0
months.24	PMC4064952	14186	14195	O	-1	-1	0

Acute	PMC4064952	14196	14201	O	-1	-1	0
decompensation	PMC4064952	14202	14216	O	-1	-1	0
of	PMC4064952	14217	14219	O	-1	-1	0
heart	PMC4064952	14220	14225	O	-1	-1	0
failure	PMC4064952	14226	14233	O	-1	-1	0
is	PMC4064952	14234	14236	O	-1	-1	0
the	PMC4064952	14237	14240	O	-1	-1	0
leading	PMC4064952	14241	14248	O	-1	-1	0
cause	PMC4064952	14249	14254	O	-1	-1	0
of	PMC4064952	14255	14257	O	-1	-1	0
hospitalization	PMC4064952	14258	14273	O	-1	-1	0
in	PMC4064952	14274	14276	O	-1	-1	0
the	PMC4064952	14277	14280	O	-1	-1	0
persistent	PMC4064952	14281	14291	O	-1	-1	0
and	PMC4064952	14292	14295	O	-1	-1	0
perma-	PMC4064952	14296	14302	O	-1	-1	0
nent	PMC4064952	14303	14307	O	-1	-1	0
forms	PMC4064952	14308	14313	O	-1	-1	0
ofAF	PMC4064952	14314	14318	O	-1	-1	0
(	PMC4064952	14319	14320	O	-1	-1	0
12.9	PMC4064952	14320	14324	O	-1	-1	0
%	PMC4064952	14324	14325	O	-1	-1	0
and	PMC4064952	14326	14329	O	-1	-1	0
13.6	PMC4064952	14330	14334	O	-1	-1	0
%	PMC4064952	14334	14335	O	-1	-1	0
,	PMC4064952	14335	14336	O	-1	-1	0
respectively	PMC4064952	14337	14349	O	-1	-1	0
)	PMC4064952	14349	14350	O	-1	-1	0
,	PMC4064952	14350	14351	O	-1	-1	0
followed	PMC4064952	14352	14360	O	-1	-1	0
by	PMC4064952	14361	14363	O	-1	-1	0
an	PMC4064952	14364	14366	O	-1	-1	0
acute	PMC4064952	14367	14372	O	-1	-1	0
coronary	PMC4064952	14373	14381	O	-1	-1	0
event	PMC4064952	14382	14387	O	-1	-1	0
(	PMC4064952	14388	14389	O	-1	-1	0
7.7	PMC4064952	14389	14392	O	-1	-1	0
%	PMC4064952	14392	14393	O	-1	-1	0
and	PMC4064952	14394	14397	O	-1	-1	0
7.3	PMC4064952	14398	14401	O	-1	-1	0
%	PMC4064952	14401	14402	O	-1	-1	0
,	PMC4064952	14402	14403	O	-1	-1	0
respectively	PMC4064952	14404	14416	O	-1	-1	0
)	PMC4064952	14416	14417	O	-1	-1	0
and	PMC4064952	14418	14421	O	-1	-1	0
stroke	PMC4064952	14422	14428	O	-1	-1	0
(	PMC4064952	14429	14430	O	-1	-1	0
5	PMC4064952	14430	14431	O	-1	-1	0
%	PMC4064952	14431	14432	O	-1	-1	0
and	PMC4064952	14433	14436	O	-1	-1	0
7.4	PMC4064952	14437	14440	O	-1	-1	0
%	PMC4064952	14440	14441	O	-1	-1	0
,	PMC4064952	14441	14442	O	-1	-1	0
respectively	PMC4064952	14443	14455	O	-1	-1	0
)	PMC4064952	14455	14456	O	-1	-1	0
.	PMC4064952	14456	14457	O	-1	-1	0

The	PMC4064952	14458	14461	O	-1	-1	0
need	PMC4064952	14462	14466	O	-1	-1	0
for	PMC4064952	14467	14470	O	-1	-1	0
new	PMC4064952	14471	14474	O	-1	-1	0
use	PMC4064952	14475	14478	O	-1	-1	0
of	PMC4064952	14479	14481	O	-1	-1	0
antiarrhythmic	PMC4064952	14482	14496	O	-1	-1	0
drugs	PMC4064952	14497	14502	O	-1	-1	0
and	PMC4064952	14503	14506	O	-1	-1	0
proarrhythmic	PMC4064952	14507	14520	O	-1	-1	0
events	PMC4064952	14521	14527	O	-1	-1	0
from	PMC4064952	14528	14532	O	-1	-1	0
antiar-	PMC4064952	14533	14540	O	-1	-1	0
rhythmic	PMC4064952	14541	14549	O	-1	-1	0
drugs	PMC4064952	14550	14555	O	-1	-1	0
are	PMC4064952	14556	14559	O	-1	-1	0
the	PMC4064952	14560	14563	O	-1	-1	0
most	PMC4064952	14564	14568	O	-1	-1	0
frequent	PMC4064952	14569	14577	O	-1	-1	0
causes	PMC4064952	14578	14584	O	-1	-1	0
of	PMC4064952	14585	14587	O	-1	-1	0
hospitalization	PMC4064952	14588	14603	O	-1	-1	0
among	PMC4064952	14604	14609	O	-1	-1	0
patients	PMC4064952	14610	14618	O	-1	-1	0
with	PMC4064952	14619	14623	O	-1	-1	0
paroxysmal	PMC4064952	14624	14634	O	-1	-1	0
AF	PMC4064952	14635	14637	O	-1	-1	0

(	PMC4064952	14638	14639	O	-1	-1	0
12.3%).24,25	PMC4064952	14639	14651	O	-1	-1	0

AF	PMC4064952	14652	14654	O	-1	-1	0
is	PMC4064952	14655	14657	O	-1	-1	0
frequently	PMC4064952	14658	14668	O	-1	-1	0
associated	PMC4064952	14669	14679	O	-1	-1	0
with	PMC4064952	14680	14684	O	-1	-1	0
cardiac	PMC4064952	14685	14692	O	-1	-1	0
disease	PMC4064952	14693	14700	O	-1	-1	0
and	PMC4064952	14701	14704	O	-1	-1	0
with	PMC4064952	14705	14709	O	-1	-1	0
cardiac	PMC4064952	14710	14717	O	-1	-1	0
/	PMC4064952	14717	14718	O	-1	-1	0
noncardiac	PMC4064952	14718	14728	O	-1	-1	0
comorbidity	PMC4064952	14729	14740	O	-1	-1	0
.	PMC4064952	14740	14741	O	-1	-1	0

Hypertensive	PMC4064952	14742	14754	O	-1	-1	0
heart	PMC4064952	14755	14760	O	-1	-1	0
disease	PMC4064952	14761	14768	O	-1	-1	0
(	PMC4064952	14769	14770	O	-1	-1	0
22%–36	PMC4064952	14770	14776	O	-1	-1	0
%	PMC4064952	14776	14777	O	-1	-1	0
)	PMC4064952	14777	14778	O	-1	-1	0
,	PMC4064952	14778	14779	O	-1	-1	0
coronary	PMC4064952	14780	14788	O	-1	-1	0
heart	PMC4064952	14789	14794	O	-1	-1	0
disease	PMC4064952	14795	14802	O	-1	-1	0
(	PMC4064952	14803	14804	O	-1	-1	0
14%–32	PMC4064952	14804	14810	O	-1	-1	0
%	PMC4064952	14810	14811	O	-1	-1	0
)	PMC4064952	14811	14812	O	-1	-1	0
,	PMC4064952	14812	14813	O	-1	-1	0
valvular	PMC4064952	14814	14822	O	-1	-1	0
heart	PMC4064952	14823	14828	O	-1	-1	0
disease	PMC4064952	14829	14836	O	-1	-1	0
(	PMC4064952	14837	14838	O	-1	-1	0
12%–26	PMC4064952	14838	14844	O	-1	-1	0
%	PMC4064952	14844	14845	O	-1	-1	0
)	PMC4064952	14845	14846	O	-1	-1	0
,	PMC4064952	14846	14847	O	-1	-1	0
and	PMC4064952	14848	14851	O	-1	-1	0
cardiomyopathy	PMC4064952	14852	14866	O	-1	-1	0
(	PMC4064952	14867	14868	O	-1	-1	0
6%–10	PMC4064952	14868	14873	O	-1	-1	0
%	PMC4064952	14873	14874	O	-1	-1	0
)	PMC4064952	14874	14875	O	-1	-1	0

are	PMC4064952	14876	14879	O	-1	-1	0
the	PMC4064952	14880	14883	O	-1	-1	0
most	PMC4064952	14884	14888	O	-1	-1	0
common	PMC4064952	14889	14895	O	-1	-1	0
illnesses	PMC4064952	14896	14905	O	-1	-1	0
associated	PMC4064952	14906	14916	O	-1	-1	0
withAF	PMC4064952	14917	14923	O	-1	-1	0
,	PMC4064952	14923	14924	O	-1	-1	0
while	PMC4064952	14925	14930	O	-1	-1	0
the	PMC4064952	14931	14934	O	-1	-1	0
most	PMC4064952	14935	14939	O	-1	-1	0
frequent	PMC4064952	14940	14948	O	-1	-1	0
comorbidities	PMC4064952	14949	14962	O	-1	-1	0
are	PMC4064952	14963	14966	O	-1	-1	0
hypertension	PMC4064952	14967	14979	O	-1	-1	0
(	PMC4064952	14980	14981	O	-1	-1	0
67%–76	PMC4064952	14981	14987	O	-1	-1	0
%	PMC4064952	14987	14988	O	-1	-1	0
)	PMC4064952	14988	14989	O	-1	-1	0
,	PMC4064952	14989	14990	O	-1	-1	0
heart	PMC4064952	14991	14996	O	-1	-1	0
failure	PMC4064952	14997	15004	O	-1	-1	0
(	PMC4064952	15005	15006	O	-1	-1	0
22%–42	PMC4064952	15006	15012	O	-1	-1	0
%	PMC4064952	15012	15013	O	-1	-1	0
)	PMC4064952	15013	15014	O	-1	-1	0
,	PMC4064952	15014	15015	O	-1	-1	0
diabetes	PMC4064952	15016	15024	O	-1	-1	0
(	PMC4064952	15025	15026	O	-1	-1	0
20%–24	PMC4064952	15026	15032	O	-1	-1	0
%	PMC4064952	15032	15033	O	-1	-1	0
)	PMC4064952	15033	15034	O	-1	-1	0
,	PMC4064952	15034	15035	O	-1	-1	0
obesity	PMC4064952	15036	15043	O	-1	-1	0
(	PMC4064952	15044	15045	O	-1	-1	0
20%–35	PMC4064952	15045	15051	O	-1	-1	0
%	PMC4064952	15051	15052	O	-1	-1	0
)	PMC4064952	15052	15053	O	-1	-1	0
,	PMC4064952	15053	15054	O	-1	-1	0
chronic	PMC4064952	15055	15062	O	-1	-1	0
pulmonary	PMC4064952	15063	15072	O	-1	-1	0
disease	PMC4064952	15073	15080	O	-1	-1	0
(	PMC4064952	15081	15082	O	-1	-1	0
10%–18	PMC4064952	15082	15088	O	-1	-1	0
%	PMC4064952	15088	15089	O	-1	-1	0
)	PMC4064952	15089	15090	O	-1	-1	0
,	PMC4064952	15090	15091	O	-1	-1	0

thyroid	PMC4064952	15092	15099	O	-1	-1	0
dysfunction	PMC4064952	15100	15111	O	-1	-1	0
(	PMC4064952	15112	15113	O	-1	-1	0
8%–11	PMC4064952	15113	15118	O	-1	-1	0
%	PMC4064952	15118	15119	O	-1	-1	0
)	PMC4064952	15119	15120	O	-1	-1	0
,	PMC4064952	15120	15121	O	-1	-1	0
renal	PMC4064952	15122	15127	O	-1	-1	0
failure	PMC4064952	15128	15135	O	-1	-1	0
(	PMC4064952	15136	15137	O	-1	-1	0
11%–22	PMC4064952	15137	15143	O	-1	-1	0
%	PMC4064952	15143	15144	O	-1	-1	0
)	PMC4064952	15144	15145	O	-1	-1	0
stroke/	PMC4064952	15146	15153	O	-1	-1	0
transient	PMC4064952	15154	15163	O	-1	-1	0
ischemic	PMC4064952	15164	15172	O	-1	-1	0
attack	PMC4064952	15173	15179	O	-1	-1	0
(	PMC4064952	15180	15181	O	-1	-1	0
9%–16	PMC4064952	15181	15186	O	-1	-1	0
%	PMC4064952	15186	15187	O	-1	-1	0
)	PMC4064952	15187	15188	O	-1	-1	0
,	PMC4064952	15188	15189	O	-1	-1	0
and	PMC4064952	15190	15193	O	-1	-1	0
neuropsychiatric	PMC4064952	15194	15210	O	-1	-1	0
disturbances	PMC4064952	15211	15223	O	-1	-1	0
(	PMC4064952	15224	15225	O	-1	-1	0
19	PMC4064952	15225	15227	O	-1	-1	0
%	PMC4064952	15227	15228	O	-1	-1	0
)	PMC4064952	15228	15229	O	-1	-1	0
.	PMC4064952	15229	15230	O	-1	-1	0

In	PMC4064952	15231	15233	O	-1	-1	0
particular	PMC4064952	15234	15244	O	-1	-1	0
,	PMC4064952	15244	15245	O	-1	-1	0
one	PMC4064952	15246	15249	O	-1	-1	0
third	PMC4064952	15250	15255	O	-1	-1	0
of	PMC4064952	15256	15258	O	-1	-1	0
AF	PMC4064952	15259	15261	O	-1	-1	0
patients	PMC4064952	15262	15270	O	-1	-1	0
have	PMC4064952	15271	15275	O	-1	-1	0
at	PMC4064952	15276	15278	O	-1	-1	0
least	PMC4064952	15279	15284	O	-1	-1	0
three	PMC4064952	15285	15290	O	-1	-1	0
associated	PMC4064952	15291	15301	O	-1	-1	0
comorbidities	PMC4064952	15302	15315	O	-1	-1	0
;	PMC4064952	15315	15316	O	-1	-1	0
no	PMC4064952	15317	15319	O	-1	-1	0
comorbid-	PMC4064952	15320	15329	O	-1	-1	0

ity	PMC4064952	15330	15333	O	-1	-1	0
or	PMC4064952	15334	15336	O	-1	-1	0
cardiac	PMC4064952	15337	15344	O	-1	-1	0
disease	PMC4064952	15345	15352	O	-1	-1	0
is	PMC4064952	15353	15355	O	-1	-1	0
present	PMC4064952	15356	15363	O	-1	-1	0
in	PMC4064952	15364	15366	O	-1	-1	0
one	PMC4064952	15367	15370	O	-1	-1	0
fifth	PMC4064952	15371	15376	O	-1	-1	0
and	PMC4064952	15377	15380	O	-1	-1	0
one	PMC4064952	15381	15384	O	-1	-1	0
quarter	PMC4064952	15385	15392	O	-1	-1	0
of	PMC4064952	15393	15395	O	-1	-1	0
patients	PMC4064952	15396	15404	O	-1	-1	0
,	PMC4064952	15404	15405	O	-1	-1	0
respectively	PMC4064952	15406	15418	O	-1	-1	0
.	PMC4064952	15418	15419	O	-1	-1	0

Lone	PMC4064952	15420	15424	O	-1	-1	0
AF	PMC4064952	15425	15427	O	-1	-1	0
(	PMC4064952	15428	15429	O	-1	-1	0
defined	PMC4064952	15429	15436	O	-1	-1	0
on	PMC4064952	15437	15439	O	-1	-1	0
the	PMC4064952	15440	15443	O	-1	-1	0
basis	PMC4064952	15444	15449	O	-1	-1	0
of	PMC4064952	15450	15452	O	-1	-1	0
the	PMC4064952	15453	15456	O	-1	-1	0
strict	PMC4064952	15457	15463	O	-1	-1	0
criteria	PMC4064952	15464	15472	O	-1	-1	0
of	PMC4064952	15473	15475	O	-1	-1	0
the	PMC4064952	15476	15479	O	-1	-1	0
European	PMC4064952	15480	15488	O	-1	-1	0
Society	PMC4064952	15489	15496	O	-1	-1	0
of	PMC4064952	15497	15499	O	-1	-1	0
Cardiology	PMC4064952	15500	15510	O	-1	-1	0
)	PMC4064952	15510	15511	O	-1	-1	0
is	PMC4064952	15512	15514	O	-1	-1	0
present	PMC4064952	15515	15522	O	-1	-1	0
in	PMC4064952	15523	15525	O	-1	-1	0
a	PMC4064952	15526	15527	O	-1	-1	0
low	PMC4064952	15528	15531	O	-1	-1	0
proportion	PMC4064952	15532	15542	O	-1	-1	0
of	PMC4064952	15543	15545	O	-1	-1	0
cases	PMC4064952	15546	15551	O	-1	-1	0
,	PMC4064952	15551	15552	O	-1	-1	0
ranging	PMC4064952	15553	15560	O	-1	-1	0
between	PMC4064952	15561	15568	O	-1	-1	0
2	PMC4064952	15569	15570	O	-1	-1	0
%	PMC4064952	15570	15571	O	-1	-1	0

and	PMC4064952	15572	15575	O	-1	-1	0
12%.4,9,16,20–23	PMC4064952	15576	15592	O	-1	-1	0

Patients	PMC4064952	15593	15601	O	-1	-1	0
with	PMC4064952	15602	15606	O	-1	-1	0
paroxysmal	PMC4064952	15607	15617	O	-1	-1	0
AF	PMC4064952	15618	15620	O	-1	-1	0
are	PMC4064952	15621	15624	O	-1	-1	0
younger	PMC4064952	15625	15632	O	-1	-1	0
and	PMC4064952	15633	15636	O	-1	-1	0
have	PMC4064952	15637	15641	O	-1	-1	0
a	PMC4064952	15642	15643	O	-1	-1	0
lower	PMC4064952	15644	15649	O	-1	-1	0
frequency	PMC4064952	15650	15659	O	-1	-1	0
of	PMC4064952	15660	15662	O	-1	-1	0
heart	PMC4064952	15663	15668	O	-1	-1	0
disease	PMC4064952	15669	15676	O	-1	-1	0
and	PMC4064952	15677	15680	O	-1	-1	0
comorbidity	PMC4064952	15681	15692	O	-1	-1	0
than	PMC4064952	15693	15697	O	-1	-1	0
those	PMC4064952	15698	15703	O	-1	-1	0
with	PMC4064952	15704	15708	O	-1	-1	0
permanent	PMC4064952	15709	15718	O	-1	-1	0
AF.16,19–21	PMC4064952	15719	15730	O	-1	-1	0
Progression	PMC4064952	15731	15742	O	-1	-1	0
to	PMC4064952	15743	15745	O	-1	-1	0
permanent	PMC4064952	15746	15755	O	-1	-1	0
AF	PMC4064952	15756	15758	O	-1	-1	0

In	PMC4064952	15759	15761	O	-1	-1	0
the	PMC4064952	15762	15765	O	-1	-1	0
past	PMC4064952	15766	15770	O	-1	-1	0
,	PMC4064952	15770	15771	O	-1	-1	0
the	PMC4064952	15772	15775	O	-1	-1	0
majority	PMC4064952	15776	15784	O	-1	-1	0
of	PMC4064952	15785	15787	O	-1	-1	0
AF	PMC4064952	15788	15790	O	-1	-1	0
studies	PMC4064952	15791	15798	O	-1	-1	0
have	PMC4064952	15799	15803	O	-1	-1	0
been	PMC4064952	15804	15808	O	-1	-1	0
carried	PMC4064952	15809	15816	O	-1	-1	0
out	PMC4064952	15817	15820	O	-1	-1	0
by	PMC4064952	15821	15823	O	-1	-1	0
considering	PMC4064952	15824	15835	O	-1	-1	0
AF	PMC4064952	15836	15838	O	-1	-1	0
as	PMC4064952	15839	15841	O	-1	-1	0
a	PMC4064952	15842	15843	O	-1	-1	0
whole	PMC4064952	15844	15849	O	-1	-1	0
,	PMC4064952	15849	15850	O	-1	-1	0
without	PMC4064952	15851	15858	O	-1	-1	0
a	PMC4064952	15859	15860	O	-1	-1	0
clear	PMC4064952	15861	15866	O	-1	-1	0
distinction	PMC4064952	15867	15878	O	-1	-1	0
of	PMC4064952	15879	15881	O	-1	-1	0
the	PMC4064952	15882	15885	O	-1	-1	0
subtypes	PMC4064952	15886	15894	O	-1	-1	0
.	PMC4064952	15894	15895	O	-1	-1	0

As	PMC4064952	15896	15898	O	-1	-1	0
shown	PMC4064952	15899	15904	O	-1	-1	0
previously	PMC4064952	15905	15915	O	-1	-1	0
,	PMC4064952	15915	15916	O	-1	-1	0
the	PMC4064952	15917	15920	O	-1	-1	0
different	PMC4064952	15921	15930	O	-1	-1	0
types	PMC4064952	15931	15936	O	-1	-1	0
of	PMC4064952	15937	15939	O	-1	-1	0
AF	PMC4064952	15940	15942	O	-1	-1	0
are	PMC4064952	15943	15946	O	-1	-1	0
associated	PMC4064952	15947	15957	O	-1	-1	0
not	PMC4064952	15958	15961	O	-1	-1	0
only	PMC4064952	15962	15966	O	-1	-1	0
with	PMC4064952	15967	15971	O	-1	-1	0
different	PMC4064952	15972	15981	O	-1	-1	0
clinical	PMC4064952	15982	15990	O	-1	-1	0
patient	PMC4064952	15991	15998	O	-1	-1	0
profiles	PMC4064952	15999	16007	O	-1	-1	0
,	PMC4064952	16007	16008	O	-1	-1	0
but	PMC4064952	16009	16012	O	-1	-1	0
also	PMC4064952	16013	16017	O	-1	-1	0
with	PMC4064952	16018	16022	O	-1	-1	0
different	PMC4064952	16023	16032	O	-1	-1	0
long	PMC4064952	16033	16037	O	-1	-1	0
-	PMC4064952	16037	16038	O	-1	-1	0
term	PMC4064952	16038	16042	O	-1	-1	0
outcomes	PMC4064952	16043	16051	O	-1	-1	0
.	PMC4064952	16051	16052	O	-1	-1	0

Epidemiological	PMC4064952	16053	16068	O	-1	-1	0
studies	PMC4064952	16069	16076	O	-1	-1	0
have	PMC4064952	16077	16081	O	-1	-1	0
shown	PMC4064952	16082	16087	O	-1	-1	0
also	PMC4064952	16088	16092	O	-1	-1	0
that	PMC4064952	16093	16097	O	-1	-1	0
the	PMC4064952	16098	16101	O	-1	-1	0
clinical	PMC4064952	16102	16110	O	-1	-1	0
setting	PMC4064952	16111	16118	O	-1	-1	0
of	PMC4064952	16119	16121	O	-1	-1	0
AF	PMC4064952	16122	16124	O	-1	-1	0
is	PMC4064952	16125	16127	O	-1	-1	0
an	PMC4064952	16128	16130	O	-1	-1	0
evolving	PMC4064952	16131	16139	O	-1	-1	0
picture	PMC4064952	16140	16147	O	-1	-1	0
that	PMC4064952	16148	16152	O	-1	-1	0
generally	PMC4064952	16153	16162	O	-1	-1	0
begins	PMC4064952	16163	16169	O	-1	-1	0
with	PMC4064952	16170	16174	O	-1	-1	0
the	PMC4064952	16175	16178	O	-1	-1	0
paroxysmal	PMC4064952	16179	16189	O	-1	-1	0
form	PMC4064952	16190	16194	O	-1	-1	0
and	PMC4064952	16195	16198	O	-1	-1	0
ends	PMC4064952	16199	16203	O	-1	-1	0
with	PMC4064952	16204	16208	O	-1	-1	0
the	PMC4064952	16209	16212	O	-1	-1	0
permanent	PMC4064952	16213	16222	O	-1	-1	0
form	PMC4064952	16223	16227	O	-1	-1	0
,	PMC4064952	16227	16228	O	-1	-1	0
covers	PMC4064952	16229	16235	O	-1	-1	0
different	PMC4064952	16236	16245	O	-1	-1	0
clinical	PMC4064952	16246	16254	O	-1	-1	0
pathways	PMC4064952	16255	16263	O	-1	-1	0
and	PMC4064952	16264	16267	O	-1	-1	0
treatment	PMC4064952	16268	16277	O	-1	-1	0
strategies	PMC4064952	16278	16288	O	-1	-1	0
,	PMC4064952	16288	16289	O	-1	-1	0
and	PMC4064952	16290	16293	O	-1	-1	0
results	PMC4064952	16294	16301	O	-1	-1	0
in	PMC4064952	16302	16304	O	-1	-1	0
different	PMC4064952	16305	16314	O	-1	-1	0
long	PMC4064952	16315	16319	O	-1	-1	0
-	PMC4064952	16319	16320	O	-1	-1	0
term	PMC4064952	16320	16324	O	-1	-1	0
outcomes.26–30	PMC4064952	16325	16339	O	-1	-1	0

From	PMC4064952	16340	16344	O	-1	-1	0
these	PMC4064952	16345	16350	O	-1	-1	0
studies	PMC4064952	16351	16358	O	-1	-1	0
,	PMC4064952	16358	16359	O	-1	-1	0
it	PMC4064952	16360	16362	O	-1	-1	0
appears	PMC4064952	16363	16370	O	-1	-1	0
that	PMC4064952	16371	16375	O	-1	-1	0
the	PMC4064952	16376	16379	O	-1	-1	0
progression	PMC4064952	16380	16391	O	-1	-1	0
from	PMC4064952	16392	16396	O	-1	-1	0
paroxysmal	PMC4064952	16397	16407	O	-1	-1	0
to	PMC4064952	16408	16410	O	-1	-1	0
permanent	PMC4064952	16411	16420	O	-1	-1	0

AF	PMC4064952	16421	16423	O	-1	-1	0
is	PMC4064952	16424	16426	O	-1	-1	0
characterized	PMC4064952	16427	16440	O	-1	-1	0
by	PMC4064952	16441	16443	O	-1	-1	0
a	PMC4064952	16444	16445	O	-1	-1	0
trend	PMC4064952	16446	16451	O	-1	-1	0
that	PMC4064952	16452	16456	O	-1	-1	0
shows	PMC4064952	16457	16462	O	-1	-1	0
an	PMC4064952	16463	16465	O	-1	-1	0
initial	PMC4064952	16466	16473	O	-1	-1	0
peak	PMC4064952	16474	16478	O	-1	-1	0
rate	PMC4064952	16479	16483	O	-1	-1	0
at	PMC4064952	16484	16486	O	-1	-1	0
the	PMC4064952	16487	16490	O	-1	-1	0
first	PMC4064952	16491	16496	O	-1	-1	0
year	PMC4064952	16497	16501	O	-1	-1	0
after	PMC4064952	16502	16507	O	-1	-1	0
AF	PMC4064952	16508	16510	O	-1	-1	0
diagnosis	PMC4064952	16511	16520	O	-1	-1	0
followed	PMC4064952	16521	16529	O	-1	-1	0
by	PMC4064952	16530	16532	O	-1	-1	0
a	PMC4064952	16533	16534	O	-1	-1	0
continuous	PMC4064952	16535	16545	O	-1	-1	0
“	PMC4064952	16546	16547	O	-1	-1	0
crescendo	PMC4064952	16547	16556	O	-1	-1	0
”	PMC4064952	16556	16557	O	-1	-1	0
that	PMC4064952	16558	16562	O	-1	-1	0
depends	PMC4064952	16563	16570	O	-1	-1	0
on	PMC4064952	16571	16573	O	-1	-1	0
the	PMC4064952	16574	16577	O	-1	-1	0
clinical	PMC4064952	16578	16586	O	-1	-1	0
profile	PMC4064952	16587	16594	O	-1	-1	0
of	PMC4064952	16595	16597	O	-1	-1	0
the	PMC4064952	16598	16601	O	-1	-1	0
patient	PMC4064952	16602	16609	O	-1	-1	0
0	PMC4064952	16610	16611	O	-1	-1	0
ATRIUM	PMC4064952	16612	16618	O	-1	-1	0
3,500	PMC4064952	16619	16624	O	-1	-1	0
pts	PMC4064952	16625	16628	O	-1	-1	0
ISAF	PMC4064952	16629	16633	O	-1	-1	0

6,000	PMC4064952	16634	16639	O	-1	-1	0
pts	PMC4064952	16640	16643	O	-1	-1	0

Euro	PMC4064952	16644	16648	O	-1	-1	0
Heart	PMC4064952	16649	16654	O	-1	-1	0
S	PMC4064952	16655	16656	O	-1	-1	0

4,200	PMC4064952	16657	16662	O	-1	-1	0
pts	PMC4064952	16663	16666	O	-1	-1	0

Study	PMC4064952	16667	16672	O	-1	-1	0
AFNET	PMC4064952	16673	16678	O	-1	-1	0

9,500	PMC4064952	16679	16684	O	-1	-1	0
pts	PMC4064952	16685	16688	O	-1	-1	0

ATA	PMC4064952	16689	16692	O	-1	-1	0
-	PMC4064952	16692	16693	O	-1	-1	0
AF	PMC4064952	16693	16695	O	-1	-1	0

7,100	PMC4064952	16696	16701	O	-1	-1	0
pts	PMC4064952	16702	16705	O	-1	-1	0

Parox	PMC4064952	16706	16711	O	-1	-1	0

Pers	PMC4064952	16712	16716	O	-1	-1	0

Perm	PMC4064952	16717	16721	O	-1	-1	0

10	PMC4064952	16722	16724	O	-1	-1	0
20	PMC4064952	16725	16727	O	-1	-1	0

30	PMC4064952	16728	16730	O	-1	-1	0
Types	PMC4064952	16731	16736	O	-1	-1	0
of	PMC4064952	16737	16739	O	-1	-1	0
atrial	PMC4064952	16740	16746	O	-1	-1	0
fibrillation	PMC4064952	16747	16759	O	-1	-1	0

(	PMC4064952	16760	16761	O	-1	-1	0
%	PMC4064952	16761	16762	O	-1	-1	0
)	PMC4064952	16762	16763	O	-1	-1	0

40	PMC4064952	16764	16766	O	-1	-1	0

50	PMC4064952	16767	16769	O	-1	-1	0

60	PMC4064952	16770	16772	O	-1	-1	0

Figure	PMC4064952	16773	16779	O	-1	-1	0

2	PMC4064952	16780	16781	O	-1	-1	0
Frequency	PMC4064952	16782	16791	O	-1	-1	0
of	PMC4064952	16792	16794	O	-1	-1	0
the	PMC4064952	16795	16798	O	-1	-1	0
different	PMC4064952	16799	16808	O	-1	-1	0
types	PMC4064952	16809	16814	O	-1	-1	0
of	PMC4064952	16815	16817	O	-1	-1	0
atrial	PMC4064952	16818	16824	O	-1	-1	0
fibrillation	PMC4064952	16825	16837	O	-1	-1	0
.	PMC4064952	16837	16838	O	-1	-1	0

Abbreviations	PMC4064952	16839	16852	O	-1	-1	0
:	PMC4064952	16852	16853	O	-1	-1	0
ATRIUM	PMC4064952	16854	16860	O	-1	-1	0
,	PMC4064952	16860	16861	O	-1	-1	0
OutpAtienT	PMC4064952	16862	16872	O	-1	-1	0
RegIstry	PMC4064952	16873	16881	O	-1	-1	0
Upon	PMC4064952	16882	16886	O	-1	-1	0
Morbidity	PMC4064952	16887	16896	O	-1	-1	0
of	PMC4064952	16897	16899	O	-1	-1	0
atrial	PMC4064952	16900	16906	O	-1	-1	0
fibrillation	PMC4064952	16907	16919	O	-1	-1	0
;	PMC4064952	16919	16920	O	-1	-1	0
ISAF	PMC4064952	16921	16925	O	-1	-1	0
,	PMC4064952	16925	16926	O	-1	-1	0
Italian	PMC4064952	16927	16934	O	-1	-1	0
Survey	PMC4064952	16935	16941	O	-1	-1	0
of	PMC4064952	16942	16944	O	-1	-1	0
Atrial	PMC4064952	16945	16951	O	-1	-1	0
Fibrillation	PMC4064952	16952	16964	O	-1	-1	0
management	PMC4064952	16965	16975	O	-1	-1	0
;	PMC4064952	16975	16976	O	-1	-1	0
Euro	PMC4064952	16977	16981	O	-1	-1	0
Heart	PMC4064952	16982	16987	O	-1	-1	0
S	PMC4064952	16988	16989	O	-1	-1	0
,	PMC4064952	16989	16990	O	-1	-1	0
Euro	PMC4064952	16991	16995	O	-1	-1	0
Heart	PMC4064952	16996	17001	O	-1	-1	0
Survey	PMC4064952	17002	17008	O	-1	-1	0
;	PMC4064952	17008	17009	O	-1	-1	0
AFNET	PMC4064952	17010	17015	O	-1	-1	0
,	PMC4064952	17015	17016	O	-1	-1	0
Central	PMC4064952	17017	17024	O	-1	-1	0
Registry	PMC4064952	17025	17033	O	-1	-1	0
of	PMC4064952	17034	17036	O	-1	-1	0
the	PMC4064952	17037	17040	O	-1	-1	0
German	PMC4064952	17041	17047	O	-1	-1	0
Competence	PMC4064952	17048	17058	O	-1	-1	0
Network	PMC4064952	17059	17066	O	-1	-1	0
on	PMC4064952	17067	17069	O	-1	-1	0
Atrial	PMC4064952	17070	17076	O	-1	-1	0
Fibrillation	PMC4064952	17077	17089	O	-1	-1	0
;	PMC4064952	17089	17090	O	-1	-1	0
ATA	PMC4064952	17091	17094	O	-1	-1	0
-	PMC4064952	17094	17095	O	-1	-1	0
AF	PMC4064952	17095	17097	O	-1	-1	0
,	PMC4064952	17097	17098	O	-1	-1	0
AntiThrombotic	PMC4064952	17099	17113	O	-1	-1	0
Agents	PMC4064952	17114	17120	O	-1	-1	0
in	PMC4064952	17121	17123	O	-1	-1	0
Atrial	PMC4064952	17124	17130	O	-1	-1	0
Fibrillation	PMC4064952	17131	17143	O	-1	-1	0
;	PMC4064952	17143	17144	O	-1	-1	0
pts	PMC4064952	17145	17148	O	-1	-1	0
,	PMC4064952	17148	17149	O	-1	-1	0
patients	PMC4064952	17150	17158	O	-1	-1	0
;	PMC4064952	17158	17159	O	-1	-1	0
Parox	PMC4064952	17160	17165	O	-1	-1	0
,	PMC4064952	17165	17166	O	-1	-1	0
paroxysmal	PMC4064952	17167	17177	O	-1	-1	0
;	PMC4064952	17177	17178	O	-1	-1	0
Pers	PMC4064952	17179	17183	O	-1	-1	0
,	PMC4064952	17183	17184	O	-1	-1	0
persistent	PMC4064952	17185	17195	O	-1	-1	0
;	PMC4064952	17195	17196	O	-1	-1	0
Perm	PMC4064952	17197	17201	O	-1	-1	0
,	PMC4064952	17201	17202	O	-1	-1	0
permanent	PMC4064952	17203	17212	O	-1	-1	0
.	PMC4064952	17212	17213	O	-1	-1	0

Clinical	PMC4064952	17214	17222	O	-1	-1	0
Epidemiology	PMC4064952	17223	17235	O	-1	-1	0
2014:6	PMC4064952	17236	17242	O	-1	-1	0
submit	PMC4064952	17243	17249	O	-1	-1	0
your	PMC4064952	17250	17254	O	-1	-1	0
manuscript	PMC4064952	17255	17265	O	-1	-1	0
|	PMC4064952	17266	17267	O	-1	-1	0

www.dovepress.com	PMC4064952	17268	17285	O	-1	-1	0

Dovepress	PMC4064952	17286	17295	O	-1	-1	0

Dovepress	PMC4064952	17296	17305	O	-1	-1	0
217	PMC4064952	17306	17309	O	-1	-1	0

Epidemiology	PMC4064952	17310	17322	O	-1	-1	0
of	PMC4064952	17323	17325	O	-1	-1	0
atrial	PMC4064952	17326	17332	O	-1	-1	0
fibrillation	PMC4064952	17333	17345	O	-1	-1	0
and	PMC4064952	17346	17349	O	-1	-1	0
the	PMC4064952	17350	17353	O	-1	-1	0
site	PMC4064952	17354	17358	O	-1	-1	0
of	PMC4064952	17359	17361	O	-1	-1	0
the	PMC4064952	17362	17365	O	-1	-1	0
patient	PMC4064952	17366	17373	O	-1	-1	0
’s	PMC4064952	17373	17375	O	-1	-1	0
clinical	PMC4064952	17376	17384	O	-1	-1	0
management	PMC4064952	17385	17395	O	-1	-1	0
.	PMC4064952	17395	17396	O	-1	-1	0

As	PMC4064952	17396	17398	O	-1	-1	0
reported	PMC4064952	17399	17407	O	-1	-1	0
by	PMC4064952	17408	17410	O	-1	-1	0
De	PMC4064952	17411	17413	O	-1	-1	0
Sisti	PMC4064952	17414	17419	O	-1	-1	0
et	PMC4064952	17420	17422	O	-1	-1	0
al	PMC4064952	17423	17425	O	-1	-1	0
in	PMC4064952	17426	17428	O	-1	-1	0
France	PMC4064952	17429	17435	B-Location	-1	-1	0
and	PMC4064952	17436	17439	O	-1	-1	0
by	PMC4064952	17440	17442	O	-1	-1	0
the	PMC4064952	17443	17446	O	-1	-1	0
Canadian	PMC4064952	17447	17455	O	-1	-1	0
Registry	PMC4064952	17456	17464	O	-1	-1	0
of	PMC4064952	17465	17467	O	-1	-1	0
Atrial	PMC4064952	17468	17474	O	-1	-1	0
Fibrillation	PMC4064952	17475	17487	O	-1	-1	0
investigators	PMC4064952	17488	17501	O	-1	-1	0
in	PMC4064952	17502	17504	O	-1	-1	0
Canada	PMC4064952	17505	17511	B-Location	-1	-1	0
,	PMC4064952	17511	17512	O	-1	-1	0
during	PMC4064952	17513	17519	O	-1	-1	0
the	PMC4064952	17520	17523	O	-1	-1	0
first	PMC4064952	17524	17529	O	-1	-1	0
year	PMC4064952	17530	17534	O	-1	-1	0
,	PMC4064952	17534	17535	O	-1	-1	0
AF	PMC4064952	17535	17537	O	-1	-1	0
evolves	PMC4064952	17538	17545	O	-1	-1	0
to	PMC4064952	17546	17548	O	-1	-1	0
the	PMC4064952	17549	17552	O	-1	-1	0
permanent	PMC4064952	17553	17562	O	-1	-1	0
form	PMC4064952	17563	17567	O	-1	-1	0
in	PMC4064952	17568	17570	O	-1	-1	0
­	PMC4064952	17571	17572	O	-1	-1	0

approximately	PMC4064952	17573	17586	O	-1	-1	0
4	PMC4064952	17587	17588	O	-1	-1	0
%	PMC4064952	17588	17589	O	-1	-1	0
of	PMC4064952	17590	17592	O	-1	-1	0
patients	PMC4064952	17593	17601	O	-1	-1	0
managed	PMC4064952	17602	17609	O	-1	-1	0
in	PMC4064952	17610	17612	O	-1	-1	0
tertiary	PMC4064952	17613	17621	O	-1	-1	0
arrhythmia	PMC4064952	17622	17632	O	-1	-1	0
centers	PMC4064952	17633	17640	O	-1	-1	0
and	PMC4064952	17641	17644	O	-1	-1	0
in	PMC4064952	17645	17647	O	-1	-1	0
9	PMC4064952	17648	17649	O	-1	-1	0
%	PMC4064952	17649	17650	O	-1	-1	0
of	PMC4064952	17651	17653	O	-1	-1	0
those	PMC4064952	17654	17659	O	-1	-1	0
managed	PMC4064952	17660	17667	O	-1	-1	0
in	PMC4064952	17668	17670	O	-1	-1	0
the	PMC4064952	17671	17674	O	-1	-1	0
real	PMC4064952	17675	17679	O	-1	-1	0
-	PMC4064952	17679	17680	O	-1	-1	0
world	PMC4064952	17680	17685	O	-1	-1	0
setting	PMC4064952	17686	17693	O	-1	-1	0
.	PMC4064952	17693	17694	O	-1	-1	0

Over	PMC4064952	17695	17699	O	-1	-1	0
time	PMC4064952	17700	17704	O	-1	-1	0
,	PMC4064952	17704	17705	O	-1	-1	0
the	PMC4064952	17706	17709	O	-1	-1	0
progression	PMC4064952	17710	17721	O	-1	-1	0
becomes	PMC4064952	17722	17729	O	-1	-1	0
less	PMC4064952	17730	17734	O	-1	-1	0
evident	PMC4064952	17735	17742	O	-1	-1	0
,	PMC4064952	17742	17743	O	-1	-1	0
with	PMC4064952	17744	17748	O	-1	-1	0
a	PMC4064952	17749	17750	O	-1	-1	0
slow	PMC4064952	17751	17755	O	-1	-1	0
but	PMC4064952	17756	17759	O	-1	-1	0
steady	PMC4064952	17760	17766	O	-1	-1	0
trend	PMC4064952	17767	17772	O	-1	-1	0
that	PMC4064952	17773	17777	O	-1	-1	0
is	PMC4064952	17778	17780	O	-1	-1	0
strictly	PMC4064952	17781	17789	O	-1	-1	0
related	PMC4064952	17790	17797	O	-1	-1	0
to	PMC4064952	17798	17800	O	-1	-1	0
poorer	PMC4064952	17801	17807	O	-1	-1	0
clinical	PMC4064952	17808	17816	O	-1	-1	0
condi-	PMC4064952	17817	17823	O	-1	-1	0

tions	PMC4064952	17824	17829	O	-1	-1	0
and	PMC4064952	17830	17833	O	-1	-1	0
reaches	PMC4064952	17834	17841	O	-1	-1	0
rates	PMC4064952	17842	17847	O	-1	-1	0
of	PMC4064952	17848	17850	O	-1	-1	0
18	PMC4064952	17851	17853	O	-1	-1	0
%	PMC4064952	17853	17854	O	-1	-1	0
and	PMC4064952	17855	17858	O	-1	-1	0
25	PMC4064952	17859	17861	O	-1	-1	0
%	PMC4064952	17861	17862	O	-1	-1	0
,	PMC4064952	17862	17863	O	-1	-1	0
respectively	PMC4064952	17864	17876	O	-1	-1	0
,	PMC4064952	17876	17877	O	-1	-1	0
at	PMC4064952	17878	17880	O	-1	-1	0
5	PMC4064952	17881	17882	O	-1	-1	0
years	PMC4064952	17883	17888	O	-1	-1	0
of	PMC4064952	17889	17891	O	-1	-1	0
follow	PMC4064952	17892	17898	O	-1	-1	0
-	PMC4064952	17898	17899	O	-1	-1	0
up	PMC4064952	17899	17901	O	-1	-1	0
.	PMC4064952	17901	17902	O	-1	-1	0

In	PMC4064952	17903	17905	O	-1	-1	0
particular	PMC4064952	17906	17916	O	-1	-1	0
,	PMC4064952	17916	17917	O	-1	-1	0
progression	PMC4064952	17918	17929	O	-1	-1	0
is	PMC4064952	17930	17932	O	-1	-1	0
slower	PMC4064952	17933	17939	O	-1	-1	0
for	PMC4064952	17940	17943	O	-1	-1	0
the	PMC4064952	17944	17947	O	-1	-1	0
paroxysmal	PMC4064952	17948	17958	O	-1	-1	0
form	PMC4064952	17959	17963	O	-1	-1	0
and	PMC4064952	17964	17967	O	-1	-1	0
faster	PMC4064952	17968	17974	O	-1	-1	0
for	PMC4064952	17975	17978	O	-1	-1	0
the	PMC4064952	17979	17982	O	-1	-1	0
persistent	PMC4064952	17983	17993	O	-1	-1	0
form.27,28	PMC4064952	17994	18004	O	-1	-1	0

In	PMC4064952	18005	18007	O	-1	-1	0
Europe	PMC4064952	18008	18014	B-Location	-1	-1	0
,	PMC4064952	18014	18015	O	-1	-1	0
the	PMC4064952	18016	18019	O	-1	-1	0
Euro	PMC4064952	18020	18024	O	-1	-1	0
Heart	PMC4064952	18025	18030	O	-1	-1	0
Survey	PMC4064952	18031	18037	O	-1	-1	0
investigators	PMC4064952	18038	18051	O	-1	-1	0
reported	PMC4064952	18052	18060	O	-1	-1	0
a	PMC4064952	18061	18062	O	-1	-1	0
progression	PMC4064952	18063	18074	O	-1	-1	0
to	PMC4064952	18075	18077	O	-1	-1	0
permanent	PMC4064952	18078	18087	O	-1	-1	0
AF	PMC4064952	18088	18090	O	-1	-1	0
in	PMC4064952	18091	18093	O	-1	-1	0
15	PMC4064952	18094	18096	O	-1	-1	0
%	PMC4064952	18096	18097	O	-1	-1	0
of	PMC4064952	18098	18100	O	-1	-1	0
patients	PMC4064952	18101	18109	O	-1	-1	0
with	PMC4064952	18110	18114	O	-1	-1	0
par-	PMC4064952	18115	18119	O	-1	-1	0
oxysmal	PMC4064952	18120	18127	O	-1	-1	0
AF	PMC4064952	18128	18130	O	-1	-1	0
and	PMC4064952	18131	18134	O	-1	-1	0
30	PMC4064952	18135	18137	O	-1	-1	0
%	PMC4064952	18137	18138	O	-1	-1	0
of	PMC4064952	18139	18141	O	-1	-1	0
those	PMC4064952	18142	18147	O	-1	-1	0
with	PMC4064952	18148	18152	O	-1	-1	0
persistent	PMC4064952	18153	18163	O	-1	-1	0
AF.29	PMC4064952	18164	18169	O	-1	-1	0

These	PMC4064952	18170	18175	O	-1	-1	0
rates	PMC4064952	18176	18181	O	-1	-1	0
are	PMC4064952	18182	18185	O	-1	-1	0
significantly	PMC4064952	18186	18199	O	-1	-1	0
higher	PMC4064952	18200	18206	O	-1	-1	0
than	PMC4064952	18207	18211	O	-1	-1	0
those	PMC4064952	18212	18217	O	-1	-1	0
found	PMC4064952	18218	18223	O	-1	-1	0
in	PMC4064952	18224	18226	O	-1	-1	0
Canada	PMC4064952	18227	18233	B-Location	-1	-1	0
,	PMC4064952	18233	18234	O	-1	-1	0
but	PMC4064952	18235	18238	O	-1	-1	0
in	PMC4064952	18239	18241	O	-1	-1	0
the	PMC4064952	18242	18245	O	-1	-1	0
European	PMC4064952	18246	18254	O	-1	-1	0
investigation	PMC4064952	18255	18268	O	-1	-1	0
patients	PMC4064952	18269	18277	O	-1	-1	0
showed	PMC4064952	18278	18284	O	-1	-1	0
either	PMC4064952	18285	18291	O	-1	-1	0
less	PMC4064952	18292	18296	O	-1	-1	0

severe	PMC4064952	18297	18303	O	-1	-1	0
cardiac	PMC4064952	18304	18311	O	-1	-1	0
disease	PMC4064952	18312	18319	O	-1	-1	0
or	PMC4064952	18320	18322	O	-1	-1	0
comorbidities	PMC4064952	18323	18336	O	-1	-1	0
.	PMC4064952	18336	18337	O	-1	-1	0

This	PMC4064952	18337	18341	O	-1	-1	0
consideration	PMC4064952	18342	18355	O	-1	-1	0
is	PMC4064952	18356	18358	O	-1	-1	0
consistent	PMC4064952	18359	18369	O	-1	-1	0
with	PMC4064952	18370	18374	O	-1	-1	0
the	PMC4064952	18375	18378	O	-1	-1	0
finding	PMC4064952	18379	18386	O	-1	-1	0
that	PMC4064952	18387	18391	O	-1	-1	0
the	PMC4064952	18392	18395	O	-1	-1	0
variables	PMC4064952	18396	18405	O	-1	-1	0
independently	PMC4064952	18406	18419	O	-1	-1	0
related	PMC4064952	18420	18427	O	-1	-1	0
to	PMC4064952	18428	18430	O	-1	-1	0
progression	PMC4064952	18431	18442	O	-1	-1	0
to	PMC4064952	18443	18445	O	-1	-1	0
permanent	PMC4064952	18446	18455	O	-1	-1	0
AF	PMC4064952	18456	18458	O	-1	-1	0
are	PMC4064952	18459	18462	O	-1	-1	0
age	PMC4064952	18463	18466	O	-1	-1	0
,	PMC4064952	18466	18467	O	-1	-1	0
an	PMC4064952	18468	18470	O	-1	-1	0
enlarged	PMC4064952	18471	18479	O	-1	-1	0
left	PMC4064952	18480	18484	O	-1	-1	0
atrium	PMC4064952	18485	18491	O	-1	-1	0
,	PMC4064952	18491	18492	O	-1	-1	0
lack	PMC4064952	18493	18497	O	-1	-1	0
of	PMC4064952	18498	18500	O	-1	-1	0
antiarrhythmic	PMC4064952	18501	18515	O	-1	-1	0
drugs	PMC4064952	18516	18521	O	-1	-1	0
,	PMC4064952	18521	18522	O	-1	-1	0
VVI	PMC4064952	18523	18526	O	-1	-1	0
pacing	PMC4064952	18527	18533	O	-1	-1	0
,	PMC4064952	18533	18534	O	-1	-1	0
and	PMC4064952	18535	18538	O	-1	-1	0

the	PMC4064952	18539	18542	O	-1	-1	0
presence	PMC4064952	18543	18551	O	-1	-1	0
of	PMC4064952	18552	18554	O	-1	-1	0
valvular	PMC4064952	18555	18563	O	-1	-1	0
heart	PMC4064952	18564	18569	O	-1	-1	0
disease	PMC4064952	18570	18577	O	-1	-1	0
,	PMC4064952	18577	18578	O	-1	-1	0
heart	PMC4064952	18579	18584	O	-1	-1	0
failure	PMC4064952	18585	18592	O	-1	-1	0
,	PMC4064952	18592	18593	O	-1	-1	0
hyperten-	PMC4064952	18594	18603	O	-1	-1	0

sion	PMC4064952	18604	18608	O	-1	-1	0
,	PMC4064952	18608	18609	O	-1	-1	0
or	PMC4064952	18610	18612	O	-1	-1	0
chronic	PMC4064952	18613	18620	O	-1	-1	0
obstructive	PMC4064952	18621	18632	O	-1	-1	0
pulmonary	PMC4064952	18633	18642	O	-1	-1	0
disease.9,26–29	PMC4064952	18643	18658	O	-1	-1	0

In	PMC4064952	18659	18661	O	-1	-1	0
this	PMC4064952	18662	18666	O	-1	-1	0
regard	PMC4064952	18667	18673	O	-1	-1	0
,	PMC4064952	18673	18674	O	-1	-1	0
the	PMC4064952	18675	18678	O	-1	-1	0
HATCH	PMC4064952	18679	18684	O	-1	-1	0
score	PMC4064952	18685	18690	O	-1	-1	0
(	PMC4064952	18691	18692	O	-1	-1	0
an	PMC4064952	18692	18694	O	-1	-1	0
acronym	PMC4064952	18695	18702	O	-1	-1	0
for	PMC4064952	18703	18706	O	-1	-1	0
“	PMC4064952	18707	18708	O	-1	-1	0
heart	PMC4064952	18708	18713	O	-1	-1	0
failure	PMC4064952	18714	18721	O	-1	-1	0
,	PMC4064952	18721	18722	O	-1	-1	0
age	PMC4064952	18723	18726	O	-1	-1	0
,	PMC4064952	18726	18727	O	-1	-1	0
previous	PMC4064952	18728	18736	O	-1	-1	0
transient	PMC4064952	18737	18746	O	-1	-1	0
ischemic	PMC4064952	18747	18755	O	-1	-1	0
attack	PMC4064952	18756	18762	O	-1	-1	0
,	PMC4064952	18762	18763	O	-1	-1	0
chronic	PMC4064952	18764	18771	O	-1	-1	0
pulmonary	PMC4064952	18772	18781	O	-1	-1	0
disease	PMC4064952	18782	18789	O	-1	-1	0
,	PMC4064952	18789	18790	O	-1	-1	0
hypertension	PMC4064952	18791	18803	O	-1	-1	0
”	PMC4064952	18803	18804	O	-1	-1	0
)	PMC4064952	18804	18805	O	-1	-1	0
can	PMC4064952	18806	18809	O	-1	-1	0
predict	PMC4064952	18810	18817	O	-1	-1	0
the	PMC4064952	18818	18821	O	-1	-1	0
risk	PMC4064952	18822	18826	O	-1	-1	0
with	PMC4064952	18827	18831	O	-1	-1	0
satisfactory	PMC4064952	18832	18844	O	-1	-1	0
power	PMC4064952	18845	18850	O	-1	-1	0
(	PMC4064952	18851	18852	O	-1	-1	0
area	PMC4064952	18852	18856	O	-1	-1	0
under	PMC4064952	18857	18862	O	-1	-1	0
the	PMC4064952	18863	18866	O	-1	-1	0
curve	PMC4064952	18867	18872	O	-1	-1	0
0.68).31	PMC4064952	18873	18881	O	-1	-1	0
Prognosis	PMC4064952	18882	18891	O	-1	-1	0

The	PMC4064952	18892	18895	O	-1	-1	0
largest	PMC4064952	18896	18903	O	-1	-1	0
epidemiological	PMC4064952	18904	18919	O	-1	-1	0
studies	PMC4064952	18920	18927	O	-1	-1	0
have	PMC4064952	18928	18932	O	-1	-1	0
clearly	PMC4064952	18933	18940	O	-1	-1	0
shown	PMC4064952	18941	18946	O	-1	-1	0
that	PMC4064952	18947	18951	O	-1	-1	0
AF	PMC4064952	18952	18954	O	-1	-1	0
is	PMC4064952	18955	18957	O	-1	-1	0
associated	PMC4064952	18958	18968	O	-1	-1	0
with	PMC4064952	18969	18973	O	-1	-1	0
an	PMC4064952	18974	18976	O	-1	-1	0
increased	PMC4064952	18977	18986	O	-1	-1	0
risk	PMC4064952	18987	18991	O	-1	-1	0
of	PMC4064952	18992	18994	O	-1	-1	0
stroke	PMC4064952	18995	19001	O	-1	-1	0
(	PMC4064952	19002	19003	O	-1	-1	0
both	PMC4064952	19003	19007	O	-1	-1	0
­	PMC4064952	19008	19009	O	-1	-1	0
ischemic	PMC4064952	19010	19018	O	-1	-1	0
and	PMC4064952	19019	19022	O	-1	-1	0
hemorrhagic	PMC4064952	19023	19034	O	-1	-1	0
)	PMC4064952	19034	19035	O	-1	-1	0
,	PMC4064952	19035	19036	O	-1	-1	0
hemorrhagic	PMC4064952	19037	19048	O	-1	-1	0
consequences	PMC4064952	19049	19061	O	-1	-1	0
(	PMC4064952	19062	19063	O	-1	-1	0
due	PMC4064952	19063	19066	O	-1	-1	0
to	PMC4064952	19067	19069	O	-1	-1	0
anticoagulation	PMC4064952	19070	19085	O	-1	-1	0
therapy	PMC4064952	19086	19093	O	-1	-1	0
)	PMC4064952	19093	19094	O	-1	-1	0
,	PMC4064952	19094	19095	O	-1	-1	0
and	PMC4064952	19096	19099	O	-1	-1	0
death	PMC4064952	19100	19105	O	-1	-1	0
.	PMC4064952	19105	19106	O	-1	-1	0

Cognitive	PMC4064952	19107	19116	O	-1	-1	0
­	PMC4064952	19117	19118	O	-1	-1	0
dysfunction	PMC4064952	19119	19130	O	-1	-1	0
,	PMC4064952	19130	19131	O	-1	-1	0
heart	PMC4064952	19132	19137	O	-1	-1	0
failure	PMC4064952	19138	19145	O	-1	-1	0
,	PMC4064952	19145	19146	O	-1	-1	0
and	PMC4064952	19147	19150	O	-1	-1	0
socioeconomic	PMC4064952	19151	19164	O	-1	-1	0
implications	PMC4064952	19165	19177	O	-1	-1	0
are	PMC4064952	19178	19181	O	-1	-1	0
further	PMC4064952	19182	19189	O	-1	-1	0
important	PMC4064952	19190	19199	O	-1	-1	0
consequences	PMC4064952	19200	19212	O	-1	-1	0
of	PMC4064952	19213	19215	O	-1	-1	0
AF	PMC4064952	19216	19218	O	-1	-1	0
.	PMC4064952	19218	19219	O	-1	-1	0

It	PMC4064952	19220	19222	O	-1	-1	0
is	PMC4064952	19223	19225	O	-1	-1	0
estimated	PMC4064952	19226	19235	O	-1	-1	0
that	PMC4064952	19236	19240	O	-1	-1	0
20	PMC4064952	19241	19243	O	-1	-1	0
%	PMC4064952	19243	19244	O	-1	-1	0
of	PMC4064952	19245	19247	O	-1	-1	0
all	PMC4064952	19248	19251	O	-1	-1	0
strokes	PMC4064952	19252	19259	O	-1	-1	0
occur	PMC4064952	19260	19265	O	-1	-1	0
in	PMC4064952	19266	19268	O	-1	-1	0
the	PMC4064952	19269	19272	O	-1	-1	0
setting	PMC4064952	19273	19280	O	-1	-1	0
of	PMC4064952	19281	19283	O	-1	-1	0
AF	PMC4064952	19284	19286	O	-1	-1	0
;	PMC4064952	19286	19287	O	-1	-1	0
this	PMC4064952	19288	19292	O	-1	-1	0
rate	PMC4064952	19293	19297	O	-1	-1	0
increases	PMC4064952	19298	19307	O	-1	-1	0
to	PMC4064952	19308	19310	O	-1	-1	0

25	PMC4064952	19311	19313	O	-1	-1	0
%	PMC4064952	19313	19314	O	-1	-1	0
in	PMC4064952	19315	19317	O	-1	-1	0
patients	PMC4064952	19318	19326	O	-1	-1	0
aged	PMC4064952	19327	19331	O	-1	-1	0
.80	PMC4064952	19332	19335	O	-1	-1	0
years	PMC4064952	19336	19341	O	-1	-1	0
.	PMC4064952	19341	19342	O	-1	-1	0

Patients	PMC4064952	19343	19351	O	-1	-1	0
with	PMC4064952	19352	19356	O	-1	-1	0
AF	PMC4064952	19357	19359	O	-1	-1	0
have	PMC4064952	19360	19364	O	-1	-1	0
an	PMC4064952	19365	19367	O	-1	-1	0
age	PMC4064952	19368	19371	O	-1	-1	0
-	PMC4064952	19371	19372	O	-1	-1	0
adjusted	PMC4064952	19372	19380	O	-1	-1	0
risk	PMC4064952	19381	19385	O	-1	-1	0
of	PMC4064952	19386	19388	O	-1	-1	0
stroke	PMC4064952	19389	19395	O	-1	-1	0
that	PMC4064952	19396	19400	O	-1	-1	0
is	PMC4064952	19401	19403	O	-1	-1	0
five	PMC4064952	19404	19408	O	-1	-1	0
-	PMC4064952	19408	19409	O	-1	-1	0
fold	PMC4064952	19409	19413	O	-1	-1	0
higher	PMC4064952	19414	19420	O	-1	-1	0
than	PMC4064952	19421	19425	O	-1	-1	0
in	PMC4064952	19426	19428	O	-1	-1	0
the	PMC4064952	19429	19432	O	-1	-1	0
normal	PMC4064952	19433	19439	O	-1	-1	0
population	PMC4064952	19440	19450	O	-1	-1	0
regardless	PMC4064952	19451	19461	O	-1	-1	0
of	PMC4064952	19462	19464	O	-1	-1	0
the	PMC4064952	19465	19468	O	-1	-1	0
type	PMC4064952	19469	19473	O	-1	-1	0

ofAF.32–34	PMC4064952	19474	19484	O	-1	-1	0

Since	PMC4064952	19485	19490	O	-1	-1	0
the	PMC4064952	19491	19494	O	-1	-1	0
introduction	PMC4064952	19495	19507	O	-1	-1	0
of	PMC4064952	19508	19510	O	-1	-1	0
systematic	PMC4064952	19511	19521	O	-1	-1	0
use	PMC4064952	19522	19525	O	-1	-1	0
of	PMC4064952	19526	19528	O	-1	-1	0
anticoagulants	PMC4064952	19529	19543	O	-1	-1	0
,	PMC4064952	19543	19544	O	-1	-1	0
the	PMC4064952	19545	19548	O	-1	-1	0
absolute	PMC4064952	19549	19557	O	-1	-1	0
number	PMC4064952	19558	19564	O	-1	-1	0
of	PMC4064952	19565	19567	O	-1	-1	0
ischemic	PMC4064952	19568	19576	O	-1	-1	0
strokes	PMC4064952	19577	19584	O	-1	-1	0
has	PMC4064952	19585	19588	O	-1	-1	0
decreased	PMC4064952	19589	19598	O	-1	-1	0
dramatically	PMC4064952	19599	19611	O	-1	-1	0
.	PMC4064952	19611	19612	O	-1	-1	0

In	PMC4064952	19613	19615	O	-1	-1	0
USA	PMC4064952	19616	19619	B-Location	-1	-1	0
,	PMC4064952	19619	19620	O	-1	-1	0
the	PMC4064952	19621	19624	O	-1	-1	0
rate	PMC4064952	19625	19629	O	-1	-1	0
of	PMC4064952	19630	19632	O	-1	-1	0
ischemic	PMC4064952	19633	19641	O	-1	-1	0
stroke	PMC4064952	19642	19648	O	-1	-1	0
among	PMC4064952	19649	19654	O	-1	-1	0
Medicare	PMC4064952	19655	19663	O	-1	-1	0
benefi-	PMC4064952	19664	19671	O	-1	-1	0
ciaries	PMC4064952	19672	19679	O	-1	-1	0
with	PMC4064952	19680	19684	O	-1	-1	0
AF	PMC4064952	19685	19687	O	-1	-1	0
aged	PMC4064952	19688	19692	O	-1	-1	0
65	PMC4064952	19693	19695	O	-1	-1	0
years	PMC4064952	19696	19701	O	-1	-1	0
or	PMC4064952	19702	19704	O	-1	-1	0
older	PMC4064952	19705	19710	O	-1	-1	0
was	PMC4064952	19711	19714	O	-1	-1	0
48	PMC4064952	19715	19717	O	-1	-1	0
per	PMC4064952	19718	19721	O	-1	-1	0
1,000	PMC4064952	19722	19727	O	-1	-1	0
person	PMC4064952	19728	19734	O	-1	-1	0
/	PMC4064952	19734	19735	O	-1	-1	0
years	PMC4064952	19735	19740	O	-1	-1	0
in	PMC4064952	19741	19743	O	-1	-1	0
1992	PMC4064952	19744	19748	O	-1	-1	0
and	PMC4064952	19749	19752	O	-1	-1	0
17	PMC4064952	19753	19755	O	-1	-1	0
per	PMC4064952	19756	19759	O	-1	-1	0
1,000	PMC4064952	19760	19765	O	-1	-1	0
person	PMC4064952	19766	19772	O	-1	-1	0
/	PMC4064952	19772	19773	O	-1	-1	0
years	PMC4064952	19773	19778	O	-1	-1	0
in	PMC4064952	19779	19781	O	-1	-1	0
2007	PMC4064952	19782	19786	O	-1	-1	0
;	PMC4064952	19786	19787	O	-1	-1	0
this	PMC4064952	19788	19792	O	-1	-1	0
means	PMC4064952	19793	19798	O	-1	-1	0
a	PMC4064952	19799	19800	O	-1	-1	0
65	PMC4064952	19801	19803	O	-1	-1	0
%	PMC4064952	19803	19804	O	-1	-1	0
decrease	PMC4064952	19805	19813	O	-1	-1	0
in	PMC4064952	19814	19816	O	-1	-1	0
the	PMC4064952	19817	19820	O	-1	-1	0
ischemic	PMC4064952	19821	19829	O	-1	-1	0
stroke	PMC4064952	19830	19836	O	-1	-1	0
rate	PMC4064952	19837	19841	O	-1	-1	0
over	PMC4064952	19842	19846	O	-1	-1	0
15	PMC4064952	19847	19849	O	-1	-1	0
years.35	PMC4064952	19850	19858	O	-1	-1	0

In	PMC4064952	19859	19861	O	-1	-1	0
Sweden	PMC4064952	19862	19868	B-Location	-1	-1	0
,	PMC4064952	19868	19869	O	-1	-1	0
the	PMC4064952	19870	19873	O	-1	-1	0
annual	PMC4064952	19874	19880	O	-1	-1	0
rate	PMC4064952	19881	19885	O	-1	-1	0
of	PMC4064952	19886	19888	O	-1	-1	0
ischemic	PMC4064952	19889	19897	O	-1	-1	0
stroke	PMC4064952	19898	19904	O	-1	-1	0
in	PMC4064952	19905	19907	O	-1	-1	0
the	PMC4064952	19908	19911	O	-1	-1	0
global	PMC4064952	19912	19918	O	-1	-1	0
population	PMC4064952	19919	19929	O	-1	-1	0
of	PMC4064952	19930	19932	O	-1	-1	0
AF	PMC4064952	19933	19935	O	-1	-1	0
patients	PMC4064952	19936	19944	O	-1	-1	0
is	PMC4064952	19945	19947	O	-1	-1	0
25	PMC4064952	19948	19950	O	-1	-1	0
per	PMC4064952	19951	19954	O	-1	-1	0
1,000	PMC4064952	19955	19960	O	-1	-1	0
person/	PMC4064952	19961	19968	O	-1	-1	0

years	PMC4064952	19969	19974	O	-1	-1	0
among	PMC4064952	19975	19980	O	-1	-1	0
those	PMC4064952	19981	19986	O	-1	-1	0
treated	PMC4064952	19987	19994	O	-1	-1	0
with	PMC4064952	19995	19999	O	-1	-1	0
anticoagulants	PMC4064952	20000	20014	O	-1	-1	0
and	PMC4064952	20015	20018	O	-1	-1	0
45	PMC4064952	20019	20021	O	-1	-1	0
per	PMC4064952	20022	20025	O	-1	-1	0
1,000	PMC4064952	20026	20031	O	-1	-1	0
person	PMC4064952	20032	20038	O	-1	-1	0
/	PMC4064952	20038	20039	O	-1	-1	0
years	PMC4064952	20039	20044	O	-1	-1	0
in	PMC4064952	20045	20047	O	-1	-1	0
those	PMC4064952	20048	20053	O	-1	-1	0
who	PMC4064952	20054	20057	O	-1	-1	0
are	PMC4064952	20058	20061	O	-1	-1	0
not	PMC4064952	20062	20065	O	-1	-1	0
treated.36	PMC4064952	20066	20076	O	-1	-1	0

In	PMC4064952	20077	20079	O	-1	-1	0
France	PMC4064952	20080	20086	B-Location	-1	-1	0
,	PMC4064952	20086	20087	O	-1	-1	0
the	PMC4064952	20088	20091	O	-1	-1	0
cumulative	PMC4064952	20092	20102	O	-1	-1	0
incidence	PMC4064952	20103	20112	O	-1	-1	0
of	PMC4064952	20113	20115	O	-1	-1	0
ischemic	PMC4064952	20116	20124	O	-1	-1	0
stroke	PMC4064952	20125	20131	O	-1	-1	0
is	PMC4064952	20132	20134	O	-1	-1	0
ten	PMC4064952	20135	20138	O	-1	-1	0
per	PMC4064952	20139	20142	O	-1	-1	0
1,000	PMC4064952	20143	20148	O	-1	-1	0
person	PMC4064952	20149	20155	O	-1	-1	0
/	PMC4064952	20155	20156	O	-1	-1	0
years	PMC4064952	20156	20161	O	-1	-1	0
in	PMC4064952	20162	20164	O	-1	-1	0
patients	PMC4064952	20165	20173	O	-1	-1	0
with	PMC4064952	20174	20178	O	-1	-1	0
a	PMC4064952	20179	20180	O	-1	-1	0
CHADS2	PMC4064952	20181	20187	O	-1	-1	0
score	PMC4064952	20188	20193	O	-1	-1	0
$	PMC4064952	20194	20195	O	-1	-1	0
1.37	PMC4064952	20195	20199	O	-1	-1	0

In	PMC4064952	20200	20202	O	-1	-1	0
such	PMC4064952	20203	20207	O	-1	-1	0
countries	PMC4064952	20208	20217	O	-1	-1	0
,	PMC4064952	20217	20218	O	-1	-1	0
during	PMC4064952	20219	20225	O	-1	-1	0
the	PMC4064952	20226	20229	O	-1	-1	0
same	PMC4064952	20230	20234	O	-1	-1	0
periods	PMC4064952	20235	20242	O	-1	-1	0
of	PMC4064952	20243	20245	O	-1	-1	0
observation	PMC4064952	20246	20257	O	-1	-1	0
and	PMC4064952	20258	20261	O	-1	-1	0
despite	PMC4064952	20262	20269	O	-1	-1	0
the	PMC4064952	20270	20273	O	-1	-1	0
wider	PMC4064952	20274	20279	O	-1	-1	0
use	PMC4064952	20280	20283	O	-1	-1	0
of	PMC4064952	20284	20286	O	-1	-1	0
anticoagulants	PMC4064952	20287	20301	O	-1	-1	0
,	PMC4064952	20301	20302	O	-1	-1	0
the	PMC4064952	20303	20306	O	-1	-1	0
rate	PMC4064952	20307	20311	O	-1	-1	0
of	PMC4064952	20312	20314	O	-1	-1	0
intracranial	PMC4064952	20315	20327	O	-1	-1	0
hemorrhage	PMC4064952	20328	20338	O	-1	-1	0
has	PMC4064952	20339	20342	O	-1	-1	0
remained	PMC4064952	20343	20351	O	-1	-1	0
unchanged	PMC4064952	20352	20361	O	-1	-1	0
at	PMC4064952	20362	20364	O	-1	-1	0
a	PMC4064952	20365	20366	O	-1	-1	0
rate	PMC4064952	20367	20371	O	-1	-1	0
of	PMC4064952	20372	20374	O	-1	-1	0
two	PMC4064952	20375	20378	O	-1	-1	0
per	PMC4064952	20379	20382	O	-1	-1	0
1,000	PMC4064952	20383	20388	O	-1	-1	0
person	PMC4064952	20389	20395	O	-1	-1	0
/	PMC4064952	20395	20396	O	-1	-1	0
years.35,36	PMC4064952	20396	20407	O	-1	-1	0
Stroke	PMC4064952	20408	20414	O	-1	-1	0
secondary	PMC4064952	20415	20424	O	-1	-1	0
to	PMC4064952	20425	20427	O	-1	-1	0
AF	PMC4064952	20428	20430	O	-1	-1	0
is	PMC4064952	20431	20433	O	-1	-1	0
associated	PMC4064952	20434	20444	O	-1	-1	0
with	PMC4064952	20445	20449	O	-1	-1	0
a	PMC4064952	20450	20451	O	-1	-1	0
50	PMC4064952	20452	20454	O	-1	-1	0
%	PMC4064952	20454	20455	O	-1	-1	0
increased	PMC4064952	20456	20465	O	-1	-1	0
risk	PMC4064952	20466	20470	O	-1	-1	0
of	PMC4064952	20471	20473	O	-1	-1	0
serious	PMC4064952	20474	20481	O	-1	-1	0
disability	PMC4064952	20482	20492	O	-1	-1	0
.	PMC4064952	20492	20493	O	-1	-1	0

Cognitive	PMC4064952	20494	20503	O	-1	-1	0
dysfunction	PMC4064952	20504	20515	O	-1	-1	0
,	PMC4064952	20515	20516	O	-1	-1	0
including	PMC4064952	20517	20526	O	-1	-1	0
vascular	PMC4064952	20527	20535	O	-1	-1	0
dementia	PMC4064952	20536	20544	O	-1	-1	0
,	PMC4064952	20544	20545	O	-1	-1	0
is	PMC4064952	20546	20548	O	-1	-1	0
present	PMC4064952	20549	20556	O	-1	-1	0
in	PMC4064952	20557	20559	O	-1	-1	0
10%–15	PMC4064952	20560	20566	O	-1	-1	0
%	PMC4064952	20566	20567	O	-1	-1	0
of	PMC4064952	20568	20570	O	-1	-1	0
patients	PMC4064952	20571	20579	O	-1	-1	0
with	PMC4064952	20580	20584	O	-1	-1	0
AF	PMC4064952	20585	20587	O	-1	-1	0
,	PMC4064952	20587	20588	O	-1	-1	0
which	PMC4064952	20589	20594	O	-1	-1	0
is	PMC4064952	20595	20597	O	-1	-1	0
twice	PMC4064952	20598	20603	O	-1	-1	0
the	PMC4064952	20604	20607	O	-1	-1	0
rate	PMC4064952	20608	20612	O	-1	-1	0
in	PMC4064952	20613	20615	O	-1	-1	0
patients	PMC4064952	20616	20624	O	-1	-1	0
without	PMC4064952	20625	20632	O	-1	-1	0
AF	PMC4064952	20633	20635	O	-1	-1	0
.	PMC4064952	20635	20636	O	-1	-1	0

Cognitive	PMC4064952	20637	20646	O	-1	-1	0
disturbances	PMC4064952	20647	20659	O	-1	-1	0
are	PMC4064952	20660	20663	O	-1	-1	0
also	PMC4064952	20664	20668	O	-1	-1	0
frequently	PMC4064952	20669	20679	O	-1	-1	0
found	PMC4064952	20680	20685	O	-1	-1	0
inAF	PMC4064952	20686	20690	O	-1	-1	0
patients	PMC4064952	20691	20699	O	-1	-1	0
,	PMC4064952	20699	20700	O	-1	-1	0
even	PMC4064952	20701	20705	O	-1	-1	0
in	PMC4064952	20706	20708	O	-1	-1	0
the	PMC4064952	20709	20712	O	-1	-1	0
absence	PMC4064952	20713	20720	O	-1	-1	0
of	PMC4064952	20721	20723	O	-1	-1	0
overt	PMC4064952	20724	20729	O	-1	-1	0
stroke	PMC4064952	20730	20736	O	-1	-1	0
,	PMC4064952	20736	20737	O	-1	-1	0
as	PMC4064952	20738	20740	O	-1	-1	0
a	PMC4064952	20741	20742	O	-1	-1	0
consequence	PMC4064952	20743	20754	O	-1	-1	0
of	PMC4064952	20755	20757	O	-1	-1	0
multiple	PMC4064952	20758	20766	O	-1	-1	0
asymptomatic	PMC4064952	20767	20779	O	-1	-1	0
cerebral	PMC4064952	20780	20788	O	-1	-1	0
emboli	PMC4064952	20789	20795	O	-1	-1	0
that	PMC4064952	20796	20800	O	-1	-1	0
can	PMC4064952	20801	20804	O	-1	-1	0
be	PMC4064952	20805	20807	O	-1	-1	0
found	PMC4064952	20808	20813	O	-1	-1	0
on	PMC4064952	20814	20816	O	-1	-1	0
cerebral	PMC4064952	20817	20825	O	-1	-1	0
imaging	PMC4064952	20826	20833	O	-1	-1	0
in	PMC4064952	20834	20836	O	-1	-1	0
a	PMC4064952	20837	20838	O	-1	-1	0
discrete	PMC4064952	20839	20847	O	-1	-1	0
percentage	PMC4064952	20848	20858	O	-1	-1	0
of	PMC4064952	20859	20861	O	-1	-1	0
cases.9,38,39	PMC4064952	20862	20875	O	-1	-1	0
AF	PMC4064952	20876	20878	O	-1	-1	0
and	PMC4064952	20879	20882	O	-1	-1	0
heart	PMC4064952	20883	20888	O	-1	-1	0
failure	PMC4064952	20889	20896	O	-1	-1	0
coexist	PMC4064952	20897	20904	O	-1	-1	0
in	PMC4064952	20905	20907	O	-1	-1	0
a	PMC4064952	20908	20909	O	-1	-1	0
large	PMC4064952	20910	20915	O	-1	-1	0
percentage	PMC4064952	20916	20926	O	-1	-1	0
of	PMC4064952	20927	20929	O	-1	-1	0
patients	PMC4064952	20930	20938	O	-1	-1	0
(	PMC4064952	20939	20940	O	-1	-1	0
22%–42	PMC4064952	20940	20946	O	-1	-1	0
%	PMC4064952	20946	20947	O	-1	-1	0
)	PMC4064952	20947	20948	O	-1	-1	0
and	PMC4064952	20949	20952	O	-1	-1	0
share	PMC4064952	20953	20958	O	-1	-1	0
risk	PMC4064952	20959	20963	O	-1	-1	0
factors	PMC4064952	20964	20971	O	-1	-1	0
.	PMC4064952	20971	20972	O	-1	-1	0

In	PMC4064952	20973	20975	O	-1	-1	0
addition	PMC4064952	20976	20984	O	-1	-1	0
,	PMC4064952	20984	20985	O	-1	-1	0
each	PMC4064952	20986	20990	O	-1	-1	0
of	PMC4064952	20991	20993	O	-1	-1	0
these	PMC4064952	20994	20999	O	-1	-1	0
conditions	PMC4064952	21000	21010	O	-1	-1	0
strongly	PMC4064952	21011	21019	O	-1	-1	0
predisposes	PMC4064952	21020	21031	O	-1	-1	0
to	PMC4064952	21032	21034	O	-1	-1	0
the	PMC4064952	21035	21038	O	-1	-1	0
other.40	PMC4064952	21039	21047	O	-1	-1	0

Women	PMC4064952	21048	21053	O	-1	-1	0
and	PMC4064952	21054	21057	O	-1	-1	0
men	PMC4064952	21058	21061	O	-1	-1	0
with	PMC4064952	21062	21066	O	-1	-1	0
AF	PMC4064952	21067	21069	O	-1	-1	0
have	PMC4064952	21070	21074	O	-1	-1	0
an	PMC4064952	21075	21077	O	-1	-1	0
eleven	PMC4064952	21078	21084	O	-1	-1	0
-	PMC4064952	21084	21085	O	-1	-1	0
fold	PMC4064952	21085	21089	O	-1	-1	0
and	PMC4064952	21090	21093	O	-1	-1	0
three	PMC4064952	21094	21099	O	-1	-1	0
-	PMC4064952	21099	21100	O	-1	-1	0
fold	PMC4064952	21100	21104	O	-1	-1	0
higher	PMC4064952	21105	21111	O	-1	-1	0
risk	PMC4064952	21112	21116	O	-1	-1	0
,	PMC4064952	21116	21117	O	-1	-1	0
respectively	PMC4064952	21118	21130	O	-1	-1	0
,	PMC4064952	21130	21131	O	-1	-1	0
of	PMC4064952	21132	21134	O	-1	-1	0
developing	PMC4064952	21135	21145	O	-1	-1	0
heart	PMC4064952	21146	21151	O	-1	-1	0
failure	PMC4064952	21152	21159	O	-1	-1	0
in	PMC4064952	21160	21162	O	-1	-1	0
comparison	PMC4064952	21163	21173	O	-1	-1	0
with	PMC4064952	21174	21178	O	-1	-1	0
those	PMC4064952	21179	21184	O	-1	-1	0
without	PMC4064952	21185	21192	O	-1	-1	0
AF	PMC4064952	21193	21195	O	-1	-1	0
.	PMC4064952	21195	21196	O	-1	-1	0

Both	PMC4064952	21197	21201	O	-1	-1	0
these	PMC4064952	21202	21207	O	-1	-1	0
conditions	PMC4064952	21208	21218	O	-1	-1	0
are	PMC4064952	21219	21222	O	-1	-1	0
associated	PMC4064952	21223	21233	O	-1	-1	0
with	PMC4064952	21234	21238	O	-1	-1	0
an	PMC4064952	21239	21241	O	-1	-1	0
adverse	PMC4064952	21242	21249	O	-1	-1	0
prognosis	PMC4064952	21250	21259	O	-1	-1	0
“	PMC4064952	21260	21261	O	-1	-1	0
quod	PMC4064952	21261	21265	O	-1	-1	0
vitam	PMC4064952	21266	21271	O	-1	-1	0
”	PMC4064952	21271	21272	O	-1	-1	0
,	PMC4064952	21272	21273	O	-1	-1	0
and	PMC4064952	21274	21277	O	-1	-1	0
the	PMC4064952	21278	21281	O	-1	-1	0
occurrence	PMC4064952	21282	21292	O	-1	-1	0
of	PMC4064952	21293	21295	O	-1	-1	0
new	PMC4064952	21296	21299	O	-1	-1	0
AF	PMC4064952	21300	21302	O	-1	-1	0
in	PMC4064952	21303	21305	O	-1	-1	0
patients	PMC4064952	21306	21314	O	-1	-1	0
with	PMC4064952	21315	21319	O	-1	-1	0
heart	PMC4064952	21320	21325	O	-1	-1	0
failure	PMC4064952	21326	21333	O	-1	-1	0
is	PMC4064952	21334	21336	O	-1	-1	0
associated	PMC4064952	21337	21347	O	-1	-1	0
with	PMC4064952	21348	21352	O	-1	-1	0
a	PMC4064952	21353	21354	O	-1	-1	0
two	PMC4064952	21355	21358	O	-1	-1	0
-	PMC4064952	21358	21359	O	-1	-1	0
fold	PMC4064952	21359	21363	O	-1	-1	0
higher	PMC4064952	21364	21370	O	-1	-1	0
risk	PMC4064952	21371	21375	O	-1	-1	0
of	PMC4064952	21376	21378	O	-1	-1	0
death	PMC4064952	21379	21384	O	-1	-1	0
in	PMC4064952	21385	21387	O	-1	-1	0
comparison	PMC4064952	21388	21398	O	-1	-1	0
with	PMC4064952	21399	21403	O	-1	-1	0
those	PMC4064952	21404	21409	O	-1	-1	0
without	PMC4064952	21410	21417	O	-1	-1	0
AF.41–43	PMC4064952	21418	21426	O	-1	-1	0

AF	PMC4064952	21427	21429	O	-1	-1	0
is	PMC4064952	21430	21432	O	-1	-1	0
also	PMC4064952	21433	21437	O	-1	-1	0
associated	PMC4064952	21438	21448	O	-1	-1	0
with	PMC4064952	21449	21453	O	-1	-1	0
increased	PMC4064952	21454	21463	O	-1	-1	0
mortality	PMC4064952	21464	21473	O	-1	-1	0
.	PMC4064952	21473	21474	O	-1	-1	0

In	PMC4064952	21475	21477	O	-1	-1	0
the	PMC4064952	21478	21481	O	-1	-1	0
USA	PMC4064952	21482	21485	B-Location	-1	-1	0
,	PMC4064952	21485	21486	O	-1	-1	0
among	PMC4064952	21487	21492	O	-1	-1	0
Medicare	PMC4064952	21493	21501	O	-1	-1	0
beneficiaries	PMC4064952	21502	21515	O	-1	-1	0
aged	PMC4064952	21516	21520	O	-1	-1	0
65	PMC4064952	21521	21523	O	-1	-1	0
years	PMC4064952	21524	21529	O	-1	-1	0
or	PMC4064952	21530	21532	O	-1	-1	0
older	PMC4064952	21533	21538	O	-1	-1	0
­	PMC4064952	21539	21540	O	-1	-1	0
followed	PMC4064952	21541	21549	O	-1	-1	0
from	PMC4064952	21550	21554	O	-1	-1	0
1993	PMC4064952	21555	21559	O	-1	-1	0
to	PMC4064952	21560	21562	O	-1	-1	0
2007	PMC4064952	21563	21567	O	-1	-1	0
,	PMC4064952	21567	21568	O	-1	-1	0
the	PMC4064952	21569	21572	O	-1	-1	0
global	PMC4064952	21573	21579	O	-1	-1	0
mortality	PMC4064952	21580	21589	O	-1	-1	0
rate	PMC4064952	21590	21594	O	-1	-1	0
after	PMC4064952	21595	21600	O	-1	-1	0
­	PMC4064952	21601	21602	O	-1	-1	0

incident	PMC4064952	21603	21611	O	-1	-1	0
AF	PMC4064952	21612	21614	O	-1	-1	0
was	PMC4064952	21615	21618	O	-1	-1	0
10.8	PMC4064952	21619	21623	O	-1	-1	0
%	PMC4064952	21623	21624	O	-1	-1	0
in	PMC4064952	21625	21627	O	-1	-1	0
the	PMC4064952	21628	21631	O	-1	-1	0
short	PMC4064952	21632	21637	O	-1	-1	0
-	PMC4064952	21637	21638	O	-1	-1	0
term	PMC4064952	21638	21642	O	-1	-1	0
(	PMC4064952	21643	21644	O	-1	-1	0
30	PMC4064952	21644	21646	O	-1	-1	0
days	PMC4064952	21647	21651	O	-1	-1	0
)	PMC4064952	21651	21652	O	-1	-1	0
,	PMC4064952	21652	21653	O	-1	-1	0
24.7	PMC4064952	21654	21658	O	-1	-1	0
%	PMC4064952	21658	21659	O	-1	-1	0
in	PMC4064952	21660	21662	O	-1	-1	0
the	PMC4064952	21663	21666	O	-1	-1	0
medium	PMC4064952	21667	21673	O	-1	-1	0
term	PMC4064952	21674	21678	O	-1	-1	0
(	PMC4064952	21679	21680	O	-1	-1	0
one	PMC4064952	21680	21683	O	-1	-1	0
year	PMC4064952	21684	21688	O	-1	-1	0
)	PMC4064952	21688	21689	O	-1	-1	0
,	PMC4064952	21689	21690	O	-1	-1	0
and	PMC4064952	21691	21694	O	-1	-1	0
42	PMC4064952	21695	21697	O	-1	-1	0
%	PMC4064952	21697	21698	O	-1	-1	0
in	PMC4064952	21699	21701	O	-1	-1	0
the	PMC4064952	21702	21705	O	-1	-1	0
long	PMC4064952	21706	21710	O	-1	-1	0
term	PMC4064952	21711	21715	O	-1	-1	0
(	PMC4064952	21716	21717	O	-1	-1	0
3	PMC4064952	21717	21718	O	-1	-1	0
years).These	PMC4064952	21719	21731	O	-1	-1	0
rates	PMC4064952	21732	21737	O	-1	-1	0
have	PMC4064952	21738	21742	O	-1	-1	0
changed	PMC4064952	21743	21750	O	-1	-1	0
only	PMC4064952	21751	21755	O	-1	-1	0
slightly	PMC4064952	21756	21764	O	-1	-1	0
and	PMC4064952	21765	21768	O	-1	-1	0
not	PMC4064952	21769	21772	O	-1	-1	0
signifi-	PMC4064952	21773	21781	O	-1	-1	0

cantly	PMC4064952	21782	21788	O	-1	-1	0
over	PMC4064952	21789	21793	O	-1	-1	0
time.10	PMC4064952	21794	21801	O	-1	-1	0

In	PMC4064952	21802	21804	O	-1	-1	0
Sweden	PMC4064952	21805	21811	B-Location	-1	-1	0
,	PMC4064952	21811	21812	O	-1	-1	0
during	PMC4064952	21813	21819	O	-1	-1	0
the	PMC4064952	21820	21823	O	-1	-1	0
period	PMC4064952	21824	21830	O	-1	-1	0
1995–2008	PMC4064952	21831	21840	O	-1	-1	0
,	PMC4064952	21840	21841	O	-1	-1	0
patients	PMC4064952	21842	21850	O	-1	-1	0
enrolled	PMC4064952	21851	21859	O	-1	-1	0
in	PMC4064952	21860	21862	O	-1	-1	0
the	PMC4064952	21863	21866	O	-1	-1	0
Swedish	PMC4064952	21867	21874	O	-1	-1	0
National	PMC4064952	21875	21883	O	-1	-1	0
Patient	PMC4064952	21884	21891	O	-1	-1	0
Registry	PMC4064952	21892	21900	O	-1	-1	0

showed	PMC4064952	21901	21907	O	-1	-1	0
a	PMC4064952	21908	21909	O	-1	-1	0
global	PMC4064952	21910	21916	O	-1	-1	0
mortality	PMC4064952	21917	21926	O	-1	-1	0
rate	PMC4064952	21927	21931	O	-1	-1	0
of	PMC4064952	21932	21934	O	-1	-1	0
40	PMC4064952	21935	21937	O	-1	-1	0
%	PMC4064952	21937	21938	O	-1	-1	0
after	PMC4064952	21939	21944	O	-1	-1	0
diagnosis	PMC4064952	21945	21954	O	-1	-1	0
of	PMC4064952	21955	21957	O	-1	-1	0
incidentAF	PMC4064952	21958	21968	O	-1	-1	0
and	PMC4064952	21969	21972	O	-1	-1	0
60	PMC4064952	21973	21975	O	-1	-1	0
%	PMC4064952	21975	21976	O	-1	-1	0
at	PMC4064952	21977	21979	O	-1	-1	0
5	PMC4064952	21980	21981	O	-1	-1	0
and	PMC4064952	21982	21985	O	-1	-1	0
10	PMC4064952	21986	21988	O	-1	-1	0
years	PMC4064952	21989	21994	O	-1	-1	0
,	PMC4064952	21994	21995	O	-1	-1	0
respectively	PMC4064952	21996	22008	O	-1	-1	0
,	PMC4064952	22008	22009	O	-1	-1	0
versus	PMC4064952	22010	22016	O	-1	-1	0
a	PMC4064952	22017	22018	O	-1	-1	0
rate	PMC4064952	22019	22023	O	-1	-1	0
of	PMC4064952	22024	22026	O	-1	-1	0
20	PMC4064952	22027	22029	O	-1	-1	0
%	PMC4064952	22029	22030	O	-1	-1	0
and	PMC4064952	22031	22034	O	-1	-1	0
40	PMC4064952	22035	22037	O	-1	-1	0
%	PMC4064952	22037	22038	O	-1	-1	0
in	PMC4064952	22039	22041	O	-1	-1	0
those	PMC4064952	22042	22047	O	-1	-1	0
withoutAF.The	PMC4064952	22048	22061	O	-1	-1	0
relative	PMC4064952	22062	22070	O	-1	-1	0
risk	PMC4064952	22071	22075	O	-1	-1	0
of	PMC4064952	22076	22078	O	-1	-1	0
dying	PMC4064952	22079	22084	O	-1	-1	0
was	PMC4064952	22085	22088	O	-1	-1	0
higher	PMC4064952	22089	22095	O	-1	-1	0
in	PMC4064952	22096	22098	O	-1	-1	0
women	PMC4064952	22099	22104	O	-1	-1	0
than	PMC4064952	22105	22109	O	-1	-1	0
in	PMC4064952	22110	22112	O	-1	-1	0
men	PMC4064952	22113	22116	O	-1	-1	0
and	PMC4064952	22117	22120	O	-1	-1	0
decreased	PMC4064952	22121	22130	O	-1	-1	0
with	PMC4064952	22131	22135	O	-1	-1	0
age	PMC4064952	22136	22139	O	-1	-1	0
.	PMC4064952	22139	22140	O	-1	-1	0

Women	PMC4064952	22141	22146	O	-1	-1	0
and	PMC4064952	22147	22150	O	-1	-1	0
men	PMC4064952	22151	22154	O	-1	-1	0
aged	PMC4064952	22155	22159	O	-1	-1	0
,	PMC4064952	22160	22161	O	-1	-1	0
65	PMC4064952	22161	22163	O	-1	-1	0
years	PMC4064952	22164	22169	O	-1	-1	0
had	PMC4064952	22170	22173	O	-1	-1	0
an	PMC4064952	22174	22176	O	-1	-1	0
adjusted	PMC4064952	22177	22185	O	-1	-1	0
rela-	PMC4064952	22186	22191	O	-1	-1	0
tive	PMC4064952	22192	22196	O	-1	-1	0
risk	PMC4064952	22197	22201	O	-1	-1	0
of	PMC4064952	22202	22204	O	-1	-1	0
4.88	PMC4064952	22205	22209	O	-1	-1	0
and	PMC4064952	22210	22213	O	-1	-1	0
3.07	PMC4064952	22214	22218	O	-1	-1	0
,	PMC4064952	22218	22219	O	-1	-1	0
respectively	PMC4064952	22220	22232	O	-1	-1	0
,	PMC4064952	22232	22233	O	-1	-1	0
of	PMC4064952	22234	22236	O	-1	-1	0
dying	PMC4064952	22237	22242	O	-1	-1	0
at	PMC4064952	22243	22245	O	-1	-1	0
one	PMC4064952	22246	22249	O	-1	-1	0
year	PMC4064952	22250	22254	O	-1	-1	0
,	PMC4064952	22254	22255	O	-1	-1	0

those	PMC4064952	22256	22261	O	-1	-1	0
aged	PMC4064952	22262	22266	O	-1	-1	0
65–74	PMC4064952	22267	22272	O	-1	-1	0
years	PMC4064952	22273	22278	O	-1	-1	0
had	PMC4064952	22279	22282	O	-1	-1	0
a	PMC4064952	22283	22284	O	-1	-1	0
risk	PMC4064952	22285	22289	O	-1	-1	0
of	PMC4064952	22290	22292	O	-1	-1	0
2.88	PMC4064952	22293	22297	O	-1	-1	0
and	PMC4064952	22298	22301	O	-1	-1	0
2.07	PMC4064952	22302	22306	O	-1	-1	0
,	PMC4064952	22306	22307	O	-1	-1	0
and	PMC4064952	22308	22311	O	-1	-1	0
those	PMC4064952	22312	22317	O	-1	-1	0
aged	PMC4064952	22318	22322	O	-1	-1	0
75–85	PMC4064952	22323	22328	O	-1	-1	0
years	PMC4064952	22329	22334	O	-1	-1	0
had	PMC4064952	22335	22338	O	-1	-1	0
a	PMC4064952	22339	22340	O	-1	-1	0
risk	PMC4064952	22341	22345	O	-1	-1	0
of	PMC4064952	22346	22348	O	-1	-1	0
2.09	PMC4064952	22349	22353	O	-1	-1	0
and	PMC4064952	22354	22357	O	-1	-1	0
1.72	PMC4064952	22358	22362	O	-1	-1	0
.	PMC4064952	22362	22363	O	-1	-1	0

AF	PMC4064952	22364	22366	O	-1	-1	0
was	PMC4064952	22367	22370	O	-1	-1	0
found	PMC4064952	22371	22376	O	-1	-1	0
to	PMC4064952	22377	22379	O	-1	-1	0
be	PMC4064952	22380	22382	O	-1	-1	0
a	PMC4064952	22383	22384	O	-1	-1	0
significant	PMC4064952	22385	22396	O	-1	-1	0
risk	PMC4064952	22397	22401	O	-1	-1	0
factor	PMC4064952	22402	22408	O	-1	-1	0
for	PMC4064952	22409	22412	O	-1	-1	0
all	PMC4064952	22413	22416	O	-1	-1	0
-	PMC4064952	22416	22417	O	-1	-1	0
cause	PMC4064952	22417	22422	O	-1	-1	0
mortality	PMC4064952	22423	22432	O	-1	-1	0
together	PMC4064952	22433	22441	O	-1	-1	0
with	PMC4064952	22442	22446	O	-1	-1	0
the	PMC4064952	22447	22450	O	-1	-1	0
presence	PMC4064952	22451	22459	O	-1	-1	0
of	PMC4064952	22460	22462	O	-1	-1	0
chronic	PMC4064952	22463	22470	O	-1	-1	0
renal	PMC4064952	22471	22476	O	-1	-1	0
failure	PMC4064952	22477	22484	O	-1	-1	0
,	PMC4064952	22484	22485	O	-1	-1	0
cancer	PMC4064952	22486	22492	O	-1	-1	0
,	PMC4064952	22492	22493	O	-1	-1	0
and	PMC4064952	22494	22497	O	-1	-1	0
chronic	PMC4064952	22498	22505	O	-1	-1	0
obstructive	PMC4064952	22506	22517	O	-1	-1	0
pulmonary	PMC4064952	22518	22527	O	-1	-1	0
disease.44	PMC4064952	22528	22538	O	-1	-1	0

Also	PMC4064952	22539	22543	O	-1	-1	0
,	PMC4064952	22543	22544	O	-1	-1	0
in	PMC4064952	22545	22547	O	-1	-1	0
Olmsted	PMC4064952	22548	22555	B-Location	-1	-1	0
County	PMC4064952	22556	22562	I-Location	-1	-1	0
,	PMC4064952	22562	22563	O	-1	-1	0
during	PMC4064952	22564	22570	O	-1	-1	0
a	PMC4064952	22571	22572	O	-1	-1	0
period	PMC4064952	22573	22579	O	-1	-1	0
of	PMC4064952	22580	22582	O	-1	-1	0
observation	PMC4064952	22583	22594	O	-1	-1	0
of	PMC4064952	22595	22597	O	-1	-1	0
24	PMC4064952	22598	22600	O	-1	-1	0
years	PMC4064952	22601	22606	O	-1	-1	0
,	PMC4064952	22606	22607	O	-1	-1	0
new	PMC4064952	22608	22611	O	-1	-1	0
-	PMC4064952	22611	22612	O	-1	-1	0
onset	PMC4064952	22612	22617	O	-1	-1	0
AF	PMC4064952	22618	22620	O	-1	-1	0
was	PMC4064952	22621	22624	O	-1	-1	0
found	PMC4064952	22625	22630	O	-1	-1	0
to	PMC4064952	22631	22633	O	-1	-1	0
be	PMC4064952	22634	22636	O	-1	-1	0
associated	PMC4064952	22637	22647	O	-1	-1	0
with	PMC4064952	22648	22652	O	-1	-1	0
a	PMC4064952	22653	22654	O	-1	-1	0
significantly	PMC4064952	22655	22668	O	-1	-1	0
increased	PMC4064952	22669	22678	O	-1	-1	0
risk	PMC4064952	22679	22683	O	-1	-1	0
(	PMC4064952	22684	22685	O	-1	-1	0
67	PMC4064952	22685	22687	O	-1	-1	0
%	PMC4064952	22687	22688	O	-1	-1	0
)	PMC4064952	22688	22689	O	-1	-1	0
of	PMC4064952	22690	22692	O	-1	-1	0
all	PMC4064952	22693	22696	O	-1	-1	0
-	PMC4064952	22696	22697	O	-1	-1	0
cause	PMC4064952	22697	22702	O	-1	-1	0
mortality	PMC4064952	22703	22712	O	-1	-1	0
that	PMC4064952	22713	22717	O	-1	-1	0
was	PMC4064952	22718	22721	O	-1	-1	0
highest	PMC4064952	22722	22729	O	-1	-1	0
(	PMC4064952	22730	22731	O	-1	-1	0
hazard	PMC4064952	22731	22737	O	-1	-1	0
ratio	PMC4064952	22738	22743	O	-1	-1	0
9.62	PMC4064952	22744	22748	O	-1	-1	0
)	PMC4064952	22748	22749	O	-1	-1	0

within	PMC4064952	22750	22756	O	-1	-1	0
the	PMC4064952	22757	22760	O	-1	-1	0
first	PMC4064952	22761	22766	O	-1	-1	0
4	PMC4064952	22767	22768	O	-1	-1	0
months	PMC4064952	22769	22775	O	-1	-1	0
of	PMC4064952	22776	22778	O	-1	-1	0
diagnosis	PMC4064952	22779	22788	O	-1	-1	0
and	PMC4064952	22789	22792	O	-1	-1	0
decreased	PMC4064952	22793	22802	O	-1	-1	0
significantly	PMC4064952	22803	22816	O	-1	-1	0
thereafter	PMC4064952	22817	22827	O	-1	-1	0
(	PMC4064952	22828	22829	O	-1	-1	0
hazard	PMC4064952	22829	22835	O	-1	-1	0
ratio	PMC4064952	22836	22841	O	-1	-1	0
1.66).45	PMC4064952	22842	22850	O	-1	-1	0

Clinical	PMC4064952	22851	22859	O	-1	-1	0
Epidemiology	PMC4064952	22860	22872	O	-1	-1	0
2014:6	PMC4064952	22873	22879	O	-1	-1	0
submit	PMC4064952	22880	22886	O	-1	-1	0
your	PMC4064952	22887	22891	O	-1	-1	0
manuscript	PMC4064952	22892	22902	O	-1	-1	0
|	PMC4064952	22903	22904	O	-1	-1	0

www.dovepress.com	PMC4064952	22905	22922	O	-1	-1	0

Dovepress	PMC4064952	22923	22932	O	-1	-1	0

Dovepress	PMC4064952	22933	22942	O	-1	-1	0
218	PMC4064952	22943	22946	O	-1	-1	0

Zoni	PMC4064952	22947	22951	O	-1	-1	0
-	PMC4064952	22951	22952	O	-1	-1	0
Berisso	PMC4064952	22952	22959	O	-1	-1	0
et	PMC4064952	22960	22962	O	-1	-1	0
al	PMC4064952	22963	22965	O	-1	-1	0

The	PMC4064952	22966	22969	O	-1	-1	0
relationship	PMC4064952	22970	22982	O	-1	-1	0
between	PMC4064952	22983	22990	O	-1	-1	0
mortality	PMC4064952	22991	23000	O	-1	-1	0
and	PMC4064952	23001	23004	O	-1	-1	0
type	PMC4064952	23005	23009	O	-1	-1	0
of	PMC4064952	23010	23012	O	-1	-1	0
AF	PMC4064952	23013	23015	O	-1	-1	0
is	PMC4064952	23016	23018	O	-1	-1	0
not	PMC4064952	23019	23022	O	-1	-1	0
clear	PMC4064952	23023	23028	O	-1	-1	0
.	PMC4064952	23028	23029	O	-1	-1	0

In	PMC4064952	23030	23032	O	-1	-1	0
the	PMC4064952	23033	23036	O	-1	-1	0
Women	PMC4064952	23037	23042	O	-1	-1	0
’s	PMC4064952	23042	23044	O	-1	-1	0
Health	PMC4064952	23045	23051	O	-1	-1	0
Study	PMC4064952	23052	23057	O	-1	-1	0
,	PMC4064952	23057	23058	O	-1	-1	0
persistent	PMC4064952	23059	23069	O	-1	-1	0
and	PMC4064952	23070	23073	O	-1	-1	0
­	PMC4064952	23074	23075	O	-1	-1	0

permanent	PMC4064952	23076	23085	O	-1	-1	0
AF	PMC4064952	23086	23088	O	-1	-1	0
(	PMC4064952	23089	23090	O	-1	-1	0
but	PMC4064952	23090	23093	O	-1	-1	0
not	PMC4064952	23094	23097	O	-1	-1	0
paroxysmal	PMC4064952	23098	23108	O	-1	-1	0
AF	PMC4064952	23109	23111	O	-1	-1	0
)	PMC4064952	23111	23112	O	-1	-1	0
have	PMC4064952	23113	23117	O	-1	-1	0
been	PMC4064952	23118	23122	O	-1	-1	0
found	PMC4064952	23123	23128	O	-1	-1	0
to	PMC4064952	23129	23131	O	-1	-1	0
be	PMC4064952	23132	23134	O	-1	-1	0
significantly	PMC4064952	23135	23148	O	-1	-1	0
associated	PMC4064952	23149	23159	O	-1	-1	0
with	PMC4064952	23160	23164	O	-1	-1	0
mortality,46	PMC4064952	23165	23177	O	-1	-1	0

and	PMC4064952	23178	23181	O	-1	-1	0
in	PMC4064952	23182	23184	O	-1	-1	0
the	PMC4064952	23185	23188	O	-1	-1	0
Loire	PMC4064952	23189	23194	O	-1	-1	0
Valley	PMC4064952	23195	23201	O	-1	-1	0
AF	PMC4064952	23202	23204	O	-1	-1	0
Project	PMC4064952	23205	23212	O	-1	-1	0
,	PMC4064952	23212	23213	O	-1	-1	0
only	PMC4064952	23214	23218	O	-1	-1	0
permanent	PMC4064952	23219	23228	O	-1	-1	0
AF	PMC4064952	23229	23231	O	-1	-1	0
was	PMC4064952	23232	23235	O	-1	-1	0
found	PMC4064952	23236	23241	O	-1	-1	0
to	PMC4064952	23242	23244	O	-1	-1	0
be	PMC4064952	23245	23247	O	-1	-1	0
significantly	PMC4064952	23248	23261	O	-1	-1	0
associated	PMC4064952	23262	23272	O	-1	-1	0
with	PMC4064952	23273	23277	O	-1	-1	0
mortality.47	PMC4064952	23278	23290	O	-1	-1	0

Thus	PMC4064952	23291	23295	O	-1	-1	0
,	PMC4064952	23295	23296	O	-1	-1	0
even	PMC4064952	23297	23301	O	-1	-1	0
though	PMC4064952	23302	23308	O	-1	-1	0
there	PMC4064952	23309	23314	O	-1	-1	0
is	PMC4064952	23315	23317	O	-1	-1	0
not	PMC4064952	23318	23321	O	-1	-1	0
yet	PMC4064952	23322	23325	O	-1	-1	0
clear	PMC4064952	23326	23331	O	-1	-1	0
evidence	PMC4064952	23332	23340	O	-1	-1	0
that	PMC4064952	23341	23345	O	-1	-1	0
the	PMC4064952	23346	23349	O	-1	-1	0
increased	PMC4064952	23350	23359	O	-1	-1	0
mortality	PMC4064952	23360	23369	O	-1	-1	0
observed	PMC4064952	23370	23378	O	-1	-1	0
in	PMC4064952	23379	23381	O	-1	-1	0
patients	PMC4064952	23382	23390	O	-1	-1	0
withAF	PMC4064952	23391	23397	O	-1	-1	0
is	PMC4064952	23398	23400	O	-1	-1	0
directly	PMC4064952	23401	23409	O	-1	-1	0
due	PMC4064952	23410	23413	O	-1	-1	0
to	PMC4064952	23414	23416	O	-1	-1	0
arrhythmia	PMC4064952	23417	23427	O	-1	-1	0
or	PMC4064952	23428	23430	O	-1	-1	0
to	PMC4064952	23431	23433	O	-1	-1	0
the	PMC4064952	23434	23437	O	-1	-1	0
numerous	PMC4064952	23438	23446	O	-1	-1	0
serious	PMC4064952	23447	23454	O	-1	-1	0
associated	PMC4064952	23455	23465	O	-1	-1	0
conditions	PMC4064952	23466	23476	O	-1	-1	0
,	PMC4064952	23476	23477	O	-1	-1	0
AF	PMC4064952	23478	23480	O	-1	-1	0
remains	PMC4064952	23481	23488	O	-1	-1	0
a	PMC4064952	23489	23490	O	-1	-1	0
marker	PMC4064952	23491	23497	O	-1	-1	0
of	PMC4064952	23498	23500	O	-1	-1	0
a	PMC4064952	23501	23502	O	-1	-1	0
poor	PMC4064952	23503	23507	O	-1	-1	0
prognosis	PMC4064952	23508	23517	O	-1	-1	0
.	PMC4064952	23517	23518	O	-1	-1	0

European	PMC4064952	23519	23527	O	-1	-1	0
perspective	PMC4064952	23528	23539	O	-1	-1	0

Although	PMC4064952	23540	23548	O	-1	-1	0
the	PMC4064952	23549	23552	O	-1	-1	0
marked	PMC4064952	23553	23559	O	-1	-1	0
differences	PMC4064952	23560	23571	O	-1	-1	0
in	PMC4064952	23572	23574	O	-1	-1	0
population	PMC4064952	23575	23585	O	-1	-1	0

characteris-	PMC4064952	23586	23598	O	-1	-1	0
tics	PMC4064952	23599	23603	O	-1	-1	0
present	PMC4064952	23604	23611	O	-1	-1	0
in	PMC4064952	23612	23614	O	-1	-1	0
the	PMC4064952	23615	23618	O	-1	-1	0
majority	PMC4064952	23619	23627	O	-1	-1	0
of	PMC4064952	23628	23630	O	-1	-1	0
the	PMC4064952	23631	23634	O	-1	-1	0
published	PMC4064952	23635	23644	O	-1	-1	0
epidemiological	PMC4064952	23645	23660	O	-1	-1	0
studies	PMC4064952	23661	23668	O	-1	-1	0
(	PMC4064952	23669	23670	O	-1	-1	0
eg	PMC4064952	23670	23672	O	-1	-1	0
,	PMC4064952	23672	23673	O	-1	-1	0
different	PMC4064952	23674	23683	O	-1	-1	0
ages	PMC4064952	23684	23688	O	-1	-1	0
at	PMC4064952	23689	23691	O	-1	-1	0
enrolment	PMC4064952	23692	23701	O	-1	-1	0
,	PMC4064952	23701	23702	O	-1	-1	0
different	PMC4064952	23703	23712	O	-1	-1	0
types	PMC4064952	23713	23718	O	-1	-1	0
of	PMC4064952	23719	23721	O	-1	-1	0
AF	PMC4064952	23722	23724	O	-1	-1	0
considered	PMC4064952	23725	23735	O	-1	-1	0
)	PMC4064952	23735	23736	O	-1	-1	0
,	PMC4064952	23736	23737	O	-1	-1	0
the	PMC4064952	23738	23741	O	-1	-1	0
available	PMC4064952	23742	23751	O	-1	-1	0
data	PMC4064952	23752	23756	O	-1	-1	0
indicate	PMC4064952	23757	23765	O	-1	-1	0
a	PMC4064952	23766	23767	O	-1	-1	0
similar	PMC4064952	23768	23775	O	-1	-1	0
preva-	PMC4064952	23776	23782	O	-1	-1	0
lence	PMC4064952	23783	23788	O	-1	-1	0
and	PMC4064952	23789	23792	O	-1	-1	0
incidence	PMC4064952	23793	23802	O	-1	-1	0
of	PMC4064952	23803	23805	O	-1	-1	0
AF	PMC4064952	23806	23808	O	-1	-1	0
throughout	PMC4064952	23809	23819	O	-1	-1	0
the	PMC4064952	23820	23823	O	-1	-1	0
developed	PMC4064952	23824	23833	O	-1	-1	0
world	PMC4064952	23834	23839	O	-1	-1	0
.	PMC4064952	23839	23840	O	-1	-1	0

At	PMC4064952	23841	23843	O	-1	-1	0
the	PMC4064952	23844	23847	O	-1	-1	0
present	PMC4064952	23848	23855	O	-1	-1	0
time	PMC4064952	23856	23860	O	-1	-1	0
,	PMC4064952	23860	23861	O	-1	-1	0
among	PMC4064952	23862	23867	O	-1	-1	0
residents	PMC4064952	23868	23877	O	-1	-1	0
aged	PMC4064952	23878	23882	O	-1	-1	0
15–20	PMC4064952	23883	23888	O	-1	-1	0
years	PMC4064952	23889	23894	O	-1	-1	0
or	PMC4064952	23895	23897	O	-1	-1	0
over	PMC4064952	23898	23902	O	-1	-1	0
in	PMC4064952	23903	23905	O	-1	-1	0
Europe	PMC4064952	23906	23912	B-Location	-1	-1	0
,	PMC4064952	23912	23913	O	-1	-1	0
the	PMC4064952	23914	23917	O	-1	-1	0
prevalence	PMC4064952	23918	23928	O	-1	-1	0
of	PMC4064952	23929	23931	O	-1	-1	0
AF	PMC4064952	23932	23934	O	-1	-1	0
can	PMC4064952	23935	23938	O	-1	-1	0
be	PMC4064952	23939	23941	O	-1	-1	0
estimated	PMC4064952	23942	23951	O	-1	-1	0
at	PMC4064952	23952	23954	O	-1	-1	0
2	PMC4064952	23955	23956	O	-1	-1	0
%	PMC4064952	23956	23957	O	-1	-1	0
,	PMC4064952	23957	23958	O	-1	-1	0
together	PMC4064952	23959	23967	O	-1	-1	0
with	PMC4064952	23968	23972	O	-1	-1	0
an	PMC4064952	23973	23975	O	-1	-1	0
incidence	PMC4064952	23976	23985	O	-1	-1	0
ranging	PMC4064952	23986	23993	O	-1	-1	0
between	PMC4064952	23994	24001	O	-1	-1	0
0.23	PMC4064952	24002	24006	O	-1	-1	0
and	PMC4064952	24007	24010	O	-1	-1	0
0.41	PMC4064952	24011	24015	O	-1	-1	0
per	PMC4064952	24016	24019	O	-1	-1	0
1,000	PMC4064952	24020	24025	O	-1	-1	0
person	PMC4064952	24026	24032	O	-1	-1	0
/	PMC4064952	24032	24033	O	-1	-1	0
years	PMC4064952	24033	24038	O	-1	-1	0
.	PMC4064952	24038	24039	O	-1	-1	0

Among	PMC4064952	24040	24045	O	-1	-1	0
these	PMC4064952	24046	24051	O	-1	-1	0
patients	PMC4064952	24052	24060	O	-1	-1	0
,	PMC4064952	24060	24061	O	-1	-1	0
the	PMC4064952	24062	24065	O	-1	-1	0
annual	PMC4064952	24066	24072	O	-1	-1	0
rate	PMC4064952	24073	24077	O	-1	-1	0
of	PMC4064952	24078	24080	O	-1	-1	0
ischemic	PMC4064952	24081	24089	O	-1	-1	0
and	PMC4064952	24090	24093	O	-1	-1	0
hemorrhagic	PMC4064952	24094	24105	O	-1	-1	0
strokes	PMC4064952	24106	24113	O	-1	-1	0
is	PMC4064952	24114	24116	O	-1	-1	0
­	PMC4064952	24117	24118	O	-1	-1	0
estimated	PMC4064952	24119	24128	O	-1	-1	0

to	PMC4064952	24129	24131	O	-1	-1	0
be	PMC4064952	24132	24134	O	-1	-1	0
2	PMC4064952	24135	24136	O	-1	-1	0
%	PMC4064952	24136	24137	O	-1	-1	0
(	PMC4064952	24138	24139	O	-1	-1	0
1.3	PMC4064952	24139	24142	O	-1	-1	0
%	PMC4064952	24142	24143	O	-1	-1	0
in	PMC4064952	24144	24146	O	-1	-1	0
France	PMC4064952	24147	24153	B-Location	-1	-1	0
,	PMC4064952	24153	24154	O	-1	-1	0
1.7	PMC4064952	24155	24158	O	-1	-1	0
%	PMC4064952	24158	24159	O	-1	-1	0
in	PMC4064952	24160	24162	O	-1	-1	0
the	PMC4064952	24163	24166	O	-1	-1	0
USA	PMC4064952	24167	24170	B-Location	-1	-1	0
,	PMC4064952	24170	24171	O	-1	-1	0
4.5	PMC4064952	24172	24175	O	-1	-1	0
%	PMC4064952	24175	24176	O	-1	-1	0
in	PMC4064952	24177	24179	O	-1	-1	0
patients	PMC4064952	24180	24188	O	-1	-1	0
not	PMC4064952	24189	24192	O	-1	-1	0
anticoagulated	PMC4064952	24193	24207	O	-1	-1	0
and	PMC4064952	24208	24211	O	-1	-1	0
2.5	PMC4064952	24212	24215	O	-1	-1	0
%	PMC4064952	24215	24216	O	-1	-1	0
in	PMC4064952	24217	24219	O	-1	-1	0
patients	PMC4064952	24220	24228	O	-1	-1	0
anticoagulated	PMC4064952	24229	24243	O	-1	-1	0
in	PMC4064952	24244	24246	O	-1	-1	0
Sweden	PMC4064952	24247	24253	B-Location	-1	-1	0
)	PMC4064952	24253	24254	O	-1	-1	0
and	PMC4064952	24255	24258	O	-1	-1	0
0.2	PMC4064952	24259	24262	O	-1	-1	0
%	PMC4064952	24262	24263	O	-1	-1	0
,	PMC4064952	24263	24264	O	-1	-1	0
respectively	PMC4064952	24265	24277	O	-1	-1	0
.	PMC4064952	24277	24278	O	-1	-1	0

The	PMC4064952	24278	24281	O	-1	-1	0
number	PMC4064952	24282	24288	O	-1	-1	0
of	PMC4064952	24289	24291	O	-1	-1	0
hospitaliza-	PMC4064952	24292	24304	O	-1	-1	0
tions	PMC4064952	24305	24310	O	-1	-1	0
for	PMC4064952	24311	24314	O	-1	-1	0
AF	PMC4064952	24315	24317	O	-1	-1	0
is	PMC4064952	24318	24320	O	-1	-1	0
0.25	PMC4064952	24321	24325	O	-1	-1	0
per	PMC4064952	24326	24329	O	-1	-1	0
year	PMC4064952	24330	24334	O	-1	-1	0
and	PMC4064952	24335	24338	O	-1	-1	0
the	PMC4064952	24339	24342	O	-1	-1	0
number	PMC4064952	24343	24349	O	-1	-1	0
of	PMC4064952	24350	24352	O	-1	-1	0
outpatient	PMC4064952	24353	24363	O	-1	-1	0

contacts	PMC4064952	24364	24372	O	-1	-1	0
is	PMC4064952	24373	24375	O	-1	-1	0
approximately	PMC4064952	24376	24389	O	-1	-1	0
six	PMC4064952	24390	24393	O	-1	-1	0
per	PMC4064952	24394	24397	O	-1	-1	0
year	PMC4064952	24398	24402	O	-1	-1	0
.	PMC4064952	24402	24403	O	-1	-1	0

This	PMC4064952	24403	24407	O	-1	-1	0
means	PMC4064952	24408	24413	O	-1	-1	0
that	PMC4064952	24414	24418	O	-1	-1	0
at	PMC4064952	24419	24421	O	-1	-1	0
the	PMC4064952	24422	24425	O	-1	-1	0
present	PMC4064952	24426	24433	O	-1	-1	0
time	PMC4064952	24434	24438	O	-1	-1	0
in	PMC4064952	24439	24441	O	-1	-1	0
the	PMC4064952	24442	24445	O	-1	-1	0
European	PMC4064952	24446	24454	O	-1	-1	0
community	PMC4064952	24455	24464	O	-1	-1	0
(	PMC4064952	24465	24466	O	-1	-1	0
population	PMC4064952	24466	24476	O	-1	-1	0
500	PMC4064952	24477	24480	O	-1	-1	0
million	PMC4064952	24481	24488	O	-1	-1	0
people	PMC4064952	24489	24495	O	-1	-1	0
)	PMC4064952	24495	24496	O	-1	-1	0

there	PMC4064952	24497	24502	O	-1	-1	0
are	PMC4064952	24503	24506	O	-1	-1	0
approximately	PMC4064952	24507	24520	O	-1	-1	0
10	PMC4064952	24521	24523	O	-1	-1	0
million	PMC4064952	24524	24531	O	-1	-1	0
patients	PMC4064952	24532	24540	O	-1	-1	0
with	PMC4064952	24541	24545	O	-1	-1	0
AF	PMC4064952	24546	24548	O	-1	-1	0
and	PMC4064952	24549	24552	O	-1	-1	0
100,000–200,000	PMC4064952	24553	24568	O	-1	-1	0
with	PMC4064952	24569	24573	O	-1	-1	0
new	PMC4064952	24574	24577	O	-1	-1	0
-	PMC4064952	24577	24578	O	-1	-1	0
onset	PMC4064952	24578	24583	O	-1	-1	0
AF	PMC4064952	24584	24586	O	-1	-1	0
.	PMC4064952	24586	24587	O	-1	-1	0

If	PMC4064952	24588	24590	O	-1	-1	0
the	PMC4064952	24591	24594	O	-1	-1	0
estimated	PMC4064952	24595	24604	O	-1	-1	0
prevalence	PMC4064952	24605	24615	O	-1	-1	0
of	PMC4064952	24616	24618	O	-1	-1	0
AF	PMC4064952	24619	24621	O	-1	-1	0
increases	PMC4064952	24622	24631	O	-1	-1	0
by	PMC4064952	24632	24634	O	-1	-1	0
0.04	PMC4064952	24635	24639	O	-1	-1	0
%	PMC4064952	24639	24640	O	-1	-1	0
per	PMC4064952	24641	24644	O	-1	-1	0
year	PMC4064952	24645	24649	O	-1	-1	0
(	PMC4064952	24650	24651	O	-1	-1	0
as	PMC4064952	24651	24653	O	-1	-1	0
observed	PMC4064952	24654	24662	O	-1	-1	0
in	PMC4064952	24663	24665	O	-1	-1	0
Iceland	PMC4064952	24666	24673	B-Location	-1	-1	0
in	PMC4064952	24674	24676	O	-1	-1	0
the	PMC4064952	24677	24680	O	-1	-1	0
overall	PMC4064952	24681	24688	O	-1	-1	0
population	PMC4064952	24689	24699	O	-1	-1	0
between	PMC4064952	24700	24707	O	-1	-1	0
1998	PMC4064952	24708	24712	O	-1	-1	0
and	PMC4064952	24713	24716	O	-1	-1	0
2008	PMC4064952	24717	24721	O	-1	-1	0
)	PMC4064952	24721	24722	O	-1	-1	0
or	PMC4064952	24723	24725	O	-1	-1	0
by	PMC4064952	24726	24728	O	-1	-1	0
0.08	PMC4064952	24729	24733	O	-1	-1	0
%	PMC4064952	24733	24734	O	-1	-1	0
(	PMC4064952	24735	24736	O	-1	-1	0
as	PMC4064952	24736	24738	O	-1	-1	0
estimated	PMC4064952	24739	24748	O	-1	-1	0
in	PMC4064952	24749	24751	O	-1	-1	0
the	PMC4064952	24752	24755	O	-1	-1	0
USA	PMC4064952	24756	24759	B-Location	-1	-1	0
on	PMC4064952	24760	24762	O	-1	-1	0
a	PMC4064952	24763	24764	O	-1	-1	0
population	PMC4064952	24765	24775	O	-1	-1	0
aged	PMC4064952	24776	24780	O	-1	-1	0
.20	PMC4064952	24781	24784	O	-1	-1	0
years),3	PMC4064952	24785	24793	O	-1	-1	0
and	PMC4064952	24794	24797	O	-1	-1	0
if	PMC4064952	24798	24800	O	-1	-1	0
the	PMC4064952	24801	24804	O	-1	-1	0
projected	PMC4064952	24805	24814	O	-1	-1	0
growth	PMC4064952	24815	24821	O	-1	-1	0
of	PMC4064952	24822	24824	O	-1	-1	0
the	PMC4064952	24825	24828	O	-1	-1	0
­	PMC4064952	24829	24830	O	-1	-1	0

European	PMC4064952	24831	24839	O	-1	-1	0
population	PMC4064952	24840	24850	O	-1	-1	0
is	PMC4064952	24851	24853	O	-1	-1	0
0.2%–0.3	PMC4064952	24854	24862	O	-1	-1	0
%	PMC4064952	24862	24863	O	-1	-1	0
(	PMC4064952	24864	24865	O	-1	-1	0
a	PMC4064952	24865	24866	O	-1	-1	0
combination	PMC4064952	24867	24878	O	-1	-1	0
of	PMC4064952	24879	24881	O	-1	-1	0
a	PMC4064952	24882	24883	O	-1	-1	0
decrease	PMC4064952	24884	24892	O	-1	-1	0
in	PMC4064952	24893	24895	O	-1	-1	0
the	PMC4064952	24896	24899	O	-1	-1	0
young	PMC4064952	24900	24905	O	-1	-1	0
population	PMC4064952	24906	24916	O	-1	-1	0
and	PMC4064952	24917	24920	O	-1	-1	0
an	PMC4064952	24921	24923	O	-1	-1	0
increase	PMC4064952	24924	24932	O	-1	-1	0
among	PMC4064952	24933	24938	O	-1	-1	0
peo-	PMC4064952	24939	24943	O	-1	-1	0

ple	PMC4064952	24944	24947	O	-1	-1	0
aged	PMC4064952	24948	24952	O	-1	-1	0
.65	PMC4064952	24953	24956	O	-1	-1	0

years),2	PMC4064952	24957	24965	O	-1	-1	0

in	PMC4064952	24966	24968	O	-1	-1	0
2030	PMC4064952	24969	24973	O	-1	-1	0
the	PMC4064952	24974	24977	O	-1	-1	0
prevalence	PMC4064952	24978	24988	O	-1	-1	0
ofAF	PMC4064952	24989	24993	O	-1	-1	0
would	PMC4064952	24994	24999	O	-1	-1	0
be	PMC4064952	25000	25002	O	-1	-1	0
2.7%–3.3	PMC4064952	25003	25011	O	-1	-1	0
%	PMC4064952	25011	25012	O	-1	-1	0
in	PMC4064952	25013	25015	O	-1	-1	0
a	PMC4064952	25016	25017	O	-1	-1	0
­	PMC4064952	25018	25019	O	-1	-1	0
European	PMC4064952	25020	25028	O	-1	-1	0
population	PMC4064952	25029	25039	O	-1	-1	0
with	PMC4064952	25040	25044	O	-1	-1	0
516–525	PMC4064952	25045	25052	O	-1	-1	0
million	PMC4064952	25053	25060	O	-1	-1	0
inhabitants	PMC4064952	25061	25072	O	-1	-1	0
.	PMC4064952	25072	25073	O	-1	-1	0

Therefore	PMC4064952	25074	25083	O	-1	-1	0
,	PMC4064952	25083	25084	O	-1	-1	0
within	PMC4064952	25085	25091	O	-1	-1	0
15	PMC4064952	25092	25094	O	-1	-1	0
years	PMC4064952	25095	25100	O	-1	-1	0
,	PMC4064952	25100	25101	O	-1	-1	0
the	PMC4064952	25102	25105	O	-1	-1	0
number	PMC4064952	25106	25112	O	-1	-1	0
of	PMC4064952	25113	25115	O	-1	-1	0
the	PMC4064952	25116	25119	O	-1	-1	0
European	PMC4064952	25120	25128	O	-1	-1	0
citizens	PMC4064952	25129	25137	O	-1	-1	0
with	PMC4064952	25138	25142	O	-1	-1	0
AF	PMC4064952	25143	25145	O	-1	-1	0
will	PMC4064952	25146	25150	O	-1	-1	0
be	PMC4064952	25151	25153	O	-1	-1	0
14–17	PMC4064952	25154	25159	O	-1	-1	0
million	PMC4064952	25160	25167	O	-1	-1	0
and	PMC4064952	25168	25171	O	-1	-1	0

the	PMC4064952	25172	25175	O	-1	-1	0
number	PMC4064952	25176	25182	O	-1	-1	0
of	PMC4064952	25183	25185	O	-1	-1	0
new	PMC4064952	25186	25189	O	-1	-1	0
AF	PMC4064952	25190	25192	O	-1	-1	0
cases	PMC4064952	25193	25198	O	-1	-1	0
will	PMC4064952	25199	25203	O	-1	-1	0
be	PMC4064952	25204	25206	O	-1	-1	0
120,000–215,000	PMC4064952	25207	25222	O	-1	-1	0
per	PMC4064952	25223	25226	O	-1	-1	0
year	PMC4064952	25227	25231	O	-1	-1	0
(	PMC4064952	25232	25233	O	-1	-1	0
estimated	PMC4064952	25233	25242	O	-1	-1	0
incidence	PMC4064952	25243	25252	O	-1	-1	0
0.23–0.41	PMC4064952	25253	25262	O	-1	-1	0
per	PMC4064952	25263	25266	O	-1	-1	0
1,000	PMC4064952	25267	25272	O	-1	-1	0
person	PMC4064952	25273	25279	O	-1	-1	0
/	PMC4064952	25279	25280	O	-1	-1	0
years	PMC4064952	25280	25285	O	-1	-1	0
)	PMC4064952	25285	25286	O	-1	-1	0
.	PMC4064952	25286	25287	O	-1	-1	0

In	PMC4064952	25288	25290	O	-1	-1	0
particular	PMC4064952	25291	25301	O	-1	-1	0
,	PMC4064952	25301	25302	O	-1	-1	0
7–8.5	PMC4064952	25303	25308	O	-1	-1	0
million	PMC4064952	25309	25316	O	-1	-1	0
people	PMC4064952	25317	25323	O	-1	-1	0
will	PMC4064952	25324	25328	O	-1	-1	0
be	PMC4064952	25329	25331	O	-1	-1	0
affected	PMC4064952	25332	25340	O	-1	-1	0
by	PMC4064952	25341	25343	O	-1	-1	0
perma-	PMC4064952	25344	25350	O	-1	-1	0
nentAF	PMC4064952	25351	25357	O	-1	-1	0
,	PMC4064952	25357	25358	O	-1	-1	0
3.5–4.2	PMC4064952	25359	25366	O	-1	-1	0
by	PMC4064952	25367	25369	O	-1	-1	0
persistentAF	PMC4064952	25370	25382	O	-1	-1	0
,	PMC4064952	25382	25383	O	-1	-1	0
and	PMC4064952	25384	25387	O	-1	-1	0
3.5–4.2	PMC4064952	25388	25395	O	-1	-1	0
by	PMC4064952	25396	25398	O	-1	-1	0
paroxysmal	PMC4064952	25399	25409	O	-1	-1	0
AF	PMC4064952	25410	25412	O	-1	-1	0
.	PMC4064952	25412	25413	O	-1	-1	0

These	PMC4064952	25414	25419	O	-1	-1	0
data	PMC4064952	25420	25424	O	-1	-1	0
are	PMC4064952	25425	25428	O	-1	-1	0
in	PMC4064952	25429	25431	O	-1	-1	0
agreement	PMC4064952	25432	25441	O	-1	-1	0
with	PMC4064952	25442	25446	O	-1	-1	0
those	PMC4064952	25447	25452	O	-1	-1	0
of	PMC4064952	25453	25455	O	-1	-1	0
Krijthe	PMC4064952	25456	25463	O	-1	-1	0
et	PMC4064952	25464	25466	O	-1	-1	0
al	PMC4064952	25467	25469	O	-1	-1	0
,	PMC4064952	25469	25470	O	-1	-1	0
who	PMC4064952	25471	25474	O	-1	-1	0
predict	PMC4064952	25475	25482	O	-1	-1	0
that	PMC4064952	25483	25487	O	-1	-1	0
there	PMC4064952	25488	25493	O	-1	-1	0
will	PMC4064952	25494	25498	O	-1	-1	0
be	PMC4064952	25499	25501	O	-1	-1	0
approximately	PMC4064952	25502	25515	O	-1	-1	0
14	PMC4064952	25516	25518	O	-1	-1	0
million	PMC4064952	25519	25526	O	-1	-1	0

AF	PMC4064952	25527	25529	O	-1	-1	0
patients	PMC4064952	25530	25538	O	-1	-1	0
among	PMC4064952	25539	25544	O	-1	-1	0
individuals	PMC4064952	25545	25556	O	-1	-1	0
aged	PMC4064952	25557	25561	O	-1	-1	0
.55	PMC4064952	25562	25565	O	-1	-1	0
years	PMC4064952	25566	25571	O	-1	-1	0
in	PMC4064952	25572	25574	O	-1	-1	0
2030.48	PMC4064952	25575	25582	O	-1	-1	0

To	PMC4064952	25583	25585	O	-1	-1	0
these	PMC4064952	25586	25591	O	-1	-1	0
figures	PMC4064952	25592	25599	O	-1	-1	0
must	PMC4064952	25600	25604	O	-1	-1	0
be	PMC4064952	25605	25607	O	-1	-1	0
added	PMC4064952	25608	25613	O	-1	-1	0
a	PMC4064952	25614	25615	O	-1	-1	0
further	PMC4064952	25616	25623	O	-1	-1	0
280,000–340,000	PMC4064952	25624	25639	O	-1	-1	0
new	PMC4064952	25640	25643	O	-1	-1	0
ischemic	PMC4064952	25644	25652	O	-1	-1	0
strokes	PMC4064952	25653	25660	O	-1	-1	0
,	PMC4064952	25660	25661	O	-1	-1	0
3.5–4	PMC4064952	25662	25667	O	-1	-1	0
million	PMC4064952	25668	25675	O	-1	-1	0
hospitalizations	PMC4064952	25676	25692	O	-1	-1	0
for	PMC4064952	25693	25696	O	-1	-1	0
AF	PMC4064952	25697	25699	O	-1	-1	0
,	PMC4064952	25699	25700	O	-1	-1	0
and	PMC4064952	25701	25704	O	-1	-1	0
100–120	PMC4064952	25705	25712	O	-1	-1	0
million	PMC4064952	25713	25720	O	-1	-1	0
outpatient	PMC4064952	25721	25731	O	-1	-1	0
visits	PMC4064952	25732	25738	O	-1	-1	0
.	PMC4064952	25738	25739	O	-1	-1	0

The	PMC4064952	25740	25743	O	-1	-1	0
magnitude	PMC4064952	25744	25753	O	-1	-1	0
of	PMC4064952	25754	25756	O	-1	-1	0
these	PMC4064952	25757	25762	O	-1	-1	0
data	PMC4064952	25763	25767	O	-1	-1	0
seems	PMC4064952	25768	25773	O	-1	-1	0
to	PMC4064952	25774	25776	O	-1	-1	0
confer	PMC4064952	25777	25783	O	-1	-1	0
an	PMC4064952	25784	25786	O	-1	-1	0
endemic	PMC4064952	25787	25794	O	-1	-1	0
dimension	PMC4064952	25795	25804	O	-1	-1	0
to	PMC4064952	25805	25807	O	-1	-1	0
this	PMC4064952	25808	25812	O	-1	-1	0
health	PMC4064952	25813	25819	O	-1	-1	0
care	PMC4064952	25820	25824	O	-1	-1	0
problem	PMC4064952	25825	25832	O	-1	-1	0
,	PMC4064952	25832	25833	O	-1	-1	0
­	PMC4064952	25834	25835	O	-1	-1	0
implying	PMC4064952	25836	25844	O	-1	-1	0
not	PMC4064952	25845	25848	O	-1	-1	0
only	PMC4064952	25849	25853	O	-1	-1	0
a	PMC4064952	25854	25855	O	-1	-1	0
greater	PMC4064952	25856	25863	O	-1	-1	0
­	PMC4064952	25864	25865	O	-1	-1	0
engagement	PMC4064952	25866	25876	O	-1	-1	0
of	PMC4064952	25877	25879	O	-1	-1	0
physicians	PMC4064952	25880	25890	O	-1	-1	0
but	PMC4064952	25891	25894	O	-1	-1	0
also	PMC4064952	25895	25899	O	-1	-1	0
a	PMC4064952	25900	25901	O	-1	-1	0
significant	PMC4064952	25902	25913	O	-1	-1	0
effort	PMC4064952	25914	25920	O	-1	-1	0
of	PMC4064952	25921	25923	O	-1	-1	0
health	PMC4064952	25924	25930	O	-1	-1	0
care	PMC4064952	25931	25935	O	-1	-1	0
systems	PMC4064952	25936	25943	O	-1	-1	0
to	PMC4064952	25944	25946	O	-1	-1	0
improve	PMC4064952	25947	25954	O	-1	-1	0
AF	PMC4064952	25955	25957	O	-1	-1	0
prevention	PMC4064952	25958	25968	O	-1	-1	0
and	PMC4064952	25969	25972	O	-1	-1	0
treatment	PMC4064952	25973	25982	O	-1	-1	0
and	PMC4064952	25983	25986	O	-1	-1	0
to	PMC4064952	25987	25989	O	-1	-1	0
facilitate	PMC4064952	25990	26000	O	-1	-1	0
the	PMC4064952	26001	26004	O	-1	-1	0
organization	PMC4064952	26005	26017	O	-1	-1	0
of	PMC4064952	26018	26020	O	-1	-1	0
social	PMC4064952	26021	26027	O	-1	-1	0
­	PMC4064952	26028	26029	O	-1	-1	0
interventions	PMC4064952	26030	26043	O	-1	-1	0
for	PMC4064952	26044	26047	O	-1	-1	0
the	PMC4064952	26048	26051	O	-1	-1	0
cure	PMC4064952	26052	26056	O	-1	-1	0
of	PMC4064952	26057	26059	O	-1	-1	0
its	PMC4064952	26060	26063	O	-1	-1	0
­	PMC4064952	26064	26065	O	-1	-1	0
consequences	PMC4064952	26066	26078	O	-1	-1	0
.	PMC4064952	26078	26079	O	-1	-1	0

In	PMC4064952	26080	26082	O	-1	-1	0
the	PMC4064952	26083	26086	O	-1	-1	0
absence	PMC4064952	26087	26094	O	-1	-1	0
of	PMC4064952	26095	26097	O	-1	-1	0
proven	PMC4064952	26098	26104	O	-1	-1	0
effective	PMC4064952	26105	26114	O	-1	-1	0
therapies	PMC4064952	26115	26124	O	-1	-1	0
for	PMC4064952	26125	26128	O	-1	-1	0
the	PMC4064952	26129	26132	O	-1	-1	0
primary	PMC4064952	26133	26140	O	-1	-1	0
prevention	PMC4064952	26141	26151	O	-1	-1	0
of	PMC4064952	26152	26154	O	-1	-1	0
AF	PMC4064952	26155	26157	O	-1	-1	0
,	PMC4064952	26157	26158	O	-1	-1	0
the	PMC4064952	26159	26162	O	-1	-1	0
attention	PMC4064952	26163	26172	O	-1	-1	0
of	PMC4064952	26173	26175	O	-1	-1	0
physicians	PMC4064952	26176	26186	O	-1	-1	0
must	PMC4064952	26187	26191	O	-1	-1	0
be	PMC4064952	26192	26194	O	-1	-1	0
directed	PMC4064952	26195	26203	O	-1	-1	0
towards	PMC4064952	26204	26211	O	-1	-1	0
preventing	PMC4064952	26212	26222	O	-1	-1	0
the	PMC4064952	26223	26226	O	-1	-1	0
cardiac	PMC4064952	26227	26234	O	-1	-1	0
conditions	PMC4064952	26235	26245	O	-1	-1	0
and	PMC4064952	26246	26249	O	-1	-1	0
comorbidities	PMC4064952	26250	26263	O	-1	-1	0
that	PMC4064952	26264	26268	O	-1	-1	0
represent	PMC4064952	26269	26278	O	-1	-1	0
significant	PMC4064952	26279	26290	O	-1	-1	0
risk	PMC4064952	26291	26295	O	-1	-1	0
factors	PMC4064952	26296	26303	O	-1	-1	0
for	PMC4064952	26304	26307	O	-1	-1	0
AF	PMC4064952	26308	26310	O	-1	-1	0
.	PMC4064952	26310	26311	O	-1	-1	0

In	PMC4064952	26312	26314	O	-1	-1	0
particular	PMC4064952	26315	26325	O	-1	-1	0
,	PMC4064952	26325	26326	O	-1	-1	0
further	PMC4064952	26327	26334	O	-1	-1	0
efforts	PMC4064952	26335	26342	O	-1	-1	0
are	PMC4064952	26343	26346	O	-1	-1	0
needed	PMC4064952	26347	26353	O	-1	-1	0
to	PMC4064952	26354	26356	O	-1	-1	0
understand	PMC4064952	26357	26367	O	-1	-1	0
better	PMC4064952	26368	26374	O	-1	-1	0
the	PMC4064952	26375	26378	O	-1	-1	0
longitudinal	PMC4064952	26379	26391	O	-1	-1	0
course	PMC4064952	26392	26398	O	-1	-1	0
of	PMC4064952	26399	26401	O	-1	-1	0
patients	PMC4064952	26402	26410	O	-1	-1	0
at	PMC4064952	26411	26413	O	-1	-1	0
risk	PMC4064952	26414	26418	O	-1	-1	0
of	PMC4064952	26419	26421	O	-1	-1	0
developing	PMC4064952	26422	26432	O	-1	-1	0
AF	PMC4064952	26433	26435	O	-1	-1	0
in	PMC4064952	26436	26438	O	-1	-1	0
order	PMC4064952	26439	26444	O	-1	-1	0
to	PMC4064952	26445	26447	O	-1	-1	0
prevent	PMC4064952	26448	26455	O	-1	-1	0
complications	PMC4064952	26456	26469	O	-1	-1	0
.	PMC4064952	26469	26470	O	-1	-1	0

Disclosure	PMC4064952	26471	26481	O	-1	-1	0

The	PMC4064952	26482	26485	O	-1	-1	0
authors	PMC4064952	26486	26493	O	-1	-1	0
report	PMC4064952	26494	26500	O	-1	-1	0
no	PMC4064952	26501	26503	O	-1	-1	0
conflicts	PMC4064952	26504	26513	O	-1	-1	0
of	PMC4064952	26514	26516	O	-1	-1	0
interest	PMC4064952	26517	26525	O	-1	-1	0
in	PMC4064952	26526	26528	O	-1	-1	0
this	PMC4064952	26529	26533	O	-1	-1	0
work	PMC4064952	26534	26538	O	-1	-1	0
.	PMC4064952	26538	26539	O	-1	-1	0

References	PMC4064952	26540	26550	O	-1	-1	0
1	PMC4064952	26551	26552	O	-1	-1	0
.	PMC4064952	26552	26553	O	-1	-1	0

Fuster	PMC4064952	26554	26560	O	-1	-1	0
V	PMC4064952	26561	26562	O	-1	-1	0
,	PMC4064952	26563	26564	O	-1	-1	0
Ryden	PMC4064952	26565	26570	O	-1	-1	0
LE	PMC4064952	26571	26573	O	-1	-1	0
,	PMC4064952	26573	26574	O	-1	-1	0
Cannom	PMC4064952	26575	26581	O	-1	-1	0
DS	PMC4064952	26582	26584	O	-1	-1	0
,	PMC4064952	26584	26585	O	-1	-1	0
et	PMC4064952	26586	26588	O	-1	-1	0
al	PMC4064952	26589	26591	O	-1	-1	0
.	PMC4064952	26591	26592	O	-1	-1	0

ACC	PMC4064952	26593	26596	O	-1	-1	0
/	PMC4064952	26596	26597	O	-1	-1	0
AHA	PMC4064952	26597	26600	O	-1	-1	0
/	PMC4064952	26600	26601	O	-1	-1	0
ESC	PMC4064952	26601	26604	O	-1	-1	0
guidelines	PMC4064952	26605	26615	O	-1	-1	0
for	PMC4064952	26616	26619	O	-1	-1	0
the	PMC4064952	26620	26623	O	-1	-1	0
management	PMC4064952	26624	26634	O	-1	-1	0
of	PMC4064952	26635	26637	O	-1	-1	0
patients	PMC4064952	26638	26646	O	-1	-1	0
with	PMC4064952	26647	26651	O	-1	-1	0
atrial	PMC4064952	26652	26658	O	-1	-1	0
fibrillation	PMC4064952	26659	26671	O	-1	-1	0
:	PMC4064952	26671	26672	O	-1	-1	0

a	PMC4064952	26673	26674	O	-1	-1	0
report	PMC4064952	26675	26681	O	-1	-1	0
of	PMC4064952	26682	26684	O	-1	-1	0
the	PMC4064952	26685	26688	O	-1	-1	0
American	PMC4064952	26689	26697	O	-1	-1	0
College	PMC4064952	26698	26705	O	-1	-1	0
of	PMC4064952	26706	26708	O	-1	-1	0
Cardiology	PMC4064952	26709	26719	O	-1	-1	0
/	PMC4064952	26719	26720	O	-1	-1	0
American	PMC4064952	26720	26728	O	-1	-1	0
Heart	PMC4064952	26729	26734	O	-1	-1	0
Association	PMC4064952	26735	26746	O	-1	-1	0
Task	PMC4064952	26747	26751	O	-1	-1	0
Force	PMC4064952	26752	26757	O	-1	-1	0
on	PMC4064952	26758	26760	O	-1	-1	0
Practice	PMC4064952	26761	26769	O	-1	-1	0
Guidelines	PMC4064952	26770	26780	O	-1	-1	0
and	PMC4064952	26781	26784	O	-1	-1	0
the	PMC4064952	26785	26788	O	-1	-1	0
European	PMC4064952	26789	26797	O	-1	-1	0
Society	PMC4064952	26798	26805	O	-1	-1	0
of	PMC4064952	26806	26808	O	-1	-1	0
Cardiology	PMC4064952	26809	26819	O	-1	-1	0
Committee	PMC4064952	26820	26829	O	-1	-1	0
for	PMC4064952	26830	26833	O	-1	-1	0
Practice	PMC4064952	26834	26842	O	-1	-1	0
Guidelines	PMC4064952	26843	26853	O	-1	-1	0
.	PMC4064952	26853	26854	O	-1	-1	0

Europace	PMC4064952	26855	26863	O	-1	-1	0
.	PMC4064952	26863	26864	O	-1	-1	0

2006;8:651–745	PMC4064952	26865	26879	O	-1	-1	0
.	PMC4064952	26879	26880	O	-1	-1	0

2	PMC4064952	26881	26882	O	-1	-1	0
.	PMC4064952	26882	26883	O	-1	-1	0

Eurostat	PMC4064952	26884	26892	O	-1	-1	0
Methodologies	PMC4064952	26893	26906	O	-1	-1	0
and	PMC4064952	26907	26910	O	-1	-1	0
Working	PMC4064952	26911	26918	O	-1	-1	0
papers	PMC4064952	26919	26925	O	-1	-1	0
.	PMC4064952	26925	26926	O	-1	-1	0

Work	PMC4064952	26927	26931	O	-1	-1	0
Session	PMC4064952	26932	26939	O	-1	-1	0
on	PMC4064952	26940	26942	O	-1	-1	0
­	PMC4064952	26943	26944	O	-1	-1	0
Demographic	PMC4064952	26945	26956	O	-1	-1	0
Progressions	PMC4064952	26957	26969	O	-1	-1	0
.	PMC4064952	26969	26970	O	-1	-1	0

Lisbon	PMC4064952	26971	26977	O	-1	-1	0
,	PMC4064952	26977	26978	O	-1	-1	0
Portugal	PMC4064952	26979	26987	O	-1	-1	0
,	PMC4064952	26987	26988	O	-1	-1	0
April	PMC4064952	26989	26994	O	-1	-1	0
28–30	PMC4064952	26995	27000	O	-1	-1	0
,	PMC4064952	27000	27001	O	-1	-1	0
2010	PMC4064952	27002	27006	O	-1	-1	0
.	PMC4064952	27006	27007	O	-1	-1	0

3	PMC4064952	27008	27009	O	-1	-1	0
.	PMC4064952	27009	27010	O	-1	-1	0

Go	PMC4064952	27011	27013	O	-1	-1	0
AS	PMC4064952	27014	27016	O	-1	-1	0
,	PMC4064952	27016	27017	O	-1	-1	0
Hylek	PMC4064952	27018	27023	O	-1	-1	0
EM	PMC4064952	27024	27026	O	-1	-1	0
,	PMC4064952	27026	27027	O	-1	-1	0
Philips	PMC4064952	27028	27035	O	-1	-1	0
KA	PMC4064952	27036	27038	O	-1	-1	0
,	PMC4064952	27038	27039	O	-1	-1	0
et	PMC4064952	27040	27042	O	-1	-1	0
al	PMC4064952	27043	27045	O	-1	-1	0
.	PMC4064952	27045	27046	O	-1	-1	0

Prevalence	PMC4064952	27047	27057	O	-1	-1	0
of	PMC4064952	27058	27060	O	-1	-1	0
diagnosed	PMC4064952	27061	27070	O	-1	-1	0
atrial	PMC4064952	27071	27077	O	-1	-1	0
fibrillation	PMC4064952	27078	27090	O	-1	-1	0
in	PMC4064952	27091	27093	O	-1	-1	0
adults	PMC4064952	27094	27100	O	-1	-1	0
:	PMC4064952	27100	27101	O	-1	-1	0
national	PMC4064952	27102	27110	O	-1	-1	0
implication	PMC4064952	27111	27122	O	-1	-1	0
for	PMC4064952	27123	27126	O	-1	-1	0
rhythm	PMC4064952	27127	27133	O	-1	-1	0
management	PMC4064952	27134	27144	O	-1	-1	0
and	PMC4064952	27145	27148	O	-1	-1	0
stroke	PMC4064952	27149	27155	O	-1	-1	0
prevention	PMC4064952	27156	27166	O	-1	-1	0
.	PMC4064952	27166	27167	O	-1	-1	0

The	PMC4064952	27168	27171	O	-1	-1	0
AnTicoagulation	PMC4064952	27172	27187	O	-1	-1	0
and	PMC4064952	27188	27191	O	-1	-1	0
RIsk	PMC4064952	27192	27196	O	-1	-1	0
factors	PMC4064952	27197	27204	O	-1	-1	0
in	PMC4064952	27205	27207	O	-1	-1	0
Atrial	PMC4064952	27208	27214	O	-1	-1	0
fibrillation	PMC4064952	27215	27227	O	-1	-1	0
(	PMC4064952	27228	27229	O	-1	-1	0
ATRIA	PMC4064952	27229	27234	O	-1	-1	0
)	PMC4064952	27234	27235	O	-1	-1	0
study	PMC4064952	27236	27241	O	-1	-1	0
.	PMC4064952	27241	27242	O	-1	-1	0

JAMA	PMC4064952	27243	27247	O	-1	-1	0
.	PMC4064952	27247	27248	O	-1	-1	0

2001;285:2370–2375	PMC4064952	27249	27267	O	-1	-1	0
.	PMC4064952	27267	27268	O	-1	-1	0

4	PMC4064952	27269	27270	O	-1	-1	0
.	PMC4064952	27270	27271	O	-1	-1	0

Murphy	PMC4064952	27272	27278	O	-1	-1	0
NF	PMC4064952	27279	27281	O	-1	-1	0
,	PMC4064952	27281	27282	O	-1	-1	0
Simpson	PMC4064952	27283	27290	O	-1	-1	0
CR	PMC4064952	27291	27293	O	-1	-1	0
,	PMC4064952	27293	27294	O	-1	-1	0
Jhund	PMC4064952	27295	27300	O	-1	-1	0
PS	PMC4064952	27301	27303	O	-1	-1	0
,	PMC4064952	27303	27304	O	-1	-1	0
et	PMC4064952	27305	27307	O	-1	-1	0
al	PMC4064952	27308	27310	O	-1	-1	0
.	PMC4064952	27310	27311	O	-1	-1	0

A	PMC4064952	27312	27313	O	-1	-1	0
national	PMC4064952	27314	27322	O	-1	-1	0
survey	PMC4064952	27323	27329	O	-1	-1	0
of	PMC4064952	27330	27332	O	-1	-1	0
the	PMC4064952	27333	27336	O	-1	-1	0
prevalence	PMC4064952	27337	27347	O	-1	-1	0
,	PMC4064952	27347	27348	O	-1	-1	0
incidence	PMC4064952	27349	27358	O	-1	-1	0
,	PMC4064952	27358	27359	O	-1	-1	0
primary	PMC4064952	27360	27367	O	-1	-1	0
care	PMC4064952	27368	27372	O	-1	-1	0
burden	PMC4064952	27373	27379	O	-1	-1	0
and	PMC4064952	27380	27383	O	-1	-1	0
treatment	PMC4064952	27384	27393	O	-1	-1	0
of	PMC4064952	27394	27396	O	-1	-1	0
atrial	PMC4064952	27397	27403	O	-1	-1	0
fibrillation	PMC4064952	27404	27416	O	-1	-1	0
in	PMC4064952	27417	27419	O	-1	-1	0
Scotland	PMC4064952	27420	27428	O	-1	-1	0
.	PMC4064952	27428	27429	O	-1	-1	0

Heart	PMC4064952	27430	27435	O	-1	-1	0
.	PMC4064952	27435	27436	O	-1	-1	0

2007;93:606–612	PMC4064952	27437	27452	O	-1	-1	0
.	PMC4064952	27452	27453	O	-1	-1	0

5	PMC4064952	27454	27455	O	-1	-1	0
.	PMC4064952	27455	27456	O	-1	-1	0

Ruskin	PMC4064952	27457	27463	O	-1	-1	0
JN	PMC4064952	27464	27466	O	-1	-1	0
,	PMC4064952	27466	27467	O	-1	-1	0
Singh	PMC4064952	27468	27473	O	-1	-1	0
JP.Atrial	PMC4064952	27474	27483	O	-1	-1	0
fibrillation	PMC4064952	27484	27496	O	-1	-1	0
endpoints	PMC4064952	27497	27506	O	-1	-1	0
:	PMC4064952	27506	27507	O	-1	-1	0
hospitalizations	PMC4064952	27508	27524	O	-1	-1	0
.	PMC4064952	27524	27525	O	-1	-1	0

Heart	PMC4064952	27526	27531	O	-1	-1	0

Rhythm	PMC4064952	27532	27538	O	-1	-1	0
.	PMC4064952	27538	27539	O	-1	-1	0

2004;1	PMC4064952	27540	27546	O	-1	-1	0

July	PMC4064952	27547	27551	O	-1	-1	0
Suppl	PMC4064952	27552	27557	O	-1	-1	0
:	PMC4064952	27557	27558	O	-1	-1	0
B31–B35	PMC4064952	27558	27565	O	-1	-1	0
.	PMC4064952	27565	27566	O	-1	-1	0

6	PMC4064952	27567	27568	O	-1	-1	0
.	PMC4064952	27568	27569	O	-1	-1	0

Santini	PMC4064952	27570	27577	O	-1	-1	0
M	PMC4064952	27578	27579	O	-1	-1	0
,	PMC4064952	27579	27580	O	-1	-1	0
De	PMC4064952	27581	27583	O	-1	-1	0
Ferrari	PMC4064952	27584	27591	O	-1	-1	0
GM	PMC4064952	27592	27594	O	-1	-1	0
,	PMC4064952	27594	27595	O	-1	-1	0
Pandozi	PMC4064952	27596	27603	O	-1	-1	0
C	PMC4064952	27604	27605	O	-1	-1	0
,	PMC4064952	27605	27606	O	-1	-1	0
et	PMC4064952	27607	27609	O	-1	-1	0
al	PMC4064952	27610	27612	O	-1	-1	0
;	PMC4064952	27612	27613	O	-1	-1	0
for	PMC4064952	27614	27617	O	-1	-1	0
the	PMC4064952	27618	27621	O	-1	-1	0
FIRE	PMC4064952	27622	27626	O	-1	-1	0
Investigators	PMC4064952	27627	27640	O	-1	-1	0
.	PMC4064952	27640	27641	O	-1	-1	0
Atrial	PMC4064952	27642	27648	O	-1	-1	0
fibrillation	PMC4064952	27649	27661	O	-1	-1	0
requiring	PMC4064952	27662	27671	O	-1	-1	0
urgent	PMC4064952	27672	27678	O	-1	-1	0
medical	PMC4064952	27679	27686	O	-1	-1	0
care	PMC4064952	27687	27691	O	-1	-1	0
.	PMC4064952	27691	27692	O	-1	-1	0

Approach	PMC4064952	27692	27700	O	-1	-1	0
and	PMC4064952	27701	27704	O	-1	-1	0
outcome	PMC4064952	27705	27712	O	-1	-1	0
in	PMC4064952	27713	27715	O	-1	-1	0
the	PMC4064952	27716	27719	O	-1	-1	0
various	PMC4064952	27720	27727	O	-1	-1	0
departments	PMC4064952	27728	27739	O	-1	-1	0
of	PMC4064952	27740	27742	O	-1	-1	0
admission	PMC4064952	27743	27752	O	-1	-1	0
.	PMC4064952	27752	27753	O	-1	-1	0

Data	PMC4064952	27754	27758	O	-1	-1	0
from	PMC4064952	27759	27763	O	-1	-1	0
the	PMC4064952	27764	27767	O	-1	-1	0
atrial	PMC4064952	27768	27774	O	-1	-1	0
­	PMC4064952	27775	27776	O	-1	-1	0

Fibrillation/	PMC4064952	27777	27790	O	-1	-1	0
Flutter	PMC4064952	27791	27798	O	-1	-1	0
Italian	PMC4064952	27799	27806	O	-1	-1	0
Registry	PMC4064952	27807	27815	O	-1	-1	0
(	PMC4064952	27816	27817	O	-1	-1	0
FIRE	PMC4064952	27817	27821	O	-1	-1	0
)	PMC4064952	27821	27822	O	-1	-1	0
.	PMC4064952	27822	27823	O	-1	-1	0

Ital	PMC4064952	27824	27828	O	-1	-1	0
Heart	PMC4064952	27829	27834	O	-1	-1	0
J.	PMC4064952	27835	27837	O	-1	-1	0
2004;5:205–213	PMC4064952	27838	27852	O	-1	-1	0
.	PMC4064952	27852	27853	O	-1	-1	0

7	PMC4064952	27854	27855	O	-1	-1	0
.	PMC4064952	27855	27856	O	-1	-1	0

Friberg	PMC4064952	27857	27864	O	-1	-1	0
L	PMC4064952	27865	27866	O	-1	-1	0
,	PMC4064952	27866	27867	O	-1	-1	0
Bergfeldt	PMC4064952	27868	27877	O	-1	-1	0
L.	PMC4064952	27878	27880	O	-1	-1	0
Atrial	PMC4064952	27881	27887	O	-1	-1	0
fibrillation	PMC4064952	27888	27900	O	-1	-1	0
prevalence	PMC4064952	27901	27911	O	-1	-1	0
revisited	PMC4064952	27912	27921	O	-1	-1	0
.	PMC4064952	27921	27922	O	-1	-1	0

J	PMC4064952	27923	27924	O	-1	-1	0
Intern	PMC4064952	27925	27931	O	-1	-1	0
Med	PMC4064952	27932	27935	O	-1	-1	0
.	PMC4064952	27935	27936	O	-1	-1	0

2013;274:461–468	PMC4064952	27937	27953	O	-1	-1	0
.	PMC4064952	27953	27954	O	-1	-1	0

8	PMC4064952	27955	27956	O	-1	-1	0
.	PMC4064952	27956	27957	O	-1	-1	0

Wilke	PMC4064952	27958	27963	O	-1	-1	0
T	PMC4064952	27964	27965	O	-1	-1	0
,	PMC4064952	27965	27966	O	-1	-1	0
Groth	PMC4064952	27967	27972	O	-1	-1	0
A	PMC4064952	27973	27974	O	-1	-1	0
,	PMC4064952	27974	27975	O	-1	-1	0
Mueller	PMC4064952	27976	27983	O	-1	-1	0
S	PMC4064952	27984	27985	O	-1	-1	0
,	PMC4064952	27985	27986	O	-1	-1	0
et	PMC4064952	27987	27989	O	-1	-1	0
al	PMC4064952	27990	27992	O	-1	-1	0
.	PMC4064952	27992	27993	O	-1	-1	0

Incidence	PMC4064952	27994	28003	O	-1	-1	0
and	PMC4064952	28004	28007	O	-1	-1	0
prevalence	PMC4064952	28008	28018	O	-1	-1	0
of	PMC4064952	28019	28021	O	-1	-1	0
atrial	PMC4064952	28022	28028	O	-1	-1	0
fibrillation	PMC4064952	28029	28041	O	-1	-1	0
:	PMC4064952	28041	28042	O	-1	-1	0
an	PMC4064952	28043	28045	O	-1	-1	0
analysis	PMC4064952	28046	28054	O	-1	-1	0
based	PMC4064952	28055	28060	O	-1	-1	0
on	PMC4064952	28061	28063	O	-1	-1	0
8.3	PMC4064952	28064	28067	O	-1	-1	0
million	PMC4064952	28068	28075	O	-1	-1	0
patients	PMC4064952	28076	28084	O	-1	-1	0
.	PMC4064952	28084	28085	O	-1	-1	0

Europace	PMC4064952	28086	28094	O	-1	-1	0
.	PMC4064952	28094	28095	O	-1	-1	0

2013;15:486–493	PMC4064952	28096	28111	O	-1	-1	0
.	PMC4064952	28111	28112	O	-1	-1	0

9	PMC4064952	28113	28114	O	-1	-1	0
.	PMC4064952	28114	28115	O	-1	-1	0

Zoni	PMC4064952	28116	28120	O	-1	-1	0
-	PMC4064952	28120	28121	O	-1	-1	0
Berisso	PMC4064952	28121	28128	O	-1	-1	0
M	PMC4064952	28129	28130	O	-1	-1	0
,	PMC4064952	28130	28131	O	-1	-1	0
Filippi	PMC4064952	28132	28139	O	-1	-1	0
A	PMC4064952	28140	28141	O	-1	-1	0
,	PMC4064952	28141	28142	O	-1	-1	0
Landolina	PMC4064952	28143	28152	O	-1	-1	0
M	PMC4064952	28153	28154	O	-1	-1	0
,	PMC4064952	28154	28155	O	-1	-1	0
et	PMC4064952	28156	28158	O	-1	-1	0
al	PMC4064952	28159	28161	O	-1	-1	0
.	PMC4064952	28161	28162	O	-1	-1	0

Frequency	PMC4064952	28163	28172	O	-1	-1	0
,	PMC4064952	28172	28173	O	-1	-1	0
patient	PMC4064952	28174	28181	O	-1	-1	0

­	PMC4064952	28182	28183	O	-1	-1	0

characteristics	PMC4064952	28184	28199	O	-1	-1	0
,	PMC4064952	28199	28200	O	-1	-1	0
treatment	PMC4064952	28201	28210	O	-1	-1	0
strategies	PMC4064952	28211	28221	O	-1	-1	0
,	PMC4064952	28221	28222	O	-1	-1	0
and	PMC4064952	28223	28226	O	-1	-1	0
resource	PMC4064952	28227	28235	O	-1	-1	0
usage	PMC4064952	28236	28241	O	-1	-1	0
of	PMC4064952	28242	28244	O	-1	-1	0
atrial	PMC4064952	28245	28251	O	-1	-1	0

­	PMC4064952	28252	28253	O	-1	-1	0
fibrillation	PMC4064952	28254	28266	O	-1	-1	0
[	PMC4064952	28267	28268	O	-1	-1	0
From	PMC4064952	28268	28272	O	-1	-1	0
the	PMC4064952	28273	28276	O	-1	-1	0
Italian	PMC4064952	28277	28284	O	-1	-1	0
Survey	PMC4064952	28285	28291	O	-1	-1	0
of	PMC4064952	28292	28294	O	-1	-1	0
Atrial	PMC4064952	28295	28301	O	-1	-1	0
Fibrillation	PMC4064952	28302	28314	O	-1	-1	0
Management	PMC4064952	28315	28325	O	-1	-1	0

(	PMC4064952	28326	28327	O	-1	-1	0
ISAF	PMC4064952	28327	28331	O	-1	-1	0
)	PMC4064952	28331	28332	O	-1	-1	0
Study	PMC4064952	28333	28338	O	-1	-1	0
]	PMC4064952	28338	28339	O	-1	-1	0
.	PMC4064952	28339	28340	O	-1	-1	0

Am	PMC4064952	28341	28343	O	-1	-1	0
J	PMC4064952	28344	28345	O	-1	-1	0
Cardiol	PMC4064952	28346	28353	O	-1	-1	0
.	PMC4064952	28353	28354	O	-1	-1	0

2013;111:705–711	PMC4064952	28355	28371	O	-1	-1	0
.	PMC4064952	28371	28372	O	-1	-1	0

10	PMC4064952	28373	28375	O	-1	-1	0
.	PMC4064952	28375	28376	O	-1	-1	0

Piccini	PMC4064952	28377	28384	O	-1	-1	0
JP	PMC4064952	28385	28387	O	-1	-1	0
,	PMC4064952	28387	28388	O	-1	-1	0
Hammil	PMC4064952	28389	28395	O	-1	-1	0
BG	PMC4064952	28396	28398	O	-1	-1	0
,	PMC4064952	28398	28399	O	-1	-1	0
Sinner	PMC4064952	28400	28406	O	-1	-1	0
MF	PMC4064952	28407	28409	O	-1	-1	0
,	PMC4064952	28409	28410	O	-1	-1	0
et	PMC4064952	28411	28413	O	-1	-1	0
al	PMC4064952	28414	28416	O	-1	-1	0
.	PMC4064952	28416	28417	O	-1	-1	0

Incidence	PMC4064952	28418	28427	O	-1	-1	0
and	PMC4064952	28428	28431	O	-1	-1	0
prevalence	PMC4064952	28432	28442	O	-1	-1	0
of	PMC4064952	28443	28445	O	-1	-1	0
atrial	PMC4064952	28446	28452	O	-1	-1	0
fibrillation	PMC4064952	28453	28465	O	-1	-1	0
and	PMC4064952	28466	28469	O	-1	-1	0
associated	PMC4064952	28470	28480	O	-1	-1	0
mortality	PMC4064952	28481	28490	O	-1	-1	0
among	PMC4064952	28491	28496	O	-1	-1	0
Medicare	PMC4064952	28497	28505	O	-1	-1	0
­	PMC4064952	28506	28507	O	-1	-1	0

beneficiaries	PMC4064952	28508	28521	O	-1	-1	0
:	PMC4064952	28521	28522	O	-1	-1	0
1993–2007	PMC4064952	28523	28532	O	-1	-1	0
.	PMC4064952	28532	28533	O	-1	-1	0

Circ	PMC4064952	28534	28538	O	-1	-1	0
Cardiovasc	PMC4064952	28539	28549	O	-1	-1	0
Qual	PMC4064952	28550	28554	O	-1	-1	0
Outcomes	PMC4064952	28555	28563	O	-1	-1	0
.	PMC4064952	28563	28564	O	-1	-1	0

2012;5:85–93	PMC4064952	28565	28577	O	-1	-1	0
.	PMC4064952	28577	28578	O	-1	-1	0

11	PMC4064952	28579	28581	O	-1	-1	0
.	PMC4064952	28581	28582	O	-1	-1	0

Stefansdottir	PMC4064952	28583	28596	O	-1	-1	0
H	PMC4064952	28597	28598	O	-1	-1	0
,	PMC4064952	28598	28599	O	-1	-1	0
Appelund	PMC4064952	28600	28608	O	-1	-1	0
T	PMC4064952	28609	28610	O	-1	-1	0
,	PMC4064952	28610	28611	O	-1	-1	0
Gudnason	PMC4064952	28612	28620	O	-1	-1	0
V	PMC4064952	28621	28622	O	-1	-1	0
,	PMC4064952	28623	28624	O	-1	-1	0
Adnar	PMC4064952	28625	28630	O	-1	-1	0
DO	PMC4064952	28631	28633	O	-1	-1	0
.	PMC4064952	28633	28634	O	-1	-1	0

Trends	PMC4064952	28635	28641	O	-1	-1	0
in	PMC4064952	28642	28644	O	-1	-1	0
the	PMC4064952	28645	28648	O	-1	-1	0
incidence	PMC4064952	28649	28658	O	-1	-1	0
and	PMC4064952	28659	28662	O	-1	-1	0
prevalence	PMC4064952	28663	28673	O	-1	-1	0
of	PMC4064952	28674	28676	O	-1	-1	0
atrial	PMC4064952	28677	28683	O	-1	-1	0
fibrillation	PMC4064952	28684	28696	O	-1	-1	0
in	PMC4064952	28697	28699	O	-1	-1	0
Iceland	PMC4064952	28700	28707	O	-1	-1	0
and	PMC4064952	28708	28711	O	-1	-1	0
future	PMC4064952	28712	28718	O	-1	-1	0
projection	PMC4064952	28719	28729	O	-1	-1	0
.	PMC4064952	28729	28730	O	-1	-1	0

Europace	PMC4064952	28731	28739	O	-1	-1	0
.	PMC4064952	28739	28740	O	-1	-1	0

2011;13:1110–1117	PMC4064952	28741	28758	O	-1	-1	0
.	PMC4064952	28758	28759	O	-1	-1	0

12	PMC4064952	28760	28762	O	-1	-1	0
.	PMC4064952	28762	28763	O	-1	-1	0

Cowan	PMC4064952	28764	28769	O	-1	-1	0
C	PMC4064952	28770	28771	O	-1	-1	0
,	PMC4064952	28771	28772	O	-1	-1	0
Healicon	PMC4064952	28773	28781	O	-1	-1	0
R	PMC4064952	28782	28783	O	-1	-1	0
,	PMC4064952	28783	28784	O	-1	-1	0
Robson	PMC4064952	28785	28791	O	-1	-1	0
I	PMC4064952	28792	28793	O	-1	-1	0
,	PMC4064952	28793	28794	O	-1	-1	0
et	PMC4064952	28795	28797	O	-1	-1	0
al	PMC4064952	28798	28800	O	-1	-1	0
.	PMC4064952	28800	28801	O	-1	-1	0

The	PMC4064952	28802	28805	O	-1	-1	0
use	PMC4064952	28806	28809	O	-1	-1	0
of	PMC4064952	28810	28812	O	-1	-1	0
anticoagulants	PMC4064952	28813	28827	O	-1	-1	0
in	PMC4064952	28828	28830	O	-1	-1	0
the	PMC4064952	28831	28834	O	-1	-1	0
management	PMC4064952	28835	28845	O	-1	-1	0
of	PMC4064952	28846	28848	O	-1	-1	0
atrial	PMC4064952	28849	28855	O	-1	-1	0
fibrillation	PMC4064952	28856	28868	O	-1	-1	0
among	PMC4064952	28869	28874	O	-1	-1	0
general	PMC4064952	28875	28882	O	-1	-1	0
practices	PMC4064952	28883	28892	O	-1	-1	0
in	PMC4064952	28893	28895	O	-1	-1	0
England	PMC4064952	28896	28903	O	-1	-1	0
.	PMC4064952	28903	28904	O	-1	-1	0
Heart	PMC4064952	28905	28910	O	-1	-1	0
.	PMC4064952	28910	28911	O	-1	-1	0

2013;99:1166–1172	PMC4064952	28912	28929	O	-1	-1	0
.	PMC4064952	28929	28930	O	-1	-1	0
13	PMC4064952	28931	28933	O	-1	-1	0
.	PMC4064952	28933	28934	O	-1	-1	0

Fitzmaurice	PMC4064952	28935	28946	O	-1	-1	0
DA	PMC4064952	28947	28949	O	-1	-1	0
,	PMC4064952	28949	28950	O	-1	-1	0
Hobbs	PMC4064952	28951	28956	O	-1	-1	0
DR	PMC4064952	28957	28959	O	-1	-1	0
,	PMC4064952	28959	28960	O	-1	-1	0
Jowet	PMC4064952	28961	28966	O	-1	-1	0
S	PMC4064952	28967	28968	O	-1	-1	0
,	PMC4064952	28968	28969	O	-1	-1	0
et	PMC4064952	28970	28972	O	-1	-1	0
al	PMC4064952	28973	28975	O	-1	-1	0
.	PMC4064952	28975	28976	O	-1	-1	0

Screening	PMC4064952	28977	28986	O	-1	-1	0
versus	PMC4064952	28987	28993	O	-1	-1	0
routine	PMC4064952	28994	29001	O	-1	-1	0
practice	PMC4064952	29002	29010	O	-1	-1	0
in	PMC4064952	29011	29013	O	-1	-1	0
detection	PMC4064952	29014	29023	O	-1	-1	0
of	PMC4064952	29024	29026	O	-1	-1	0
atrial	PMC4064952	29027	29033	O	-1	-1	0
fibrillation	PMC4064952	29034	29046	O	-1	-1	0
in	PMC4064952	29047	29049	O	-1	-1	0
patients	PMC4064952	29050	29058	O	-1	-1	0
aged	PMC4064952	29059	29063	O	-1	-1	0
65	PMC4064952	29064	29066	O	-1	-1	0
or	PMC4064952	29067	29069	O	-1	-1	0
over	PMC4064952	29070	29074	O	-1	-1	0
:	PMC4064952	29074	29075	O	-1	-1	0

cluster	PMC4064952	29076	29083	O	-1	-1	0
randomised	PMC4064952	29084	29094	O	-1	-1	0
controlled	PMC4064952	29095	29105	O	-1	-1	0
trial	PMC4064952	29106	29111	O	-1	-1	0
.	PMC4064952	29111	29112	O	-1	-1	0

BMJ	PMC4064952	29113	29116	O	-1	-1	0
.	PMC4064952	29116	29117	O	-1	-1	0

2007;335:386–391	PMC4064952	29118	29134	O	-1	-1	0
.	PMC4064952	29134	29135	O	-1	-1	0

Clinical	PMC4064952	29136	29144	O	-1	-1	0
Epidemiology	PMC4064952	29145	29157	O	-1	-1	0
2014:6	PMC4064952	29158	29164	O	-1	-1	0
submit	PMC4064952	29165	29171	O	-1	-1	0
your	PMC4064952	29172	29176	O	-1	-1	0
manuscript	PMC4064952	29177	29187	O	-1	-1	0
|	PMC4064952	29188	29189	O	-1	-1	0

www.dovepress.com	PMC4064952	29190	29207	O	-1	-1	0

Dovepress	PMC4064952	29208	29217	O	-1	-1	0

Dovepress	PMC4064952	29218	29227	O	-1	-1	0
219	PMC4064952	29228	29231	O	-1	-1	0

Epidemiology	PMC4064952	29232	29244	O	-1	-1	0
of	PMC4064952	29245	29247	O	-1	-1	0
atrial	PMC4064952	29248	29254	O	-1	-1	0
fibrillation	PMC4064952	29255	29267	O	-1	-1	0
14	PMC4064952	29268	29270	O	-1	-1	0
.	PMC4064952	29270	29271	O	-1	-1	0

Rho	PMC4064952	29272	29275	O	-1	-1	0
RW	PMC4064952	29276	29278	O	-1	-1	0
,	PMC4064952	29278	29279	O	-1	-1	0
Page	PMC4064952	29280	29284	O	-1	-1	0
RL	PMC4064952	29285	29287	O	-1	-1	0
.	PMC4064952	29287	29288	O	-1	-1	0

Asymptomatic	PMC4064952	29289	29301	O	-1	-1	0
atrial	PMC4064952	29302	29308	O	-1	-1	0
fibrillation	PMC4064952	29309	29321	O	-1	-1	0
.	PMC4064952	29321	29322	O	-1	-1	0

Progr	PMC4064952	29323	29328	O	-1	-1	0
Cardiovasc	PMC4064952	29329	29339	O	-1	-1	0

Dis	PMC4064952	29340	29343	O	-1	-1	0
.	PMC4064952	29343	29344	O	-1	-1	0

2005;48:78–87	PMC4064952	29345	29358	O	-1	-1	0
.	PMC4064952	29358	29359	O	-1	-1	0

15	PMC4064952	29360	29362	O	-1	-1	0
.	PMC4064952	29362	29363	O	-1	-1	0

Chugh	PMC4064952	29364	29369	O	-1	-1	0
SS	PMC4064952	29370	29372	O	-1	-1	0
,	PMC4064952	29372	29373	O	-1	-1	0
Havmoeller	PMC4064952	29374	29384	O	-1	-1	0
R	PMC4064952	29385	29386	O	-1	-1	0
,	PMC4064952	29386	29387	O	-1	-1	0
Narayanan	PMC4064952	29388	29397	O	-1	-1	0
K	PMC4064952	29398	29399	O	-1	-1	0
,	PMC4064952	29399	29400	O	-1	-1	0
et	PMC4064952	29401	29403	O	-1	-1	0
al	PMC4064952	29404	29406	O	-1	-1	0
.	PMC4064952	29406	29407	O	-1	-1	0

Worldwide	PMC4064952	29407	29416	O	-1	-1	0
­	PMC4064952	29417	29418	O	-1	-1	0

epidemiology	PMC4064952	29419	29431	O	-1	-1	0
of	PMC4064952	29432	29434	O	-1	-1	0
atrial	PMC4064952	29435	29441	O	-1	-1	0
fibrillation	PMC4064952	29442	29454	O	-1	-1	0
:	PMC4064952	29454	29455	O	-1	-1	0
a	PMC4064952	29456	29457	O	-1	-1	0
global	PMC4064952	29458	29464	O	-1	-1	0
burden	PMC4064952	29465	29471	O	-1	-1	0
of	PMC4064952	29472	29474	O	-1	-1	0
disease	PMC4064952	29475	29482	O	-1	-1	0
study	PMC4064952	29483	29488	O	-1	-1	0
.	PMC4064952	29488	29489	O	-1	-1	0

Circulation	PMC4064952	29490	29501	O	-1	-1	0
.	PMC4064952	29501	29502	O	-1	-1	0

2014;129:837–847	PMC4064952	29503	29519	O	-1	-1	0
.	PMC4064952	29519	29520	O	-1	-1	0
16	PMC4064952	29521	29523	O	-1	-1	0
.	PMC4064952	29523	29524	O	-1	-1	0

Gomez	PMC4064952	29525	29530	O	-1	-1	0
-	PMC4064952	29530	29531	O	-1	-1	0
Doblas	PMC4064952	29531	29537	O	-1	-1	0
JJ	PMC4064952	29538	29540	O	-1	-1	0
,	PMC4064952	29540	29541	O	-1	-1	0
Muniz	PMC4064952	29542	29547	O	-1	-1	0
J	PMC4064952	29548	29549	O	-1	-1	0
,	PMC4064952	29549	29550	O	-1	-1	0
Alonso	PMC4064952	29551	29557	O	-1	-1	0
Martin	PMC4064952	29558	29564	O	-1	-1	0
JJ	PMC4064952	29565	29567	O	-1	-1	0
,	PMC4064952	29567	29568	O	-1	-1	0
et	PMC4064952	29569	29571	O	-1	-1	0
al	PMC4064952	29572	29574	O	-1	-1	0
.	PMC4064952	29574	29575	O	-1	-1	0

Prevalence	PMC4064952	29576	29586	O	-1	-1	0
of	PMC4064952	29587	29589	O	-1	-1	0
atrial	PMC4064952	29590	29596	O	-1	-1	0
fibrillation	PMC4064952	29597	29609	O	-1	-1	0
in	PMC4064952	29610	29612	O	-1	-1	0
Spain	PMC4064952	29613	29618	O	-1	-1	0
.	PMC4064952	29618	29619	O	-1	-1	0

OFRECE	PMC4064952	29620	29626	O	-1	-1	0
study	PMC4064952	29627	29632	O	-1	-1	0
results	PMC4064952	29633	29640	O	-1	-1	0
.	PMC4064952	29640	29641	O	-1	-1	0

Rev	PMC4064952	29642	29645	O	-1	-1	0
Esp	PMC4064952	29646	29649	O	-1	-1	0
Cardiol	PMC4064952	29650	29657	O	-1	-1	0
.	PMC4064952	29657	29658	O	-1	-1	0
2014;67(4):259–269	PMC4064952	29659	29677	O	-1	-1	0
.	PMC4064952	29677	29678	O	-1	-1	0

17	PMC4064952	29679	29681	O	-1	-1	0
.	PMC4064952	29681	29682	O	-1	-1	0

Kannel	PMC4064952	29683	29689	O	-1	-1	0
WB	PMC4064952	29690	29692	O	-1	-1	0
,	PMC4064952	29692	29693	O	-1	-1	0
Abbot	PMC4064952	29694	29699	O	-1	-1	0
RD	PMC4064952	29700	29702	O	-1	-1	0
,	PMC4064952	29702	29703	O	-1	-1	0
Savage	PMC4064952	29704	29710	O	-1	-1	0
DD	PMC4064952	29711	29713	O	-1	-1	0
,	PMC4064952	29713	29714	O	-1	-1	0
McNamara	PMC4064952	29715	29723	O	-1	-1	0
PM	PMC4064952	29724	29726	O	-1	-1	0
.	PMC4064952	29726	29727	O	-1	-1	0

Epidemiologic	PMC4064952	29728	29741	O	-1	-1	0
features	PMC4064952	29742	29750	O	-1	-1	0
of	PMC4064952	29751	29753	O	-1	-1	0
chronic	PMC4064952	29754	29761	O	-1	-1	0
atrial	PMC4064952	29762	29768	O	-1	-1	0
fibrillation	PMC4064952	29769	29781	O	-1	-1	0
:	PMC4064952	29781	29782	O	-1	-1	0
the	PMC4064952	29783	29786	O	-1	-1	0
Framingham	PMC4064952	29787	29797	O	-1	-1	0
Study	PMC4064952	29798	29803	O	-1	-1	0
.	PMC4064952	29803	29804	O	-1	-1	0

N	PMC4064952	29805	29806	O	-1	-1	0
Engl	PMC4064952	29807	29811	O	-1	-1	0
J	PMC4064952	29812	29813	O	-1	-1	0
Med	PMC4064952	29814	29817	O	-1	-1	0
.	PMC4064952	29817	29818	O	-1	-1	0
1982;306:1018–1022	PMC4064952	29819	29837	O	-1	-1	0
.	PMC4064952	29837	29838	O	-1	-1	0

18	PMC4064952	29839	29841	O	-1	-1	0
.	PMC4064952	29841	29842	O	-1	-1	0

Myasaka	PMC4064952	29843	29850	O	-1	-1	0
Y	PMC4064952	29851	29852	O	-1	-1	0
,	PMC4064952	29852	29853	O	-1	-1	0
Barnes	PMC4064952	29854	29860	O	-1	-1	0
ME	PMC4064952	29861	29863	O	-1	-1	0
,	PMC4064952	29863	29864	O	-1	-1	0
Gersh	PMC4064952	29865	29870	O	-1	-1	0
BJ	PMC4064952	29871	29873	O	-1	-1	0
,	PMC4064952	29873	29874	O	-1	-1	0
et	PMC4064952	29875	29877	O	-1	-1	0
al	PMC4064952	29878	29880	O	-1	-1	0
.	PMC4064952	29880	29881	O	-1	-1	0

Secular	PMC4064952	29882	29889	O	-1	-1	0
trends	PMC4064952	29890	29896	O	-1	-1	0
in	PMC4064952	29897	29899	O	-1	-1	0
incidence	PMC4064952	29900	29909	O	-1	-1	0
of	PMC4064952	29910	29912	O	-1	-1	0
atrial	PMC4064952	29913	29919	O	-1	-1	0
fibrillation	PMC4064952	29920	29932	O	-1	-1	0
in	PMC4064952	29933	29935	O	-1	-1	0
Olmsted	PMC4064952	29936	29943	O	-1	-1	0
County	PMC4064952	29944	29950	O	-1	-1	0
,	PMC4064952	29950	29951	O	-1	-1	0
Minnesota	PMC4064952	29952	29961	O	-1	-1	0
,	PMC4064952	29961	29962	O	-1	-1	0
1980	PMC4064952	29963	29967	O	-1	-1	0
to	PMC4064952	29968	29970	O	-1	-1	0
2000	PMC4064952	29971	29975	O	-1	-1	0
,	PMC4064952	29975	29976	O	-1	-1	0
and	PMC4064952	29977	29980	O	-1	-1	0
the	PMC4064952	29981	29984	O	-1	-1	0
implications	PMC4064952	29985	29997	O	-1	-1	0
on	PMC4064952	29998	30000	O	-1	-1	0
the	PMC4064952	30001	30004	O	-1	-1	0
future	PMC4064952	30005	30011	O	-1	-1	0
prevalence	PMC4064952	30012	30022	O	-1	-1	0
.	PMC4064952	30022	30023	O	-1	-1	0

Circulation	PMC4064952	30024	30035	O	-1	-1	0
.	PMC4064952	30035	30036	O	-1	-1	0

2006;114	PMC4064952	30037	30045	O	-1	-1	0
:	PMC4064952	30045	30046	O	-1	-1	0

119–125	PMC4064952	30047	30054	O	-1	-1	0
.	PMC4064952	30054	30055	O	-1	-1	0

19	PMC4064952	30056	30058	O	-1	-1	0
.	PMC4064952	30058	30059	O	-1	-1	0

MeinertzT	PMC4064952	30060	30069	O	-1	-1	0
,	PMC4064952	30069	30070	O	-1	-1	0
Kirch	PMC4064952	30071	30076	O	-1	-1	0
,	PMC4064952	30076	30077	O	-1	-1	0
Rosin	PMC4064952	30078	30083	O	-1	-1	0
L	PMC4064952	30084	30085	O	-1	-1	0
,	PMC4064952	30085	30086	O	-1	-1	0
Pittrow	PMC4064952	30087	30094	O	-1	-1	0
D	PMC4064952	30095	30096	O	-1	-1	0
,	PMC4064952	30096	30097	O	-1	-1	0
Wilich	PMC4064952	30098	30104	O	-1	-1	0
SN	PMC4064952	30105	30107	O	-1	-1	0
,	PMC4064952	30107	30108	O	-1	-1	0
Kirchof	PMC4064952	30109	30116	O	-1	-1	0

P;ATRIUM	PMC4064952	30117	30125	O	-1	-1	0
Investigators	PMC4064952	30126	30139	O	-1	-1	0
.	PMC4064952	30139	30140	O	-1	-1	0

Management	PMC4064952	30141	30151	O	-1	-1	0
of	PMC4064952	30152	30154	O	-1	-1	0
atrial	PMC4064952	30155	30161	O	-1	-1	0
fibrillation	PMC4064952	30162	30174	O	-1	-1	0
by	PMC4064952	30175	30177	O	-1	-1	0
primary	PMC4064952	30178	30185	O	-1	-1	0
care	PMC4064952	30186	30190	O	-1	-1	0

physicians	PMC4064952	30191	30201	O	-1	-1	0
in	PMC4064952	30202	30204	O	-1	-1	0
Germany	PMC4064952	30205	30212	O	-1	-1	0
:	PMC4064952	30212	30213	O	-1	-1	0

baseline	PMC4064952	30214	30222	O	-1	-1	0
results	PMC4064952	30223	30230	O	-1	-1	0
of	PMC4064952	30231	30233	O	-1	-1	0
the	PMC4064952	30234	30237	O	-1	-1	0
ATRIUM	PMC4064952	30238	30244	O	-1	-1	0
registry	PMC4064952	30245	30253	O	-1	-1	0
.	PMC4064952	30253	30254	O	-1	-1	0

Clin	PMC4064952	30255	30259	O	-1	-1	0
Res	PMC4064952	30260	30263	O	-1	-1	0
Cardiol	PMC4064952	30264	30271	O	-1	-1	0
.	PMC4064952	30271	30272	O	-1	-1	0

2011;100:897–905	PMC4064952	30273	30289	O	-1	-1	0
.	PMC4064952	30289	30290	O	-1	-1	0

20	PMC4064952	30291	30293	O	-1	-1	0
.	PMC4064952	30293	30294	O	-1	-1	0

Nabauer	PMC4064952	30295	30302	O	-1	-1	0
M	PMC4064952	30303	30304	O	-1	-1	0
,	PMC4064952	30304	30305	O	-1	-1	0
GerthA	PMC4064952	30306	30312	O	-1	-1	0
,	PMC4064952	30312	30313	O	-1	-1	0
Limbourg	PMC4064952	30314	30322	O	-1	-1	0
T	PMC4064952	30323	30324	O	-1	-1	0
,	PMC4064952	30324	30325	O	-1	-1	0
et	PMC4064952	30326	30328	O	-1	-1	0
al	PMC4064952	30329	30331	O	-1	-1	0
.	PMC4064952	30331	30332	O	-1	-1	0

The	PMC4064952	30333	30336	O	-1	-1	0
Registry	PMC4064952	30337	30345	O	-1	-1	0
of	PMC4064952	30346	30348	O	-1	-1	0
German	PMC4064952	30349	30355	O	-1	-1	0
Com-	PMC4064952	30356	30360	O	-1	-1	0
petence	PMC4064952	30361	30368	O	-1	-1	0
Network	PMC4064952	30369	30376	O	-1	-1	0
on	PMC4064952	30377	30379	O	-1	-1	0
atrial	PMC4064952	30380	30386	O	-1	-1	0
fibrillation	PMC4064952	30387	30399	O	-1	-1	0
:	PMC4064952	30399	30400	O	-1	-1	0
patient	PMC4064952	30401	30408	O	-1	-1	0
characteristics	PMC4064952	30409	30424	O	-1	-1	0
and	PMC4064952	30425	30428	O	-1	-1	0
initial	PMC4064952	30429	30436	O	-1	-1	0
management	PMC4064952	30437	30447	O	-1	-1	0
.	PMC4064952	30447	30448	O	-1	-1	0

Europace	PMC4064952	30449	30457	O	-1	-1	0
.	PMC4064952	30457	30458	O	-1	-1	0

2009;11:423–434	PMC4064952	30459	30474	O	-1	-1	0
.	PMC4064952	30474	30475	O	-1	-1	0

21	PMC4064952	30476	30478	O	-1	-1	0
.	PMC4064952	30478	30479	O	-1	-1	0

Nieuwlaat	PMC4064952	30480	30489	O	-1	-1	0
R	PMC4064952	30490	30491	O	-1	-1	0
,	PMC4064952	30491	30492	O	-1	-1	0
Capucci	PMC4064952	30493	30500	O	-1	-1	0
A	PMC4064952	30501	30502	O	-1	-1	0
,	PMC4064952	30502	30503	O	-1	-1	0
Camm	PMC4064952	30504	30508	O	-1	-1	0
AJ	PMC4064952	30509	30511	O	-1	-1	0
,	PMC4064952	30511	30512	O	-1	-1	0
et	PMC4064952	30513	30515	O	-1	-1	0
al	PMC4064952	30516	30518	O	-1	-1	0
;	PMC4064952	30518	30519	O	-1	-1	0
European	PMC4064952	30520	30528	O	-1	-1	0
Heart	PMC4064952	30529	30534	O	-1	-1	0
Survey	PMC4064952	30535	30541	O	-1	-1	0
Investigators	PMC4064952	30542	30555	O	-1	-1	0
.	PMC4064952	30555	30556	O	-1	-1	0

Atrial	PMC4064952	30557	30563	O	-1	-1	0
fibrillation	PMC4064952	30564	30576	O	-1	-1	0
management	PMC4064952	30577	30587	O	-1	-1	0
:	PMC4064952	30587	30588	O	-1	-1	0
a	PMC4064952	30589	30590	O	-1	-1	0
prospective	PMC4064952	30591	30602	O	-1	-1	0
survey	PMC4064952	30603	30609	O	-1	-1	0
in	PMC4064952	30610	30612	O	-1	-1	0
ESC	PMC4064952	30613	30616	O	-1	-1	0
member	PMC4064952	30617	30623	O	-1	-1	0
countries	PMC4064952	30624	30633	O	-1	-1	0
:	PMC4064952	30633	30634	O	-1	-1	0
the	PMC4064952	30635	30638	O	-1	-1	0
Euro	PMC4064952	30639	30643	O	-1	-1	0
Heart	PMC4064952	30644	30649	O	-1	-1	0
Survey	PMC4064952	30650	30656	O	-1	-1	0
on	PMC4064952	30657	30659	O	-1	-1	0
Atrial	PMC4064952	30660	30666	O	-1	-1	0
Fibrillation	PMC4064952	30667	30679	O	-1	-1	0
.	PMC4064952	30679	30680	O	-1	-1	0

Eur	PMC4064952	30681	30684	O	-1	-1	0
Heart	PMC4064952	30685	30690	O	-1	-1	0
J.	PMC4064952	30691	30693	O	-1	-1	0
2005;26:2422–2434	PMC4064952	30694	30711	O	-1	-1	0
.	PMC4064952	30711	30712	O	-1	-1	0

22	PMC4064952	30713	30715	O	-1	-1	0
.	PMC4064952	30715	30716	O	-1	-1	0

Di	PMC4064952	30717	30719	O	-1	-1	0
Pasquale	PMC4064952	30720	30728	O	-1	-1	0
G	PMC4064952	30729	30730	O	-1	-1	0
,	PMC4064952	30730	30731	O	-1	-1	0
Mathieu	PMC4064952	30732	30739	O	-1	-1	0
G	PMC4064952	30740	30741	O	-1	-1	0
,	PMC4064952	30741	30742	O	-1	-1	0
Maggioni	PMC4064952	30743	30751	O	-1	-1	0
AP	PMC4064952	30752	30754	O	-1	-1	0
,	PMC4064952	30754	30755	O	-1	-1	0
et	PMC4064952	30756	30758	O	-1	-1	0
al	PMC4064952	30759	30761	O	-1	-1	0
;	PMC4064952	30761	30762	O	-1	-1	0
on	PMC4064952	30763	30765	O	-1	-1	0
behalf	PMC4064952	30766	30772	O	-1	-1	0
of	PMC4064952	30773	30775	O	-1	-1	0
ATA	PMC4064952	30776	30779	O	-1	-1	0
-	PMC4064952	30779	30780	O	-1	-1	0
AF	PMC4064952	30780	30782	O	-1	-1	0
Investigators	PMC4064952	30783	30796	O	-1	-1	0
.	PMC4064952	30796	30797	O	-1	-1	0

Current	PMC4064952	30798	30805	O	-1	-1	0
presentation	PMC4064952	30806	30818	O	-1	-1	0
and	PMC4064952	30819	30822	O	-1	-1	0
management	PMC4064952	30823	30833	O	-1	-1	0
of	PMC4064952	30834	30836	O	-1	-1	0
7148	PMC4064952	30837	30841	O	-1	-1	0
patients	PMC4064952	30842	30850	O	-1	-1	0
with	PMC4064952	30851	30855	O	-1	-1	0
atrial	PMC4064952	30856	30862	O	-1	-1	0
fibrillation	PMC4064952	30863	30875	O	-1	-1	0
in	PMC4064952	30876	30878	O	-1	-1	0
cardiology	PMC4064952	30879	30889	O	-1	-1	0
and	PMC4064952	30890	30893	O	-1	-1	0
internal	PMC4064952	30894	30902	O	-1	-1	0
­	PMC4064952	30903	30904	O	-1	-1	0

medicine	PMC4064952	30905	30913	O	-1	-1	0
hospital	PMC4064952	30914	30922	O	-1	-1	0
centers	PMC4064952	30923	30930	O	-1	-1	0
:	PMC4064952	30930	30931	O	-1	-1	0
the	PMC4064952	30932	30935	O	-1	-1	0
ATA	PMC4064952	30936	30939	O	-1	-1	0
-	PMC4064952	30939	30940	O	-1	-1	0
AF	PMC4064952	30940	30942	O	-1	-1	0
study	PMC4064952	30943	30948	O	-1	-1	0
.	PMC4064952	30948	30949	O	-1	-1	0

Int	PMC4064952	30950	30953	O	-1	-1	0
J	PMC4064952	30954	30955	O	-1	-1	0
Cardiol	PMC4064952	30956	30963	O	-1	-1	0
.	PMC4064952	30963	30964	O	-1	-1	0

2013;167:2895–2903	PMC4064952	30965	30983	O	-1	-1	0
.	PMC4064952	30983	30984	O	-1	-1	0

23	PMC4064952	30985	30987	O	-1	-1	0
.	PMC4064952	30987	30988	O	-1	-1	0

Levy	PMC4064952	30989	30993	O	-1	-1	0
S	PMC4064952	30994	30995	O	-1	-1	0
,	PMC4064952	30995	30996	O	-1	-1	0
Maarek	PMC4064952	30997	31003	O	-1	-1	0
M	PMC4064952	31004	31005	O	-1	-1	0
,	PMC4064952	31005	31006	O	-1	-1	0
Coumel	PMC4064952	31007	31013	O	-1	-1	0
P	PMC4064952	31014	31015	O	-1	-1	0
,	PMC4064952	31015	31016	O	-1	-1	0
et	PMC4064952	31017	31019	O	-1	-1	0
al	PMC4064952	31020	31022	O	-1	-1	0
;	PMC4064952	31022	31023	O	-1	-1	0
on	PMC4064952	31024	31026	O	-1	-1	0
behalf	PMC4064952	31027	31033	O	-1	-1	0
of	PMC4064952	31034	31036	O	-1	-1	0
the	PMC4064952	31037	31040	O	-1	-1	0
College	PMC4064952	31041	31048	O	-1	-1	0
of	PMC4064952	31049	31051	O	-1	-1	0
French	PMC4064952	31052	31058	O	-1	-1	0
Cardiologists	PMC4064952	31059	31072	O	-1	-1	0
.	PMC4064952	31072	31073	O	-1	-1	0

Characterization	PMC4064952	31074	31090	O	-1	-1	0
of	PMC4064952	31091	31093	O	-1	-1	0
different	PMC4064952	31094	31103	O	-1	-1	0
subsets	PMC4064952	31104	31111	O	-1	-1	0
of	PMC4064952	31112	31114	O	-1	-1	0
atrial	PMC4064952	31115	31121	O	-1	-1	0
fibril-	PMC4064952	31122	31129	O	-1	-1	0
lation	PMC4064952	31130	31136	O	-1	-1	0
in	PMC4064952	31137	31139	O	-1	-1	0
general	PMC4064952	31140	31147	O	-1	-1	0
practice	PMC4064952	31148	31156	O	-1	-1	0
in	PMC4064952	31157	31159	O	-1	-1	0
France	PMC4064952	31160	31166	O	-1	-1	0
.	PMC4064952	31166	31167	O	-1	-1	0

The	PMC4064952	31168	31171	O	-1	-1	0
ALFA	PMC4064952	31172	31176	O	-1	-1	0
study	PMC4064952	31177	31182	O	-1	-1	0
.	PMC4064952	31182	31183	O	-1	-1	0

Circulation	PMC4064952	31184	31195	O	-1	-1	0
.	PMC4064952	31195	31196	O	-1	-1	0

1999;99:3028–3035	PMC4064952	31197	31214	O	-1	-1	0
.	PMC4064952	31214	31215	O	-1	-1	0

24	PMC4064952	31216	31218	O	-1	-1	0
.	PMC4064952	31218	31219	O	-1	-1	0

Chiang	PMC4064952	31220	31226	O	-1	-1	0
CE	PMC4064952	31227	31229	O	-1	-1	0
,	PMC4064952	31229	31230	O	-1	-1	0
Naditch	PMC4064952	31231	31238	O	-1	-1	0
-	PMC4064952	31238	31239	O	-1	-1	0
Brulé	PMC4064952	31239	31244	O	-1	-1	0
L	PMC4064952	31245	31246	O	-1	-1	0
,	PMC4064952	31246	31247	O	-1	-1	0
Murin	PMC4064952	31248	31253	O	-1	-1	0
J	PMC4064952	31254	31255	O	-1	-1	0
,	PMC4064952	31255	31256	O	-1	-1	0
et	PMC4064952	31257	31259	O	-1	-1	0
al	PMC4064952	31260	31262	O	-1	-1	0
.	PMC4064952	31262	31263	O	-1	-1	0

Distribution	PMC4064952	31264	31276	O	-1	-1	0
and	PMC4064952	31277	31280	O	-1	-1	0
risk	PMC4064952	31281	31285	O	-1	-1	0
profile	PMC4064952	31286	31293	O	-1	-1	0
of	PMC4064952	31294	31296	O	-1	-1	0
paroxysmal	PMC4064952	31297	31307	O	-1	-1	0
,	PMC4064952	31307	31308	O	-1	-1	0
persistent	PMC4064952	31309	31319	O	-1	-1	0
,	PMC4064952	31319	31320	O	-1	-1	0
and	PMC4064952	31321	31324	O	-1	-1	0
permanent	PMC4064952	31325	31334	O	-1	-1	0
atrial	PMC4064952	31335	31341	O	-1	-1	0
fibrillation	PMC4064952	31342	31354	O	-1	-1	0
in	PMC4064952	31355	31357	O	-1	-1	0
routine	PMC4064952	31358	31365	O	-1	-1	0
clinical	PMC4064952	31366	31374	O	-1	-1	0
practice	PMC4064952	31375	31383	O	-1	-1	0
.	PMC4064952	31383	31384	O	-1	-1	0

insight	PMC4064952	31385	31392	O	-1	-1	0
from	PMC4064952	31393	31397	O	-1	-1	0
the	PMC4064952	31398	31401	O	-1	-1	0
real	PMC4064952	31402	31406	O	-1	-1	0
-	PMC4064952	31406	31407	O	-1	-1	0
life	PMC4064952	31407	31411	O	-1	-1	0
global	PMC4064952	31412	31418	O	-1	-1	0
survey	PMC4064952	31419	31425	O	-1	-1	0
evaluating	PMC4064952	31426	31436	O	-1	-1	0
patients	PMC4064952	31437	31445	O	-1	-1	0
with	PMC4064952	31446	31450	O	-1	-1	0
atrial	PMC4064952	31451	31457	O	-1	-1	0
fibrillation	PMC4064952	31458	31470	O	-1	-1	0
international	PMC4064952	31471	31484	O	-1	-1	0
registry	PMC4064952	31485	31493	O	-1	-1	0
.	PMC4064952	31493	31494	O	-1	-1	0

Circ	PMC4064952	31495	31499	O	-1	-1	0
Arrhythm	PMC4064952	31500	31508	O	-1	-1	0
Electrophysiol	PMC4064952	31509	31523	O	-1	-1	0
.	PMC4064952	31523	31524	O	-1	-1	0

2012;5:632–639	PMC4064952	31525	31539	O	-1	-1	0
.	PMC4064952	31539	31540	O	-1	-1	0

25	PMC4064952	31541	31543	O	-1	-1	0
.	PMC4064952	31543	31544	O	-1	-1	0

McManus	PMC4064952	31545	31552	O	-1	-1	0
DD	PMC4064952	31553	31555	O	-1	-1	0
,	PMC4064952	31555	31556	O	-1	-1	0
Rienstra	PMC4064952	31557	31565	O	-1	-1	0
M	PMC4064952	31566	31567	O	-1	-1	0
,	PMC4064952	31567	31568	O	-1	-1	0

Benjamin	PMC4064952	31569	31577	O	-1	-1	0
EJ.An	PMC4064952	31578	31583	O	-1	-1	0
update	PMC4064952	31584	31590	O	-1	-1	0
on	PMC4064952	31591	31593	O	-1	-1	0
the	PMC4064952	31594	31597	O	-1	-1	0
prognosis	PMC4064952	31598	31607	O	-1	-1	0
of	PMC4064952	31608	31610	O	-1	-1	0
patients	PMC4064952	31611	31619	O	-1	-1	0
with	PMC4064952	31620	31624	O	-1	-1	0
atrial	PMC4064952	31625	31631	O	-1	-1	0
fibrillation	PMC4064952	31632	31644	O	-1	-1	0
.	PMC4064952	31644	31645	O	-1	-1	0

Circulation	PMC4064952	31646	31657	O	-1	-1	0
.	PMC4064952	31657	31658	O	-1	-1	0

2012;126	PMC4064952	31659	31667	O	-1	-1	0
:	PMC4064952	31667	31668	O	-1	-1	0
e143–e146	PMC4064952	31668	31677	O	-1	-1	0
.	PMC4064952	31677	31678	O	-1	-1	0

26	PMC4064952	31679	31681	O	-1	-1	0
.	PMC4064952	31681	31682	O	-1	-1	0

Nieuwlaat	PMC4064952	31683	31692	O	-1	-1	0
R	PMC4064952	31693	31694	O	-1	-1	0
,	PMC4064952	31694	31695	O	-1	-1	0
Prins	PMC4064952	31696	31701	O	-1	-1	0
MH	PMC4064952	31702	31704	O	-1	-1	0
,	PMC4064952	31704	31705	O	-1	-1	0
Le	PMC4064952	31706	31708	O	-1	-1	0
Heuzey	PMC4064952	31709	31715	O	-1	-1	0
JY	PMC4064952	31716	31718	O	-1	-1	0
,	PMC4064952	31718	31719	O	-1	-1	0
et	PMC4064952	31720	31722	O	-1	-1	0
al	PMC4064952	31723	31725	O	-1	-1	0
.	PMC4064952	31725	31726	O	-1	-1	0

Prognosis	PMC4064952	31727	31736	O	-1	-1	0
,	PMC4064952	31736	31737	O	-1	-1	0
disease	PMC4064952	31738	31745	O	-1	-1	0
progression	PMC4064952	31746	31757	O	-1	-1	0
,	PMC4064952	31757	31758	O	-1	-1	0
and	PMC4064952	31759	31762	O	-1	-1	0
treatment	PMC4064952	31763	31772	O	-1	-1	0
of	PMC4064952	31773	31775	O	-1	-1	0
atrial	PMC4064952	31776	31782	O	-1	-1	0
fibrillation	PMC4064952	31783	31795	O	-1	-1	0
patients	PMC4064952	31796	31804	O	-1	-1	0
during	PMC4064952	31805	31811	O	-1	-1	0
1	PMC4064952	31812	31813	O	-1	-1	0
year	PMC4064952	31814	31818	O	-1	-1	0
.	PMC4064952	31818	31819	O	-1	-1	0

Follow	PMC4064952	31820	31826	O	-1	-1	0
up	PMC4064952	31827	31829	O	-1	-1	0
of	PMC4064952	31830	31832	O	-1	-1	0
the	PMC4064952	31833	31836	O	-1	-1	0
Euro	PMC4064952	31837	31841	O	-1	-1	0
Heart	PMC4064952	31842	31847	O	-1	-1	0
Survey	PMC4064952	31848	31854	O	-1	-1	0
on	PMC4064952	31855	31857	O	-1	-1	0
atrial	PMC4064952	31858	31864	O	-1	-1	0
fibrillation	PMC4064952	31865	31877	O	-1	-1	0
.	PMC4064952	31877	31878	O	-1	-1	0

Eur	PMC4064952	31879	31882	O	-1	-1	0
Heart	PMC4064952	31883	31888	O	-1	-1	0
J.	PMC4064952	31889	31891	O	-1	-1	0

2008;29:1181–1189	PMC4064952	31892	31909	O	-1	-1	0
.	PMC4064952	31909	31910	O	-1	-1	0

27	PMC4064952	31911	31913	O	-1	-1	0
.	PMC4064952	31913	31914	O	-1	-1	0

De	PMC4064952	31915	31917	O	-1	-1	0
Sisti	PMC4064952	31918	31923	O	-1	-1	0
A	PMC4064952	31924	31925	O	-1	-1	0
,	PMC4064952	31925	31926	O	-1	-1	0
Leclercq	PMC4064952	31927	31935	O	-1	-1	0
JF	PMC4064952	31936	31938	O	-1	-1	0
,	PMC4064952	31938	31939	O	-1	-1	0
Halimi	PMC4064952	31940	31946	O	-1	-1	0
F	PMC4064952	31947	31948	O	-1	-1	0
,	PMC4064952	31948	31949	O	-1	-1	0
Fiorello	PMC4064952	31950	31958	O	-1	-1	0
P	PMC4064952	31959	31960	O	-1	-1	0
,	PMC4064952	31960	31961	O	-1	-1	0
Bertrand	PMC4064952	31962	31970	O	-1	-1	0
C	PMC4064952	31971	31972	O	-1	-1	0
,	PMC4064952	31972	31973	O	-1	-1	0

Attuel	PMC4064952	31974	31980	O	-1	-1	0
P.­	PMC4064952	31981	31984	O	-1	-1	0

Evaluation	PMC4064952	31985	31995	O	-1	-1	0
of	PMC4064952	31996	31998	O	-1	-1	0
time	PMC4064952	31999	32003	O	-1	-1	0
course	PMC4064952	32004	32010	O	-1	-1	0
predicting	PMC4064952	32011	32021	O	-1	-1	0
factors	PMC4064952	32022	32029	O	-1	-1	0
of	PMC4064952	32030	32032	O	-1	-1	0
progression	PMC4064952	32033	32044	O	-1	-1	0
of	PMC4064952	32045	32047	O	-1	-1	0
­	PMC4064952	32048	32049	O	-1	-1	0
paroxysmal	PMC4064952	32050	32060	O	-1	-1	0
or	PMC4064952	32061	32063	O	-1	-1	0
persistent	PMC4064952	32064	32074	O	-1	-1	0
atrial	PMC4064952	32075	32081	O	-1	-1	0
fibrillation	PMC4064952	32082	32094	O	-1	-1	0
to	PMC4064952	32095	32097	O	-1	-1	0
permanent	PMC4064952	32098	32107	O	-1	-1	0
atrial	PMC4064952	32108	32114	O	-1	-1	0
fibrillation	PMC4064952	32115	32127	O	-1	-1	0
.	PMC4064952	32127	32128	O	-1	-1	0

Pacing	PMC4064952	32129	32135	O	-1	-1	0
Clin	PMC4064952	32136	32140	O	-1	-1	0
Electrophysiol	PMC4064952	32141	32155	O	-1	-1	0
.	PMC4064952	32155	32156	O	-1	-1	0

2014;37:345–355	PMC4064952	32157	32172	O	-1	-1	0
.	PMC4064952	32172	32173	O	-1	-1	0

28	PMC4064952	32174	32176	O	-1	-1	0
.	PMC4064952	32176	32177	O	-1	-1	0

Kerr	PMC4064952	32178	32182	O	-1	-1	0
CR	PMC4064952	32183	32185	O	-1	-1	0
,	PMC4064952	32185	32186	O	-1	-1	0
Humphries	PMC4064952	32187	32196	O	-1	-1	0
KH	PMC4064952	32197	32199	O	-1	-1	0
,	PMC4064952	32199	32200	O	-1	-1	0
Talajic	PMC4064952	32201	32208	O	-1	-1	0
M	PMC4064952	32209	32210	O	-1	-1	0
,	PMC4064952	32210	32211	O	-1	-1	0
et	PMC4064952	32212	32214	O	-1	-1	0
al	PMC4064952	32215	32217	O	-1	-1	0
.	PMC4064952	32217	32218	O	-1	-1	0

Progression	PMC4064952	32219	32230	O	-1	-1	0
to	PMC4064952	32231	32233	O	-1	-1	0
chronic	PMC4064952	32234	32241	O	-1	-1	0
atrial	PMC4064952	32242	32248	O	-1	-1	0
fibrillation	PMC4064952	32249	32261	O	-1	-1	0
after	PMC4064952	32262	32267	O	-1	-1	0
the	PMC4064952	32268	32271	O	-1	-1	0
initial	PMC4064952	32272	32279	O	-1	-1	0
diagnosis	PMC4064952	32280	32289	O	-1	-1	0
of	PMC4064952	32290	32292	O	-1	-1	0
paroxysmal	PMC4064952	32293	32303	O	-1	-1	0
atrial	PMC4064952	32304	32310	O	-1	-1	0
fibrillation	PMC4064952	32311	32323	O	-1	-1	0
:	PMC4064952	32323	32324	O	-1	-1	0

results	PMC4064952	32325	32332	O	-1	-1	0
from	PMC4064952	32333	32337	O	-1	-1	0
the	PMC4064952	32338	32341	O	-1	-1	0
Canadian	PMC4064952	32342	32350	O	-1	-1	0
Registry	PMC4064952	32351	32359	O	-1	-1	0
of	PMC4064952	32360	32362	O	-1	-1	0
Atrial	PMC4064952	32363	32369	O	-1	-1	0
Fibrillation	PMC4064952	32370	32382	O	-1	-1	0
.	PMC4064952	32382	32383	O	-1	-1	0

Am	PMC4064952	32384	32386	O	-1	-1	0
Heart	PMC4064952	32387	32392	O	-1	-1	0
J.	PMC4064952	32393	32395	O	-1	-1	0
2005;149:489–496	PMC4064952	32396	32412	O	-1	-1	0
.	PMC4064952	32412	32413	O	-1	-1	0

29	PMC4064952	32414	32416	O	-1	-1	0
.	PMC4064952	32416	32417	O	-1	-1	0

Jahangir	PMC4064952	32418	32426	O	-1	-1	0
A	PMC4064952	32427	32428	O	-1	-1	0
,	PMC4064952	32428	32429	O	-1	-1	0
Lee	PMC4064952	32430	32433	O	-1	-1	0
V	PMC4064952	32434	32435	O	-1	-1	0
,	PMC4064952	32435	32436	O	-1	-1	0
Friedman	PMC4064952	32437	32445	O	-1	-1	0
PA	PMC4064952	32446	32448	O	-1	-1	0
,	PMC4064952	32448	32449	O	-1	-1	0
et	PMC4064952	32450	32452	O	-1	-1	0
al	PMC4064952	32453	32455	O	-1	-1	0
.	PMC4064952	32455	32456	O	-1	-1	0

Long	PMC4064952	32457	32461	O	-1	-1	0
-	PMC4064952	32461	32462	O	-1	-1	0
term	PMC4064952	32462	32466	O	-1	-1	0
progression	PMC4064952	32467	32478	O	-1	-1	0
and	PMC4064952	32479	32482	O	-1	-1	0
outcomes	PMC4064952	32483	32491	O	-1	-1	0
with	PMC4064952	32492	32496	O	-1	-1	0
aging	PMC4064952	32497	32502	O	-1	-1	0
in	PMC4064952	32503	32505	O	-1	-1	0
patients	PMC4064952	32506	32514	O	-1	-1	0
with	PMC4064952	32515	32519	O	-1	-1	0
lone	PMC4064952	32520	32524	O	-1	-1	0
atrial	PMC4064952	32525	32531	O	-1	-1	0
fibrillation	PMC4064952	32532	32544	O	-1	-1	0
,	PMC4064952	32544	32545	O	-1	-1	0
A	PMC4064952	32546	32547	O	-1	-1	0
30-year	PMC4064952	32548	32555	O	-1	-1	0
follow	PMC4064952	32556	32562	O	-1	-1	0
up	PMC4064952	32563	32565	O	-1	-1	0
study	PMC4064952	32566	32571	O	-1	-1	0
.	PMC4064952	32571	32572	O	-1	-1	0

Circulation	PMC4064952	32573	32584	O	-1	-1	0
.	PMC4064952	32584	32585	O	-1	-1	0

2007;115:3050–3056	PMC4064952	32586	32604	O	-1	-1	0
.	PMC4064952	32604	32605	O	-1	-1	0

30	PMC4064952	32606	32608	O	-1	-1	0
.	PMC4064952	32608	32609	O	-1	-1	0

DeVoos	PMC4064952	32610	32616	O	-1	-1	0
CB	PMC4064952	32617	32619	O	-1	-1	0
,	PMC4064952	32619	32620	O	-1	-1	0
Pisters	PMC4064952	32621	32628	O	-1	-1	0
R	PMC4064952	32629	32630	O	-1	-1	0
,	PMC4064952	32630	32631	O	-1	-1	0
Nieuwlaat	PMC4064952	32632	32641	O	-1	-1	0
R	PMC4064952	32642	32643	O	-1	-1	0
,	PMC4064952	32643	32644	O	-1	-1	0
et	PMC4064952	32645	32647	O	-1	-1	0
al	PMC4064952	32648	32650	O	-1	-1	0
.	PMC4064952	32650	32651	O	-1	-1	0

Progression	PMC4064952	32652	32663	O	-1	-1	0
from	PMC4064952	32664	32668	O	-1	-1	0
paroxysmal	PMC4064952	32669	32679	O	-1	-1	0
to	PMC4064952	32680	32682	O	-1	-1	0
persistent	PMC4064952	32683	32693	O	-1	-1	0
atrial	PMC4064952	32694	32700	O	-1	-1	0
fibrillation	PMC4064952	32701	32713	O	-1	-1	0
.	PMC4064952	32713	32714	O	-1	-1	0

Clinical	PMC4064952	32715	32723	O	-1	-1	0
correlates	PMC4064952	32724	32734	O	-1	-1	0
and	PMC4064952	32735	32738	O	-1	-1	0
prognosis	PMC4064952	32739	32748	O	-1	-1	0
.	PMC4064952	32748	32749	O	-1	-1	0

J	PMC4064952	32750	32751	O	-1	-1	0
Am	PMC4064952	32752	32754	O	-1	-1	0

Coll	PMC4064952	32755	32759	O	-1	-1	0
Cardiol	PMC4064952	32760	32767	O	-1	-1	0
.	PMC4064952	32767	32768	O	-1	-1	0

2010;55:725–731	PMC4064952	32769	32784	O	-1	-1	0
.	PMC4064952	32784	32785	O	-1	-1	0

31	PMC4064952	32786	32788	O	-1	-1	0
.	PMC4064952	32788	32789	O	-1	-1	0

Self	PMC4064952	32790	32794	O	-1	-1	0
WH	PMC4064952	32795	32797	O	-1	-1	0
,	PMC4064952	32797	32798	O	-1	-1	0
Wasserman	PMC4064952	32799	32808	O	-1	-1	0
BS	PMC4064952	32809	32811	O	-1	-1	0
,	PMC4064952	32811	32812	O	-1	-1	0
McNaughton	PMC4064952	32813	32823	O	-1	-1	0
CD	PMC4064952	32824	32826	O	-1	-1	0
,	PMC4064952	32826	32827	O	-1	-1	0
Darbar	PMC4064952	32828	32834	O	-1	-1	0
D.	PMC4064952	32835	32837	O	-1	-1	0
­	PMC4064952	32838	32839	O	-1	-1	0

Evaluating	PMC4064952	32840	32850	O	-1	-1	0

the	PMC4064952	32851	32854	O	-1	-1	0
HATCH	PMC4064952	32855	32860	O	-1	-1	0
score	PMC4064952	32861	32866	O	-1	-1	0
for	PMC4064952	32867	32870	O	-1	-1	0
predicting	PMC4064952	32871	32881	O	-1	-1	0
progression	PMC4064952	32882	32893	O	-1	-1	0
to	PMC4064952	32894	32896	O	-1	-1	0
sustained	PMC4064952	32897	32906	O	-1	-1	0
atrial	PMC4064952	32907	32913	O	-1	-1	0
fibrillation	PMC4064952	32914	32926	O	-1	-1	0
in	PMC4064952	32927	32929	O	-1	-1	0
ED	PMC4064952	32930	32932	O	-1	-1	0
patients	PMC4064952	32933	32941	O	-1	-1	0
with	PMC4064952	32942	32946	O	-1	-1	0
new	PMC4064952	32947	32950	O	-1	-1	0
atrial	PMC4064952	32951	32957	O	-1	-1	0
fibrillation	PMC4064952	32958	32970	O	-1	-1	0
.	PMC4064952	32970	32971	O	-1	-1	0

Am	PMC4064952	32972	32974	O	-1	-1	0
J	PMC4064952	32975	32976	O	-1	-1	0
Emerg	PMC4064952	32977	32982	O	-1	-1	0
Med	PMC4064952	32983	32986	O	-1	-1	0
.	PMC4064952	32986	32987	O	-1	-1	0

2013;31:792–797	PMC4064952	32988	33003	O	-1	-1	0
.	PMC4064952	33003	33004	O	-1	-1	0

32	PMC4064952	33005	33007	O	-1	-1	0
.	PMC4064952	33007	33008	O	-1	-1	0

American	PMC4064952	33009	33017	O	-1	-1	0
Heart	PMC4064952	33018	33023	O	-1	-1	0
Association	PMC4064952	33024	33035	O	-1	-1	0
.	PMC4064952	33035	33036	O	-1	-1	0

Heart	PMC4064952	33037	33042	O	-1	-1	0
and	PMC4064952	33043	33046	O	-1	-1	0
Stroke	PMC4064952	33047	33053	O	-1	-1	0
Statistical	PMC4064952	33054	33065	O	-1	-1	0
Update	PMC4064952	33066	33072	O	-1	-1	0
.	PMC4064952	33072	33073	O	-1	-1	0
Dallas	PMC4064952	33074	33080	O	-1	-1	0
,	PMC4064952	33080	33081	O	-1	-1	0
TX	PMC4064952	33082	33084	O	-1	-1	0
,	PMC4064952	33084	33085	O	-1	-1	0
USA	PMC4064952	33086	33089	O	-1	-1	0
:	PMC4064952	33089	33090	O	-1	-1	0
American	PMC4064952	33091	33099	O	-1	-1	0
Heart	PMC4064952	33100	33105	O	-1	-1	0
Association	PMC4064952	33106	33117	O	-1	-1	0
;	PMC4064952	33117	33118	O	-1	-1	0
1999	PMC4064952	33119	33123	O	-1	-1	0
.	PMC4064952	33123	33124	O	-1	-1	0

Available	PMC4064952	33125	33134	O	-1	-1	0
from	PMC4064952	33135	33139	O	-1	-1	0
:	PMC4064952	33139	33140	O	-1	-1	0
http://www.nanocorthx.com/Articles/HeartDiseaseStrokeStatistics.pdf	PMC4064952	33141	33208	O	-1	-1	0
.	PMC4064952	33208	33209	O	-1	-1	0

Accessed	PMC4064952	33210	33218	O	-1	-1	0
May	PMC4064952	33219	33222	O	-1	-1	0
29	PMC4064952	33223	33225	O	-1	-1	0
,	PMC4064952	33225	33226	O	-1	-1	0
2014	PMC4064952	33227	33231	O	-1	-1	0
.	PMC4064952	33231	33232	O	-1	-1	0

33	PMC4064952	33233	33235	O	-1	-1	0
.	PMC4064952	33235	33236	O	-1	-1	0

WolfPA	PMC4064952	33237	33243	O	-1	-1	0
,	PMC4064952	33243	33244	O	-1	-1	0
AbbottRD	PMC4064952	33244	33252	O	-1	-1	0
,	PMC4064952	33252	33253	O	-1	-1	0
KannelWB.Atrialfibrillationasanindependentrisk	PMC4064952	33253	33299	O	-1	-1	0
factor	PMC4064952	33300	33306	O	-1	-1	0
for	PMC4064952	33307	33310	O	-1	-1	0
stroke	PMC4064952	33311	33317	O	-1	-1	0
:	PMC4064952	33317	33318	O	-1	-1	0
the	PMC4064952	33319	33322	O	-1	-1	0
Framingham	PMC4064952	33323	33333	O	-1	-1	0
Study	PMC4064952	33334	33339	O	-1	-1	0
.	PMC4064952	33339	33340	O	-1	-1	0

Stroke	PMC4064952	33341	33347	O	-1	-1	0
.	PMC4064952	33347	33348	O	-1	-1	0

1991;22:983–988	PMC4064952	33349	33364	O	-1	-1	0
.	PMC4064952	33364	33365	O	-1	-1	0

34	PMC4064952	33366	33368	O	-1	-1	0
.	PMC4064952	33368	33369	O	-1	-1	0

Friberg	PMC4064952	33370	33377	O	-1	-1	0
L	PMC4064952	33378	33379	O	-1	-1	0
,	PMC4064952	33379	33380	O	-1	-1	0
Hammar	PMC4064952	33381	33387	O	-1	-1	0
N	PMC4064952	33388	33389	O	-1	-1	0
,	PMC4064952	33389	33390	O	-1	-1	0
Rosenqvist	PMC4064952	33391	33401	O	-1	-1	0
M.	PMC4064952	33402	33404	O	-1	-1	0
Stroke	PMC4064952	33405	33411	O	-1	-1	0
in	PMC4064952	33412	33414	O	-1	-1	0
paroxysmal	PMC4064952	33415	33425	O	-1	-1	0
atrial	PMC4064952	33426	33432	O	-1	-1	0
fibril-	PMC4064952	33433	33440	O	-1	-1	0

lation	PMC4064952	33441	33447	O	-1	-1	0
:	PMC4064952	33447	33448	O	-1	-1	0
report	PMC4064952	33449	33455	O	-1	-1	0
from	PMC4064952	33456	33460	O	-1	-1	0
the	PMC4064952	33461	33464	O	-1	-1	0
Stockolm	PMC4064952	33465	33473	O	-1	-1	0
Cohort	PMC4064952	33474	33480	O	-1	-1	0
ofAtrial	PMC4064952	33481	33489	O	-1	-1	0
Fibrillation	PMC4064952	33490	33502	O	-1	-1	0
.	PMC4064952	33502	33503	O	-1	-1	0

Eur	PMC4064952	33504	33507	O	-1	-1	0
Heart	PMC4064952	33508	33513	O	-1	-1	0

J.	PMC4064952	33514	33516	O	-1	-1	0
2010;31:967–972	PMC4064952	33517	33532	O	-1	-1	0
.	PMC4064952	33532	33533	O	-1	-1	0

35	PMC4064952	33534	33536	O	-1	-1	0
.	PMC4064952	33536	33537	O	-1	-1	0

Shroff	PMC4064952	33538	33544	O	-1	-1	0
GR	PMC4064952	33545	33547	O	-1	-1	0
,	PMC4064952	33547	33548	O	-1	-1	0
Solid	PMC4064952	33549	33554	O	-1	-1	0
CA	PMC4064952	33555	33557	O	-1	-1	0
,	PMC4064952	33557	33558	O	-1	-1	0
Herzog	PMC4064952	33559	33565	O	-1	-1	0
CA	PMC4064952	33566	33568	O	-1	-1	0
.	PMC4064952	33568	33569	O	-1	-1	0

Temporal	PMC4064952	33570	33578	O	-1	-1	0
trends	PMC4064952	33579	33585	O	-1	-1	0
in	PMC4064952	33586	33588	O	-1	-1	0
ischemic	PMC4064952	33589	33597	O	-1	-1	0
stroke	PMC4064952	33598	33604	O	-1	-1	0
and	PMC4064952	33605	33608	O	-1	-1	0
anticoagulation	PMC4064952	33609	33624	O	-1	-1	0
therapy	PMC4064952	33625	33632	O	-1	-1	0
among	PMC4064952	33633	33638	O	-1	-1	0
Medicare	PMC4064952	33639	33647	O	-1	-1	0
patients	PMC4064952	33648	33656	O	-1	-1	0
with	PMC4064952	33657	33661	O	-1	-1	0
atrial	PMC4064952	33662	33668	O	-1	-1	0
fibrillation	PMC4064952	33669	33681	O	-1	-1	0
:	PMC4064952	33681	33682	O	-1	-1	0
a	PMC4064952	33683	33684	O	-1	-1	0
15-year	PMC4064952	33685	33692	O	-1	-1	0
perspective	PMC4064952	33693	33704	O	-1	-1	0
(	PMC4064952	33705	33706	O	-1	-1	0
1992–2007	PMC4064952	33706	33715	O	-1	-1	0
)	PMC4064952	33715	33716	O	-1	-1	0
.	PMC4064952	33716	33717	O	-1	-1	0

JAMA	PMC4064952	33718	33722	O	-1	-1	0
Intern	PMC4064952	33723	33729	O	-1	-1	0
Med	PMC4064952	33730	33733	O	-1	-1	0
.	PMC4064952	33733	33734	O	-1	-1	0

2013;173:159–160	PMC4064952	33735	33751	O	-1	-1	0
.	PMC4064952	33751	33752	O	-1	-1	0

36	PMC4064952	33753	33755	O	-1	-1	0
.	PMC4064952	33755	33756	O	-1	-1	0

Friberg	PMC4064952	33757	33764	O	-1	-1	0
L	PMC4064952	33765	33766	O	-1	-1	0
,	PMC4064952	33766	33767	O	-1	-1	0
Rosenqvist	PMC4064952	33768	33778	O	-1	-1	0
M	PMC4064952	33779	33780	O	-1	-1	0
,	PMC4064952	33780	33781	O	-1	-1	0
Lip	PMC4064952	33782	33785	O	-1	-1	0
GYH	PMC4064952	33786	33789	O	-1	-1	0
.	PMC4064952	33789	33790	O	-1	-1	0

Net	PMC4064952	33791	33794	O	-1	-1	0
clinical	PMC4064952	33795	33803	O	-1	-1	0
benefit	PMC4064952	33804	33811	O	-1	-1	0
of	PMC4064952	33812	33814	O	-1	-1	0
warfarin	PMC4064952	33815	33823	O	-1	-1	0
use	PMC4064952	33824	33827	O	-1	-1	0
in	PMC4064952	33828	33830	O	-1	-1	0
patients	PMC4064952	33831	33839	O	-1	-1	0
with	PMC4064952	33840	33844	O	-1	-1	0
atrial	PMC4064952	33845	33851	O	-1	-1	0
fibrillation	PMC4064952	33852	33864	O	-1	-1	0
:	PMC4064952	33864	33865	O	-1	-1	0
a	PMC4064952	33866	33867	O	-1	-1	0
report	PMC4064952	33868	33874	O	-1	-1	0
of	PMC4064952	33875	33877	O	-1	-1	0
the	PMC4064952	33878	33881	O	-1	-1	0
Swedish	PMC4064952	33882	33889	O	-1	-1	0
Atrial	PMC4064952	33890	33896	O	-1	-1	0
Fibrillation	PMC4064952	33897	33909	O	-1	-1	0
Cohort	PMC4064952	33910	33916	O	-1	-1	0
Study	PMC4064952	33917	33922	O	-1	-1	0
.	PMC4064952	33922	33923	O	-1	-1	0

Circulation	PMC4064952	33924	33935	O	-1	-1	0
.	PMC4064952	33935	33936	O	-1	-1	0

2012;125:2298–2307	PMC4064952	33937	33955	O	-1	-1	0
.	PMC4064952	33955	33956	O	-1	-1	0

37	PMC4064952	33957	33959	O	-1	-1	0
.	PMC4064952	33959	33960	O	-1	-1	0

Cotté	PMC4064952	33961	33966	O	-1	-1	0
FE	PMC4064952	33967	33969	O	-1	-1	0
,	PMC4064952	33969	33970	O	-1	-1	0
Chaize	PMC4064952	33971	33977	O	-1	-1	0
G	PMC4064952	33978	33979	O	-1	-1	0
,	PMC4064952	33979	33980	O	-1	-1	0
Kachaner	PMC4064952	33981	33989	O	-1	-1	0
I	PMC4064952	33990	33991	O	-1	-1	0
,	PMC4064952	33991	33992	O	-1	-1	0
Gaudin	PMC4064952	33993	33999	O	-1	-1	0
AF	PMC4064952	34000	34002	O	-1	-1	0
,	PMC4064952	34002	34003	O	-1	-1	0
Vainchtock	PMC4064952	34004	34014	O	-1	-1	0
A	PMC4064952	34015	34016	O	-1	-1	0
,	PMC4064952	34016	34017	O	-1	-1	0
Durand	PMC4064952	34018	34024	O	-1	-1	0
-	PMC4064952	34024	34025	O	-1	-1	0
Zaleski	PMC4064952	34025	34032	O	-1	-1	0
L.	PMC4064952	34033	34035	O	-1	-1	0
Incidence	PMC4064952	34036	34045	O	-1	-1	0
and	PMC4064952	34046	34049	O	-1	-1	0
cost	PMC4064952	34050	34054	O	-1	-1	0
of	PMC4064952	34055	34057	O	-1	-1	0
stroke	PMC4064952	34058	34064	O	-1	-1	0
and	PMC4064952	34065	34068	O	-1	-1	0
haemorrhage	PMC4064952	34069	34080	O	-1	-1	0
in	PMC4064952	34081	34083	O	-1	-1	0
patients	PMC4064952	34084	34092	O	-1	-1	0
diagnosed	PMC4064952	34093	34102	O	-1	-1	0
with	PMC4064952	34103	34107	O	-1	-1	0
atrial	PMC4064952	34108	34114	O	-1	-1	0
fibrillation	PMC4064952	34115	34127	O	-1	-1	0
.	PMC4064952	34127	34128	O	-1	-1	0

J	PMC4064952	34129	34130	O	-1	-1	0
Stroke	PMC4064952	34131	34137	O	-1	-1	0
Cerebrovasc	PMC4064952	34138	34149	O	-1	-1	0
Dis	PMC4064952	34150	34153	O	-1	-1	0
.	PMC4064952	34153	34154	O	-1	-1	0

2014;23:73–83	PMC4064952	34155	34168	O	-1	-1	0
.	PMC4064952	34168	34169	O	-1	-1	0

38	PMC4064952	34170	34172	O	-1	-1	0
.	PMC4064952	34172	34173	O	-1	-1	0

Ott	PMC4064952	34174	34177	O	-1	-1	0
AO	PMC4064952	34178	34180	O	-1	-1	0
,	PMC4064952	34180	34181	O	-1	-1	0
Breteler	PMC4064952	34182	34190	O	-1	-1	0
MM	PMC4064952	34191	34193	O	-1	-1	0
,	PMC4064952	34193	34194	O	-1	-1	0
de	PMC4064952	34195	34197	O	-1	-1	0
Bruyne	PMC4064952	34198	34204	O	-1	-1	0
MC	PMC4064952	34205	34207	O	-1	-1	0
,	PMC4064952	34207	34208	O	-1	-1	0
van	PMC4064952	34209	34212	O	-1	-1	0
Harskamp	PMC4064952	34213	34221	O	-1	-1	0
F	PMC4064952	34222	34223	O	-1	-1	0
,	PMC4064952	34223	34224	O	-1	-1	0
Grobbee	PMC4064952	34225	34232	O	-1	-1	0
DE	PMC4064952	34233	34235	O	-1	-1	0
,	PMC4064952	34235	34236	O	-1	-1	0
Hoffman	PMC4064952	34237	34244	O	-1	-1	0
A.	PMC4064952	34245	34247	O	-1	-1	0
Atrial	PMC4064952	34248	34254	O	-1	-1	0
fibrillation	PMC4064952	34255	34267	O	-1	-1	0
and	PMC4064952	34268	34271	O	-1	-1	0
dementia	PMC4064952	34272	34280	O	-1	-1	0
in	PMC4064952	34281	34283	O	-1	-1	0
a	PMC4064952	34284	34285	O	-1	-1	0
population	PMC4064952	34286	34296	O	-1	-1	0
-	PMC4064952	34296	34297	O	-1	-1	0
based	PMC4064952	34297	34302	O	-1	-1	0
study	PMC4064952	34303	34308	O	-1	-1	0
.	PMC4064952	34308	34309	O	-1	-1	0

Stroke	PMC4064952	34310	34316	O	-1	-1	0
.	PMC4064952	34316	34317	O	-1	-1	0

1997;28:316–321	PMC4064952	34318	34333	O	-1	-1	0
.	PMC4064952	34333	34334	O	-1	-1	0

39	PMC4064952	34335	34337	O	-1	-1	0
.	PMC4064952	34337	34338	O	-1	-1	0

Cha	PMC4064952	34339	34342	O	-1	-1	0
MJ	PMC4064952	34343	34345	O	-1	-1	0
,	PMC4064952	34345	34346	O	-1	-1	0
Park	PMC4064952	34347	34351	O	-1	-1	0
H	PMC4064952	34352	34353	O	-1	-1	0
,	PMC4064952	34353	34354	O	-1	-1	0
Lee	PMC4064952	34355	34358	O	-1	-1	0
MH	PMC4064952	34359	34361	O	-1	-1	0
,	PMC4064952	34361	34362	O	-1	-1	0
ChoY	PMC4064952	34363	34367	O	-1	-1	0
,	PMC4064952	34367	34368	O	-1	-1	0
Choi	PMC4064952	34369	34373	O	-1	-1	0
EK	PMC4064952	34374	34376	O	-1	-1	0
,	PMC4064952	34376	34377	O	-1	-1	0
Oh	PMC4064952	34378	34380	O	-1	-1	0
S.	PMC4064952	34381	34383	O	-1	-1	0
Prevalence	PMC4064952	34384	34394	O	-1	-1	0
and	PMC4064952	34395	34398	O	-1	-1	0
risk	PMC4064952	34399	34403	O	-1	-1	0

factors	PMC4064952	34404	34411	O	-1	-1	0
for	PMC4064952	34412	34415	O	-1	-1	0
silent	PMC4064952	34416	34422	O	-1	-1	0
ischemic	PMC4064952	34423	34431	O	-1	-1	0
stroke	PMC4064952	34432	34438	O	-1	-1	0
in	PMC4064952	34439	34441	O	-1	-1	0
patients	PMC4064952	34442	34450	O	-1	-1	0
with	PMC4064952	34451	34455	O	-1	-1	0
atrial	PMC4064952	34456	34462	O	-1	-1	0
fibrillation	PMC4064952	34463	34475	O	-1	-1	0
as	PMC4064952	34476	34478	O	-1	-1	0
determined	PMC4064952	34479	34489	O	-1	-1	0
by	PMC4064952	34490	34492	O	-1	-1	0
brain	PMC4064952	34493	34498	O	-1	-1	0
magnetic	PMC4064952	34499	34507	O	-1	-1	0
resonance	PMC4064952	34508	34517	O	-1	-1	0
imaging	PMC4064952	34518	34525	O	-1	-1	0
.	PMC4064952	34525	34526	O	-1	-1	0

Am	PMC4064952	34527	34529	O	-1	-1	0
J	PMC4064952	34530	34531	O	-1	-1	0
Cardiol	PMC4064952	34532	34539	O	-1	-1	0
.	PMC4064952	34539	34540	O	-1	-1	0
2014;113:656–661	PMC4064952	34541	34557	O	-1	-1	0
.	PMC4064952	34557	34558	O	-1	-1	0

40	PMC4064952	34559	34561	O	-1	-1	0
.	PMC4064952	34561	34562	O	-1	-1	0

Anter	PMC4064952	34563	34568	O	-1	-1	0
E	PMC4064952	34569	34570	O	-1	-1	0
,	PMC4064952	34570	34571	O	-1	-1	0
Jessup	PMC4064952	34572	34578	O	-1	-1	0
M	PMC4064952	34579	34580	O	-1	-1	0
,	PMC4064952	34580	34581	O	-1	-1	0
Callans	PMC4064952	34582	34589	O	-1	-1	0
DJ	PMC4064952	34590	34592	O	-1	-1	0
.	PMC4064952	34592	34593	O	-1	-1	0

Atrial	PMC4064952	34594	34600	O	-1	-1	0
fibrillation	PMC4064952	34601	34613	O	-1	-1	0
and	PMC4064952	34614	34617	O	-1	-1	0
heart	PMC4064952	34618	34623	O	-1	-1	0
­	PMC4064952	34624	34625	O	-1	-1	0
failure	PMC4064952	34626	34633	O	-1	-1	0
:	PMC4064952	34633	34634	O	-1	-1	0
treatment	PMC4064952	34635	34644	O	-1	-1	0
considerations	PMC4064952	34645	34659	O	-1	-1	0
for	PMC4064952	34660	34663	O	-1	-1	0
a	PMC4064952	34664	34665	O	-1	-1	0
dual	PMC4064952	34666	34670	O	-1	-1	0
epidemic	PMC4064952	34671	34679	O	-1	-1	0
.	PMC4064952	34679	34680	O	-1	-1	0

Circulation	PMC4064952	34681	34692	O	-1	-1	0
.	PMC4064952	34692	34693	O	-1	-1	0

2009;119	PMC4064952	34694	34702	O	-1	-1	0
:	PMC4064952	34702	34703	O	-1	-1	0

2516–2525	PMC4064952	34704	34713	O	-1	-1	0
.	PMC4064952	34713	34714	O	-1	-1	0

41	PMC4064952	34715	34717	O	-1	-1	0
.	PMC4064952	34717	34718	O	-1	-1	0

WangTJ	PMC4064952	34719	34725	O	-1	-1	0
,	PMC4064952	34725	34726	O	-1	-1	0
LarsonMG	PMC4064952	34726	34734	O	-1	-1	0
,	PMC4064952	34734	34735	O	-1	-1	0
LevyD	PMC4064952	34735	34740	O	-1	-1	0
,	PMC4064952	34740	34741	O	-1	-1	0
et	PMC4064952	34741	34743	O	-1	-1	0
al	PMC4064952	34744	34746	O	-1	-1	0
.	PMC4064952	34746	34747	O	-1	-1	0

Temporalrelationsofatrial	PMC4064952	34747	34772	O	-1	-1	0
­	PMC4064952	34773	34774	O	-1	-1	0
fibrillation	PMC4064952	34775	34787	O	-1	-1	0
and	PMC4064952	34788	34791	O	-1	-1	0
congestive	PMC4064952	34792	34802	O	-1	-1	0
heart	PMC4064952	34803	34808	O	-1	-1	0
failure	PMC4064952	34809	34816	O	-1	-1	0
and	PMC4064952	34817	34820	O	-1	-1	0
their	PMC4064952	34821	34826	O	-1	-1	0
joint	PMC4064952	34827	34832	O	-1	-1	0
influence	PMC4064952	34833	34842	O	-1	-1	0
on	PMC4064952	34843	34845	O	-1	-1	0
mortality	PMC4064952	34846	34855	O	-1	-1	0
:	PMC4064952	34855	34856	O	-1	-1	0
the	PMC4064952	34857	34860	O	-1	-1	0
Framingham	PMC4064952	34861	34871	O	-1	-1	0
Heart	PMC4064952	34872	34877	O	-1	-1	0
Study	PMC4064952	34878	34883	O	-1	-1	0
.	PMC4064952	34883	34884	O	-1	-1	0

Circulation	PMC4064952	34885	34896	O	-1	-1	0
.	PMC4064952	34896	34897	O	-1	-1	0

2003;107:2920–2925	PMC4064952	34898	34916	O	-1	-1	0
.	PMC4064952	34916	34917	O	-1	-1	0

42	PMC4064952	34918	34920	O	-1	-1	0
.	PMC4064952	34920	34921	O	-1	-1	0

Mountantonakis	PMC4064952	34922	34936	O	-1	-1	0
SE	PMC4064952	34937	34939	O	-1	-1	0
,	PMC4064952	34939	34940	O	-1	-1	0
Grau	PMC4064952	34941	34945	O	-1	-1	0
-	PMC4064952	34945	34946	O	-1	-1	0
Sepulveda	PMC4064952	34946	34955	O	-1	-1	0
MV	PMC4064952	34956	34958	O	-1	-1	0
,	PMC4064952	34959	34960	O	-1	-1	0
Bhatt	PMC4064952	34961	34966	O	-1	-1	0
DL	PMC4064952	34967	34969	O	-1	-1	0
,	PMC4064952	34969	34970	O	-1	-1	0
Hernandez	PMC4064952	34971	34980	O	-1	-1	0
AF	PMC4064952	34981	34983	O	-1	-1	0
,	PMC4064952	34983	34984	O	-1	-1	0

Peterson	PMC4064952	34985	34993	O	-1	-1	0
ED	PMC4064952	34994	34996	O	-1	-1	0
,	PMC4064952	34996	34997	O	-1	-1	0
Fonarow	PMC4064952	34998	35005	O	-1	-1	0
GC	PMC4064952	35006	35008	O	-1	-1	0
.	PMC4064952	35008	35009	O	-1	-1	0

Presence	PMC4064952	35010	35018	O	-1	-1	0
of	PMC4064952	35019	35021	O	-1	-1	0
atrial	PMC4064952	35022	35028	O	-1	-1	0
fibrillation	PMC4064952	35029	35041	O	-1	-1	0
is	PMC4064952	35042	35044	O	-1	-1	0
­	PMC4064952	35045	35046	O	-1	-1	0
independently	PMC4064952	35047	35060	O	-1	-1	0
associated	PMC4064952	35061	35071	O	-1	-1	0
with	PMC4064952	35072	35076	O	-1	-1	0
adverse	PMC4064952	35077	35084	O	-1	-1	0
outcomes	PMC4064952	35085	35093	O	-1	-1	0
in	PMC4064952	35094	35096	O	-1	-1	0
patients	PMC4064952	35097	35105	O	-1	-1	0
hospitalized	PMC4064952	35106	35118	O	-1	-1	0
with	PMC4064952	35119	35123	O	-1	-1	0
heart	PMC4064952	35124	35129	O	-1	-1	0
failure	PMC4064952	35130	35137	O	-1	-1	0
:	PMC4064952	35137	35138	O	-1	-1	0
an	PMC4064952	35139	35141	O	-1	-1	0
analysis	PMC4064952	35142	35150	O	-1	-1	0
of	PMC4064952	35151	35153	O	-1	-1	0
Get	PMC4064952	35154	35157	O	-1	-1	0
with	PMC4064952	35158	35162	O	-1	-1	0
the	PMC4064952	35163	35166	O	-1	-1	0
Guidelines	PMC4064952	35167	35177	O	-1	-1	0
–	PMC4064952	35178	35179	O	-1	-1	0
Heart	PMC4064952	35180	35185	O	-1	-1	0
Failure	PMC4064952	35186	35193	O	-1	-1	0
.	PMC4064952	35193	35194	O	-1	-1	0

Circ	PMC4064952	35195	35199	O	-1	-1	0

Heart	PMC4064952	35200	35205	O	-1	-1	0
Fail	PMC4064952	35206	35210	O	-1	-1	0
.	PMC4064952	35210	35211	O	-1	-1	0

2012;5:191–201	PMC4064952	35212	35226	O	-1	-1	0
.	PMC4064952	35226	35227	O	-1	-1	0

43	PMC4064952	35228	35230	O	-1	-1	0
.	PMC4064952	35230	35231	O	-1	-1	0

Chamberlain	PMC4064952	35232	35243	O	-1	-1	0
AM	PMC4064952	35244	35246	O	-1	-1	0
,	PMC4064952	35246	35247	O	-1	-1	0
Redfield	PMC4064952	35248	35256	O	-1	-1	0
MM	PMC4064952	35257	35259	O	-1	-1	0
,	PMC4064952	35259	35260	O	-1	-1	0
Alonso	PMC4064952	35261	35267	O	-1	-1	0
A	PMC4064952	35268	35269	O	-1	-1	0
,	PMC4064952	35269	35270	O	-1	-1	0
Weston	PMC4064952	35271	35277	O	-1	-1	0
SA	PMC4064952	35278	35280	O	-1	-1	0
,	PMC4064952	35280	35281	O	-1	-1	0
Roger	PMC4064952	35282	35287	O	-1	-1	0
VL	PMC4064952	35288	35290	O	-1	-1	0
.	PMC4064952	35290	35291	O	-1	-1	0
Atrial	PMC4064952	35292	35298	O	-1	-1	0
fibrillation	PMC4064952	35299	35311	O	-1	-1	0
and	PMC4064952	35312	35315	O	-1	-1	0
mortality	PMC4064952	35316	35325	O	-1	-1	0
in	PMC4064952	35326	35328	O	-1	-1	0
heart	PMC4064952	35329	35334	O	-1	-1	0
failure	PMC4064952	35335	35342	O	-1	-1	0
:	PMC4064952	35342	35343	O	-1	-1	0
a	PMC4064952	35344	35345	O	-1	-1	0
community	PMC4064952	35346	35355	O	-1	-1	0
study	PMC4064952	35356	35361	O	-1	-1	0
.	PMC4064952	35361	35362	O	-1	-1	0
Circ	PMC4064952	35363	35367	O	-1	-1	0
Heart	PMC4064952	35368	35373	O	-1	-1	0
Fail	PMC4064952	35374	35378	O	-1	-1	0
.	PMC4064952	35378	35379	O	-1	-1	0

2011;4:740–746	PMC4064952	35380	35394	O	-1	-1	0
.	PMC4064952	35394	35395	O	-1	-1	0

44	PMC4064952	35396	35398	O	-1	-1	0
.	PMC4064952	35398	35399	O	-1	-1	0

Andersson	PMC4064952	35400	35409	O	-1	-1	0
T	PMC4064952	35410	35411	O	-1	-1	0
,	PMC4064952	35411	35412	O	-1	-1	0
Magnuson	PMC4064952	35413	35421	O	-1	-1	0
A	PMC4064952	35422	35423	O	-1	-1	0
,	PMC4064952	35423	35424	O	-1	-1	0
Bryngelson	PMC4064952	35425	35435	O	-1	-1	0
IL	PMC4064952	35436	35438	O	-1	-1	0
,	PMC4064952	35438	35439	O	-1	-1	0
et	PMC4064952	35440	35442	O	-1	-1	0
al	PMC4064952	35443	35445	O	-1	-1	0
.	PMC4064952	35445	35446	O	-1	-1	0

All	PMC4064952	35447	35450	O	-1	-1	0
cause	PMC4064952	35451	35456	O	-1	-1	0
mortality	PMC4064952	35457	35466	O	-1	-1	0
in	PMC4064952	35467	35469	O	-1	-1	0
272186	PMC4064952	35470	35476	O	-1	-1	0
patients	PMC4064952	35477	35485	O	-1	-1	0
hospitalized	PMC4064952	35486	35498	O	-1	-1	0
with	PMC4064952	35499	35503	O	-1	-1	0
incident	PMC4064952	35504	35512	O	-1	-1	0
atrial	PMC4064952	35513	35519	O	-1	-1	0
fibrillation1995–2008	PMC4064952	35520	35541	O	-1	-1	0
:	PMC4064952	35541	35542	O	-1	-1	0
a	PMC4064952	35543	35544	O	-1	-1	0
Swedish	PMC4064952	35545	35552	O	-1	-1	0
nationwide	PMC4064952	35553	35563	O	-1	-1	0
long	PMC4064952	35564	35568	O	-1	-1	0
-	PMC4064952	35568	35569	O	-1	-1	0
term	PMC4064952	35569	35573	O	-1	-1	0
case	PMC4064952	35574	35578	O	-1	-1	0
-	PMC4064952	35578	35579	O	-1	-1	0
control	PMC4064952	35579	35586	O	-1	-1	0
study	PMC4064952	35587	35592	O	-1	-1	0
.	PMC4064952	35592	35593	O	-1	-1	0

Eur	PMC4064952	35594	35597	O	-1	-1	0
Heart	PMC4064952	35598	35603	O	-1	-1	0
J.	PMC4064952	35604	35606	O	-1	-1	0

2013;34:1061–1067	PMC4064952	35607	35624	O	-1	-1	0
.	PMC4064952	35624	35625	O	-1	-1	0

45	PMC4064952	35626	35628	O	-1	-1	0
.	PMC4064952	35628	35629	O	-1	-1	0

Myasaka	PMC4064952	35630	35637	O	-1	-1	0
Y	PMC4064952	35638	35639	O	-1	-1	0
,	PMC4064952	35639	35640	O	-1	-1	0
Barnes	PMC4064952	35641	35647	O	-1	-1	0
ME	PMC4064952	35648	35650	O	-1	-1	0
,	PMC4064952	35650	35651	O	-1	-1	0
Bailey	PMC4064952	35652	35658	O	-1	-1	0
KR	PMC4064952	35659	35661	O	-1	-1	0
,	PMC4064952	35661	35662	O	-1	-1	0
et	PMC4064952	35663	35665	O	-1	-1	0
al	PMC4064952	35666	35668	O	-1	-1	0
.	PMC4064952	35668	35669	O	-1	-1	0

Mortality	PMC4064952	35670	35679	O	-1	-1	0
trends	PMC4064952	35680	35686	O	-1	-1	0
in	PMC4064952	35687	35689	O	-1	-1	0
patients	PMC4064952	35690	35698	O	-1	-1	0

diagnosed	PMC4064952	35699	35708	O	-1	-1	0
with	PMC4064952	35709	35713	O	-1	-1	0
first	PMC4064952	35714	35719	O	-1	-1	0
atrial	PMC4064952	35720	35726	O	-1	-1	0
fibrillation	PMC4064952	35727	35739	O	-1	-1	0
:	PMC4064952	35739	35740	O	-1	-1	0
a	PMC4064952	35741	35742	O	-1	-1	0
21-year	PMC4064952	35743	35750	O	-1	-1	0
community	PMC4064952	35751	35760	O	-1	-1	0
-	PMC4064952	35760	35761	O	-1	-1	0
based	PMC4064952	35761	35766	O	-1	-1	0
study	PMC4064952	35767	35772	O	-1	-1	0
.	PMC4064952	35772	35773	O	-1	-1	0

J	PMC4064952	35774	35775	O	-1	-1	0
Am	PMC4064952	35776	35778	O	-1	-1	0
Coll	PMC4064952	35779	35783	O	-1	-1	0
Cardiol	PMC4064952	35784	35791	O	-1	-1	0
.	PMC4064952	35791	35792	O	-1	-1	0

2007;49:986–992	PMC4064952	35793	35808	O	-1	-1	0
.	PMC4064952	35808	35809	O	-1	-1	0

46	PMC4064952	35810	35812	O	-1	-1	0
.	PMC4064952	35812	35813	O	-1	-1	0

Conen	PMC4064952	35814	35819	O	-1	-1	0
D	PMC4064952	35820	35821	O	-1	-1	0
,	PMC4064952	35821	35822	O	-1	-1	0
Chae	PMC4064952	35823	35827	O	-1	-1	0
CU	PMC4064952	35828	35830	O	-1	-1	0
,	PMC4064952	35830	35831	O	-1	-1	0
Glynn	PMC4064952	35832	35837	O	-1	-1	0
RJ	PMC4064952	35838	35840	O	-1	-1	0
,	PMC4064952	35840	35841	O	-1	-1	0
et	PMC4064952	35842	35844	O	-1	-1	0
al	PMC4064952	35845	35847	O	-1	-1	0
.	PMC4064952	35847	35848	O	-1	-1	0

Risk	PMC4064952	35849	35853	O	-1	-1	0
of	PMC4064952	35854	35856	O	-1	-1	0
death	PMC4064952	35857	35862	O	-1	-1	0
and	PMC4064952	35863	35866	O	-1	-1	0
cardiovascular	PMC4064952	35867	35881	O	-1	-1	0
events	PMC4064952	35882	35888	O	-1	-1	0
in	PMC4064952	35889	35891	O	-1	-1	0
initially	PMC4064952	35892	35901	O	-1	-1	0
healthy	PMC4064952	35902	35909	O	-1	-1	0
women	PMC4064952	35910	35915	O	-1	-1	0
with	PMC4064952	35916	35920	O	-1	-1	0
new	PMC4064952	35921	35924	O	-1	-1	0
-	PMC4064952	35924	35925	O	-1	-1	0
onset	PMC4064952	35925	35930	O	-1	-1	0
atrial	PMC4064952	35931	35937	O	-1	-1	0
fibrillation	PMC4064952	35938	35950	O	-1	-1	0
.	PMC4064952	35950	35951	O	-1	-1	0
JAMA	PMC4064952	35952	35956	O	-1	-1	0
.	PMC4064952	35956	35957	O	-1	-1	0

2011;305:2080–2087	PMC4064952	35958	35976	O	-1	-1	0
.	PMC4064952	35976	35977	O	-1	-1	0

47	PMC4064952	35978	35980	O	-1	-1	0
.	PMC4064952	35980	35981	O	-1	-1	0

Benerjee	PMC4064952	35982	35990	O	-1	-1	0
A	PMC4064952	35991	35992	O	-1	-1	0
,	PMC4064952	35992	35993	O	-1	-1	0
Taillandier	PMC4064952	35994	36005	O	-1	-1	0
S	PMC4064952	36006	36007	O	-1	-1	0
,	PMC4064952	36007	36008	O	-1	-1	0
Olesen	PMC4064952	36009	36015	O	-1	-1	0
JB	PMC4064952	36016	36018	O	-1	-1	0
,	PMC4064952	36018	36019	O	-1	-1	0
et	PMC4064952	36020	36022	O	-1	-1	0
al	PMC4064952	36023	36025	O	-1	-1	0
.	PMC4064952	36025	36026	O	-1	-1	0

Pattern	PMC4064952	36027	36034	O	-1	-1	0
of	PMC4064952	36035	36037	O	-1	-1	0
atrial	PMC4064952	36038	36044	O	-1	-1	0
fibrillation	PMC4064952	36045	36057	O	-1	-1	0
and	PMC4064952	36058	36061	O	-1	-1	0
risk	PMC4064952	36062	36066	O	-1	-1	0
of	PMC4064952	36067	36069	O	-1	-1	0
outcomes	PMC4064952	36070	36078	O	-1	-1	0
:	PMC4064952	36078	36079	O	-1	-1	0
the	PMC4064952	36080	36083	O	-1	-1	0
Loire	PMC4064952	36084	36089	O	-1	-1	0
Valley	PMC4064952	36090	36096	O	-1	-1	0
Atrial	PMC4064952	36097	36103	O	-1	-1	0
Fibrillation	PMC4064952	36104	36116	O	-1	-1	0
Project	PMC4064952	36117	36124	O	-1	-1	0
.	PMC4064952	36124	36125	O	-1	-1	0

Int	PMC4064952	36126	36129	O	-1	-1	0
J	PMC4064952	36130	36131	O	-1	-1	0
Cardiol	PMC4064952	36132	36139	O	-1	-1	0
.	PMC4064952	36139	36140	O	-1	-1	0

2013;167:2682–2687	PMC4064952	36141	36159	O	-1	-1	0
.	PMC4064952	36159	36160	O	-1	-1	0

48	PMC4064952	36161	36163	O	-1	-1	0
.	PMC4064952	36163	36164	O	-1	-1	0

Krijthe	PMC4064952	36165	36172	O	-1	-1	0
BP	PMC4064952	36173	36175	O	-1	-1	0
,	PMC4064952	36175	36176	O	-1	-1	0
Kunst	PMC4064952	36177	36182	O	-1	-1	0
A	PMC4064952	36183	36184	O	-1	-1	0
,	PMC4064952	36184	36185	O	-1	-1	0
Benjamin	PMC4064952	36186	36194	O	-1	-1	0
EJ	PMC4064952	36195	36197	O	-1	-1	0
,	PMC4064952	36197	36198	O	-1	-1	0
et	PMC4064952	36199	36201	O	-1	-1	0
al	PMC4064952	36202	36204	O	-1	-1	0
.	PMC4064952	36204	36205	O	-1	-1	0

Projections	PMC4064952	36206	36217	O	-1	-1	0
of	PMC4064952	36218	36220	O	-1	-1	0
the	PMC4064952	36221	36224	O	-1	-1	0
number	PMC4064952	36225	36231	O	-1	-1	0
of	PMC4064952	36232	36234	O	-1	-1	0
individuals	PMC4064952	36235	36246	O	-1	-1	0
with	PMC4064952	36247	36251	O	-1	-1	0
atrial	PMC4064952	36252	36258	O	-1	-1	0
fibrillation	PMC4064952	36259	36271	O	-1	-1	0
in	PMC4064952	36272	36274	O	-1	-1	0
the	PMC4064952	36275	36278	O	-1	-1	0
European	PMC4064952	36279	36287	O	-1	-1	0
Union	PMC4064952	36288	36293	O	-1	-1	0
from	PMC4064952	36294	36298	O	-1	-1	0
2000	PMC4064952	36299	36303	O	-1	-1	0
to	PMC4064952	36304	36306	O	-1	-1	0
2060	PMC4064952	36307	36311	O	-1	-1	0
.	PMC4064952	36311	36312	O	-1	-1	0

Eur	PMC4064952	36313	36316	O	-1	-1	0
Heart	PMC4064952	36317	36322	O	-1	-1	0
J.	PMC4064952	36323	36325	O	-1	-1	0
2013;34:2746–2751	PMC4064952	36326	36343	O	-1	-1	0
.	PMC4064952	36343	36344	O	-1	-1	0

Clinical	PMC4064952	36345	36353	O	-1	-1	0
Epidemiology	PMC4064952	36354	36366	O	-1	-1	0
Publish	PMC4064952	36367	36374	O	-1	-1	0
your	PMC4064952	36375	36379	O	-1	-1	0
work	PMC4064952	36380	36384	O	-1	-1	0
in	PMC4064952	36385	36387	O	-1	-1	0
this	PMC4064952	36388	36392	O	-1	-1	0
journal	PMC4064952	36393	36400	O	-1	-1	0

Submit	PMC4064952	36401	36407	O	-1	-1	0
your	PMC4064952	36408	36412	O	-1	-1	0
manuscript	PMC4064952	36413	36423	O	-1	-1	0
here	PMC4064952	36424	36428	O	-1	-1	0
:	PMC4064952	36428	36429	O	-1	-1	0

http://www.dovepress.com/clinical-epidemiology-journal	PMC4064952	36430	36484	O	-1	-1	0

Clinical	PMC4064952	36485	36493	O	-1	-1	0
Epidemiology	PMC4064952	36494	36506	O	-1	-1	0
is	PMC4064952	36507	36509	O	-1	-1	0
an	PMC4064952	36510	36512	O	-1	-1	0
international	PMC4064952	36513	36526	O	-1	-1	0
,	PMC4064952	36526	36527	O	-1	-1	0
peer	PMC4064952	36528	36532	O	-1	-1	0
-	PMC4064952	36532	36533	O	-1	-1	0
reviewed	PMC4064952	36533	36541	O	-1	-1	0
,	PMC4064952	36541	36542	O	-1	-1	0
open	PMC4064952	36543	36547	O	-1	-1	0
access	PMC4064952	36548	36554	O	-1	-1	0
journal	PMC4064952	36555	36562	O	-1	-1	0
focusing	PMC4064952	36563	36571	O	-1	-1	0
on	PMC4064952	36572	36574	O	-1	-1	0
disease	PMC4064952	36575	36582	O	-1	-1	0
and	PMC4064952	36583	36586	O	-1	-1	0
drug	PMC4064952	36587	36591	O	-1	-1	0
epidemiology	PMC4064952	36592	36604	O	-1	-1	0
,	PMC4064952	36604	36605	O	-1	-1	0
identification	PMC4064952	36606	36620	O	-1	-1	0
of	PMC4064952	36621	36623	O	-1	-1	0
risk	PMC4064952	36624	36628	O	-1	-1	0
factors	PMC4064952	36629	36636	O	-1	-1	0
and	PMC4064952	36637	36640	O	-1	-1	0
screening	PMC4064952	36641	36650	O	-1	-1	0
procedures	PMC4064952	36651	36661	O	-1	-1	0
to	PMC4064952	36662	36664	O	-1	-1	0
develop	PMC4064952	36665	36672	O	-1	-1	0
optimal	PMC4064952	36673	36680	O	-1	-1	0
preventative	PMC4064952	36681	36693	O	-1	-1	0
initiatives	PMC4064952	36694	36705	O	-1	-1	0
and	PMC4064952	36706	36709	O	-1	-1	0
programs	PMC4064952	36710	36718	O	-1	-1	0
.	PMC4064952	36718	36719	O	-1	-1	0

Specific	PMC4064952	36720	36728	O	-1	-1	0
topics	PMC4064952	36729	36735	O	-1	-1	0
include	PMC4064952	36736	36743	O	-1	-1	0
:	PMC4064952	36743	36744	O	-1	-1	0
diagnosis	PMC4064952	36745	36754	O	-1	-1	0
,	PMC4064952	36754	36755	O	-1	-1	0
prognosis	PMC4064952	36756	36765	O	-1	-1	0
,	PMC4064952	36765	36766	O	-1	-1	0
treatment	PMC4064952	36767	36776	O	-1	-1	0
,	PMC4064952	36776	36777	O	-1	-1	0
screening	PMC4064952	36778	36787	O	-1	-1	0
,	PMC4064952	36787	36788	O	-1	-1	0
prevention	PMC4064952	36789	36799	O	-1	-1	0
,	PMC4064952	36799	36800	O	-1	-1	0
risk	PMC4064952	36801	36805	O	-1	-1	0
factor	PMC4064952	36806	36812	O	-1	-1	0
modification	PMC4064952	36813	36825	O	-1	-1	0
,	PMC4064952	36825	36826	O	-1	-1	0
systematic	PMC4064952	36827	36837	O	-1	-1	0
reviews	PMC4064952	36838	36845	O	-1	-1	0
,	PMC4064952	36845	36846	O	-1	-1	0
risk	PMC4064952	36847	36851	O	-1	-1	0
&	PMC4064952	36852	36853	O	-1	-1	0
safety	PMC4064952	36854	36860	O	-1	-1	0
of	PMC4064952	36861	36863	O	-1	-1	0
medical	PMC4064952	36864	36871	O	-1	-1	0
interventions	PMC4064952	36872	36885	O	-1	-1	0
,	PMC4064952	36885	36886	O	-1	-1	0
epidemiology	PMC4064952	36887	36899	O	-1	-1	0
&	PMC4064952	36900	36901	O	-1	-1	0
bio-	PMC4064952	36902	36906	O	-1	-1	0
statical	PMC4064952	36907	36915	O	-1	-1	0
methods	PMC4064952	36916	36923	O	-1	-1	0
,	PMC4064952	36923	36924	O	-1	-1	0
evaluation	PMC4064952	36925	36935	O	-1	-1	0
of	PMC4064952	36936	36938	O	-1	-1	0
guidelines	PMC4064952	36939	36949	O	-1	-1	0
,	PMC4064952	36949	36950	O	-1	-1	0
translational	PMC4064952	36951	36964	O	-1	-1	0
medicine	PMC4064952	36965	36973	O	-1	-1	0
,	PMC4064952	36973	36974	O	-1	-1	0
health	PMC4064952	36975	36981	O	-1	-1	0
policies	PMC4064952	36982	36990	O	-1	-1	0
&	PMC4064952	36991	36992	O	-1	-1	0
economic	PMC4064952	36993	37001	O	-1	-1	0
evaluations	PMC4064952	37002	37013	O	-1	-1	0
.	PMC4064952	37013	37014	O	-1	-1	0

The	PMC4064952	37014	37017	O	-1	-1	0
manuscript	PMC4064952	37018	37028	O	-1	-1	0
management	PMC4064952	37029	37039	O	-1	-1	0
system	PMC4064952	37040	37046	O	-1	-1	0
is	PMC4064952	37047	37049	O	-1	-1	0
completely	PMC4064952	37050	37060	O	-1	-1	0
online	PMC4064952	37061	37067	O	-1	-1	0
and	PMC4064952	37068	37071	O	-1	-1	0
includes	PMC4064952	37072	37080	O	-1	-1	0
a	PMC4064952	37081	37082	O	-1	-1	0
very	PMC4064952	37083	37087	O	-1	-1	0
quick	PMC4064952	37088	37093	O	-1	-1	0
and	PMC4064952	37094	37097	O	-1	-1	0
fair	PMC4064952	37098	37102	O	-1	-1	0
peer	PMC4064952	37103	37107	O	-1	-1	0
-	PMC4064952	37107	37108	O	-1	-1	0
review	PMC4064952	37108	37114	O	-1	-1	0
system	PMC4064952	37115	37121	O	-1	-1	0
,	PMC4064952	37121	37122	O	-1	-1	0
which	PMC4064952	37123	37128	O	-1	-1	0
is	PMC4064952	37129	37131	O	-1	-1	0
all	PMC4064952	37132	37135	O	-1	-1	0
easy	PMC4064952	37136	37140	O	-1	-1	0
to	PMC4064952	37141	37143	O	-1	-1	0
use	PMC4064952	37144	37147	O	-1	-1	0
.	PMC4064952	37147	37148	O	-1	-1	0

Clinical	PMC4064952	37149	37157	O	-1	-1	0
Epidemiology	PMC4064952	37158	37170	O	-1	-1	0
2014:6	PMC4064952	37171	37177	O	-1	-1	0
submit	PMC4064952	37178	37184	O	-1	-1	0
your	PMC4064952	37185	37189	O	-1	-1	0
manuscript	PMC4064952	37190	37200	O	-1	-1	0
|	PMC4064952	37201	37202	O	-1	-1	0

www.dovepress.com	PMC4064952	37203	37220	O	-1	-1	0

Dovepress	PMC4064952	37221	37230	O	-1	-1	0

Dovepress	PMC4064952	37231	37240	O	-1	-1	0

Dovepress	PMC4064952	37241	37250	O	-1	-1	0

220	PMC4064952	37251	37254	O	-1	-1	0

Zoni	PMC4064952	37255	37259	O	-1	-1	0
-	PMC4064952	37259	37260	O	-1	-1	0
Berisso	PMC4064952	37260	37267	O	-1	-1	0

et	PMC4064952	37268	37270	O	-1	-1	0
al	PMC4064952	37271	37273	O	-1	-1	0

